[go: up one dir, main page]

WO2025079634A1 - Condensed ring compound, and harmful arthropod-controlling composition containing same - Google Patents

Condensed ring compound, and harmful arthropod-controlling composition containing same Download PDF

Info

Publication number
WO2025079634A1
WO2025079634A1 PCT/JP2024/036248 JP2024036248W WO2025079634A1 WO 2025079634 A1 WO2025079634 A1 WO 2025079634A1 JP 2024036248 W JP2024036248 W JP 2024036248W WO 2025079634 A1 WO2025079634 A1 WO 2025079634A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
optionally substituted
substituents selected
halogen atoms
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/JP2024/036248
Other languages
French (fr)
Japanese (ja)
Inventor
裕人 小幡
晃一郎 土田
美咲 西田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of WO2025079634A1 publication Critical patent/WO2025079634A1/en
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01M—CATCHING, TRAPPING OR SCARING OF ANIMALS; APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS
    • A01M29/00—Scaring or repelling devices, e.g. bird-scaring apparatus
    • A01M29/12—Scaring or repelling devices, e.g. bird-scaring apparatus using odoriferous substances, e.g. aromas, pheromones or chemical agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A01N65/12—Asteraceae or Compositae [Aster or Sunflower family], e.g. daisy, pyrethrum, artichoke, lettuce, sunflower, wormwood or tarragon
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/02—Acaricides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/04—Insecticides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Definitions

  • the present invention relates to a fused ring compound and a composition for controlling harmful arthropods that contains the same.
  • Patent Document 1 describes that certain compounds have a pest control effect.
  • the present invention aims to provide a compound that has excellent control effect against harmful arthropods.
  • Group A C1-C6 chain hydrocarbon group ⁇ the C1-C6 chain hydrocarbon group may be substituted with one or more substituents selected from the group consisting of a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom ⁇
  • a C3-C6 cycloalkyl group ⁇ the C3-C6 cycloalkyl group may be substituted with one or more substituents selected from the group consisting of a C1-C6 alkoxy group, a cyano group, and a halogen atom ⁇
  • a phenyl group optionally substituted with one or more substituents selected from Group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from Group B, OR 3a , SF 5 , NR 3d OR 3b , NR 3b C(O)R 3c , NR 3d
  • R 3a represents a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of a halogen atom and a cyano group, a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, C(O)R 3c , C(O)OR 3j , C(O)NR 3f R 3g , S(O) 2 R 3k , or a hydrogen atom;
  • R 3b represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom;
  • R 3c represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6
  • Group B a group consisting of C1-C6 chain hydrocarbon groups optionally substituted with one or more halogen atoms, C3-C6 cycloalkyl groups optionally substituted with one or more halogen atoms, C1-C6 alkoxy groups optionally substituted with one or more halogen atoms, cyano groups, hydroxy groups, and halogen atoms.
  • Group C a C3-C6 cycloalkyl group optionally substituted by one or more substituents selected from group E, a phenyl group optionally substituted by one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted by one or more substituents selected from group B, OR 3a , NR 3d OR 3b , NR 3b C(O)R 3c , NR 3d NR 3b C(O)R 3c , NR 3b C(O)OR 3e , NR 3d NR 3b C(O)OR 3e , NR 3b C(O ) NR 3f R 3g , NR 3d NR 3b C(O)NR 3f R 3g , N ⁇ S(O) p R 3h R 3i , C(O)R 3c , C(O) OR the group consisting of C(O)NR 3f R 3g , S(O) m R 3k ,
  • Group F a group consisting of a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from Group E, a phenyl group optionally substituted with one or more substituents selected from Group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from Group B, OR 3a , S(O) mR 3k , C(O)R 3c , C(O)OR 3j , C(O)NR 3fR 3g , NR 3bR 3c , NR 3bC (O)R 3c , NR 3bC (O)NR 3fR 3g , N ⁇ S(O) pR 3hR 3i , a 3- to 6-membered non-aromatic heterocyclic group, a cyano group, and a halogen atom.
  • compound N of the present invention or an N-oxide thereof (hereinafter, compound N of the present invention or an N-oxide thereof will be referred to as compound of the present invention).
  • R 3a is a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of halogen atoms and cyano groups, a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, C(O)R 3c , C(O)OR 3j , C(O)NR 3f R 3g , or a hydrogen atom.
  • L is a single bond, R 1 is a methyl group;
  • Q is a group represented by formula A1, a group represented by formula A2, or a group represented by formula A3;
  • Q1 is CR3q1 , Q2 is CR3q2 , and
  • Q3 is CR3q3 ;
  • R 3q1 , R 3q2 , and R 3q3 are the same or different and each is a methyl group, a halogen atom, or a hydrogen atom;
  • the combination of Q 1a and Q 2a is A combination in which Q 1a is CR 3q4 and Q 2a is CR 3q5 ; a combination in which Q 1a is a nitrogen atom and Q 2a is CR 3q5 ; or a combination in which Q 1a is CR 3q4 and Q 2a is a nitrogen atom, R 3q4 , R 3q5 and R 4 are the same or different and each is a methyl group, a halogen atom,
  • L is a single bond;
  • R 1 is a methyl group;
  • Q is a group represented by formula A1 or a group represented by formula A2,
  • Q1 is CR3q1
  • Q2 is CR3q2
  • Q3 is CR3q3 ;
  • R 3q1 , R 3q2 , and R 3q3 are a hydrogen atom;
  • R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group ⁇ the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom ⁇
  • X is NR10C (Z) R11 or NR10C (
  • a harmful arthropod control composition comprising the compound according to any one of [1] to [4] or an N-oxide thereof and an inert carrier.
  • a composition comprising one or more components selected from the group consisting of group (a), group (b), group (c), and group (d), and a compound or an N-oxide thereof according to any one of [1] to [4]: Group (a): A group consisting of insecticidal active ingredients, acaricidal active ingredients and nematicidal active ingredients; Group (b): bactericidal active ingredient; Group (c): plant growth regulating ingredients; Group (d): repellent components.
  • a method for controlling harmful arthropods comprising applying an effective amount of the compound according to any one of [1] to [4] or an N-oxide thereof, or an effective amount of the composition according to claim 6 to harmful arthropods or a habitat of harmful arthropods.
  • a seed or a vegetative reproductive organ carrying an effective amount of the compound according to any one of [1] to [4] or an N-oxide thereof, or an effective amount of the composition according to claim 6.
  • the present invention makes it possible to control harmful arthropods.
  • a halogen atom means a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom.
  • a substituent has two or more halogen atoms or substituents, those halogen atoms or substituents may be the same or different.
  • CX-CY means that the number of carbon atoms is X to Y.
  • C1-C6 means that the number of carbon atoms is 1 to 6.
  • the chain hydrocarbon group refers to an alkyl group, an alkenyl group, or an alkynyl group.
  • alkyl group examples include a methyl group, an ethyl group, a propyl group, an isopropyl group, a 1,1-dimethylpropyl group, a 1,2-dimethylpropyl group, a 1-ethylpropyl group, a butyl group, a sec-butyl group, a tert-butyl group, a pentyl group, and a hexyl group.
  • alkenyl group examples include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 1-methyl-1-propenyl group, a 1-methyl-2-propenyl group, a 1,2-dimethyl-1-propenyl group, a 1-ethyl-2-propenyl group, a 3-butenyl group, a 4-pentenyl group, and a 5-hexenyl group.
  • alkynyl group examples include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 1-methyl-2-propynyl group, a 1,1-dimethyl-2-propynyl group, a 1-ethyl-2-propynyl group, a 2-butynyl group, a 4-pentynyl group, and a 5-hexynyl group.
  • alkoxy groups include methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butoxy, pentyloxy, and hexyloxy groups.
  • Examples of the 5- or 6-membered aromatic heterocyclic group include a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group, an isoxazolyl group, a thiazolyl group, an isothiazolyl group, an oxadiazolyl group, a thiadiazolyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, and a pyrazinyl group.
  • Examples of the 9-membered aromatic heterocyclic group include a benzoxazolyl group, a benzoisoxazolyl group, a benzothiazolyl group, a benzoisothiazolyl group, and a triazolopyridyl group.
  • Examples of the 10-membered aromatic heterocyclic group include a quinolyl group, an isoquinolyl group, a quinazolinyl group, and a quinazolonyl group.
  • the (C3-C6 cycloalkyl)C1-C3 alkyl group optionally substituted with one or more halogen atoms refers to a group in which the (C3-C6 cycloalkyl) and/or (C1-C3 alkyl) may have one or more halogen atoms, and examples thereof include a cyclopropylmethyl group, a cyclopropylethyl group, a (2,2-difluorocyclopropyl)methyl group, a 2-cyclopropyl-1,1,2,2-tetrafluoroethyl group, and a 2-(2,2-difluorocyclopropyl)-1,1,2,2-tetrafluoroethyl group.
  • Examples of the phenyl C1-C3 alkyl group ⁇ the phenyl moiety in the phenyl C1-C3 alkyl group may be substituted with one or more substituents selected from group B ⁇ include a benzyl group, a 2-fluorobenzyl group, a 4-chlorobenzyl group, a 4-(trifluoromethyl)benzyl group, and a 2-[4-(trifluoromethyl)phenyl]ethyl group.
  • Examples of the 3- to 6-membered non-aromatic heterocyclic group include an oxetanyl group, a pyrrolidinyl group, a 2-oxopyrrolidinyl group, a 2-oxoimidazolidinyl group, a 3,4,5,6-tetrahydro-2-pyrimidinyl group, a tetrahydrofuranyl group, a piperidyl group, a tetrahydropyranyl group, an isoxazolidinyl group, and a morpholinyl group.
  • alkylsulfonyl group examples include a methylsulfonyl group, an ethylsulfonyl group, a propylsulfonyl group, and an isopropylsulfonyl group.
  • cycloalkylsulfonyl group examples include a cyclopropylsulfonyl group, a cyclobutylsulfonyl group, and a cyclohexylsulfonyl group.
  • Cycloalkyl groups include, for example, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl groups.
  • the N-oxide of the compound represented by formula (I) means a structure in which at least one nitrogen atom contained in the compound represented by formula (I) is substituted with an oxo group.
  • Compound N of the present invention may form an acid addition salt.
  • acids that form acid addition salts include inorganic acids such as hydrogen chloride, phosphoric acid, and sulfuric acid, and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid. Acid addition salts can be obtained, for example, by mixing compound N of the present invention with an acid.
  • Q is a group represented by formula A1-1, a group represented by formula A1-2, a group represented by formula A2-1, a group represented by formula A2-2, a group represented by formula A2-3, a group represented by formula A3-1, a group represented by formula A3-2, a group represented by formula A4-1, a group represented by formula A4-2, or a group represented by formula A5-1 (# represents a bonding site to R2 , and ⁇ represents a bonding site to a carbon atom), and R 3q1 , R 3q2 , R 3q3 , R 3q4 , R 3q5 and R Compounds in which 4 is the same or different and is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituent
  • a compound of the present invention N in which L is a single bond or -(CR 4a R 4b ) n -, R 4a and R 4b are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, and n is 1, 2, or 3.
  • R 4a and R 4b are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, and n is 1, 2, or 3.
  • n is 1, 2, or 3.
  • a compound of the present invention in which R 1 in compound N is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
  • R 1 in compound N is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
  • R 1 is a methyl group.
  • R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
  • Aspect 15 The compound according to aspect 2, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
  • R 2 is a phenyl group, a 5- or 6-membered aromatic heterocyclic group ⁇ the phenyl group and the 5- or 6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom ⁇ , C(O)NR 6 R 7 , NR 16 C(O)R 17 , NR 16 C(O)OR 17 , NR 16 C(O)NR 17 R 18 , OR 18 , a group represented by formula E1-1, a group represented by formula E1-2,
  • R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group ⁇ the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom ⁇ , C( ⁇ NOR 9 )R 5 , C( ⁇ NOR 9 )
  • R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group ⁇ the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group are optionally substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom ⁇ , C( ⁇ NOR 9 )R 5 , C( ⁇ NOR 9
  • R 2 is a phenyl group, a 5- or 6-membered aromatic heterocyclic group ⁇ the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom ⁇ , C(O)NR 6 R 7 , NR 16 C(O)R 17 , OR 18 , a group represented by formula E1-1, a group represented by formula E1-2, a group represented by formula E2-1, a group represented by formula E2-2, a group represented by formula E
  • X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1
  • X 1 is a 9- or 10-membered aromatic heterocyclic group ⁇ the 9- or 10-membered aromatic heterocyclic group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • a cyclopropyl group ⁇ the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1
  • X 1 is a 9- or 10-membered aromatic heterocyclic group ⁇ the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • a cyclopropyl group ⁇ the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1
  • X 1 is a 9- or 10-membered aromatic heterocyclic group ⁇ the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • a cyclopropyl group ⁇ the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1
  • X 1 is a 9- or 10-membered aromatic heterocyclic group ⁇ the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • a cyclopropyl group ⁇ the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1
  • X 1 is a 9- or 10-membered aromatic heterocyclic group ⁇ the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • a cyclopropyl group ⁇ the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1
  • X 1 is a 9- or 10-membered aromatic heterocyclic group ⁇ the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • a cyclopropyl group ⁇ the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group or a pyrazolyl group ⁇ the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group or a pyrazolyl group ⁇ the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 , or NR 10 C(O)NR 11 R 12
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 , or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group ⁇ the phenyl group, the pyridyl group, and the pyrazolyl group are optionally substituted with a cyclopropyl group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group, and a halogen atom ⁇
  • X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group or a pyrazolyl group ⁇ the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group or a pyrazolyl group ⁇ the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group or a pyrazolyl group ⁇ the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group and a halogen atom ⁇
  • X is NR 10 C(O)R 11
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 , or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group ⁇ the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group, and a halogen
  • X is NR 10 C(O)R 11
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 , or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group ⁇ the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group, and a halogen atom ⁇
  • R 13 is a C1-C3 alkyl group
  • OR 14
  • X is NR 10 C(O)R 11
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 , or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group ⁇ the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group, and a halogen atom ⁇
  • R 13 is a C1-C3 alkyl group
  • OR 14
  • X is NR 10 C(O)R 11
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 , or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group ⁇ the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group, and a halogen atom ⁇
  • R 13 is a C1-C3
  • X is NR 10 C(O)R 11
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 , or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group ⁇ the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group, and a halogen atom ⁇
  • R 13 is a C1-C3
  • X is NR 10 C(O)R 11
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 , or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group ⁇ the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group, and a halogen atom ⁇
  • R 13 is a C1-C3
  • Aspect 66 A compound according to any one of Aspects 1 to 36 or compound N of the present invention, wherein R 2 is a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group A, X is NR 11 C(O)R 12 , R 11 is a C1-C6 alkyl group optionally substituted with one or more substituents selected from group F, and R 12 is a phenyl group optionally substituted with one or more substituents selected from group A.
  • Q is a group represented by formula A3-3 (# represents the bonding site to R2 , and ⁇ represents the bonding site to a carbon atom), and R3q5 and R4 are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom.
  • R3q5 and R4 are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom.
  • a compound in aspect A4, wherein R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group ⁇ the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, NR 3b C(O)R 3c , C(O)NR 3f R 3g , a cyano group, and a halogen atom ⁇ .
  • X is NR 10 C(O)R 11
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 , or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group ⁇ the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group, and a halogen atom ⁇
  • R 13 is a C1-C3
  • Aspect A7 The compound in Aspect A4, wherein X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group or a hydrogen atom, and R 11 is a phenyl group ⁇ the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, a C1-C3 alkoxy group substituted with one or more halogen atoms, a cyano group, and a halogen atom ⁇ .
  • X is NR 10 C(O)R 11
  • R 10 is a C1-C3 alkyl group
  • OR 14 C(O)R 13 , C(O)OR 13 , or a hydrogen atom
  • R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group ⁇ the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group
  • a C1-C3 alkyl group ⁇ the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom ⁇
  • OR 3a S(O) m R 3k , a cyano group, and a halogen atom ⁇
  • R 13 is a C1-C3
  • A9 The compound in Aspect A5, wherein X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group or a hydrogen atom, and R 11 is a phenyl group ⁇ the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, a C1-C3 alkoxy group substituted with one or more halogen atoms, a cyano group, and a halogen atom ⁇ .
  • the compound represented by formula (I-1) (hereinafter referred to as compound (I-1)) can be produced by reacting a compound represented by formula (I-2) (hereinafter referred to as compound (I-2)) with a compound represented by formula (I-3) (hereinafter referred to as compound (I-3)).
  • a solvent for example, ethers such as tetrahydrofuran (hereinafter referred to as THF), 1,4-dioxane, 1,2-dimethoxyethane, methyl tert-butyl ether, diethyl ether, etc.
  • ethers halogenated hydrocarbons such as dichloromethane, chloroform, etc.
  • halogenated hydrocarbons such as dichloromethane, chloroform, etc.
  • nitriles such as acetonitrile, etc.
  • aromatic hydrocarbons such as toluene, xylene, etc.
  • aromatic hydrocarbons aprotic polar solvents such as N-methylpyrrolidone (hereinafter referred to as NMP), N,N-dimethylformamide (hereinafter referred to as DMF), etc.
  • NMP N-methylpyrrolidone
  • DMF N,N-dimethylformamide
  • aprotic polar solvents aprotic polar solvents
  • the reaction can be carried out using a base as necessary, for example, organic bases such as triethylamine, N,N-diisopropylethylamine, pyridine, 4-(dimethylamino)pyridine (hereinafter referred to as organic bases), and alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate (hereinafter referred to as alkali metal carbonates).
  • organic bases such as triethylamine, N,N-diisopropylethylamine, pyridine, 4-(dimethylamino)pyridine (hereinafter referred to as organic bases), and alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate (hereinafter referred to as alkali metal carbonates).
  • compound (I-3) is usually used in a ratio of 1 to 10 moles per mole of compound (I-2).
  • the reaction temperature is usually in the range of 0° C. to 200° C.
  • the reaction time is usually in
  • compound (I-3) is a commercially available compound or can be prepared using known methods.
  • the compound represented by formula (I) (i.e., compound N of the present invention) can be produced by reacting a compound represented by formula (I-8) (hereinafter referred to as compound (I-8)) with a compound represented by formula (IM) (hereinafter referred to as compound (IM)).
  • X a represents a chlorine atom, a bromine atom, or an iodine atom
  • M A represents a 9-borabicyclo[3.3.1]nonan-9-yl group, a borono group, a 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group, or a tributylstannyl group, and the other symbols have the same meanings as above.
  • the reaction is usually carried out in a solvent, such as ethers, aromatic hydrocarbons, aprotic polar solvents, water, and mixtures of two or more thereof.
  • the metal catalyst examples include palladium catalysts such as tetrakis(triphenylphosphine)palladium(0), 1,1'-bis(diphenylphosphino)ferrocenepalladium(II) dichloride, tris(dibenzylideneacetone)dipalladium(0), palladium(II) acetate, etc.; nickel catalysts such as bis(cyclooctadiene)nickel(0), nickel(II) chloride, etc.; iron catalysts such as iron(III) chloride, iron(III) acetylacetonate, etc.; copper catalysts such as copper(I) iodide, copper(I) chloride, etc.; and combinations of two or more of these.
  • palladium catalysts such as tetrakis(triphenylphosphine)palladium(0), 1,1'-bis(diphenylphosphino)ferrocenepalladium(II) dichloride, tris(di
  • the reaction may, if necessary, use a ligand, a base, and/or an inorganic halide.
  • the ligand include triphenylphosphine, xantphos, 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 1,1'-bis(diphenylphosphino)ferrocene, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 1,2-bis(diphenylphosphino)ethane, 2,2'-bipyridine, 2-aminoethanol, 8-hydroxyquinoline, and 1,10-phenanthroline.
  • the bases include alkali metal carbonates and organic bases.
  • Inorganic halides include alkali metal fluorides such as potassium fluoride and sodium fluoride; and alkali metal chlorides such as lithium chloride and sodium chloride.
  • compound (IM) is usually used in a ratio of 1 to 10 moles and metal catalyst is usually used in a ratio of 0.01 to 0.5 moles per mole of compound (I-8).
  • metal catalyst is usually used in a ratio of 0.01 to 0.5 moles per mole of compound (I-8).
  • the ligand is usually used in a ratio of 0.01 to 1 mole per mole of compound (I-8).
  • the base is usually used in a ratio of 0.1 to 5 moles per mole of compound (I-8).
  • the inorganic halide When an inorganic halide is used in the reaction, the inorganic halide is usually used in a ratio of 0.1 to 5 moles per mole of compound (I-8).
  • the reaction temperature is usually in the range of ⁇ 20° C. to 200° C.
  • the reaction time is usually in the range of 0.1 to 72 hours.
  • the compound N of the present invention can be obtained by carrying out post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer.
  • Compounds (IM) are commercially available compounds or can be prepared using known methods.
  • the reaction can also be carried out in accordance with, for example, the method described in Example H2 of WO 2020/070049.
  • the compound represented by formula (I-1A) (hereinafter referred to as compound (I-1A)) can be produced by reacting a compound represented by formula (I-2A) (hereinafter referred to as compound (I-2A)) with a compound represented by formula (M-g) (hereinafter referred to as compound (M-g)) in the presence of an acid.
  • X represents a leaving group such as a chlorine atom
  • Boc represents a tert-butoxycarbonyl group
  • the other symbols have the same meanings as above.
  • the reaction is usually carried out in a solvent, which may include ethers, halogenated hydrocarbons, aromatic hydrocarbons, nitriles, aprotic polar solvents, water, and mixtures of two or more thereof.
  • the acid used in the reaction includes, for example, trifluoroacetic acid and hydrogen chloride.
  • hydrogen chloride a solution of hydrogen chloride such as hydrochloric acid or a hydrogen chloride/methanol solution may be used in the reaction.
  • the reaction can be carried out, for example, by first mixing compound (I-2A) with an acid, then distilling off the acid, and mixing compound (Mg).
  • a base can be used as necessary.
  • the base include organic bases.
  • the base is usually used in a ratio of 1 to 10 moles per mole of compound (I-2A).
  • compound (Mg) is usually used in a ratio of 1 to 2 moles and acid is usually used in a ratio of 1 to 100 moles, relative to 1 mole of compound (I-2A).
  • the reaction temperature is usually within the range of ⁇ 20 to 200° C.
  • the reaction time is usually within the range of 0.1 to 24 hours.
  • Compound (Mg) is a commercially available compound or can be prepared using known methods.
  • Compound (I-1A) can also be produced by reacting compound (I-2A) with a compound represented by formula (Me) (hereinafter referred to as compound (Me)) in the presence of a condensing agent and an acid.
  • a condensing agent for reacting compound (I-2A) with a compound represented by formula (Me) (hereinafter referred to as compound (Me)) in the presence of a condensing agent and an acid.
  • a solvent which may include ethers, halogenated hydrocarbons, aromatic hydrocarbons, nitriles, esters such as ethyl acetate and butyl acetate (hereinafter referred to as esters), aprotic polar solvents, nitrogen-containing aromatic compounds such as pyridine, picoline, lutidine, and quinoline (hereinafter referred to as nitrogen-containing aromatic compounds), and mixtures of two or more of these.
  • a solvent which may include ethers, halogenated hydrocarbon
  • the acid used in the reaction includes, for example, trifluoroacetic acid and hydrogen chloride.
  • hydrogen chloride a solution of hydrogen chloride such as hydrochloric acid or a hydrogen chloride/methanol solution may be subjected to the reaction.
  • the reaction can be carried out, for example, by first mixing compound (I-2A) with an acid, then distilling off the acid, and mixing compound (Me) with a condensing agent.
  • Condensing agents used in the reaction include, for example, carbodiimides such as 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride and 1,3-dicyclohexylcarbodiimide.
  • a catalyst may be used in the reaction, if necessary.
  • An example of the catalyst is 1-hydroxybenzotriazole.
  • the catalyst is usually used in a ratio of 0.01 to 0.5 moles per mole of compound (I-2A).
  • a base can be used as necessary.
  • the base include organic bases.
  • the base is usually used in a ratio of 1 to 5 moles per mole of compound (I-2A).
  • compound (Me) is usually used in a ratio of 1 to 2 moles
  • a condensing agent is usually used in a ratio of 1 to 5 moles
  • an acid is usually used in a ratio of 1 to 100 moles, relative to 1 mole of compound (I-2A).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 48 hours.
  • the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-1A).
  • Compound (Me) is a commercially available compound or can be prepared using known methods.
  • Compound (I-1A) can also be produced by reacting a compound represented by formula (I-11) (hereinafter referred to as compound (I-11)) with compound (I-3). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 1, except that compound (I-11) is used in place of compound (I-2).
  • Compound (I-1A) can also be produced by reacting compound (I-11) with compound (Me) in the presence of a condensing agent.
  • a condensing agent In the formula, the symbols have the same meanings as defined above.
  • the reaction is usually carried out in a solvent.
  • the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, esters, nitriles, aprotic polar solvents, nitrogen-containing aromatic compounds, and mixtures of two or more of these.
  • Condensing agents used in the reaction include, for example, carbodiimides such as 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride and 1,3-dicyclohexylcarbodiimide.
  • a catalyst may be used in the reaction, if necessary.
  • An example of the catalyst is 1-hydroxybenzotriazole.
  • the catalyst is usually used in a ratio of 0.01 to 0.5 moles per mole of compound (I-11).
  • a base can be used as necessary. Examples of the base include organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 5 moles per mole of compound (I-11).
  • compound (Me) is usually used in a ratio of 1 to 2 moles and a condensing agent is usually used in a ratio of 1 to 5 moles, relative to 1 mole of compound (I-11).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 48 hours. After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-1A).
  • the compound represented by formula (I-1B) (hereinafter referred to as compound (I-1B)) can be produced by reacting a compound represented by formula (I-2B) (hereinafter referred to as compound (I-2B)) with compound (I-3). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 1, except that compound (I-2B) is used in place of compound (I-2).
  • Production method 8 Compound (I-1B) can also be produced by reacting compound (I-2B) with compound (Me) in the presence of a condensing agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 6, except for using compound (I-2B) instead of compound (I-11).
  • Production method 9 Compound (I-1) can also be produced by reacting a compound represented by formula (I-20) (hereinafter referred to as compound (I-20)) with compound (IM). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 2, except that compound (I-20) is used in place of compound (I-8).
  • the compound represented by formula (II-1) (hereinafter referred to as compound (II-1)) can be produced by reacting a compound represented by formula (II-2) (hereinafter referred to as compound (II-2)) with compound (I-3). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 1, except that compound (II-2) is used in place of compound (I-2).
  • Compound (II-1) can also be produced by reacting compound (II-2) with compound (Me) in the presence of a condensing agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 6, except that compound (II-2) is used in place of compound (I-11).
  • Compound (II-1) can also be produced by reacting a compound represented by formula (II-19) (hereinafter referred to as compound (II-19)) with compound (IM). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 2, except that compound (II-19) is used in place of compound (I-8).
  • the compound represented by formula (II-1A) (hereinafter referred to as compound (II-1A)) can be produced by reacting a compound represented by formula (II-3A) (hereinafter referred to as compound (II-3A)) with compound (I-3) in the presence of an acid.
  • a compound represented by formula (II-3A) (hereinafter referred to as compound (II-3A))
  • compound (I-3) in place of compound (Mg).
  • Compound (I-2) can be produced from a compound represented by formula (I-4) (hereinafter referred to as compound (I-4)). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION, p. 727.
  • Compound (I-2) may form an acid addition salt.
  • acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.
  • Compound (I-4) can be produced by reacting a compound represented by formula (I-5) (hereinafter referred to as compound (I-5)) with compound (IM). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 2, except that compound (I-5) is used in place of compound (I-8).
  • Compound (I-5) can be produced by reacting a compound represented by formula (I-6) (hereinafter referred to as compound (I-6)) with a halogenating agent.
  • a compound represented by formula (I-6) hereinafter referred to as compound (I-6)
  • a halogenating agent for example, acetyl alcohol, acetyl ether, benzyl ether, benzyl ether, benzyl, nitriles, ethers, aromatic hydrocarbons, aprotic polar solvents, halogenated hydrocarbons, water, and mixtures thereof.
  • a solvent for example, alcohols such as methanol and ethanol (hereinafter referred to as alcohols), nitriles, ethers, aromatic hydrocarbons, aprotic polar solvents, halogenated hydrocarbons, water, and mixtures thereof.
  • halogenating agent examples include chlorine, bromine, iodine, N-chlorosuccinimide, N-bromosuccinimide, and N-iodosuccinimide (hereinafter referred to as NIS).
  • a base can be used as necessary.
  • the base include alkali metal carbonates.
  • the base is usually used in a ratio of 1 to 10 moles per mole of compound (I-6).
  • the halogenating agent is usually used in a ratio of 1 to 10 moles per mole of compound (I-6).
  • the reaction temperature is usually in the range of ⁇ 20° C. to 200° C.
  • the reaction time is usually in the range of 0.1 to 72 hours. After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-5).
  • Compound (I-6) can be produced from a compound represented by formula (I-7) (hereinafter referred to as compound (I-7)). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out, for example, according to the method described in Intermediate 23 of WO 2007/147794 or Example 5 of WO 2003/037900.
  • Compound (I-7) is a commercially available compound or can be prepared using known methods.
  • Compound (I-9) can be produced from a compound represented by formula (I-7A) (hereinafter referred to as compound (I-7A)) and a compound represented by formula (IA) (hereinafter referred to as compound (IA)).
  • compound (I-7A) a compound represented by formula (IA)
  • the symbols have the same meanings as defined above.
  • the reaction can be carried out, for example, according to the method described in International Publication No. 2007/147794, Intermediate 23.
  • Reference Manufacturing Method 6 Compound (I-8) can be produced by reacting compound (I-10) with a halogenating agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 3, except for using compound (I-10) instead of compound (I-6).
  • Compound (I-11) can be produced from a compound represented by formula (I-2A) (hereinafter referred to as compound (I-2A)). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION, p. 727.
  • Compound (I-11) may form an acid addition salt.
  • acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.
  • Compound (I-2A) can be produced by reacting a compound represented by formula (I-12) (hereinafter referred to as compound (I-12)) with compound (IM). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 2, except that compound (I-12) is used in place of compound (I-8).
  • Compound (I-12) can be produced by reacting a compound represented by formula (I-13) (hereinafter referred to as compound (I-13)) with a halogenating agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 3, except for using compound (I-13) instead of compound (I-6).
  • Compound (I-13) is a commercially available compound or can be prepared using known methods.
  • Compound (I-2) can also be produced from a compound represented by formula (I-4B) (hereinafter referred to as compound (I-4B)).
  • compound (I-4B) a compound represented by formula (I-4B)
  • Cbz represents a benzyloxycarbonyl group, and the other symbols have the same meanings as defined above.
  • the reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION p. 750.
  • Compound (I-2) may form an acid addition salt.
  • acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.
  • Compound (I-4B) can be produced by reacting a compound represented by formula (I-5B) (hereinafter referred to as compound (I-5B)) with compound (IM). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 2, except that compound (I-5B) is used in place of compound (I-8).
  • Reference Manufacturing Method 3-1 Compound (I-5B) can be produced by reacting a compound represented by formula (I-6B) (hereinafter referred to as compound (I-6B)) with a halogenating agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 3, except for using compound (I-6B) instead of compound (I-6).
  • Compound (I-6B) can be produced from a compound represented by formula (I-7B) (hereinafter referred to as compound (I-7B)).
  • compound (I-7B) a compound represented by formula (I-7B) (hereinafter referred to as compound (I-7B)).
  • the reaction may be carried out, for example, according to the method described in WO 2007/147794 Intermediate 23, the method described in WO 2003/037900 Example 5, the method described in WO 2007/134362 Example 1, the method described in WO 2021/158634 Intermediate BMR step 1, or Huaxue Xuebao (2005), 63 (9), 855-860.
  • Compound (I-7B) can be produced from a compound represented by formula (I-14B) (hereinafter referred to as compound (I-14B)). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out, for example, in accordance with the method described in WO 2016/148145, Example 1-1, Step 1-1-3.
  • Compound (I-14B) can be produced from a compound represented by formula (I-14A) (hereinafter referred to as compound (I-14A)). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out, for example, according to the method described in Inventive Example 25 of US Patent Application Publication No. 2002/6387938. Compound (I-14A) is a commercially available compound or can be prepared using known methods.
  • Compound (I-2B) can be produced by reacting a compound represented by formula (I-15) (hereinafter, compound (I-15) with an amine or an ammonium salt, and a reducing agent.
  • a compound represented by formula (I-15) hereinafter, compound (I-15)
  • an amine or an ammonium salt and a reducing agent.
  • the reaction is usually carried out in a solvent.
  • the solvent used in the reaction include alcohols, ethers, aprotic polar solvents, and mixtures thereof.
  • the amines include methylamine and ethylamine.
  • the ammonium salt includes ammonium acetate and the like.
  • an acid can be used as necessary. Examples of the acid include organic acids such as acetic acid.
  • the acid When an acid is used in the reaction, the acid is usually used in a ratio of 0.1 to 10 moles per mole of compound (I-15).
  • the reducing agent In the reaction, the reducing agent is usually used in a ratio of 1 to 10 moles per mole of compound (I-15).
  • the reaction temperature is usually in the range of ⁇ 20° C. to 200° C.
  • the reaction time is usually in the range of 0.1 to 72 hours.
  • compound (I-2B) can be obtained by carrying out post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer.
  • Compound (I-15) can be produced by reacting a compound represented by formula (I-16) (hereinafter referred to as compound (I-16)) with a compound represented by formula (M-f) (hereinafter referred to as compound (M-f)).
  • Xd represents a chlorine atom, a bromine atom, or an iodine atom, and the other symbols have the same meanings as defined above.
  • the reaction is usually carried out in a solvent, such as, for example, ethers, aromatic hydrocarbons, aprotic polar solvents, and mixtures of two or more thereof.
  • compound (Mf) is usually used in a ratio of 1 to 10 moles per mole of compound (I-16).
  • the reaction temperature is usually in the range of ⁇ 20° C. to 200° C.
  • the reaction time is usually in the range of 0.1 to 72 hours.
  • the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-15).
  • Compound (Mf) is a commercially available compound or can be prepared using known methods.
  • Compound (I-16) can be produced by reacting a compound represented by formula (I-17) (hereinafter referred to as compound (I-17)) with compound (IM). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 2, except that compound (I-17) is used in place of compound (I-8).
  • Compound (I-17) can be produced by reacting a compound represented by formula (I-18) (hereinafter referred to as compound (I-18)) with a compound represented by formula (M-g) (hereinafter referred to as compound (M-g)) in the presence of a condensing agent.
  • a compound represented by formula (I-18) hereinafter referred to as compound (I-18)
  • M-g compound represented by formula (M-g)
  • a condensing agent In the formula, the symbols have the same meanings as defined above.
  • the reaction is usually carried out in a solvent.
  • the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, esters, nitriles, aprotic polar solvents, nitrogen-containing aromatic compounds, and mixtures of two or more of these.
  • the condensing agent used in the reaction includes, for example, 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate.
  • a base can be used as necessary.
  • the base include organic bases.
  • the base is usually used in a ratio of 1 to 10 moles per mole of compound (I-18).
  • compound (Mg) is usually used in a ratio of 1 to 3 mol and a condensing agent is usually used in a ratio of 1 to 5 mol, relative to 1 mol of compound (I-18).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 48 hours. After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-17).
  • Compound (I-18) can be produced by subjecting a compound represented by formula (I-19) (hereinafter referred to as compound (I-19)) to hydrolysis reaction in the presence of a base.
  • a compound represented by formula (I-19) hereinafter referred to as compound (I-19)
  • the reaction is carried out in the presence of a base, water and an organic solvent, such as ethers, nitriles, alcohols, and mixtures thereof.
  • the base used in the reaction includes, for example, alkali metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide, etc.
  • the reaction time is usually in the range of 5 minutes to 72 hours, and the reaction temperature is usually in the range of 0° C. to 100° C.
  • the amount of the base used in the reaction can be any amount from 1 mole to an excess amount, and is preferably 1 to 5 moles, per mole of compound (I-19).
  • the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-18).
  • Compound (I-19) is a commercially available compound or can be prepared using known methods.
  • the compound represented by formula (I-20) (hereinafter referred to as compound (I-20)) can be produced by reacting a compound represented by formula (I-21) (hereinafter referred to as compound (I-21)) with a halogenating agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 3, except for using compound (I-21) instead of compound (I-6).
  • Compound (I-21) can be produced by reacting a compound represented by formula (I-22) (hereinafter referred to as compound (I-22)) with compound (I-3). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 1, except that compound (I-22) is used in place of compound (I-2).
  • Reference Manufacturing Method 18 Compound (I-21) can also be produced by reacting compound (I-22) with compound (Me) in the presence of a condensing agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 6, except that compound (I-22) is used in place of compound (I-11).
  • Compound (I-22) can be produced by reacting a compound represented by formula (I-23) (hereinafter, compound (I-23) with an amine or an ammonium salt, and a reducing agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 11, except for using compound (I-23) instead of compound (I-15).
  • Compound (I-23) can be produced by reacting a compound represented by formula (I-24) (hereinafter referred to as compound (I-24)) with compound (Mf). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 12, except for using compound (I-24) instead of compound (I-16).
  • Compound (I-24) can be produced by reacting a compound represented by formula (I-25) (hereinafter referred to as compound (I-25)) with compound (Mg) in the presence of a Lewis acid.
  • a Lewis acid In the formula, the symbols have the same meanings as defined above.
  • the reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, aprotic polar solvents, and mixtures of two or more of these.
  • the Lewis acid used in the reaction includes, for example, trimethylaluminum. In the reaction, the Lewis acid is usually used in a proportion of 0.1 to 5 moles per mole of compound (I-25).
  • compound (Mg) is usually used in a ratio of 1 to 5 moles per mole of compound (I-25).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 48 hours.
  • the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-24).
  • Compound (I-25) is a commercially available compound or can be prepared using known methods.
  • Compound (II-2) can be produced from a compound represented by formula (II-3) (hereinafter referred to as compound (II-3)).
  • compound (II-3) a compound represented by formula (II-3)
  • PG represents a tert-butoxycarbonyl group or a benzyloxycarbonyl group, and the other symbols have the same meanings as defined above.
  • the reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION, p. 727 or p. 750.
  • Compound (II-2) may form an acid addition salt.
  • acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.
  • Compound (II-3) can be produced by reacting a compound represented by formula (II-4) (hereinafter referred to as compound (II-4)) with a compound represented by formula (M-h) (hereinafter referred to as compound (M-h)) in the presence of an acid.
  • a compound represented by formula (II-4) hereinafter referred to as compound (II-4)
  • a compound represented by formula (M-h) hereinafter referred to as compound (M-h)
  • the reaction is usually carried out in a solvent.
  • the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, esters, nitriles, aprotic polar solvents, and mixtures of two or more of these.
  • the acid used in the reaction includes organic acids such as trifluoroacetic acid and acetic acid.
  • the acid is usually used in a proportion of 0.1 to 100 moles per mole of compound (II-4).
  • a base can be used as necessary. Examples of the base include organic bases.
  • the base is usually used in a ratio of 1 to 10 moles per mole of compound (II-4).
  • compound (Mh) is usually used in an amount of 1 to 10 moles per mole of compound (II-4).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 48 hours. After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-3).
  • Compound (II-4) can be produced by reacting a compound represented by formula (II-5) (hereinafter referred to as compound (II-5)) with a hydrazine.
  • a compound represented by formula (II-5) hereinafter referred to as compound (II-5)
  • Xb represents a chlorine atom or a bromine atom, and the other symbols have the same meanings as defined above.
  • the reaction is usually carried out in a solvent, for example, ethers, halogenated hydrocarbons, aromatic hydrocarbons, alcohols, aprotic polar solvents, water, and mixtures of two or more of these.
  • the hydrazines used in the reaction include anhydrous hydrazine, hydrazine monohydrate, hydrazine monohydrochloride, and the like.
  • the hydrazine is usually used in an amount of 1 to 10 moles per mole of compound (II-5).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 48 hours. After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-4).
  • Compound (II-5) can be produced by reacting a compound represented by formula (II-6) (hereinafter referred to as compound (II-6)) with a halogenating agent.
  • a compound represented by formula (II-6) hereinafter referred to as compound (II-6)
  • the reaction is usually carried out in a solvent.
  • the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, nitriles, aprotic polar solvents, nitrogen-containing aromatic compounds, and mixtures of two or more of these.
  • the halogenating agent used in the reaction includes phosphorus oxychloride and the like.
  • the halogenating agent is usually used in a ratio of 1 to 10 moles per mole of compound (II-6).
  • a base can be used as necessary.
  • the base include organic bases.
  • the base is usually used in a ratio of 1 to 10 moles per mole of compound (II-6).
  • a quaternary ammonium salt can be used as necessary.
  • the quaternary ammonium salt include triethylbenzylammonium chloride.
  • the quaternary ammonium salt is usually used in a ratio of 0.1 to 5 moles per mole of compound (II-6).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 48 hours.
  • Compound (II-6) can be produced by reacting a compound represented by formula (II-7) (hereinafter referred to as compound (II-7)) with compound (IM). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 2, except that compound (II-7) is used in place of compound (I-8).
  • Compound (II-7) can be produced by reacting a compound represented by formula (II-8) (hereinafter referred to as compound (II-8)) with a halogenating agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 3, except that compound (II-8) is used in place of compound (I-6).
  • Compound (II-8) can be produced by reacting a compound represented by formula (II-9) (hereinafter referred to as compound (II-9)) with a compound represented by formula (Mi) (hereinafter referred to as compound (Mi)).
  • a compound represented by formula (Mi) hereinafter referred to as compound (Mi)
  • R y represents a C1-C4 alkyl group, and the other symbols have the same meanings as defined above.
  • the reaction is usually carried out in a solvent, such as alcohols, ethers, aromatic hydrocarbons, nitriles, aprotic polar solvents, halogenated hydrocarbons, and mixtures of two or more of these.
  • compound (Mi) is usually used in a ratio of 1 to 5 moles per mole of compound (II-9).
  • a base can be used as necessary.
  • the base include alkali metal alkoxides such as sodium methoxide and sodium ethoxide; alkali metal carbonates; and organic bases.
  • the base is usually used in a ratio of 1 to 10 moles per mole of compound (II-9).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound represented by formula (II-10) (hereinafter referred to as compound (II-10)) can be produced by reacting a compound represented by formula (II-11) (hereinafter referred to as compound (II-11)) with a halogenating agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 3, except that compound (II-11) is used in place of compound (I-6).
  • Reference Manufacturing Method 30 Compound (II-11) can be produced by reacting a compound represented by formula (II-12) (hereinafter referred to as compound (II-12)) with compound (Mh) in the presence of an acid. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 23, except for using compound (II-12) instead of compound (II-4).
  • Compound (II-12) can be produced by reacting a compound represented by formula (II-13) (hereinafter referred to as compound (II-13)) with a hydrazine. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 24, except for using compound (II-13) instead of compound (II-5).
  • Reference Manufacturing Method 32 Compound (II-13) can be produced by reacting compound (II-8) with a halogenating agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 25, except for using compound (II-8) instead of compound (II-6).
  • Compound (II-3A) can be produced by reacting a compound represented by formula (II-14) (hereinafter referred to as compound (II-14)) with compound (IM). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 2, except that compound (II-14) is used in place of compound (I-8).
  • Compound (II-14) can be produced by reacting a compound represented by formula (II-15) (hereinafter referred to as compound (II-15)) with a compound represented by formula (M-j) (hereinafter referred to as compound (M-j)).
  • Xc represents a chlorine atom, a bromine atom, or an iodine atom
  • Rz represents a C1-C3 alkyl group, and the other symbols have the same meanings as defined above.
  • the reaction is usually carried out in a solvent, such as ethers, aromatic hydrocarbons, aprotic polar solvents, halogenated hydrocarbons, and mixtures of two or more of these.
  • compound (Mj) is usually used in a ratio of 1 to 5 moles per mole of compound (II-15).
  • an acid can be used as necessary.
  • the acid include organic acids such as acetic acid and p-toluenesulfonic acid.
  • the acid is usually used in a ratio of 0.1 to 100 moles per mole of compound (II-15).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 48 hours. After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-14).
  • Compound (II-15) can be produced from a compound represented by formula (II-16) (hereinafter referred to as compound (II-16)).
  • PG 1 represents a 2,4,6-trimethoxyphenylmethyl group, a 2,4-dimethoxyphenylmethyl group, or a 4-methoxyphenylmethyl group, and the other symbols have the same meanings as above.
  • the reaction is usually carried out in a solvent, such as ethers, alcohols, aromatic hydrocarbons, aprotic polar solvents, halogenated hydrocarbons, water, and mixtures of two or more of these.
  • an acid can be used as necessary.
  • the acid examples include inorganic acids such as hydrochloric acid, and organic acids such as trifluoroacetic acid and p-toluenesulfonic acid.
  • the acid is usually used in a ratio of 0.1 to 100 moles per mole of compound (II-16).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 72 hours. After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-15).
  • Compound (II-16) can be produced by reacting a compound represented by formula (II-17) (hereinafter referred to as compound (II-17)) with a compound represented by formula (M-k) (hereinafter referred to as compound (M-k)).
  • a solvent such as ethers, aromatic hydrocarbons, aprotic polar solvents, nitriles, halogenated hydrocarbons, and mixtures of two or more of these.
  • compound (Mk) is usually used in a ratio of 1 to 5 moles per mole of compound (II-17).
  • a base can be used as necessary.
  • Examples of the base include alkali metal carbonates and organic bases.
  • the base is usually used in a ratio of 0.1 to 10 moles per mole of compound (II-17).
  • the reaction temperature is usually in the range of ⁇ 20 to 200° C.
  • the reaction time is usually in the range of 0.1 to 48 hours. After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-16).
  • Reference Manufacturing Method 37 Compound (II-17) can be produced by reacting compound (II-7) with a halogenating agent. (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Reference Production Method 25, except for using compound (II-7) instead of compound (II-6).
  • the compound represented by the formula (II-18) (hereinafter referred to as compound (II-18)) can be produced from compound (II-10). (In the formula, the symbols have the same meanings as defined above.)
  • the reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION, p. 727 or p. 750.
  • Compound (II-18) may form an acid addition salt.
  • acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.
  • Reference Manufacturing Method 39 Compound (II-19) can be produced by reacting compound (II-18) with compound (I-3). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 1, except that compound (II-18) is used in place of compound (I-2).
  • Reference Manufacturing Method 40 Compound (II-3) can be produced by reacting compound (II-10) with compound (IM). (In the formula, the symbols have the same meanings as defined above.) The reaction can be carried out according to Production Method 2, except that compound (II-10) is used in place of compound (I-8).
  • the compound of the present invention can be mixed or used in combination with one or more components (hereinafter referred to as the present components) selected from the group consisting of the following groups (a), (b), (c) and (d):
  • the above-mentioned mixed or concomitant use means that the compound of the present invention and the present ingredient are used simultaneously, separately or with an interval between them.
  • the compound of the present invention and this ingredient may be contained in separate preparations or may be contained in a single preparation.
  • composition A containing one or more components selected from the group consisting of Group (a), Group (b), Group (c), and Group (d) (i.e., the present components), and a compound of the present invention.
  • Group (a) includes acetylcholinesterase inhibitors (e.g., carbamate insecticides, organophosphate insecticides), GABAergic chloride channel blockers (e.g., phenylpyrazole insecticides), sodium channel modulators (e.g., pyrethroid insecticides), nicotinic acetylcholine receptor competitive modulators (e.g., neonicotinoid insecticides), nicotinic acetylcholine receptor allosteric modulators, glutamatergic chloride channel allosteric modulators (e.g., macrolide insecticides), juvenile hormone mimics, multisite inhibitors, chordotonal organ TRPV channel modulators, mite growth inhibitors, The group consists of microbial insect midgut membrane disruptors, mitochondrial ATP synthase inhibitors, oxidative phosphorylation uncouplers, nicotinic acetylcholine receptor channel blockers (e.g., ner
  • Group (b) consists of nucleic acid synthesis inhibitors (e.g., phenylamide fungicides, acylamino acid fungicides), cell division and cytoskeleton inhibitors (e.g., MBC fungicides), respiratory inhibitors (e.g., QoI fungicides, QiI fungicides), amino acid synthesis and protein synthesis inhibitors (e.g., anilinopyridine fungicides), signal transduction inhibitors, lipid synthesis and membrane synthesis inhibitors, sterol biosynthesis inhibitors (e.g., DMI fungicides such as triazoles), cell wall biosynthesis inhibitors, melanin synthesis inhibitors, plant defense inducers, multisite contact active fungicides, microbial fungicides, and other fungicidal active ingredients. These are described in the classification based on the mechanism of action of FRAC.
  • nucleic acid synthesis inhibitors e.g., phenylamide fungicides, acylamino
  • Group (c) is a group of plant growth regulators (including mycorrhizal fungi and rhizobia).
  • Group (d) is a group of repellent components.
  • alanycarb + SX means a combination of alanycarb and SX.
  • the abbreviation SX means any one of the compounds of the present invention selected from the compound group SX1 to SX1338 and the compounds of the present invention 1 to 58.
  • the present components described below are all known components and can be obtained from commercially available preparations or produced by known methods. When the present components are microorganisms, they can also be obtained from a bacterial depository institution.
  • the numbers in parentheses represent CAS RN (registered trademark).
  • Kurstaki strain EG2348 + SX Bacillus thuringiensis subsp. Kurstaki strain EG7841 + SX, Bacillus thuringiensis subsp. Kurstaki strain EVB113-19 + SX, Bacillus thuringiensis subsp. Kurstaki strain F810 + SX, Bacillus thuringiensis subsp. Kurstaki strain HD-1 + SX, Bacillus thuringiensis subsp. Kurstaki strain PB54 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-11 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12 + SX, Bacillus thuringiensis subsp.
  • Amyloliquefaciens strain FZB24 + SX Bacillus subtilis strain Y1336 + SX, Burkholderia cepacia + SX, Burkholderia cepacia type strain Wisconsin J82 + SX, Burkholderia cepacia type Wisconsin strain M54 + SX, Candida oleophila strain O + SX, Candida saitoana + SX, Chaetomium cupreum + carotovora strain CGE234M403 + SX, Fusarium oxysporum strain Fo47 + SX, Gliocladium catenulatum strain J1446 + SX, Paenibacillus polymyxa strain AC-1 + SX, Paenibacillus polymyxa strain BS-0105 + SX, Pantoea agglomerans strain E325 + SX, Phlebiopsis gigantea strain VRA1992 + SX, Pseudomonas aureofaciens strain TX-1 + SX,
  • the ratio of the compound of the present invention to this component is not particularly limited, but examples of the ratio by weight (compound of the present invention: this component) include 1000:1 to 1:1000, 500:1 to 1:500, 100:1 to 1:100, 50:1, 20:1, 10:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:20, and 1:50.
  • the compound of the present invention is effective against harmful arthropods such as harmful insects and harmful mites, harmful nematodes, and harmful mollusks.
  • harmful arthropods such as harmful insects and harmful mites, harmful nematodes, and harmful mollusks.
  • harmful arthropods, harmful nematodes, and harmful mollusks include the following:
  • Hemiptera Delphacids, such as Laodelphax striatellus, Nilaparvata lugens, Sogatella furcifera, Peregrinus maidis, Javesella pellucida, Perkinsiella saccharicida, Tagosodes orizicolus, and Stenocranus pacificus.
  • Aphis pomi, snow willow aphid (Aphis spiraecola), green peach aphid (Myzus persicae), strawberry aphid (Brachycaudus helichrysi), radish aphid (Brevicoryne brassicae), rosy apple aphid (Dysaphis plantaginea), false radish aphid (Lipaphis erysimi), tulip long-horn aphid (Macrosiphum euphorbiae), oats Aulacorthum solani, lettuce aphid (Nasonovia ribisnigri), wheat curl aphid (Rhopalosiphum padi), corn aphid (Rhopalosiphum maidis), citrus black aphid (Toxoptera citricida), peach buttercup aphid (Hyalopterus pruni), barnyard millet aphid (Melana
  • Aleyrodidae such as the whitefly (Pealius euryae); the family Coccinellidae, such as the palm scale insect (Abgrallaspis cyanophylli), the red scale insect (Aonidiella aurantii), the pear scale insect (Diaspidiotus perniciosus), the mulberry scale insect (Pseudaulacaspis pentagona), the Yanon scale insect (Unaspis yanonensis), and the false Yanon scale insect (Unaspis citri).
  • Lepidoptera Chilo suppressalis, Dark headed stem borer, Chilo polychrysus, White stem borer, Scirpophaga innotata, Scirpophaga incertulas, Rupela albina, Cnaphalocrocis medinalis, Marasmia patnalis, Marasmia exigua, Notarcha derogata, Ostrinia furnacalis, European corn borer, Hellula undalis, Herpetogramma luct Crambidae, such as the Japanese bush moth (Parapediasia teterrellus), the rice case worm (Nymphula depunctalis), the sugar cane borer (Diatraea saccharalis), and the eggplant fruit borer (Leucinodes orbonalis); Pyralidae, such as the corn moth (Elasmopalpus lignosellus), the Indian meal moth (Plodia interpunctella), the two-spotted moth (
  • Heliothis virescens such as Heliothis virescens, Helicoverpa spp. such as Helicoverpa armigera, corn earworm (Helicoverpa zea), Noctuidae such as Velvet bean caterpillar (Anticarsia gemmatalis), cotton leafworm (Alabama argillacea), hop wine borer (Hydraecia immanis), Pieridae such as Pieris rapae, pear fruit moth (Grapholita molesta), plum fruit moth (Grapholita dimorpha), bean cicada (Coleoptera pedunculidae), etc.
  • Heliothis virescens such as Helicoverpa armigera, corn earworm (Helicoverpa zea), Noctuidae such as Velvet bean caterpillar (Anticarsia gemmatalis), cotton leafworm (Alabama argillacea), hop wine borer (Hydraecia
  • Tortricidae such as the grass moth (Leguminivora glycinivorella), the bean pea moth (Matsumuraeses azukivora), the smaller apple tortrix moth (Adoxophyes orana fasciata), the smaller tea tortrix moth (Adoxophyes honmai), the tea tortrix moth (Homona magnima), the common tortrix moth (Archips fuscocupreanus), the codling moth (Cydia pomonella), the sugar candy moth (Tetramoera schistaceana), the bean shoot borer (Epinotia aporema), the citrus fruit borer (Citripestis sagittiferella), and the European grape wine moth (Lobesia botrana); the Gracilariidae family, such as the tea leaf moth (Caloptilia theivora) and the golden leaf moth (Phyllonorycter ringoniella); the Carposini
  • the family Plutellidae includes the diamondback moth (Plutella xylostella);
  • the family Gelechiidae includes the peach leaf moth (Anarsia lineatella), the potato leaf moth (Helcystogramma triannulella), the red cotton moth (Pectinophora gossypiella), the potato tuber moth (Pthorimaea operculella), and the tomato leaf moth (Tuta absolutea);
  • the family Arctiidae includes the fall webworm (Hyphantria cunea);
  • the family Castniidae includes the giant sugarcane borer (Telchin licus);
  • the family Cossidae includes the lesser cotton candy (Cossus insularis); the family Ascotis selenari Geometridae such as Parasa lepida; Limacodidae
  • Thysanoptera Thripidae, such as Frankliniella occidentalis, Thrips palmi, Scirtothrips dorsalis, Thrips tabaci, Frankliniella intonsa, Stenchaetothrips biformis, Echinothrips americanus, Scirtothrips perseae; Phlaeothripidae, such as Haplothrips aculeatus.
  • Diptera Anthomyiidae such as Delia platura, Delia antiqua, Pegomyia cunicularia, etc.; Ulidiidae such as Tetanops myopaeformis, etc.; Agromyza oryzae, Liriomyza sativae, Liriomyza trifolii, Chromatomyia horticola, etc.
  • Agromyzidae (Agromyzidae); Chloropidae (Chlorops oryzae), etc.; Bactrocera cucurbitae (Melon fly), Bactrocera dorsalis (Oriental fruit fly), Bactrocera latifrons (Eastern fruit fly), Bactrocera oleae (Olive fruit fly), Bactrocera tryoni (Queensland fruit fly), Ceratitis capitata (Mediterranean fruit fly), Rhagoletis pomonella (Apple maggot), Rhagoletis suzukii (Sugar apple fly), Rhagoletis japonica (Chrysocarpus japonica), Rhagoletis japonica (Rhagoletis ...
  • Tephritidae such as Hacochlaena japonica
  • Ephydridae such as Hydrellia griseola, Hydrellia philippina, and Hydrellia sasakii
  • Drosophilidae such as Drosophila suzukii and Drosophila melanogaster
  • Megaselia spiracularis Psychodidae, such as Clogmia albipunctata, Sciaridae, such as Bradysia difformis and Bradysia odoriphaga
  • Cecidomyiidae such as Mayetiola destructor and Orseolia oryzae
  • Diopsidae such as Diopsis macrophthalma
  • Glos Family Glossinidae such as Glossina sina palpalis and Glossina morsitans
  • Family Simuliidae such as Simulium japonicum and Simulium damnosum
  • Diabrotica spp. e.g. Western corn rootworm (Diabrotica virgifera virgifera), Southern corn rootworm (Diabrotica undecimpunctata howardi), Northern corn rootworm (Diabrotica barberi), Mexican corn rootworm (Diabrotica virgifera zeae), Banded cucumber beetle (Diabrotica balteata), Cucumber beetle (Diabrotica speciosa), etc.), Bean leaf beetle (Cerotoma trifurcata), Red-necked leaf beetle (Oulema melanopus), Cucumber leaf beetle (Aulacophora femoralis), Striped flea beetle (Phyllotreta striolat a), cabbage free beetle (Phyllotreta cruciferae), western black free beetle (Phyllotreta pusilla), cabbage stem free beetle (Psylliodes chry
  • fungus weevils such as Araecerus coffeee Family Anthriibidae; Family Aponidae such as sweet potato weevil (Cylas formicarius); Family Bruchidae such as Brazilian bean weevil (Zabrotes subfasciatus); Family Scolytidae such as pine bark beetle (Tomicus piniperda) and coffee berry borer (Hypothenemus hampei); Family Scolytidae such as potato weevil (Hypothenemus hampei); Bug (Euscepes postfasciatus), Alfalfa weevil (Hypera postica), Maize weevil (Sitophilus zeamais), Rice weevil (Sitophilus oryzae), Granary maize weevil (Sitophilus granarius), Rice weevil (Echinocnemus squameus), Rice water weevil (Lis
  • Aracanthus spp. such as the rust gourd weevil (Scepticus griseus), the brown gourd weevil (Scepticus uniformis), Aracanthus mourei, and the cotton root borer (Eutinobothrus brasiliensis); eum, Tribolium confusum, Alphitobius diaperinus and other Tenebrionidae; Epilachna vigintioctopunctata and other Coccinellidae; Lyctus brunneus, Rhizope rtha dominica; Ptinidae; Cerambycidae; Anoplophora malasiaca, Migdolus fryanus, Aromia bungii; Melanotus okinawensis, Brown-necked wire beetle; Elateridae, including Agriotes fuscicollis, Melanotus legatus, Anchastus spp., Conoderus spp.,
  • Hymenoptera Tenthredinidae such as Athalia rosae and Athalia japonica; Solenopsis spp. such as Solenopsis invicta and Solenopsis geminata; Atta spp.
  • Atta capiguara and Acrom yrmex spp. such as Atta capiguara and Acrom yrmex spp.), Paraponera clavata, Ochetellus glaber, Monomorium pharaonis, Argentine ant (Linepithema humile), Formica japonica, Pristomyrmex punctutus, Pheidole noda, Pheidole megacephala, Camponotus spp., such as the Japanese camponotus (Camponotus japonicus), Camponotus spp., such as the red-breasted camponotus (Camponotus obscuripes), Pogonomyrmex spp., such as Pogonomyrmex occidentalis, Wasmania spp., such as Wasmania auropunctata, and Anoplolepis gracilipinas.
  • Vespidae such as the giant hornet (Vespa mandarinia), the hairy hornet (Vespa simillima), the small hornet (Vespa analis), the red hornet (Vespa velutina), and the Japanese paper wasp (Polistes jokahamae); Siricidae (Wasps) such as the fir wasp (Urocerus gigas); and Bethylidae (Hornets).
  • Vespidae such as the giant hornet (Vespa mandarinia), the hairy hornet (Vespa simillima), the small hornet (Vespa analis), the red hornet (Vespa velutina), and the Japanese paper wasp (Polistes jokahamae); Siricidae (Wasps) such as the fir wasp (Urocerus gigas); and Bethylidae (Hornets).
  • Family Ectobiidae such as the German cockroach (Blattella germanica); Family Blattidae, such as the Siberian cockroach (Periplaneta fuliginosa), the American cockroach (Periplaneta americana), the American cockroach (Periplaneta australiae), the brown cockroach (Periplaneta brunnea), and the Asian cockroach (Blatta orientalis); Family Reticulitermes speratus, Formosan termite (Coptotermes formosanus), Formosan dry wood termite (Incisitermes minor), Formosan termite (Cryptotermes domesticus), Formosan termite (Odontotermes formosanus), and Formosan termite (Neotermes Termites of the family Termitidae, such as Glyptotermes satsumensis, Glyptotermes nakajimai, Glyptotermes fuscus,
  • Order Siphonaptera Family Pulicidae such as the human flea (Pulex irritans), cat flea (Ctenocephalides felis), dog flea (Ctenocephalides canis), rat flea (Xenopsylla cheopis), chicken flea (Echidnophaga gallinacea), etc.; Family Hectopsyllidae such as the sand flea (Tunga penetrans); Family Ceratophyllidae such as the European rat flea (Nosopsyllus fasciatus).
  • Family Pulicidae such as the human flea (Pulex irritans), cat flea (Ctenocephalides felis), dog flea (Ctenocephalides canis), rat flea (Xenopsylla cheopis), chicken flea (Echidnophaga gallinacea), etc.
  • Family Hectopsyllidae such as the sand flea (Tunga penetrans)
  • Psocodae Family Pediculidae such as head lice (Pediculus humanus capitis); Family Pthiridae such as pubic lice (Pthirus pubis); Family Haematopinidae such as cow lice (Haematopinus eurysternus) and pig lice (Haematopinus suis); Family Linognathus vituli, Sheep trunk lice Family Linognathidae, such as body lice (Linognathus ovillus) and cow lice (Solenopotes capillatus); Family Bovicoliidae, such as cow lice (Bovicola bovis), sheep lice (Bovicola ovis), Bovicola breviceps, Damalinia forficula, and Werneckiella spp.; Family Bovicoliidae, such as dog lice (T Family Trichodectidae, such as richodectes canis and Felicola subrostratus; Family Menoponi
  • Trogiidae such as Trogium pulsatorium
  • Liposcelidae or Liposcelididae such as Liposcelis corrodens, Liposcelis bostrychophila, Liposcelis pearmani, and Liposcelis entomophila.
  • Thysanura Family Lepismatidae, including the Japanese silverfish (Ctenolepisma villosa) and the European silverfish (Lepisma saccharina).
  • Eriophyidae such as Acarus carinatus, Acaphylla theavagrans, Eriophyes chibaensis, Aculus Louendali, Aceria diospyri, Aceria tosichella, Shevtchenkella sp.; Tarsonemidae, such as Polyphagotarsonemus latus; Deutzia purpurea, such as Brevipalpus phoenicis.
  • Order Araneae Family Eutichuridae such as Cheiracanthium japonicum; Family Theridiidae such as Latrodectus hasseltii.
  • Polydesmida Paradoxosomatidae, including Oxidus gracilis, Nedyopus tambanus, etc.
  • Isopoda Family Armadillidiidae, including Armadillidium vulgare.
  • Chilopoda Scutigeridae such as Thereuonema hilgendorfi; Scolopendridae such as Scolopendra subspinipes; Ethopolyidae such as Bothropolys rugosus.
  • Class Gastropoda Family Limacidae such as the brown slug (Limax marginatus) and the yellow slug (Limax flavus); Family Philomycidae such as the slug (Meghimatium bilineatum); Family Ampullariidae such as the apple snail (Pomacea canaliculata); Family Lymnaeidae such as the lymnae snail (Austropeplea ollula).
  • Nematoda Aphelenchoididae, such as Aphelenchoides besseyi; Pratylenchidae, such as Pratylenchus coffeee, Pratylenchus brachyurus, Pratylenchus neglectus, and Radopholus similis Java root-knot nematode (Meloidogyne javanica), sweet potato root-knot nematode (Meloidogyne incognita), guava root-knot nematodes (Meloidogyne enterolobii), northern root-knot nematode (Meloidogyne hapla), soybean cyst nematode (Heterodera glycines), potato cyst nematode (Globodera rostochien sis, Globodera pallida, Meloidogyne chitwoodi, etc.
  • Java root-knot nematode Java root-k
  • the harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes may be harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes that have reduced sensitivity to insecticides, acaricides, molluscicides, or nematocides, or that have developed resistance to the insecticides, acaricides, molluscicides, or nematocides.
  • the method for controlling harmful arthropods of the present invention is carried out by applying an effective amount of the compound of the present invention or composition A directly to the harmful arthropods and/or to the habitat of the harmful arthropods (plants, soil, inside a house, animals, etc.).
  • Examples of the method for controlling harmful arthropods of the present invention include foliage treatment, soil treatment, root treatment, shower treatment, fumigation treatment, water surface treatment and seed treatment.
  • the compound of the present invention or composition A is usually mixed with an inactivated carrier such as a solid carrier, a liquid carrier, or a gaseous carrier and a surfactant, and formulation auxiliary agents such as a binder, a dispersant, or a stabilizer are added as necessary to prepare an aqueous suspension preparation, an oil suspension preparation, an oil solution, an emulsion, an emulsion preparation, a microemulsion preparation, a microcapsule preparation, a wettable powder, a wettable granule, a dust, a granule, a tablet, an aerosol, a resin preparation, etc.
  • an inactivated carrier such as a solid carrier, a liquid carrier, or a gaseous carrier and a surfactant
  • formulation auxiliary agents such as a binder, a dispersant, or a stabilizer are added as necessary to prepare an aqueous suspension preparation, an oil suspension preparation, an oil solution, an emulsion, an emulsion preparation,
  • Solid carriers include, for example, clay (pyrophyllite clay, kaolin clay, etc.), talc, calcium carbonate, diatomaceous earth, zeolite, bentonite, acid clay, attapulgite, white carbon, ammonium sulfate, vermiculite, perlite, pumice, silica sand, fine powders and granules of chemical fertilizers (ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, ammonium chloride, etc.), and resins (polyethylene, polypropylene, polyester, polyurethane, polyamide, polyvinyl chloride, etc.).
  • clay pyrophyllite clay, kaolin clay, etc.
  • talc calcium carbonate
  • diatomaceous earth zeolite
  • bentonite acid clay
  • attapulgite white carbon
  • ammonium sulfate vermiculite
  • perlite perlite
  • pumice pumice
  • Liquid carriers include, for example, water, alcohols (ethanol, cyclohexanol, benzyl alcohol, propylene glycol, polyethylene glycol, etc.), ketones (acetone, cyclohexanone, etc.), aromatic hydrocarbons (xylene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, etc.), esters (ethyl acetate, methyl oleate, propylene carbonate, etc.), nitriles (acetonitrile, etc.), ethers (ethylene glycol dimethyl ether, etc.), amides (N,N-dimethylformamide, N,N-dimethyloctanamide, etc.), sulfoxides (dimethyl sulfoxide, etc.), lactams (N-methylpyrrolidone, N-octylpyrrolidone, etc.), fatty
  • Gaseous carriers include, for example, fluorocarbons, butane gas, LPG (liquefied petroleum gas), dimethyl ether, nitrogen, and carbon dioxide.
  • Surfactants include, for example, nonionic surfactants (polyoxyethylene alkyl ethers, polyoxyethylene alkylaryl ethers, polyethylene glycol fatty acid esters, etc.) and anionic surfactants (alkyl sulfonates, alkylaryl sulfonates, alkyl sulfates, etc.).
  • formulation adjuvants include binders, dispersants, colorants, and stabilizers, and specific examples include polysaccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), acid isopropyl phosphate, and dibutylhydroxytoluene.
  • adjuvants can be used as components that enhance or support the efficacy of the compounds of the present invention.
  • Specific examples include Nimbus (registered trademark), Assist (registered trademark), Aureo (registered trademark), Iharol (registered trademark), Silwet L-77 (registered trademark), BreakThru (registered trademark), SundanceII (registered trademark), Induce (registered trademark), Penetrator (registered trademark), AgriDex (registered trademark), Lutensol A8 (registered trademark), NP-7 (registered trademark), Triton (registered trademark), Nufilm (registered trademark), Emulgator NP7 (registered trademark), Emulad (registered trademark), TRITON X 45 (registered trademark), AGRAL 90 (registered trademark), AGROTIN (registered trademark), ARPON (registered trademark), EnSpray N (registered trademark), and BANOLE (registered trademark).
  • plants include whole plants, stems and leaves, flowers, spikes, fruits, trunks, branches, crowns, seeds, vegetative reproductive organs, and seedlings.
  • a vegetative reproductive organ is a part of a plant, such as a root, stem, or leaf, that has the ability to grow when it is separated from the main body and placed in soil.
  • vegetative reproductive organs include tuberous roots, creeping roots, bulbs, corms (or solid bulbs), tubers, rhizomes, stolons, rhizophores, cane cuttings, propagules, and vine cuttings. Stolons are sometimes called runners, and bulbils are also called bulbils and are divided into broad buds and bulbils. Vines refer to shoots (a collective term for leaves and stems) of sweet potatoes, Chinese yams, etc. Bulbs are a collective term for bulbs, corms, tubers, rhizomes, stem fragments, rhizophores, or tuberous roots.
  • Potato cultivation begins with planting tubers in the soil, and the tubers used are generally called seed potatoes.
  • An example of a method for controlling harmful arthropods by applying an effective amount of the compound of the present invention or composition A to soil is a method of applying an effective amount of the compound of the present invention or composition A to the soil before or after planting a plant. More specifically, for example, planting hole treatment (spraying in planting holes, mixing soil for planting hole treatment), plant base treatment (spraying at the plant base, mixing soil at the plant base, irrigation at the plant base, plant base treatment in the latter half of the seedling raising period), planting furrow treatment (spraying in planting furrow, mixing soil in planting furrow), crop row treatment (spraying in crop row, mixing soil in crop row, crop row spray during the growing season), crop row treatment at the time of sowing (crop row spraying at the time of sowing, mixing soil in crop row at the time of sowing), overall treatment (overall soil spray, overall soil mixing), side row treatment, water surface treatment (water surface application, water surface application after flooding), other soil spray treatments (foliar spraying of granules during the growing season, spraying
  • irrigation treatments include (soil irrigation, seedling irrigation, chemical injection treatment, ground level irrigation, chemical drip irrigation, chemigation), seedling box treatments (seedling box spraying, seedling box irrigation, seedling box flooding with chemicals), seedling tray treatments (seedling tray spraying, seedling tray irrigation, seedling tray flooding with chemicals), seedbed treatments (seedling bed spraying, seedling bed irrigation, water seedling bed spraying, seedling immersion), bed soil mixing treatments (bed soil mixing, bed soil mixing before sowing, spraying before soil cover at sowing, spraying after soil cover at sowing, soil cover mixing), and other treatments (mixing culture soil, plowing in, mixing topsoil, mixing soil from areas that have fallen off due to rain, planting position treatment, spraying granular inflorescences, mixing paste fertilizer).
  • Examples of seed treatment include treatment of seeds or vegetative reproductive organs with the compound of the present invention or composition A. More specifically, examples of the treatment include spraying treatment in which a suspension of the compound of the present invention or composition A is misted and sprayed onto the surface of a seed or vegetative reproductive organ, smearing treatment in which the compound of the present invention or composition A is applied to the seed or vegetative reproductive organ, immersion treatment in which the seed or vegetative reproductive organ is immersed in a liquid of the compound of the present invention or composition A for a certain period of time, and a method of coating the seed or vegetative reproductive organ with a carrier containing the compound of the present invention or composition A (film coating treatment, pellet coating treatment, etc.).
  • the above-mentioned vegetative reproductive organ particularly includes seed potatoes.
  • composition A When applying composition A to seeds or vegetative reproductive organs, composition A can be applied to the seeds or vegetative reproductive organs as one formulation, or composition A can be applied to the seeds or vegetative reproductive organs in multiple separate applications as different formulations.
  • Examples of the method of applying composition A in multiple separate applications as different formulations include a method of applying a formulation containing only the compound of the present invention as an active ingredient, air-drying the seeds or vegetative reproductive organs, and then applying a formulation containing this component; and a method of applying a formulation containing the compound of the present invention and this component as active ingredients, air-drying the seeds or vegetative reproductive organs, and then applying a formulation containing this component other than the component that has already been applied.
  • the seed or vegetative reproductive organ carrying the compound of the present invention or composition A means a seed or vegetative reproductive organ having the compound of the present invention or composition A attached to its surface.
  • the seed or vegetative reproductive organ carrying the compound of the present invention or composition A may have a material other than the compound of the present invention or composition A attached thereto before or after the compound of the present invention or composition A is attached to the seed or vegetative reproductive organ.
  • the layer may consist of one or more layers.
  • each layer may contain one or more active ingredients, or each layer may consist of a layer containing one or more active ingredients and a layer containing no active ingredients. Seeds or vegetative reproductive organs carrying the compound of the present invention or composition A can be obtained, for example, by applying a formulation containing the compound of the present invention or composition A to the seeds or vegetative reproductive organs by the seed treatment methods described above.
  • the application amount is usually 1 to 10,000 g of the compound of the present invention per 10,000 m2 .
  • the compound of the present invention is usually applied in an amount of 0.001 to 100 g per 1 kg of seeds or vegetative reproductive organs.
  • the compound of the present invention or composition A is formulated as an emulsifiable concentrate, wettable powder, flowable agent, or the like, it is usually applied after diluting with water so that the active ingredient concentration is 0.01 to 10,000 ppm, and granules, dusts, and the like are usually applied as is.
  • the compound or composition A of the present invention can also be applied by wrapping the resin preparation in a sheet or string shape around the crop, stretching it near the crop, or spreading it on the soil around the base of the plant.
  • the application amount is usually 0.01 to 1000 mg of the compound of the present invention per 1 m2 of treatment area when applied on a surface, and usually 0.01 to 500 mg of the compound of the present invention per 1 m3 of treatment space when applied in a space.
  • the compound of the present invention or composition A is formulated as an emulsifiable concentrate, wettable powder, flowable agent, etc., it is usually applied after diluting with water so that the active ingredient concentration is 0.1 to 10000 ppm, and when it is an oil agent, aerosol agent, fumigation agent, poison bait, etc., it is applied as it is.
  • the compound of the present invention or composition A When the compound of the present invention or composition A is used for controlling external parasites in livestock such as cows, horses, pigs, sheep, goats, and chickens, and small animals such as dogs, cats, rats, and mice, it can be administered to animals by methods known in veterinary medicine. Specific methods of use include, for example, administration by tablet, inclusion in feed, suppository, or injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) for systemic inhibition, and for non-systemic inhibition, for example, spraying an oil or aqueous liquid, pour-on treatment, or spot-on treatment, washing the animal with a shampoo preparation, or attaching a resin preparation to the animal as a collar or ear tag.
  • the amount of the compound of the present invention or composition A when administered to an animal is usually in the range of 0.1 to 1000 mg per 1 kg of the animal's body weight.
  • the compound of the present invention or composition A can be used as an agent for controlling harmful arthropods in agricultural land such as fields, paddy fields, lawns, orchards, etc.
  • agricultural land such as fields, paddy fields, lawns, orchards, etc.
  • plants include the following.
  • the above plants are not particularly limited as long as they are varieties that are commonly cultivated.
  • the above plants also include plants that can be produced by natural crossbreeding, plants that can be generated by mutation, F1 hybrid plants, and genetically modified crops.
  • genetically modified crops include plants that have been given resistance to herbicides such as HPPD (4-hydroxyphenylpyruvate dioxygenase enzyme) inhibitors such as isoxaflutole, ALS (acetolactate synthase) inhibitors such as imazethapyr and thifensulfuron methyl, EPSP (5-enolpyruvylshikimate-3-phosphate synthase) inhibitors, glutamine synthetase inhibitors, PPO (protoporphyrinogen oxidase) inhibitors, bromoxynil, or dicamba; plants that are able to synthesize selective toxins known from the Bacillus genus, such as Bacillus thuringiensis; and plants that can be given specific insecticid
  • Me represents a methyl group
  • Et represents an ethyl group
  • Boc represents a tert-butoxycarbonyl group
  • Cbz represents a benzyloxycarbonyl group.
  • LCMS liquid chromatography/mass spectrometry
  • MS mass spectrometry
  • Detector LCMS-2020 (Shimadzu Corporation)
  • Ionization method DUIS method (ESI, APCI)
  • Reference Manufacturing Example 1 0.41 g of 1,1,3,3-tetramethoxypropane and 8.3 mL of acetic acid were added to 0.50 g of tert-butyl [(1S)-1-(5-amino-1H-pyrazol-3-yl)ethyl] (methyl)carbamate produced according to the method described in Example 1-1 of JP 2018-76234 A, and the mixture was stirred under heating and reflux for 3 hours. The reaction solution was allowed to cool to room temperature, and 0.46 g of N-iodosuccinimide was added and stirred for another 16 hours. The resulting mixture was poured into an ice-cooled saturated aqueous sodium hydrogen carbonate solution and extracted with chloroform.
  • the resulting organic layer was washed successively with a saturated aqueous sodium thiosulfate solution, water, and saturated saline. The resulting organic layer was dried over sodium sulfate and concentrated. To the resulting residue, 0.52 g of 2-tributylstannylpyrimidine, 0.16 g of tetrakistriphenylphosphine palladium, 0.05 g of copper (I) iodide, 0.06 g of lithium chloride, and 7.1 mL of 1,4-dioxane were added and stirred at 100°C for 12 hours. The resulting mixture was allowed to cool to room temperature, water was added, and extraction was performed using chloroform.
  • Reference Manufacturing Example 12 2.0 mL of acetic acid, 2.0 mL of chloroform, and 0.325 g of N-iodosuccinimide were added to 0.485 g of intermediate 11, and the mixture was stirred at room temperature for 5 hours. Water was added to the resulting mixture, and the mixture was extracted with chloroform. The resulting organic layer was washed successively with a saturated aqueous solution of sodium hydrogen carbonate, a saturated aqueous solution of sodium thiosulfate, water, and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.500 g of intermediate 12 represented by the following formula.
  • Reference Manufacturing Example 13-1 293 mL of acetonitrile, 61.3 mL of triethylamine, and 55.9 g of magnesium chloride were added to 18.7 g of cyanoacetic acid in this order, and the mixture was stirred at room temperature for 23 hours to obtain mixture A. 28.5 g of 1,1'-carbonyldiimidazole and 3.58 g of 4-dimethylaminopyridine were added to a mixture of 34.8 g of N-methyl-N-(phenylmethoxycarbonyl)-L-alanine and 200 mL of THF in this order, and the mixture was stirred at room temperature for 4 hours to obtain mixture B.
  • Reference Production Example 18 The compound and its physical properties produced according to Reference Production Example 14 are shown below, except that acetylacetone was used instead of 1,1,3,3-tetramethoxypropane.
  • Intermediate 18 1 H-NMR (CDCl 3 ) ⁇ : 7.39-7.31 (5H, m), 6.52 (1H, s), 6.41 (1H, s), 5.78-5.65 (1H, m), 5.21 (2H, s), 2.79 (3H, s), 2.70 (3H, s), 2.54 (3H, s), 1.62 (3H, d).
  • Reference Production Example 20 A compound produced according to Reference Production Example 14 using 1,1,3,3-tetraethoxy-2-methylpropane instead of 1,1,3,3-tetramethoxypropane and its physical properties are shown below.
  • Intermediate 20 1 H-NMR (CDCl 3 ) ⁇ : 8.42 (1H, s), 8.33 (1H, d), 7.39-7.32 (5H, m), 6.52-6.47 (1H, m), 5.77-5.70 (1H, m), 5.21 (2H, s), 2.77 (3H, s), 2.36 (3H, s), 1.62 (3H, d).
  • Reference Production Example 45 The compound prepared according to Reference Production Example 4 using Intermediate 56 instead of Intermediate 3 and its physical properties are shown below.
  • Intermediate 57 1 H-NMR (CDCl 3 ) ⁇ : 9.45 (1H, s), 9.01 (2H, d), 8.46 (1H, s), 7.43 (1H, t), 7.33-7.31 (5H, m), 5.82 (1H, d), 5.38-5.37 (1H, m), 5.05-4.99 (2H, m), 1.57 (3H, d).
  • Reference Production Example 49 8.4 mL of hydrogen chloride (5-10 wt % methanol solution) was added to 0.50 g of intermediate 60, and the mixture was stirred at 90° C. for 15 hours. The resulting mixture was allowed to cool to room temperature and then concentrated, and 4.2 mL of DMF, 4.2 mL of bromoacetaldehyde dimethyl acetal, and 1.0 mL of acetic acid were added, and the mixture was stirred at 80° C. for 15 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated saline in that order. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated.
  • hydrogen chloride 5-10 wt % methanol solution
  • Reference Manufacturing Example 50 The compound prepared according to Reference Production Example 4 using Intermediate 61 instead of Intermediate 3 and its physical properties are shown below.
  • Intermediate 62 1 H-NMR (CDCl 3 ) ⁇ : 8.98 (2H, d), 7.72 (1H, d), 7.54 (1H, d), 7.37-7.37 (1H, m), 7.34-7.31 (5H, m), 6.00 (1H, d), 5.14-5.13 (1H, m), 5.05-5.03 (2H, m), 2.86 (3H, s), 1.49 (3H, d).
  • Reference Production Example 52 The compound and its physical properties are shown below, which were produced according to Reference Production Example 4, except that Intermediate 63 was used instead of Intermediate 3, and tributyl(1-ethoxyvinyl)stannane was used instead of 2-tributylstannylpyrimidine.
  • Intermediate 64 1 H-NMR (CDCl 3 ) ⁇ : 9.41 (1H, s), 8.44 (1H, s), 8.25 (2H, s), 8.02 (1H, s), 7.30 (1H, d), 5.87-5.84 (1H, m), 4.87 (1H, d), 4.81 (1H, d), 4.13-4.09 (2H, m), 1.64 (3H, d), 1.45 (3H, t).
  • Reference Manufacturing Example 66 A mixture of 0.30 g of Intermediate 66 and 5.0 mL of a hydrogen chloride/1,4-dioxane solution (4 mol/L) was stirred at room temperature for 15 hours, and the resulting mixture was concentrated. To a mixed solution of the obtained residue and 5.0 mL of THF, 0.37 mL of triethylamine and 0.27 mL of 3,5-bis(trifluoromethyl)benzoyl chloride were added in that order, and the mixture was stirred at room temperature for 1 hour. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was washed with water and saturated saline in that order.
  • Production Example 6 2.9 mL of THF, 2.3 ⁇ L of DMF, and 0.061 mL of oxalyl chloride were added to 0.165 g of 3,5-bis(difluoromethoxy)benzoic acid in this order, and the mixture was stirred at room temperature for 1 hour. The resulting mixture was concentrated, and 0.5 mL of THF was added to the residue to obtain mixture C. Mixture C was added to a mixture of 0.15 g of intermediate 17, 0.164 mL of triethylamine, and 1.2 mL of THF, and the mixture was stirred at room temperature for 1 hour. Water was added to the resulting mixture, and the mixture was extracted with chloroform.
  • Production Example 9 A compound produced according to Production Example 2 using Intermediate 36 instead of Intermediate 6 and its physical properties are shown below.
  • Production Example 15-1 A compound prepared according to Preparation Example 15 using 2-tributylstannylpyridine instead of 2-tributylstannylthiazole and its physical properties are shown below.
  • Compound 40 of the present invention 1 H-NMR (CDCl 3 ) ⁇ : 9.47 (1H, s), 8.85-8.84 (1H, m), 8.45 (1H, s), 8.22 (2H, s), 8.01-8.00 (2H, m), 7.97-7.96 (1H, m), 7.51 (1H, d), 7.47-7.46 (1H, m), 5.80-5.77 (1H, m), 1.67 (3H, d).
  • Production Example 17 A mixture of 0.20 g of the present compound 41, 0.10 g of methoxyamine hydrochloride, 0.074 g of sodium acetate, and 4.5 mL of ethanol was stirred at 50° C. for 3 hours. The resulting mixture was allowed to cool to room temperature, water was added, and extraction was performed using ethyl acetate. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.20 g of the present compound 42.
  • Production Example 17-1 A compound prepared according to Preparation Example 17 using hydroxylamine hydrochloride instead of methoxyamine hydrochloride and its physical properties are shown below.
  • Compound 43 of the present invention 1 H-NMR (DMSO-D 6 ) ⁇ : 9.30 (1H, d), 9.20 (1H, s), 8.80 (1H, s), 8.45 (2H, s), 8.30 (1H, s), 5.16 (1H, s), 2.29 (3H, s), 1.50 (3H, d).
  • Formula (L-1) (hereinafter, referred to as compound (L-1)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Table L1] to [Table L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX1).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX2).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX3).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX4).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX5).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX6).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX8).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX9).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX10).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX11).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX12).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX14).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX15).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX16).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX18).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX19).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX20).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX21).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX22).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX23).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX24).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX26).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX27).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX28).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX29).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX30).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX31).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX32).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX33).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX34).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX35).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX36).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX37).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX38).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX39).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX40).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX41).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX42).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX43).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX44).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX45).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX46).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX47).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX48).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX49).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX50).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX51).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX52).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX53).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX54).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX55).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX56).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX57).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX58).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX59).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX60).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX61).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX62).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX63).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX64).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX65).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX66).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX67).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX68).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX69).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX70).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX71).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX72).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX73).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX74).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX75).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX76).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX77).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX78).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX79).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX80).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX81).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX82).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX83).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX84).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX85).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX86).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX87).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX88).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX89).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX90).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX91).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX92).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX93).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX94).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX95).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX96).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX97).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX98).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX99).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX100).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX101).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX102).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX103).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX104).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX105).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX106).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX107).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX108).
  • Formula (L-2) (hereinafter, referred to as compound (L-2)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents a bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX109).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX110).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX111).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX112).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX113).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX114).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX115).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX116).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX117).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX118).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX119).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX120).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX121).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX122).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX123).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX124).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX125).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX126).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX127).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX128).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX129).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX130).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX131).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX132).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX133).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX134).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX135).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX136).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX137).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX138).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX139).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX140).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX141).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX142).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX143).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX144).
  • compound group SX145 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX145).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX146).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX147).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX148).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX149).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX150).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX151).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX152).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX153).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX154).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX155).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX156).
  • compound group SX157 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX157).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX158).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX159).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX160).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX161).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX162).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX163).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX164).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX165).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX166).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX167).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX168).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX169).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX170).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX171).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX172).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX173).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX174).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX175).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX176).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX177).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX178).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX179).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX180).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX181).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX182).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX183).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX184).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX185).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX186).
  • compound group SX187 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX187).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX188).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX189).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX190).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX191).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX192).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX193).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX194).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX195).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX196).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX197).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX198).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX199).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX200).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX201).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX202).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX203).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX204).
  • compound group SX205 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX205).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX206).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX207).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX208).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX209).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX210).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX211).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX212).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX213).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX214).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX215).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX216).
  • Formula (L-3) (hereinafter, referred to as compound (L-3)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX217).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX218).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX219).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX220).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX221).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX222).
  • compound group SX222 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX223).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX224).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX225).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX226).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX227).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX228).
  • compound group SX229 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX229).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX230).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX231).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX232).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX233).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX234)
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX235).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX236).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX237).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX238).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX239).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX240).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX241).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX242).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX243).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX244)
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX245).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX246).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX247).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX248).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX249).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX250).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX251).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX252).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX253).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX254)
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX255).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX256).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX257).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX258).
  • compound group SX259 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX259).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX260).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX261).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX262).
  • compound group SX263 a compound in which R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX263).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX264).
  • compound group SX264 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX265).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX266).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX267).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX268).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX269).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX270).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX271).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX272).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX273).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX274)
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX275).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX278).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX279).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX280).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX281).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX282).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX283).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX284)
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX285).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX286).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX287).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX290).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX291).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX300).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX301).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX302).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX303).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX306).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX307).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX308).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX309).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX310).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX311).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX312).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX313).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX314).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX315).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX316).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX317).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX320).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX321).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX326).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX327).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX332).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX333).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX336).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX337).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX338).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX339).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX340).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX341).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX342).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX343).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX344)
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX345).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX348).
  • compound group SX349 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX349).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX352).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX353).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX358).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX359).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX360).
  • compound group SX361 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX361).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX362).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX363).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX364)
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX365).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX370).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX371).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX372).
  • compound group SX373 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX373).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX374)
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX375).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX378).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX379).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX380).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX381).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX382).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX383).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX384)
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX385).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX388).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX389).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX390).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX391).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX392).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX393).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX394)
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX395).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX396).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX397).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX398).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX399).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX400).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX401).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX406).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX407).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX412).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX413).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX414)
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX415).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX418).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX419).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX420).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX421).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX422).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX423).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX428).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX429).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX436).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX437).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX438).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX439).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX440).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX441).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX442).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX443).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX444)
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX445).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX446).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX447).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX448).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX449).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX458).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX459).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX460).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX461).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX464).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX465).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX466).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX467).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX472).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX473).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX474).
  • compound group SX475 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX475).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX476).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX477).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX478).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX479).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX482).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX483).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX484)
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX485).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX490).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-10
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX491).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX500).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX501).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX502).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX503).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX504)
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX505).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX508).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX509).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX512).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX513).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX514)
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX515).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX518).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX519).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX520).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX521).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX522).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX523).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX528).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX529).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX532).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX533).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX534)
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX535).
  • Formula (L-6) (hereinafter, referred to as compound (L-6)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents a bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Table L1] to [Table L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX541).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX546)
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX547).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX548).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX549).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX562).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX563).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX566)
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX567).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX570).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX571).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX572).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX573).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX582).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX583).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX588).
  • compound group SX589 a compound in which R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX589).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX590).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX591).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX592).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX593).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX604).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX605).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-11
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX606).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX607).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX608).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX609).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX610).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX611).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX612).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX613).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX618).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX619).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX620).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX621).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX622).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX623).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX628).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX629).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX632).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX633).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX634)
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX635).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX640).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX641).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX642).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-18
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX643).
  • R 1 is a hydrogen atom
  • R 11 is T2-3, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX653).
  • R 1 is a methyl group
  • R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX654).
  • compound SX655 is any of the substituents described in [Tables L1] to [Tables L20].
  • R 1 is a methyl group, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX656).
  • R 1 is a hydrogen atom, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX657).
  • R 1 is a methyl group, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX658).
  • R 1 is a hydrogen atom
  • R 11 is T2-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX661).
  • R 1 is a methyl group
  • R 11 is T2-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX662).
  • R 1 is a hydrogen atom
  • R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX663).
  • R 1 is a methyl group
  • R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX664).
  • R 1 is a hydrogen atom
  • R 11 is T2-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX665).
  • R 1 is a methyl group
  • R 11 is T2-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX666).
  • R 1 is a hydrogen atom
  • R 11 is T2-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX667).
  • R 1 is a methyl group
  • R 11 is T2-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX668).
  • R 1 is a hydrogen atom
  • R 11 is T2-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX669).
  • R 1 is a methyl group, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX670).
  • R 1 is a hydrogen atom
  • R 11 is T2-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX671).
  • R 1 is a methyl group
  • R 11 is T2-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX672).
  • R 1 is a methyl group
  • R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX676).
  • R 1 is a hydrogen atom
  • R 11 is T2-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX677).
  • R 1 is a methyl group
  • R 11 is T2-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX678).
  • Formula (L-8) (hereinafter, referred to as compound (L-8)), in which R 1 is a hydrogen atom, R 11 is T2-1 (# 5 represents a bonding site to the nitrogen atom), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX683).
  • R 1 is a methyl group, R 11 is T2-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX684).
  • R 1 is a hydrogen atom, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX685).
  • R 1 is a methyl group, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX686).
  • compound (L-8) a compound in which R 1 is a hydrogen atom, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX687).
  • R 1 is a methyl group
  • R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX688).
  • R 1 is a hydrogen atom
  • R 11 is T2-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX689).
  • R 1 is a methyl group
  • R 11 is T2-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX690).
  • R 1 is a hydrogen atom
  • R 11 is T2-5
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX691).
  • R 1 is a hydrogen atom
  • R 11 is T2-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX695).
  • R 1 is a methyl group
  • R 11 is T2-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX696).
  • R 1 is a hydrogen atom
  • R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX697).
  • R 1 is a methyl group
  • R 11 is T2-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX704).
  • compound group SX704 a compound in which R 1 is a hydrogen atom
  • R 11 is T2-12
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX705)
  • R 1 is a methyl group
  • R 11 is T2-12
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX706).
  • R 1 is a hydrogen atom
  • R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX709).
  • R 1 is a methyl group
  • R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX710).
  • R 1 is a hydrogen atom
  • R 11 is T2-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX711).
  • R 1 is a methyl group
  • R 11 is T2-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX718).
  • R 1 is a hydrogen atom
  • R 11 is T2-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX719).
  • R 1 is a methyl group
  • R 11 is T2-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX720).
  • R 1 is a hydrogen atom
  • R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX721).
  • R 1 is a methyl group
  • R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX722).
  • R 1 is a hydrogen atom
  • R 11 is T2-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX723).
  • R 1 is a methyl group
  • R 11 is T2-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX724).
  • compound group SX725 a compound in which R 1 is a hydrogen atom, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX725).
  • R 1 is a methyl group
  • R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX744).
  • R 1 is a hydrogen atom
  • R 11 is T2-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX745).
  • R 1 is a methyl group
  • R 11 is T2-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX746).
  • R 1 is a methyl group
  • R 11 is T2-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX752).
  • R 1 is a hydrogen atom
  • R 11 is T2-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX753).
  • R 1 is a methyl group
  • R 11 is T2-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX754).
  • compound (L-10) a compound in which R 1 is a hydrogen atom, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX757).
  • compound (L-10) R 1 is a methyl group, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX758).
  • R 1 is a hydrogen atom
  • R 11 is T2-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX767).
  • R 1 is a methyl group
  • R 11 is T2-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX768).
  • R 1 is a hydrogen atom
  • R 11 is T2-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX769).
  • compound (L-10) a compound in which R 1 is a hydrogen atom, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX779).
  • R 1 is a methyl group
  • R 11 is T2-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX780).
  • R 1 is a hydrogen atom
  • R 11 is T2-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX781).
  • R 1 is a methyl group
  • R 11 is T2-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX782).
  • R 1 is a hydrogen atom
  • R 11 is T2-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX783).
  • Formula (L-11) (hereinafter, referred to as compound (L-11)), in which R 1 is a hydrogen atom, R 11 is T2-1 (# 5 represents a bonding site to the nitrogen atom), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX785).
  • R 1 is a methyl group, R 11 is T2-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX786).
  • R 1 is a hydrogen atom, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX787).
  • R 1 is a methyl group, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX788).
  • R 1 is a hydrogen atom
  • R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX795).
  • R 1 is a methyl group
  • R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX796).
  • R 1 is a hydrogen atom
  • R 11 is T2-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX797).
  • R 1 is a hydrogen atom
  • R 11 is T2-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX801).
  • R 1 is a methyl group
  • R 11 is T2-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX802).
  • R 1 is a hydrogen atom
  • R 11 is T2-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX803).
  • R 1 is a methyl group
  • R 11 is T2-13
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX810).
  • R 1 is a hydrogen atom
  • R 11 is T2-14
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX811).
  • R 1 is a methyl group
  • R 1 is a hydrogen atom
  • R 11 is T2-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX813).
  • R 1 is a methyl group
  • R 11 is T2-15
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX814).
  • R 1 is a hydrogen atom
  • R 11 is T2-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX815).
  • R 1 is a methyl group
  • R 11 is T2-16
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX816).
  • R 1 is a hydrogen atom
  • R 11 is T2-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX817).
  • R 1 is a methyl group
  • R 11 is T2-17
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX818).
  • R 1 is a methyl group
  • R 11 is T2-10
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX838).
  • R 1 is a hydrogen atom
  • R 11 is T2-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX839).
  • R 1 is a methyl group
  • R 11 is T2-11
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX840).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-1
  • # 6 represents the bonding site to the carbon atom of the carbonyl group
  • R 2 is any of the substituents described in [Table L1] to [Table L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX853).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX860).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX861).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX864)
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX865).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX868).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX869).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX872).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX873).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX874)
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX875).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX878).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX879).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX880).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX881).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX882).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX883).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX890).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX891).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX896).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX897).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX898).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX899).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX900).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX901).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX913).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX914).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX933).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX934).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX935)
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX936).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX949).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX950).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX953).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX954).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX965)
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX966).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX967).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX968).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX971).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX972).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX973).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX974).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX975).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX976).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX977).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX978).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX985)
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX986).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX987).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX988).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX991).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX992).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX993).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX994).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX997).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX998).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1001).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1002).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1007).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1008).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1011).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1012).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1017).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1018).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1021).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1022).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1023).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1024).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1031).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1032).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1037).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1038).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1041).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1042).
  • compound (L-4) a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1045).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1046).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1049).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1050).
  • compound (L-4) a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1051).
  • compound group SX1052 a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1052).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1055)
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1056).
  • compound (L-4) a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1057).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1058).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1059).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1060).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1065).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1066).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1071).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1072).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1075).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1076).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1077).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1078).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1079).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1080).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1095)
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1096).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1097).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1098).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1101).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1102).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1107).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1108).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1113).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1114).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1115)
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1116).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-1
  • # 6 represents the bonding site to the carbon atom of the carbonyl group
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX1123).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1124).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1129).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1130).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1139).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1140).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1141).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1142).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1147).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1148).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1149).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1150).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1153).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1154).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1155).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1156).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1157).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1158).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1159).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1160).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1167).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1168).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1169).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1170).
  • compound (L-6) a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1171).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1172).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1173).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1174).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1175)
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T3-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1176).
  • Formula (L-13) (hereinafter, referred to as compound (L-13)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX1177).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1178).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1179).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1180).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-1
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1181).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1184).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1185).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1186).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-2
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1187).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1190).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1191).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1192).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1193).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-3
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1194).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1195).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-4
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1200).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1201).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-5
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1206).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1207).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1208).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1209).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-6
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1212).
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1213).
  • R 1 is a methyl group
  • R 10 is a hydrogen atom
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1214).
  • R 1 is a hydrogen atom
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1215).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1216).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-7
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1217).
  • R 1 is a methyl group
  • R 10 is a methyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1222).
  • R 1 is a hydrogen atom
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1223).
  • R 1 is a methyl group
  • R 10 is an ethyl group
  • R 11 is T1-8
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1224)
  • R 1 is a hydrogen atom
  • R 10 is a hydrogen atom
  • R 11 is T1-9
  • R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1225).

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Organic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Insects & Arthropods (AREA)
  • Dentistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Provided is a compound having an excellent controlling effect against harmful arthropods. A compound represented by formula (I) [wherein L represents a single bond, or the like; R1 represents a C1-C6 linear hydrocarbon group, or the like; R2 represents a 5- or 6-membered aromatic heterocyclic group, or the like; X represents NR11C(Z)R12, or the like; Z represents an oxygen atom, or the like; R11 represents a C1-C6 linear hydrocarbon group, or the like; R12 represents a phenyl group that may be substituted by one or more substituents, or the like; and Q represents a group represented by formula A1 (wherein # represents a binding position to 2, and ● represents a binding position to a carbon atom)] or an N-oxide thereof has an excellent controlling effect against harmful arthropods.

Description

縮合環化合物及びそれを含有する有害節足動物防除組成物Fused ring compound and harmful arthropod control composition containing the same

　本特許出願は、日本国特許出願２０２３－１７６５１７号（２０２３年１０月１２日出願）に基づくパリ条約上の優先権および利益を主張するものであり、ここに引用することによって、上記出願に記載された内容の全体が本明細書中に組み込まれるものとする。
　本発明は縮合環化合物及びそれを含有する有害節足動物防除組成物に関する。 This patent application claims priority and the benefit of Japanese Patent Application No. 2023-176517 (filed on October 12, 2023) under the Paris Convention, the entire contents of which are incorporated herein by reference.
The present invention relates to a fused ring compound and a composition for controlling harmful arthropods that contains the same.

　これまでに有害節足動物の防除を目的として、様々な化合物が検討されている。例えば、特許文献１にはある種の化合物が有害生物防除効果を有することが記載されている。 Various compounds have been investigated so far for the purpose of controlling harmful arthropods. For example, Patent Document 1 describes that certain compounds have a pest control effect.

国際公開第２０２２／２３３７７７号International Publication No. 2022/233777

　本発明は、有害節足動物に対して優れた防除効力を有する化合物を提供することを目的とする。 The present invention aims to provide a compound that has excellent control effect against harmful arthropods.

　本発明者らは、有害節足動物に対して優れた防除方法を見出すべく検討した結果、下記式（Ｉ）で示される化合物が有害節足動物に対して優れた防除効力を有することを見出した。
　本発明は、以下の通りである。
〔１〕　〔１〕　式（Ｉ）

Figure JPOXMLDOC01-appb-C000004
〔式中、
　Ｌは、単結合、又は－（ＣＲ4aＲ4b）n－を表し、
　Ｒ4a及びＲ4bは、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、シアノ基、ヒドロキシ基、ハロゲン原子、又は水素原子を表し、
　ｎは、１、２、３、４、５、又は６を表し、
　Ｒ1は、シクロプロピル基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、シアノ基、ハロゲン原子、ヒドロキシ基、又は水素原子を表し、
　Ｑは、式Ａ１で示される基、式Ａ２で示される基、式Ａ３で示される基、式Ａ４で示される基、式Ａ５で示される基、又は式Ａ６で示される基（＃はＲ2との結合部位を表し、●は炭素原子との結合部位を表す）を表し、
Figure JPOXMLDOC01-appb-C000005
 　Ｑ1、Ｑ2、及びＱ3の組合せは、
　　Ｑ1がＣＲ3q1であり、Ｑ2がＣＲ3q2であり、Ｑ3がＣＲ3q3である組合せ；
　　Ｑ1が窒素原子であり、Ｑ2がＣＲ3q2であり、Ｑ3がＣＲ3q3である組合せ；
　　Ｑ1がＣＲ3q1であり、Ｑ2が窒素原子であり、Ｑ3がＣＲ3q3である組合せ；又は
　　Ｑ1がＣＲ3q1であり、Ｑ2がＣＲ3q2であり、Ｑ3が窒素原子である組合せを表し、
　Ｑ1a及びＱ2aの組合せは、
　　Ｑ1aがＣＲ3q4であり、Ｑ2aがＣＲ3q5である組合せ；
　　Ｑ1aが窒素原子であり、Ｑ2aがＣＲ3q5である組合せ；又は
　　Ｑ1aがＣＲ3q4であり、Ｑ2aが窒素原子である組合せを表し、
　Ｒ3q1、Ｒ3q2、Ｒ3q3、Ｒ3q4、Ｒ3q5及びＲ4は、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、ＮＲ6Ｃ（Ｏ）Ｒ5、ＮＲ6Ｃ（Ｏ）ＯＲ5、ＮＲ6Ｃ（Ｏ）ＮＲ5Ｒ12、Ｃ（Ｏ）ＮＲ6Ｒ7、Ｃ（＝ＮＯＲ9）Ｒ5、Ｃ（＝ＮＯＲ9）（ＮＲ6Ｒ7）、Ｎ＝Ｓ（Ｏ）pＲ28Ｒ15、シアノ基、ハロゲン原子、又は水素原子を表し、
　Ｚ1は、酸素原子、又は硫黄原子を表し、
　ｐは、０又は１を表し、
　Ｒ5は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ6は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ7は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ9は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ12は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ15は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基を表し、
　Ｒ2は、群Ａより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ａより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、Ｃ（Ｏ）ＮＲ6Ｒ7、Ｃ（＝ＮＯＲ9）Ｒ5、Ｃ（＝ＮＯＲ9）（ＮＲ6Ｒ7）、Ｃ（Ｏ）Ｒ5、ＮＲ16Ｃ（Ｏ）Ｒ17、ＮＲ16Ｃ（Ｏ）ＯＲ17、ＮＲ16Ｃ（Ｏ）ＮＲ17Ｒ18、Ｓ（Ｏ）2ＮＲ16Ｒ17、ＯＲ18、Ｓ（Ｏ）mＲ15、メルカプト基、式Ｅ１で示される基、式Ｅ２で示される基、又は式Ｅ３で示される基（＃2は式Ａ１で示される基、式Ａ２で示される基、式Ａ３で示される基、式Ａ４で示される基、式Ａ５で示される基、又は式Ａ６で示される基との結合部位を表す）を表し、
Figure JPOXMLDOC01-appb-C000006
 　ｍは、０、１、又は２を表し、
　Ｒ16、Ｒ17、及びＲ18は、同一又は相異なり、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員複素環基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ2がＮＲ16Ｃ（Ｏ）Ｒ17である場合、Ｒ16及びＲ17は、Ｒ16が結合する窒素原子、及びＲ17が結合する炭素原子と一緒になって、Ｃ１－Ｃ３鎖式炭化水素基｛該Ｃ１－Ｃ３鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよい｝で置換されていてもよい５若しくは６員非芳香族複素環を形成していてもよく、
　Ｒ2がＮＲ16Ｃ（Ｏ）ＯＲ17である場合、Ｒ16及びＲ17は、Ｒ16が結合する窒素原子、窒素原子が結合する炭素原子、及びＲ17が結合する酸素原子と一緒になって、Ｃ１－Ｃ３鎖式炭化水素基｛該Ｃ１－Ｃ３鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよい｝で置換されていてもよい５若しくは６員非芳香族複素環を形成していてもよく、
　Ｒ2がＮＲ16Ｃ（Ｏ）ＮＲ17Ｒ18である場合、Ｒ16及びＲ17は、Ｒ16が結合する窒素原子、窒素原子が結合する炭素原子、及びＲ17が結合する窒素原子と一緒になって、Ｃ１－Ｃ３鎖式炭化水素基｛該Ｃ１－Ｃ３鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよい｝で置換されていてもよい５若しくは６員非芳香族複素環を形成していてもよく、
　Ｑ5は、ＣＲE11Ｒ27、ＮＲE12、酸素原子、又は硫黄原子を表し、
　Ｑ4は、ＣＲE13又は窒素原子を表し、
　Ｑ6は、ＣＲE14又は窒素原子を表し、
　Ｑ7は、ＣＲE15又は窒素原子を表し、
　Ｑ8は、ＣＲE16又は窒素原子を表し、
　Ｑ9は、ＣＲE17又は窒素原子を表し（但し、式Ｅ２で示される基において、Ｑ6及びＱ7が同時に窒素原子である場合、Ｑ6、Ｑ8、及びＱ9が同時に窒素原子である場合、並びにＱ7、Ｑ8、及びＱ9が同時に窒素原子である場合を除く）、
　Ｑ10は、ＣＲE18又は窒素原子を表し、
　ＲE11及びＲE31は、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、Ｃ（Ｏ）ＮＲ7Ｒ8、ＮＲ9Ｃ（Ｏ）Ｒ5、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、シアノ基、ハロゲン原子、又は水素原子を表し、
　Ｒ8は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　ＲE12及びＲE32は、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ27は、ハロゲン原子及びシアノ基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は水素原子を表し、
　ＲE13、ＲE14、ＲE15、ＲE16、ＲE17、及びＲE18は、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、Ｃ（Ｏ）ＮＲ7Ｒ8、ＮＲ9Ｃ（Ｏ）Ｒ5、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、シアノ基、ハロゲン原子、又は水素原子を表し、
　Ｘは、ＮＲ10Ｃ（Ｚ）Ｒ11、ＮＲ10Ｃ（Ｏ）ＯＲ11、ＮＲ10Ｃ（Ｚ）ＮＲ11Ｒ12、ＮＲ10Ｃ（＝ＮＯＲ9）Ｒ11、ＮＲ10Ｃ（＝ＮＯＲ9）（ＮＲ11Ｒ12）、Ｎ＝Ｃ（ＯＲ9）Ｒ11、Ｎ＝Ｃ（ＳＲ15）Ｒ11、Ｎ＝Ｃ（ＮＲ6Ｒ7）Ｒ11、ＮＲ10Ｘ1、又はＮ＝Ｓ（Ｏ）pＲ11Ｒ28を表し、
　Ｚは、酸素原子、又は硫黄原子を表し、
　Ｘ1は、群Ａより選ばれる１以上の置換基で置換されていてもよい９若しくは１０員芳香族複素環基を表し、
　Ｒ10は、群Ｆより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、Ｃ（＝ＮＲ7）Ｒ13、Ｃ（Ｏ）ＮＲ6Ｒ7 、又は水素原子を表し、
　Ｒ11は、群Ａより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は群Ａより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基を表し、
　Ｒ13は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、フェニル基｛該フェニル基は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、１以上のハロゲン原子で置換されていてもよい５若しくは６員芳香族複素環基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ14は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいフェニルメチル基、１以上のハロゲン原子で置換されていてもよいフェニル基、又は水素原子を表し、
　Ｒ28は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基を表す。
　群Ａ：Ｃ１－Ｃ６鎖式炭化水素基｛該Ｃ１－Ｃ６鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、Ｃ３－Ｃ６シクロアルキル基｛該Ｃ３－Ｃ６シクロアルキル基は、Ｃ１－Ｃ６アルコキシ基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ＯＲ3a、ＳＦ5、ＮＲ3dＯＲ3b、ＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3dＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3bＣ（Ｏ）ＯＲ3e、ＮＲ3dＮＲ3bＣ（Ｏ）ＯＲ3e、ＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、ＮＲ3dＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、Ｎ＝Ｓ（Ｏ）pＲ3hＲ3i、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）2ＮＲ3fＲ3g、ＮＲ3bＣ（＝ＮＯＲ3j）Ｒ3d、ＮＲ3bＳ（Ｏ）2Ｒ3k、Ｓ（Ｏ）mＲ3k、シアノ基、ニトロ基、及びハロゲン原子からなる群。
　Ｒ3aは、ハロゲン原子及びシアノ基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）2Ｒ3k、又は水素原子を表し、
　Ｒ3bは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子を表し、
　Ｒ3cは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、又は水素原子を表し、
　Ｒ3dは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子を表し、
　Ｒ3eは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよい（Ｃ３－Ｃ６シクロアルキル）Ｃ１－Ｃ３アルキル基、又は（Ｃ１－Ｃ３アルキル）フェニル基｛該（Ｃ１－Ｃ３アルキル）フェニル基におけるフェニル部分は、群Ｂより選ばれる１以上の置換基で置換されていてもよい｝を表し、
　Ｒ3fは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子を表し、
　Ｒ3gは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ3hは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、又は１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基を表し、
　Ｒ3iは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、又は１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基を表し、
　Ｒ3jは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は水素原子を表し、
　Ｒ3kは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基を表す。
　群Ｂ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、シアノ基、ヒドロキシ基、及びハロゲン原子からなる群。
　群Ｃ：群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ＯＲ3a、ＮＲ3dＯＲ3b、ＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3dＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3bＣ（Ｏ）ＯＲ3e、ＮＲ3dＮＲ3bＣ（Ｏ）ＯＲ3e、ＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、ＮＲ3dＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、Ｎ＝Ｓ（Ｏ）pＲ3hＲ3i、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、ニトロ基、及びハロゲン原子からなる群。
　群Ｅ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、ＯＲ3a、Ｓ（Ｏ）mＲ3k、オキソ基、シアノ基、及びハロゲン原子からなる群。
　群Ｆ：群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ＯＲ3a、Ｓ（Ｏ）mＲ3k、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、ＮＲ3bＲ3c、ＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、Ｎ＝Ｓ（Ｏ）pＲ3hＲ3i、３－６員非芳香族複素環基、シアノ基、及びハロゲン原子からなる群。〕
で示される化合物（以下、本発明化合物Ｎと記す）又はそのＮオキシド（以下、本発明化合物Ｎ又はそのＮオキシドを本発明化合物と記す）。
〔２〕　Ｒ3aが、ハロゲン原子及びシアノ基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、又は水素原子である、〔１〕に記載の化合物又はそのＮオキシド。
〔３〕　式（Ｉ）中、
　Ｌが、単結合であり、
　Ｒ1が、メチル基であり、
　Ｑが、式Ａ１で示される基、式Ａ２で示される基、又は式Ａ３で示される基であり、
　Ｑ1がＣＲ3q1であり、Ｑ2がＣＲ3q2であり、Ｑ3がＣＲ3q3であり、
　Ｒ3q1、Ｒ3q2、及びＲ3q3が、同一又は相異なり、メチル基、ハロゲン原子、又は水素原子であり、
　Ｑ1a及びＱ2aの組合せが、
　　Ｑ1aがＣＲ3q4であり、Ｑ2aがＣＲ3q5である組合せ；
　　Ｑ1aが窒素原子であり、Ｑ2aがＣＲ3q5である組合せ；又は
　　Ｑ1aがＣＲ3q4であり、Ｑ2aが窒素原子である組合せであり、
　Ｒ3q4、Ｒ3q5及びＲ4が、同一又は相異なり、メチル基、ハロゲン原子、又は水素原子であり、
　Ｒ2が、フェニル基、ピラゾリル基、チアゾリル基、オキサジアゾリル基、ピリジル基、ピリミジニル基｛該フェニル基、該ピラゾリル基、該チアゾリル基、該オキサジアゾリル基、該ピリジル基、及び該ピリミジニル基は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルコキシ基、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、Ｃ（Ｏ）ＮＲ6Ｒ7、Ｃ（＝ＮＯＲ9）Ｒ5、Ｃ（＝ＮＯＲ9）（ＮＲ6Ｒ7）、Ｃ（Ｏ）Ｒ5、又はＳ（Ｏ）mＲ15であり、
　Ｒ5が、Ｃ１－Ｃ３アルキル基であり、
　Ｒ6が、メチル基、又は水素原子であり、
　Ｒ7が、Ｃ１－Ｃ３アルキル基、又は水素原子であり、
　Ｒ9が、Ｃ１－Ｃ３アルキル基、又は水素原子であり、
　Ｒ15が、Ｃ１－Ｃ３アルキル基であり、
　ｍが、０、１、又は２であり、
　Ｘが、ＮＲ10Ｃ（Ｚ）Ｒ11、又はＮＲ10Ｃ（Ｚ）ＮＲ11Ｒ12であり、
　Ｚが、酸素原子であり、
　Ｒ10が、メチル基、又は水素原子であり、
　Ｒ11が、フェニル基、ピラゾリル基、ピリジル基{該フェニル基、該ピラゾリル基、及び該ピリジル基は、トリフルオロメチル基、ジフルオロメチル基、トリフルオロメトキシ基、ジフルオロメトキシ基、メタンスルホニル基、トリフルオロメタンスルホニル基、シアノ基、シアノ基に置換されていてもよいシクロプロピル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、
　Ｒ12が、水素原子である、〔１〕若しくは〔２〕に記載の化合物又はそのＮオキシド。
〔４〕　式（Ｉ）中、
　Ｌが、単結合であり、
　Ｒ1が、メチル基であり、
　Ｑが、式Ａ１で示される基、又は式Ａ２で示される基であり、
　Ｑ1がＣＲ3q1であり、Ｑ2がＣＲ3q2であり、Ｑ3がＣＲ3q3であり、
　Ｒ3q1、Ｒ3q2、及びＲ3q3が、水素原子であり、
　Ｒ2が、フェニル基、ピラゾリル基、ピリジル基、又はピリミジニル基｛該フェニル基、該ピラゾリル基、該ピリジル基、及び該ピリミジニル基は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、
　Ｘが、ＮＲ10Ｃ（Ｚ）Ｒ11、又はＮＲ10Ｃ（Ｚ）ＮＲ11Ｒ12であり、
　Ｚが、酸素原子であり、
　Ｒ10が、メチル基、又は水素原子であり、
　Ｒ11が、フェニル基、ピラゾリル基、ピリジル基{該フェニル基、該ピラゾリル基、及び該ピリジル基は、トリフルオロメチル基、ジフルオロメチル基、トリフルオロメトキシ基、ジフルオロメトキシ基、メタンスルホニル基、トリフルオロメタンスルホニル基、シアノ基、シアノ基に置換されていてもよいシクロプロピル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、
　Ｒ12が、水素原子である、〔１〕～〔３〕のいずれかに記載の化合物又はそのＮオキシド。
〔５〕　〔１〕～〔４〕のいずれかに記載の化合物又はそのＮオキシドと、不活性担体とを含有する有害節足動物防除組成物。
〔６〕　群（ａ）、群（ｂ）、群（ｃ）及び群（ｄ）からなる群より選ばれる１以上の成分、並びに、〔１〕～〔４〕のいずれかに記載の化合物又はそのＮオキシドを含有する組成物：
　群（ａ）：殺虫活性成分、殺ダニ活性成分及び殺線虫活性成分からなる群；
　群（ｂ）：殺菌活性成分；
　群（ｃ）：植物成長調整成分；
　群（ｄ）：忌避成分。
〔７〕　〔１〕～〔４〕のいずれかに記載の化合物若しくはそのＮオキシドの有効量又は請求項６に記載の組成物の有効量を有害節足動物又は有害節足動物の生息場所に施用する有害節足動物の防除方法。
〔８〕　〔１〕～〔４〕のいずれかに記載の化合物若しくはそのＮオキシドの有効量又は請求項６に記載の組成物の有効量を保持している種子又は栄養生殖器官。 The present inventors have conducted studies to find an excellent method for controlling harmful arthropods, and as a result have found that a compound represented by the following formula (I) has excellent control activity against harmful arthropods.
The present invention is as follows.
[1] [1] Formula (I)
Figure JPOXMLDOC01-appb-C000004
 [Wherein,
L represents a single bond or --(CR 4a R 4b ) n --;
R 4a and R 4b are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a cyano group, a hydroxyl group, a halogen atom, or a hydrogen atom;
n represents 1, 2, 3, 4, 5, or 6;
R 1 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a cyclopropyl group and a halogen atom, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a cyano group, a halogen atom, a hydroxyl group, or a hydrogen atom;
Q represents a group represented by formula A1, a group represented by formula A2, a group represented by formula A3, a group represented by formula A4, a group represented by formula A5, or a group represented by formula A6 (# represents a bonding site to R2 , and ● represents a bonding site to a carbon atom);
Figure JPOXMLDOC01-appb-C000005
 The combination of Q 1 , Q 2 , and Q 3 is
A combination in which Q1 is CR3q1 , Q2 is CR3q2 , and Q3 is CR3q3 ;
A combination in which Q 1 is a nitrogen atom, Q 2 is CR 3q2 , and Q 3 is CR 3q3 ;
a combination in which Q 1 is CR 3q1 , Q 2 is a nitrogen atom, and Q 3 is CR 3q3 ; or a combination in which Q 1 is CR 3q1 , Q 2 is CR 3q2 , and Q 3 is a nitrogen atom;
The combination of Q 1a and Q 2a is
A combination in which Q 1a is CR 3q4 and Q 2a is CR 3q5 ;
a combination in which Q 1a is a nitrogen atom and Q 2a is CR 3q5 ; or a combination in which Q 1a is CR 3q4 and Q 2a is a nitrogen atom;
R 3q1 , R 3q2 , R 3q3 , R 3q4 , R 3q5 and R 4 are the same or different and are a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, NR 6 C(O)R 5 , NR 6 C(O)OR 5 , NR 6 C(O)NR 5 R 12 , C(O)NR 6 R 7 , C(═NOR 9 )R 5 , C(═NOR 9 )( NR 6 R 7 ), N═S(O) p R 28 R 15 , a cyano group, a halogen atom, or a hydrogen atom;
Z represents an oxygen atom or a sulfur atom;
p represents 0 or 1;
R5 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom;
R 6 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
R 7 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a phenyl group which may be substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group which may be substituted with one or more substituents selected from group B, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
R 9 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom;
R 12 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
R 15 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a phenyl group which may be substituted with one or more substituents selected from group B, or a 5- or 6-membered aromatic heterocyclic group which may be substituted with one or more substituents selected from group B;
R2 is a phenyl group which may be substituted by one or more substituents selected from group A, a 5- or 6-membered aromatic heterocyclic group which may be substituted by one or more substituents selected from group A, C(O) NR6R7 , C(= NOR9 ) R5 , C(= NOR9 )( NR6R7 ), C(O) R5 , NR16C (O) R17 , NR16C (O) OR17 , NR16C (O) NR17R18 , S(O ) 2NR16R17 , OR18 , S( O ) mR15 , a mercapto group, a group represented by formula E1 , a group represented by formula E2, or a group represented by formula E3 (# 2 represents a bonding site to a group represented by formula A1, a group represented by formula A2, a group represented by formula A3, a group represented by formula A4, a group represented by formula A5, or a group represented by formula A6),
Figure JPOXMLDOC01-appb-C000006
 m represents 0, 1, or 2;
R 16 , R 17 , and R 18 are the same or different and represent a phenyl group which may be substituted with one or more substituents selected from group B, a 5- or 6-membered heterocyclic group which may be substituted with one or more substituents selected from group B, a C1-C6 alkyl group which may be substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
When R 2 is NR 16 C(O)R 17 , R 16 and R 17 may together with the nitrogen atom to which R 16 is bonded and the carbon atom to which R 17 is bonded form a 5- or 6-membered non-aromatic heterocycle which may be substituted with a C1-C3 chain hydrocarbon group (the C1-C3 chain hydrocarbon group may be substituted with one or more halogen atoms);
When R 2 is NR 16 C(O)OR 17 , R 16 and R 17 may together with the nitrogen atom to which R 16 is bonded, the carbon atom to which the nitrogen atom is bonded, and the oxygen atom to which R 17 is bonded form a 5- or 6-membered non-aromatic heterocycle which may be substituted with a C1-C3 chain hydrocarbon group (the C1-C3 chain hydrocarbon group may be substituted with one or more halogen atoms);
When R 2 is NR 16 C(O)NR 17 R 18 , R 16 and R 17 may together with the nitrogen atom to which R 16 is bonded, the carbon atom to which the nitrogen atom is bonded, and the nitrogen atom to which R 17 is bonded form a 5- or 6-membered non-aromatic heterocycle which may be substituted with a C1-C3 chain hydrocarbon group (the C1-C3 chain hydrocarbon group may be substituted with one or more halogen atoms);
Q5 represents CR E11 R 27 , NR E12 , an oxygen atom or a sulfur atom;
Q4 represents CR E13 or a nitrogen atom;
Q6 represents CR E14 or a nitrogen atom;
Q7 represents CR E15 or a nitrogen atom;
Q8 represents CR E16 or a nitrogen atom;
Q9 represents CR E17 or a nitrogen atom (excluding the cases where, in the group represented by formula E2, Q6 and Q7 are simultaneously nitrogen atoms, Q6 , Q8 and Q9 are simultaneously nitrogen atoms, and Q7 , Q8 and Q9 are simultaneously nitrogen atoms);
Q represents CR or a nitrogen atom;
R E11 and R E31 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, C(O)NR 7 R 8 , NR 9 C(O)R 5 , a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, a cyano group, a halogen atom, or a hydrogen atom;
R 8 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
R E12 and R E32 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom;
R 27 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of halogen atoms and cyano groups, a phenyl group optionally substituted with one or more substituents selected from group B, or a hydrogen atom;
R E13 , R E14 , R E15 , R E16 , R E17 , and R E18 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, C(O)NR 7 R 8 , NR 9 C(O)R 5 , a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, a cyano group, a halogen atom, or a hydrogen atom;
X represents NR10C (Z) R11 , NR10C (O)OR11, NR10C(Z) NR11R12 , NR10C (= NOR9 ) R11 , NR10C (= NOR9 ) ( NR11R12 ), N = C( OR9 ) R11 , N = C( SR15 ) R11 , N=C ( NR6R7 ) R11 , NR10X1 , or N = S(O) pR11R28 ;
Z represents an oxygen atom or a sulfur atom;
X 1 represents a 9- or 10-membered aromatic heterocyclic group optionally substituted by one or more substituents selected from group A;
R 10 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group F, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, OR 14 , C(O)R 13 , C(O)OR 13 , C(═NR 7 )R 13 , C(O)NR 6 R 7 , or a hydrogen atom;
R 11 represents a phenyl group which may be substituted with one or more substituents selected from group A, or a 5- or 6-membered aromatic heterocyclic group which may be substituted with one or more substituents selected from group A,
R 13 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group {the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom}, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 14 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 28 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, or a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E.
Group A: C1-C6 chain hydrocarbon group {the C1-C6 chain hydrocarbon group may be substituted with one or more substituents selected from the group consisting of a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom}, a C3-C6 cycloalkyl group {the C3-C6 cycloalkyl group may be substituted with one or more substituents selected from the group consisting of a C1-C6 alkoxy group, a cyano group, and a halogen atom}, a phenyl group optionally substituted with one or more substituents selected from Group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from Group B, OR 3a , SF 5 , NR 3d OR 3b , NR 3b C(O)R 3c , NR 3d NR 3b C(O)R 3c , NR 3b C (O)OR 3e , NR 3d NR 3b C (O)OR 3e , NR 3b C(O)NR 3f R 3g , NR 3d NR 3b C(O)NR 3f R 3g , N=S(O) p R 3h R 3i , C(O)R 3c , C(O)OR 3j , C(O)NR 3f R 3g , S(O) 2 A group consisting of NR 3f R 3g , NR 3b C(=NOR 3j )R 3d , NR 3b S(O) 2 R 3k , S(O) m R 3k , a cyano group, a nitro group, and a halogen atom.
R 3a represents a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of a halogen atom and a cyano group, a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, C(O)R 3c , C(O)OR 3j , C(O)NR 3f R 3g , S(O) 2 R 3k , or a hydrogen atom;
R 3b represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 3c represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, or a hydrogen atom;
R 3d represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 3e represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a (C3-C6 cycloalkyl)C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a (C1-C3 alkyl)phenyl group {the phenyl moiety in the (C1-C3 alkyl)phenyl group may be substituted with one or more substituents selected from group B},
R 3f represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 3g represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 3h represents a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms;
R 3i represents a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms;
R 3j represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, or a hydrogen atom;
R 3k represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms.
Group B: a group consisting of C1-C6 chain hydrocarbon groups optionally substituted with one or more halogen atoms, C3-C6 cycloalkyl groups optionally substituted with one or more halogen atoms, C1-C6 alkoxy groups optionally substituted with one or more halogen atoms, cyano groups, hydroxy groups, and halogen atoms.
Group C: a C3-C6 cycloalkyl group optionally substituted by one or more substituents selected from group E, a phenyl group optionally substituted by one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted by one or more substituents selected from group B, OR 3a , NR 3d OR 3b , NR 3b C(O)R 3c , NR 3d NR 3b C(O)R 3c , NR 3b C(O)OR 3e , NR 3d NR 3b C(O)OR 3e , NR 3b C(O ) NR 3f R 3g , NR 3d NR 3b C(O)NR 3f R 3g , N═S(O) p R 3h R 3i , C(O)R 3c , C(O) OR the group consisting of C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, a nitro group, and a halogen atom ;
Group E: a group consisting of a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, OR 3a , S(O) m R 3k , an oxo group, a cyano group, and a halogen atom.
Group F: a group consisting of a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from Group E, a phenyl group optionally substituted with one or more substituents selected from Group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from Group B, OR 3a , S(O) mR 3k , C(O)R 3c , C(O)OR 3j , C(O)NR 3fR 3g , NR 3bR 3c , NR 3bC (O)R 3c , NR 3bC (O)NR 3fR 3g , N═S(O) pR 3hR 3i , a 3- to 6-membered non-aromatic heterocyclic group, a cyano group, and a halogen atom.
(hereinafter referred to as compound N of the present invention) or an N-oxide thereof (hereinafter, compound N of the present invention or an N-oxide thereof will be referred to as compound of the present invention).
[2] The compound according to [1] or an N-oxide thereof, wherein R 3a is a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of halogen atoms and cyano groups, a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, C(O)R 3c , C(O)OR 3j , C(O)NR 3f R 3g , or a hydrogen atom.
[3] In formula (I),
L is a single bond,
R 1 is a methyl group;
Q is a group represented by formula A1, a group represented by formula A2, or a group represented by formula A3;
Q1 is CR3q1 , Q2 is CR3q2 , and Q3 is CR3q3 ;
R 3q1 , R 3q2 , and R 3q3 are the same or different and each is a methyl group, a halogen atom, or a hydrogen atom;
The combination of Q 1a and Q 2a is
A combination in which Q 1a is CR 3q4 and Q 2a is CR 3q5 ;
a combination in which Q 1a is a nitrogen atom and Q 2a is CR 3q5 ; or a combination in which Q 1a is CR 3q4 and Q 2a is a nitrogen atom,
R 3q4 , R 3q5 and R 4 are the same or different and each is a methyl group, a halogen atom, or a hydrogen atom;
R 2 is a phenyl group, a pyrazolyl group, a thiazolyl group, an oxadiazolyl group, a pyridyl group, a pyrimidinyl group {the phenyl group, the pyrazolyl group, the thiazolyl group, the oxadiazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom}, C(O)NR 6 R 7 , C(═NOR 9 )R 5 , C(═NOR 9 )(NR 6 R 7 ), C(O)R 5 , or S(O) m R 15 ;
R5 is a C1-C3 alkyl group;
R6 is a methyl group or a hydrogen atom;
R 7 is a C1-C3 alkyl group or a hydrogen atom;
R 9 is a C1-C3 alkyl group or a hydrogen atom;
R 15 is a C1-C3 alkyl group;
m is 0, 1, or 2;
X is NR10C (Z) R11 or NR10C (Z) NR11R12 ;
Z is an oxygen atom;
R 10 is a methyl group or a hydrogen atom;
R 11 is a phenyl group, a pyrazolyl group, or a pyridyl group {the phenyl group, the pyrazolyl group, and the pyridyl group may be substituted with one or more substituents selected from the group consisting of a trifluoromethyl group, a difluoromethyl group, a trifluoromethoxy group, a difluoromethoxy group, a methanesulfonyl group, a trifluoromethanesulfonyl group, a cyano group, a cyclopropyl group which may be substituted with a cyano group, and a halogen atom},
The compound according to [1] or [2], wherein R 12 is a hydrogen atom, or an N-oxide thereof.
[4] In formula (I),
L is a single bond;
R 1 is a methyl group;
Q is a group represented by formula A1 or a group represented by formula A2,
Q1 is CR3q1 , Q2 is CR3q2 , and Q3 is CR3q3 ;
R 3q1 , R 3q2 , and R 3q3 are a hydrogen atom;
R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group {the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom},
X is NR10C (Z) R11 or NR10C (Z) NR11R12 ;
Z is an oxygen atom;
R 10 is a methyl group or a hydrogen atom;
R 11 is a phenyl group, a pyrazolyl group, or a pyridyl group {the phenyl group, the pyrazolyl group, and the pyridyl group may be substituted with one or more substituents selected from the group consisting of a trifluoromethyl group, a difluoromethyl group, a trifluoromethoxy group, a difluoromethoxy group, a methanesulfonyl group, a trifluoromethanesulfonyl group, a cyano group, a cyclopropyl group which may be substituted with a cyano group, and a halogen atom},
The compound or N-oxide thereof according to any one of [1] to [3], wherein R 12 is a hydrogen atom.
[5] A harmful arthropod control composition comprising the compound according to any one of [1] to [4] or an N-oxide thereof and an inert carrier.
[6] A composition comprising one or more components selected from the group consisting of group (a), group (b), group (c), and group (d), and a compound or an N-oxide thereof according to any one of [1] to [4]:
Group (a): A group consisting of insecticidal active ingredients, acaricidal active ingredients and nematicidal active ingredients;
Group (b): bactericidal active ingredient;
Group (c): plant growth regulating ingredients;
Group (d): repellent components.
[7] A method for controlling harmful arthropods, comprising applying an effective amount of the compound according to any one of [1] to [4] or an N-oxide thereof, or an effective amount of the composition according to claim 6 to harmful arthropods or a habitat of harmful arthropods.
[8] A seed or a vegetative reproductive organ carrying an effective amount of the compound according to any one of [1] to [4] or an N-oxide thereof, or an effective amount of the composition according to claim 6.

　本発明により、有害節足動物を防除することができる。 The present invention makes it possible to control harmful arthropods.

　本発明における置換基について説明する。
　ハロゲン原子とは、フッ素原子、塩素原子、臭素原子、又はヨウ素原子を意味する。
　置換基が２以上のハロゲン原子又は置換基を有している場合、それらのハロゲン原子又は置換基は、各々同一でも異なっていてもよい。
　本明細書における「ＣＸ－ＣＹ」との表記は、炭素原子数がＸ乃至Ｙであることを意味する。例えば「Ｃ１－Ｃ６」との表記は、炭素原子数が１乃至６であることを意味する。
　鎖式炭化水素基とは、アルキル基、アルケニル基又はアルキニル基を表す。
　アルキル基としては、例えば、メチル基、エチル基、プロピル基、イソプロピル基、１，１－ジメチルプロピル基、１，２－ジメチルプロピル基、１－エチルプロピル基、ブチル基、ｓｅｃ－ブチル基、ｔｅｒｔ－ブチル基、ペンチル基、及びヘキシル基が挙げられる。
　アルケニル基としては、例えば、ビニル基、１－プロペニル基、２－プロペニル基、１－メチル－１－プロペニル基、１－メチル－２－プロペニル基、１，２－ジメチル－１－プロペニル基、１－エチル－２－プロペニル基、３－ブテニル基、４－ペンテニル基、及び５－ヘキセニル基が挙げられる。
　アルキニル基としては、例えば、エチニル基、１－プロピニル基、２－プロピニル基、１－メチル－２－プロピニル基、１，１－ジメチル－２－プロピニル基、１－エチル－２－プロピニル基、２－ブチニル基、４－ペンチニル基、及び５－ヘキシニル基が挙げられる。
　アルコキシ基としては、例えば、メトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、ｔｅｒｔ－ブトキシ基、ペンチルオキシ基、及びヘキシルオキシ基が挙げられる。
　５若しくは６員芳香族複素環基としては、例えば、ピラゾリル基、イミダゾリル基、トリアゾリル基、テトラゾリル基、オキサゾリル基、イソオキサゾリル基、チアゾリル基、イソチアゾリル基、オキサジアゾリル基、チアジアゾリル基、ピリジル基、ピリダジニル基、ピリミジニル基、及びピラジニル基が挙げられる。
　９員芳香族複素環基としては、例えば、ベンゾオキサゾリル基、ベンゾイソオキサゾリル基、ベンゾチアゾリル基、ベンゾイソチアゾリル基、及びトリアゾロピリジル基が挙げられる。１０員芳香族複素環基としては、例えば、キノリル基、イソキノリル基、キナゾリニル基、及びキナゾロニル基が挙げられる。
　１以上のハロゲン原子で置換されていてもよい（Ｃ３－Ｃ６シクロアルキル）Ｃ１－Ｃ３アルキル基とは、（Ｃ３－Ｃ６シクロアルキル）及び／又は（Ｃ１－Ｃ３アルキル）が１以上のハロゲン原子を有していてもよい基を表し、例えば、シクロプロピルメチル基、シクロプロピルエチル基、（２，２－ジフルオロシクロプロピル）メチル基、２－シクロプロピル－１，１，２，２－テトラフルオロエチル基、及び２－（２，２－ジフルオロシクロプロピル）－１，１，２，２－テトラフルオロエチル基が挙げられる。
　フェニルＣ１－Ｃ３アルキル基｛該フェニルＣ１－Ｃ３アルキル基におけるフェニル部分は、群Ｂより選ばれる１以上の置換基で置換されていてもよい｝とは、例えば、ベンジル基、２－フルオロベンジル基、４－クロロベンジル基、４－（トリフルオロメチル）ベンジル基、及び２－［４－（トリフルオロメチル）フェニル］エチル基が挙げられる。
　３－６員非芳香族複素環基としては、例えば、オキセタニル基、ピロリジニル基、２－オキソピロリジニル基、２－オキソイミダゾリジニル基、３，４，５，６－テトラヒドロ－２－ピリミジニル基、テトラヒドロフラニル基、ピペリジル基、テトラヒドロピラニル基、イソオキサゾリジニル基、及びモルホリニル基が挙げられる。
　アルキルスルホニル基としては、例えば、メチルスルホニル基、エチルスルホニル基、プロピルスルホニル基、及びイソプロピルスルホニル基が挙げられる。
　シクロアルキルスルホニル基としては、例えば、シクロプロピルスルホニル基、シクロブチルスルホニル基、及びシクロヘキシルスルホニル基が挙げられる。 The substituents in the present invention will be described below.
A halogen atom means a fluorine atom, a chlorine atom, a bromine atom, or an iodine atom.
When a substituent has two or more halogen atoms or substituents, those halogen atoms or substituents may be the same or different.
In this specification, the notation "CX-CY" means that the number of carbon atoms is X to Y. For example, the notation "C1-C6" means that the number of carbon atoms is 1 to 6.
The chain hydrocarbon group refers to an alkyl group, an alkenyl group, or an alkynyl group.
Examples of the alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a 1,1-dimethylpropyl group, a 1,2-dimethylpropyl group, a 1-ethylpropyl group, a butyl group, a sec-butyl group, a tert-butyl group, a pentyl group, and a hexyl group.
Examples of the alkenyl group include a vinyl group, a 1-propenyl group, a 2-propenyl group, a 1-methyl-1-propenyl group, a 1-methyl-2-propenyl group, a 1,2-dimethyl-1-propenyl group, a 1-ethyl-2-propenyl group, a 3-butenyl group, a 4-pentenyl group, and a 5-hexenyl group.
Examples of the alkynyl group include an ethynyl group, a 1-propynyl group, a 2-propynyl group, a 1-methyl-2-propynyl group, a 1,1-dimethyl-2-propynyl group, a 1-ethyl-2-propynyl group, a 2-butynyl group, a 4-pentynyl group, and a 5-hexynyl group.
Examples of alkoxy groups include methoxy, ethoxy, propoxy, isopropoxy, butoxy, tert-butoxy, pentyloxy, and hexyloxy groups.
Examples of the 5- or 6-membered aromatic heterocyclic group include a pyrazolyl group, an imidazolyl group, a triazolyl group, a tetrazolyl group, an oxazolyl group, an isoxazolyl group, a thiazolyl group, an isothiazolyl group, an oxadiazolyl group, a thiadiazolyl group, a pyridyl group, a pyridazinyl group, a pyrimidinyl group, and a pyrazinyl group.
Examples of the 9-membered aromatic heterocyclic group include a benzoxazolyl group, a benzoisoxazolyl group, a benzothiazolyl group, a benzoisothiazolyl group, and a triazolopyridyl group. Examples of the 10-membered aromatic heterocyclic group include a quinolyl group, an isoquinolyl group, a quinazolinyl group, and a quinazolonyl group.
The (C3-C6 cycloalkyl)C1-C3 alkyl group optionally substituted with one or more halogen atoms refers to a group in which the (C3-C6 cycloalkyl) and/or (C1-C3 alkyl) may have one or more halogen atoms, and examples thereof include a cyclopropylmethyl group, a cyclopropylethyl group, a (2,2-difluorocyclopropyl)methyl group, a 2-cyclopropyl-1,1,2,2-tetrafluoroethyl group, and a 2-(2,2-difluorocyclopropyl)-1,1,2,2-tetrafluoroethyl group.
Examples of the phenyl C1-C3 alkyl group {the phenyl moiety in the phenyl C1-C3 alkyl group may be substituted with one or more substituents selected from group B} include a benzyl group, a 2-fluorobenzyl group, a 4-chlorobenzyl group, a 4-(trifluoromethyl)benzyl group, and a 2-[4-(trifluoromethyl)phenyl]ethyl group.
Examples of the 3- to 6-membered non-aromatic heterocyclic group include an oxetanyl group, a pyrrolidinyl group, a 2-oxopyrrolidinyl group, a 2-oxoimidazolidinyl group, a 3,4,5,6-tetrahydro-2-pyrimidinyl group, a tetrahydrofuranyl group, a piperidyl group, a tetrahydropyranyl group, an isoxazolidinyl group, and a morpholinyl group.
Examples of the alkylsulfonyl group include a methylsulfonyl group, an ethylsulfonyl group, a propylsulfonyl group, and an isopropylsulfonyl group.
Examples of the cycloalkylsulfonyl group include a cyclopropylsulfonyl group, a cyclobutylsulfonyl group, and a cyclohexylsulfonyl group.

　シクロアルキル基としては、例えばシクロプロピル基、シクロブチル基、シクロペンチル基、及びシクロヘキシル基が挙げられる。 Cycloalkyl groups include, for example, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl groups.

　本発明化合物は、一つ以上の立体異性体が存在する場合がある。立体異性体としては、エナンチオマー、ジアステレオマー及び幾何異性体などが挙げられる。本発明化合物には各立体異性体及び任意の比率の立体異性体混合物が含まれる。 The compound of the present invention may exist as one or more stereoisomers. Examples of stereoisomers include enantiomers, diastereomers, and geometric isomers. The compound of the present invention includes each stereoisomer and a mixture of stereoisomers in any ratio.

　式（Ｉ）で示される化合物のＮオキシドは、式（Ｉ）で示される化合物に含まれる少なくとも１つの窒素原子がオキソ基で置換された構造を意味する。 The N-oxide of the compound represented by formula (I) means a structure in which at least one nitrogen atom contained in the compound represented by formula (I) is substituted with an oxo group.

　本発明化合物Ｎは、酸付加塩を形成することがある。酸付加塩を形成する酸としては、例えば、塩化水素、リン酸、硫酸等の無機酸、及び酢酸、トリフルオロ酢酸、安息香酸、ｐ－トルエンスルホン酸等の有機酸が挙げられる。酸付加塩は、例えば、本発明化合物Ｎと酸とを混合することにより得られる。 Compound N of the present invention may form an acid addition salt. Examples of acids that form acid addition salts include inorganic acids such as hydrogen chloride, phosphoric acid, and sulfuric acid, and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid. Acid addition salts can be obtained, for example, by mixing compound N of the present invention with an acid.

　本発明化合物Ｎの態様としては、以下の化合物が挙げられる。 The following compounds are examples of compound N of the present invention.

〔態様１〕本発明化合物Ｎにおいて、Ｑが式Ａ１－１で示される基、式Ａ１－２で示される基、式Ａ２－１で示される基、式Ａ２－２で示される基、式Ａ２－３で示される基、式Ａ３－１で示される基、式Ａ３－２で示される基、式Ａ４－１で示される基、式Ａ４－２で示される基、又は式Ａ５－１で示される基（＃はＲ2との結合部位を表し、●は炭素原子との結合部位を表す）であり、Ｒ3q1、Ｒ3q2、Ｒ3q3、Ｒ3q4、Ｒ3q5及びＲ4が、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、群Ｂより選ばれる1以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、群Ｅより選ばれる１以上の置換基で置換されていてもよいシクロプロピル基、シアノ基、ハロゲン原子、又は水素原子である化合物。

Figure JPOXMLDOC01-appb-C000007
〔態様２〕本発明化合物Ｎにおいて、Ｑが式Ａ１－１で示される基、式Ａ１－２で示される基、式Ａ２－１で示される基、式Ａ２－２で示される基、式Ａ２－３で示される基、式Ａ３－１で示される基、又は式Ａ３－２で示される基（＃はＲ2との結合部位を表し、●は炭素原子との結合部位を表す）であり、Ｒ3q1、Ｒ3q2、Ｒ3q3、Ｒ3q4、Ｒ3q5及びＲ4が、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいシクロプロピル基、シアノ基、ハロゲン原子、又は水素原子である化合物。
〔態様３〕本発明化合物Ｎにおいて、Ｑが式Ａ１－１で示される基、式Ａ２－１で示される基、式Ａ３－１で示される基、又は式Ａ３－２で示される基（＃はＲ2との結合部位を表し、●は炭素原子との結合部位を表す）であり、Ｒ3q1、Ｒ3q2、Ｒ3q3、Ｒ3q4、Ｒ3q5及びＲ4が、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、ハロゲン原子、又は水素原子である化合物。
〔態様４〕本発明化合物Ｎにおいて、Ｌが単結合、又は－（ＣＲ4aＲ4b）n－であり、Ｒ4a及びＲ4bが、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基であり、ｎが１、２、又は３である化合物。
〔態様５〕本発明化合物Ｎにおいて、Ｌが単結合である化合物。
〔態様６〕態様１において、Ｌが単結合、又は－（ＣＲ4aＲ4b）n－であり、Ｒ4a及びＲ4bが、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子であり、ｎが１、２、又は３である化合物。
〔態様７〕態様２において、Ｌが単結合、又は－（ＣＲ4aＲ4b）n－であり、Ｒ4a及びＲ4bが、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子であり、ｎが１、２、又は３である化合物。
〔態様８〕態様３において、Ｌが単結合、又は－（ＣＲ4aＲ4b）n－であり、Ｒ4a及びＲ4bが、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子であり、ｎが１、２、又は３である化合物。
〔態様９〕態様１において、Ｌが単結合である化合物。
〔態様１０〕態様２において、Ｌが単結合である化合物。
〔態様１１〕態様３において、Ｌが単結合である化合物。
〔態様１２〕本発明化合物Ｎにおいて、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様１３〕本発明化合物Ｎにおいて、Ｒ1がメチル基である化合物。
〔態様１４〕態様１において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様１５〕態様２において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様１６〕態様３において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様１７〕態様４において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様１８〕態様５において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様１９〕態様６において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様２０〕態様７において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様２１〕態様８において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様２２〕態様９において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様２３〕態様１０において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様２４〕態様１１において、Ｒ1が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、又は水素原子である化合物。
〔態様２５〕態様１において、Ｒ1がメチル基である化合物。
〔態様２６〕態様２において、Ｒ1がメチル基である化合物。
〔態様２７〕態様３において、Ｒ1がメチル基である化合物。
〔態様２８〕態様４において、Ｒ1がメチル基である化合物。
〔態様２９〕態様５において、Ｒ1がメチル基である化合物。
〔態様３０〕態様６において、Ｒ1がメチル基である化合物。
〔態様３１〕態様７において、Ｒ1がメチル基である化合物。
〔態様３２〕態様８において、Ｒ1がメチル基である化合物。
〔態様３３〕態様９において、Ｒ1がメチル基である化合物。
〔態様３４〕態様１０において、Ｒ1がメチル基である化合物。
〔態様３５〕態様１１において、Ｒ1がメチル基である化合物。
〔態様３６〕本発明化合物Ｎにおいて、Ｑが式Ａ１で示される基であり、Ｑ1、Ｑ2、及びＱ3がＣＨであり、Ｒ1がシクロプロピル基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６アルキル基であり、Ｌが単結合である化合物。
〔態様３７〕態様１～態様３６又は本発明化合物Ｎのいずれかにおいて、Ｒ2がフェニル基、５若しくは６員芳香族複素環基｛該フェニル基、及び該５若しくは６員芳香族複素環基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよいシクロプロピル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、ＯＲ3a、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、Ｃ（Ｏ）ＮＲ6Ｒ7、ＮＲ16Ｃ（Ｏ）Ｒ17、ＮＲ16Ｃ（Ｏ）ＯＲ17、ＮＲ16Ｃ（Ｏ）ＮＲ17Ｒ18、ＯＲ18、式Ｅ１－１で示される基、式Ｅ１－２で示される基、式Ｅ２－１で示される基、式Ｅ２－２で示される基、式Ｅ３－１で示される基、又は式Ｅ３－２で示される基（＃2は式Ａ１で示される基、式Ａ２で示される基、式Ａ３で示される基、式Ａ４で示される基、式Ａ５で示される基、又は式Ａ６で示される基との結合部位を表す）であり、
Figure JPOXMLDOC01-appb-C000008
 Ｒ18が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子であり、Ｒ2がＮＲ16Ｃ（Ｏ）Ｒ17であり、Ｒ16及びＲ17が、Ｒ16が結合する窒素原子、及びＲ17が結合する炭素原子と一緒になって、Ｃ１－Ｃ３鎖式炭化水素基｛該Ｃ１－Ｃ３鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよい｝で置換されていてもよい５若しくは６員非芳香族複素環を形成する場合、Ｒ2が、式Ｅ４－１で示される基、式Ｅ４－２で示される基、式Ｅ４－３で示される基、式Ｅ４－４で示される基、又は式Ｅ４－５で示される基であり、
Figure JPOXMLDOC01-appb-C000009
 Ｒ2がＮＲ16Ｃ（Ｏ）ＯＲ17であり、Ｒ16及びＲ17が、Ｒ16が結合する窒素原子、窒素原子が結合する炭素原子、及びＲ17が結合する酸素原子と一緒になって、Ｃ１－Ｃ３鎖式炭化水素基｛該Ｃ１－Ｃ３鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよい｝で置換されていてもよい５若しくは６員非芳香族複素環を形成する場合、Ｒ2が、式Ｅ５－１で示される基、式Ｅ５－２で示される基、式Ｅ５－３で示される基、式Ｅ５－４で示される基、式Ｅ５－５で示される基、式Ｅ５－６で示される基、又は式Ｅ５－７で示される基であり、
Figure JPOXMLDOC01-appb-C000010
 Ｒ2がＮＲ16Ｃ（Ｏ）ＮＲ17Ｒ18であり、Ｒ16及びＲ17が、Ｒ16が結合する窒素原子、窒素原子が結合する炭素原子、及びＲ17が結合する窒素原子と一緒になって、Ｃ１－Ｃ３鎖式炭化水素基｛該Ｃ１－Ｃ３鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよい｝で置換されていてもよい５若しくは６員非芳香族複素環を形成する場合、Ｒ2が、式Ｅ６－１で示される基、式Ｅ６－２で示される基、式Ｅ６－３で示される基、又は式Ｅ６－４で示される基であり、
Figure JPOXMLDOC01-appb-C000011
 ＲE31が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、ハロゲン原子、又は水素原子であり、ＲE12及びＲE32が、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいシクロプロピル基、又は水素原子であり、ＲE13、ＲE14、ＲE15、ＲE16、ＲE17、及びＲE18が、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、Ｃ（Ｏ）ＮＲ7Ｒ8、ＮＲ9Ｃ（Ｏ）Ｒ5、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、シアノ基、ハロゲン原子、又は水素原子であり、Ｒ8が群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子である化合物。
〔態様３８〕態様１～態様３６又は本発明化合物Ｎのいずれかにおいて、Ｒ2がフェニル基、ピラゾリル基、ピリジル基、又はピリミジニル基｛該フェニル基、該ピラゾリル基、該ピリジル基、及び該ピリミジニル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよいシクロプロピル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルコキシ基、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、Ｃ（＝ＮＯＲ9）Ｒ5、Ｃ（＝ＮＯＲ9）（ＮＲ6Ｒ7）、式Ｅ１－１で示される基、式Ｅ１－２で示される基、式Ｅ２－１で示される基、式Ｅ２－２で示される基、式Ｅ４－１で示される基、式Ｅ５－１で示される基、式Ｅ５－３で示される基、又は式Ｅ６－１で示される基（＃2は炭素原子との結合部位を表す）であり、ＲE12が、1以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいシクロプロピル基、又は水素原子であり、ＲE13、ＲE14、ＲE15、ＲE16、及びＲE17が、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルコキシ基、Ｃ（Ｏ）ＮＲ7Ｒ8、ＮＲ9Ｃ（Ｏ）Ｒ5、１以上のハロゲン原子で置換されていてもよいシクロプロピル基、シアノ基、ハロゲン原子、又は水素原子である化合物。
〔態様３９〕態様１～態様３６又は本発明化合物Ｎのいずれかにおいて、Ｒ2がフェニル基、ピラゾリル基、ピリジル基、又はピリミジニル基｛該フェニル基、該ピラゾリル基、該ピリジル基、及び該ピリミジニル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよいシクロプロピル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルコキシ基、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、Ｃ（＝ＮＯＲ9）Ｒ5、Ｃ（＝ＮＯＲ9）（ＮＲ6Ｒ7）、式Ｅ１－１で示される基、又は式Ｅ１－２で示される基（＃2は炭素原子との結合部位を表す）である化合物。
〔態様４０〕態様１～態様３６又は本発明化合物Ｎのいずれかにおいて、Ｒ2がフェニル基、ピラゾリル基、ピリジル基、又はピリミジニル基｛該フェニル基、該ピラゾリル基、該ピリジル基、及び該ピリミジニル基は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。
〔態様４１〕態様１～態様３６又は本発明化合物Ｎのいずれかにおいて、Ｒ2がフェニル基、５若しくは６員芳香族複素環基｛該フェニル基、及び該５若しくは６員芳香族複素環基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよいシクロプロピル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、ＯＲ3a、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、Ｃ（Ｏ）ＮＲ6Ｒ7、ＮＲ16Ｃ（Ｏ）Ｒ17、ＯＲ18、式Ｅ１－１で示される基、式Ｅ１－２で示される基、式Ｅ２－１で示される基、式Ｅ２－２で示される基、式Ｅ３－１で示される基、式Ｅ３－２で示される基、式Ｅ４－１で示される基、式Ｅ４－２で示される基、式Ｅ４－３で示される基、式Ｅ４－４で示される基、式Ｅ４－５で示される基、式Ｅ５－１で示される基、式Ｅ５－２で示される基、式Ｅ５－３で示される基、式Ｅ５－４で示される基、式Ｅ５－５で示される基、式Ｅ５－６で示される基、式Ｅ５－７で示される基、式Ｅ６－１で示される基、式Ｅ６－２で示される基、式Ｅ６－３で示される基、又は式Ｅ６－４で示される基（＃2は炭素原子との結合部位を表す）であり、Ｒ18が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子であり、ＲE31が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、ハロゲン原子、又は水素原子であり、ＲE12及びＲE32が、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいシクロプロピル基、又は水素原子であり、Ｒ27がハロゲン原子及びシアノ基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子であり、ＲE13、ＲE14、ＲE15、ＲE16、ＲE17、及びＲE18が、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、Ｃ（Ｏ）ＮＲ7Ｒ8、ＮＲ9Ｃ（Ｏ）Ｒ5、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、シアノ基、ハロゲン原子、又は水素原子であり、Ｒ8が群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子である化合物。
〔態様４２〕態様１～態様３６又は本発明化合物Ｎのいずれかにおいて、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、ＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12、又はＮＲ10Ｘ1であり、Ｘ1が９若しくは１０員芳香族複素環基｛該９若しくは１０員芳香族複素環基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シクロプロピル基｛該シクロプロピル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3bが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3cが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、フェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、１以上のハロゲン原子で置換されていてもよい｝であり、Ｒ3fが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3gが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様４３〕態様３７において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、ＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12、又はＮＲ10Ｘ1であり、Ｘ1が９若しくは１０員芳香族複素環基｛該９若しくは１０員芳香族複素環基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シクロプロピル基｛該シクロプロピル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シアノ基で置換されていてもよいシクロプロピル基、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3bが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3cが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、フェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、１以上のハロゲン原子で置換されていてもよい｝であり、Ｒ3fが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3gが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様４４〕態様３８において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、ＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12、又はＮＲ10Ｘ1であり、Ｘ1が９若しくは１０員芳香族複素環基｛該９若しくは１０員芳香族複素環基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シクロプロピル基｛該シクロプロピル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シアノ基で置換されていてもよいシクロプロピル基、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3bが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3cが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、フェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、１以上のハロゲン原子で置換されていてもよい｝であり、Ｒ3fが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3gが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様４５〕態様３９において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、ＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12、又はＮＲ10Ｘ1であり、Ｘ1が９若しくは１０員芳香族複素環基｛該９若しくは１０員芳香族複素環基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シクロプロピル基｛該シクロプロピル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シアノ基で置換されていてもよいシクロプロピル基、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3bが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3cが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、フェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、１以上のハロゲン原子で置換されていてもよい｝であり、Ｒ3fが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3gが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様４６〕態様４０において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、ＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12、又はＮＲ10Ｘ1であり、Ｘ1が９若しくは１０員芳香族複素環基｛該９若しくは１０員芳香族複素環基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シクロプロピル基｛該シクロプロピル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シアノ基で置換されていてもよいシクロプロピル基、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3bが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3cが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、フェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、１以上のハロゲン原子で置換されていてもよい｝であり、Ｒ3fが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3gが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様４７〕態様４１において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、ＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12、又はＮＲ10Ｘ1であり、Ｘ1が９若しくは１０員芳香族複素環基｛該９若しくは１０員芳香族複素環基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シクロプロピル基｛該シクロプロピル基は、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、シアノ基で置換されていてもよいシクロプロピル基、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3bが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3cが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、フェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、１以上のハロゲン原子で置換されていてもよい｝であり、Ｒ3fが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3gが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様４８〕態様１～態様３６又は本発明化合物Ｎにおいて、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、又はＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様４９〕態様３７において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、又はＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５０〕態様３８において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、又はＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５１〕態様３９において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、又はＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５２〕態様４０において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、又はＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５３〕態様４１において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11、又はＮＲ10Ｃ（Ｏ）ＮＲ11Ｒ12であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及び該ピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる置換基で置換されていてもよい｝であり、Ｒ12が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５４〕態様１～態様３６又は本発明化合物Ｎのいずれかにおいて、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５５〕態様３７において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５６〕態様３８において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５７〕態様３９において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５８〕態様４０において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様５９〕態様４１において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様６０〕態様１～態様３６又は本発明化合物Ｎのいずれかにおいて、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10が水素原子であり、Ｒ11がフェニル基｛該フェニル基は、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルキル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。
〔態様６１〕態様３７において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10が水素原子であり、Ｒ11がフェニル基｛該フェニル基は、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルキル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。
〔態様６２〕態様３８において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10が水素原子であり、Ｒ11がフェニル基｛該フェニル基は、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルキル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。
〔態様６３〕態様３９において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10が水素原子であり、Ｒ11がフェニル基｛該フェニル基は、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルキル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。
〔態様６４〕態様４０において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10が水素原子であり、Ｒ11がフェニル基｛該フェニル基は、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルキル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。
〔態様６５〕態様４１において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10が水素原子であり、Ｒ11がフェニル基｛該フェニル基は、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルキル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。
〔態様６６〕態様１～態様３６又は本発明化合物Ｎのいずれかにおいて、Ｒ2が群Ａより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基であり、ＸがＮＲ11Ｃ（Ｏ）Ｒ12であり、Ｒ11が群Ｆより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６アルキル基であり、Ｒ12が群Ａより選ばれる１以上の置換基で置換されていてもよいフェニル基である化合物。 [Aspect 1] In compound N of the present invention, Q is a group represented by formula A1-1, a group represented by formula A1-2, a group represented by formula A2-1, a group represented by formula A2-2, a group represented by formula A2-3, a group represented by formula A3-1, a group represented by formula A3-2, a group represented by formula A4-1, a group represented by formula A4-2, or a group represented by formula A5-1 (# represents a bonding site to R2 , and ● represents a bonding site to a carbon atom), and R 3q1 , R 3q2 , R 3q3 , R 3q4 , R 3q5 and R Compounds in which 4 is the same or different and is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, a cyclopropyl group optionally substituted with one or more substituents selected from group E, a cyano group, a halogen atom, or a hydrogen atom.
Figure JPOXMLDOC01-appb-C000007
 [Aspect 2] A compound in which, in compound N of the present invention, Q is a group represented by formula A1-1, a group represented by formula A1-2, a group represented by formula A2-1, a group represented by formula A2-2, a group represented by formula A2-3, a group represented by formula A3-1 or a group represented by formula A3-2 (# represents the bonding site to R2 , and ● represents the bonding site to a carbon atom), and R 3q1 , R 3q2 , R 3q3 , R 3q4 , R 3q5 and R 4 are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a cyclopropyl group optionally substituted with one or more substituents selected from group E, a cyano group, a halogen atom, or a hydrogen atom.
[Aspect 3] A compound in which, in compound N of the present invention, Q is a group represented by formula A1-1, a group represented by formula A2-1, a group represented by formula A3-1, or a group represented by formula A3-2 (# represents the bonding site to R2 , and ● represents the bonding site to a carbon atom), and R 3q1 , R 3q2 , R 3q3 , R 3q4 , R 3q5 , and R 4 are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom.
[Embodiment 4] A compound of the present invention N, in which L is a single bond or -(CR 4a R 4b ) n -, R 4a and R 4b are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, and n is 1, 2, or 3.
[Embodiment 5] The compound N of the present invention, wherein L is a single bond.
[Aspect 6] The compound in aspect 1, wherein L is a single bond or -(CR 4a R 4b ) n -, R 4a and R 4b are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom, and n is 1, 2, or 3.
[Aspect 7] The compound in aspect 2, wherein L is a single bond or -(CR 4a R 4b ) n -, R 4a and R 4b are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom, and n is 1, 2, or 3.
[Aspect 8] The compound according to aspect 3, wherein L is a single bond or -(CR 4a R 4b ) n -, R 4a and R 4b are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom, and n is 1, 2, or 3.
[Aspect 9] The compound according to aspect 1, wherein L is a single bond.
[Aspect 10] The compound according to aspect 2, wherein L is a single bond.
[Aspect 11] The compound according to aspect 3, wherein L is a single bond.
[Embodiment 12] A compound of the present invention, in which R 1 in compound N is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Embodiment 13] The compound N of the present invention, in which R 1 is a methyl group.
[Aspect 14] The compound according to aspect 1, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 15] The compound according to aspect 2, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 16] The compound according to aspect 3, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 17] The compound according to aspect 4, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 18] The compound according to aspect 5, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 19] The compound according to aspect 6, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 20] The compound according to aspect 7, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 21] The compound according to aspect 8, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 22] The compound according to aspect 9, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 23] The compound according to aspect 10, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 24] The compound according to aspect 11, wherein R 1 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom.
[Aspect 25] The compound according to aspect 1, wherein R 1 is a methyl group.
[Aspect 26] The compound according to aspect 2, wherein R 1 is a methyl group.
[Aspect 27] The compound according to aspect 3, wherein R 1 is a methyl group.
[Aspect 28] The compound according to aspect 4, wherein R 1 is a methyl group.
[Aspect 29] The compound according to aspect 5, wherein R 1 is a methyl group.
[Aspect 30] The compound according to aspect 6, wherein R 1 is a methyl group.
[Embodiment 31] The compound according to embodiment 7, wherein R 1 is a methyl group.
[Embodiment 32] The compound according to embodiment 8, wherein R 1 is a methyl group.
[Embodiment 33] The compound according to embodiment 9, wherein R 1 is a methyl group.
[Embodiment 34] The compound according to embodiment 10, wherein R 1 is a methyl group.
[Embodiment 35] The compound according to embodiment 11, wherein R 1 is a methyl group.
[Embodiment 36] A compound N of the present invention, in which Q is a group represented by formula A1, Q 1 , Q 2 , and Q 3 are CH, R 1 is a C1-C6 alkyl group optionally substituted with one or more substituents selected from the group consisting of a cyclopropyl group and a halogen atom, and L is a single bond.
[Aspect 37] In any one of Aspects 1 to 36 or Compound N of the present invention, R 2 is a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group are optionally substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, C(O)NR 6 R 7 , NR 16 C(O)R 17 , NR 16 C(O)OR 17 , NR 16 C(O)NR 17 R 18 , OR 18 , a group represented by formula E1-1, a group represented by formula E1-2, a group represented by formula E2-1, a group represented by formula E2-2, a group represented by formula E3-1, or a group represented by formula E3-2 (# 2 represents a bonding site with a group represented by formula A1, a group represented by formula A2, a group represented by formula A3, a group represented by formula A4, a group represented by formula A5, or a group represented by formula A6),
Figure JPOXMLDOC01-appb-C000008
 When R 18 is a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom, and R 2 is NR 16 C(O)R 17 , and R 16 and R 17 together with the nitrogen atom to which R 16 is bonded and the carbon atom to which R 17 is bonded form a 5- or 6-membered non-aromatic heterocycle optionally substituted with a C1-C3 chain hydrocarbon group {the C1-C3 chain hydrocarbon group may be substituted with one or more halogen atoms}, R 2 is a group represented by formula E4-1, a group represented by formula E4-2, a group represented by formula E4-3, a group represented by formula E4-4, or a group represented by formula E4-5,
Figure JPOXMLDOC01-appb-C000009
 When R 2 is NR 16 C(O)OR 17 and R 16 and R 17 , together with the nitrogen atom to which R 16 is bonded, the carbon atom to which the nitrogen atom is bonded, and the oxygen atom to which R 17 is bonded, form a 5- or 6-membered non-aromatic heterocycle optionally substituted with a C1-C3 chain hydrocarbon group (the C1-C3 chain hydrocarbon group may be substituted with one or more halogen atoms), R 2 is a group represented by formula E5-1, a group represented by formula E5-2, a group represented by formula E5-3, a group represented by formula E5-4, a group represented by formula E5-5, a group represented by formula E5-6, or a group represented by formula E5-7,
Figure JPOXMLDOC01-appb-C000010
 When R 2 is NR 16 C(O)NR 17 R 18 , and R 16 and R 17 together with the nitrogen atom to which R 16 is bonded, the carbon atom to which the nitrogen atom is bonded, and the nitrogen atom to which R 17 is bonded form a 5- or 6-membered non-aromatic heterocycle optionally substituted with a C1-C3 chain hydrocarbon group (the C1-C3 chain hydrocarbon group may be substituted with one or more halogen atoms), R 2 is a group represented by formula E6-1, a group represented by formula E6-2, a group represented by formula E6-3, or a group represented by formula E6-4,
Figure JPOXMLDOC01-appb-C000011
 R E31 is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R E12 and R E32 are the same or different and are a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a cyclopropyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom; R E13 , R E14 , R E15 , R E16 , R E17 , and R E18 are the same or different and are a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, C(O)NR 7 R 8 , NR 9 C(O)R 5 , a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, a cyano group, a halogen atom, or a hydrogen atom; R Compounds in which 8 is a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, or a hydrogen atom.
[Aspect 38] In any one of Aspects 1 to 36 or Compound N of the present invention, R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group {the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, C(═NOR 9 )R 5 , C(═NOR 9 )(NR 6 R 7 ), a group represented by the formula E1-1, a group represented by the formula E1-2, a group represented by the formula E2-1, a group represented by the formula E2-2, a group represented by the formula E4-1, a group represented by the formula E5-1, a group represented by the formula E5-3, or a group represented by the formula E6-1 (# 2 represents a bonding site to a carbon atom); R E12 is a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a cyclopropyl group optionally substituted with one or more halogen atoms, or a hydrogen atom; R E13 , R E14 , R E15 , R E16 , and R E17 are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, C(O)NR 7 R 8 , NR 9 C(O)R 5 a cyclopropyl group optionally substituted with one or more halogen atoms, a cyano group, a halogen atom, or a hydrogen atom.
[Aspect 39] In any one of Aspects 1 to 36 or Compound N of the present invention, R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group {the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group are optionally substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, C(═NOR 9 )R 5 , C(═NOR 9 )(NR 6 R 7 ), a group represented by the formula E1-1, or a group represented by the formula E1-2 (# 2 represents the bonding site with the carbon atom.
[Aspect 40] A compound according to any one of Aspects 1 to 36 or compound N of the present invention, wherein R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group {the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, NR 3b C(O)R 3c , C(O)NR 3f R 3g , a cyano group, and a halogen atom}.
[Aspect 41] In any one of Aspects 1 to 36 or Compound N of the present invention, R 2 is a phenyl group, a 5- or 6-membered aromatic heterocyclic group {the phenyl group and the 5- or 6-membered aromatic heterocyclic group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, C(O)NR 6 R 7 , NR 16 C(O)R 17 , OR 18 , a group represented by formula E1-1, a group represented by formula E1-2, a group represented by formula E2-1, a group represented by formula E2-2, a group represented by formula E3-1, a group represented by formula E3-2, a group represented by formula E4-1, a group represented by formula E4-2, a group represented by formula E4-3, a group represented by formula E4-4, a group represented by formula E4-5, a group represented by formula E5-1, a group represented by formula E5-2, a group represented by formula E5-3, a group represented by formula E5-4, a group represented by formula E5-5, a group represented by formula E5-6, a group represented by formula E5-7, a group represented by formula E6-1, a group represented by formula E6-2, a group represented by formula E6-3, or a group represented by formula E6-4 (# 2 represents a bonding site to a carbon atom), and R 18 is a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom; R is a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom; R and R are the same or different and are a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a cyclopropyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom; R is a C1- C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a halogen atom and a cyano group, or a hydrogen atom; R, R , R, R , R, R , R , R, R , and R Compounds in which E18 are the same or different and are a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, C(O)NR 7 R 8 , NR 9 C(O)R 5 , a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, a cyano group, a halogen atom, or a hydrogen atom, and R 8 is a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, or a hydrogen atom.
[Aspect 42] In any one of Aspects 1 to 36 or Compound N of the present invention, X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1 , X 1 is a 9- or 10-membered aromatic heterocyclic group {the 9- or 10-membered aromatic heterocyclic group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, a cyclopropyl group {the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, and R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom; R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}; R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom; R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom; R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3b is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3c is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group may be substituted with one or more halogen atoms}, R 3f is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3g is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group.
[Aspect 43] In aspect 37, X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1 , X 1 is a 9- or 10-membered aromatic heterocyclic group {the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, a cyclopropyl group {the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, and R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, a cyclopropyl group optionally substituted with a cyano group, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3b is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3c is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group may be substituted with one or more halogen atoms}, R 3f is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3g is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group.
[Aspect 44] In aspect 38, X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1 , X 1 is a 9- or 10-membered aromatic heterocyclic group {the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, a cyclopropyl group {the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, and R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, a cyclopropyl group optionally substituted with a cyano group, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3b is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3c is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group may be substituted with one or more halogen atoms}, R 3f is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3g is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group.
[Aspect 45] In aspect 39, X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1 , X 1 is a 9- or 10-membered aromatic heterocyclic group {the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, a cyclopropyl group {the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, and R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, a cyclopropyl group optionally substituted with a cyano group, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3b is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3c is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group may be substituted with one or more halogen atoms}, R 3f is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3g is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group.
[Aspect 46] In aspect 40, X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1 , X 1 is a 9- or 10-membered aromatic heterocyclic group {the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, a cyclopropyl group {the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, and R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, a cyclopropyl group optionally substituted with a cyano group, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3b is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3c is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group may be substituted with one or more halogen atoms}, R 3f is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3g is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group.
[Aspect 47] In aspect 41, X is NR 10 C(O)R 11 , NR 10 C(O)NR 11 R 12 , or NR 10 X 1 , X 1 is a 9- or 10-membered aromatic heterocyclic group {the 9- or 10-membered aromatic heterocyclic group is optionally substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, a cyclopropyl group {the cyclopropyl group may be substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom}, OR 3a , NR 3b C(O)R 3c , C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, and a halogen atom}, and R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, a cyclopropyl group optionally substituted with a cyano group, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3b is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3c is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group may be substituted with one or more halogen atoms}, R 3f is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, R 3g is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a cyclopropyl group.
[Aspect 48] In Aspects 1 to 36 or Compound N of the Invention, X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 or a hydrogen atom, R 11 is a phenyl group, a pyridyl group or a pyrazolyl group {the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group and a halogen atom}, and R Compounds in which R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 49] In aspect 37, X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 or a hydrogen atom, R 11 is a phenyl group, a pyridyl group or a pyrazolyl group {the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group and a halogen atom}, and R Compounds in which R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 50] In aspect 38, X is NR 10 C(O)R 11 , or NR 10 C(O)NR 11 R 12 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are optionally substituted with a cyclopropyl group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, and R Compounds in which R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 51] In aspect 39, X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 or a hydrogen atom, R 11 is a phenyl group, a pyridyl group or a pyrazolyl group {the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group and a halogen atom}, and R Compounds in which R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 52] In aspect 40, X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 or a hydrogen atom, R 11 is a phenyl group, a pyridyl group or a pyrazolyl group {the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group and a halogen atom}, and R Compounds in which R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 53] In aspect 41, X is NR 10 C(O)R 11 or NR 10 C(O)NR 11 R 12 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 or a hydrogen atom, R 11 is a phenyl group, a pyridyl group or a pyrazolyl group {the phenyl group, the pyridyl group and the pyrazolyl group are optionally substituted with a cyclopropyl group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group and a halogen atom}, and R Compounds in which R 12 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 54] In any one of Aspects 1 to 36 or Compound N of the present invention, X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 55] In aspect 37, X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 56] In aspect 38, X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, and R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 57] In aspect 39, X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 58] In aspect 40, X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 59] In aspect 41, X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect 60] A compound according to any one of Aspects 1 to 36 or compound N of the present invention, wherein X is NR 10 C(O)R 11 , R 10 is a hydrogen atom, and R 11 is a phenyl group (the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, and a halogen atom).
[Aspect 61] The compound in aspect 37, wherein X is NR 10 C(O)R 11 , R 10 is a hydrogen atom, and R 11 is a phenyl group (the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, and a halogen atom).
[Aspect 62] The compound in aspect 38, wherein X is NR 10 C(O)R 11 , R 10 is a hydrogen atom, and R 11 is a phenyl group {the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, and a halogen atom}.
[Aspect 63] The compound according to aspect 39, wherein X is NR 10 C(O)R 11 , R 10 is a hydrogen atom, and R 11 is a phenyl group (the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, and a halogen atom).
[Aspect 64] The compound in aspect 40, wherein X is NR 10 C(O)R 11 , R 10 is a hydrogen atom, and R 11 is a phenyl group (the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, and a halogen atom).
[Aspect 65] The compound in aspect 41, wherein X is NR 10 C(O)R 11 , R 10 is a hydrogen atom, and R 11 is a phenyl group (the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, and a halogen atom).
[Aspect 66] A compound according to any one of Aspects 1 to 36 or compound N of the present invention, wherein R 2 is a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group A, X is NR 11 C(O)R 12 , R 11 is a C1-C6 alkyl group optionally substituted with one or more substituents selected from group F, and R 12 is a phenyl group optionally substituted with one or more substituents selected from group A.

〔態様Ａ１〕本発明化合物Ｎにおいて、Ｑが式Ａ３－３で示される基（＃はＲ2との結合部位を表し、●は炭素原子との結合部位を表す）であり、Ｒ3q5及びＲ4が、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３鎖式炭化水素基、ハロゲン原子、又は水素原子である化合物。

Figure JPOXMLDOC01-appb-C000012
〔態様Ａ２〕態様Ａ１において、Ｌが単結合である化合物。
〔態様Ａ３〕態様Ａ１において、Ｒ1がメチル基である化合物。
〔態様Ａ４〕態様Ａ２において、Ｒ1がメチル基である化合物。
〔態様Ａ５〕態様Ａ４において、Ｒ2がフェニル基、ピラゾリル基、ピリジル基、又はピリミジニル基｛該フェニル基、該ピラゾリル基、該ピリジル基、及び該ピリミジニル基は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、ＮＲ3bＣ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＮＲ3fＲ3g、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。
〔態様Ａ６〕態様Ａ４において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様Ａ７〕態様Ａ４において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ11がフェニル基｛該フェニル基は、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルキル基、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルコキシ基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。
〔態様Ａ８〕態様Ａ５において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、又は水素原子であり、Ｒ11がフェニル基、ピリジル基、又はピラゾリル基｛該フェニル基、該ピリジル基、及びピラゾリル基は、シアノ基で置換されていてもよいシクロプロピル基、Ｃ１－Ｃ３アルキル基｛該Ｃ１－Ｃ３アルキル基は、シクロプロピル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、ＯＲ3a、Ｓ（Ｏ）mＲ3k、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、Ｒ13が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シクロプロピル基、又は水素原子であり、Ｒ14が１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、フェニルメチル基｛該フェニルメチル基におけるフェニル部分は、１以上のハロゲン原子で置換されていてもよい｝、又は水素原子であり、Ｒ3aが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ3kが１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、又はシクロプロピル基である化合物。
〔態様Ａ９〕態様Ａ５において、ＸがＮＲ10Ｃ（Ｏ）Ｒ11であり、Ｒ10がＣ１－Ｃ３アルキル基、又は水素原子であり、Ｒ11がフェニル基｛該フェニル基は、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルキル基、１以上のハロゲン原子で置換されているＣ１－Ｃ３アルコキシ基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝である化合物。 [Aspect A1] In compound N of the present invention, Q is a group represented by formula A3-3 (# represents the bonding site to R2 , and ● represents the bonding site to a carbon atom), and R3q5 and R4 are the same or different and are a C1-C3 chain hydrocarbon group optionally substituted with one or more halogen atoms, a halogen atom, or a hydrogen atom.
Figure JPOXMLDOC01-appb-C000012
 [Aspect A2] The compound in aspect A1, wherein L is a single bond.
[Aspect A3] The compound according to aspect A1, wherein R 1 is a methyl group.
[Aspect A4] The compound according to Aspect A2, wherein R 1 is a methyl group.
[Aspect A5] A compound in aspect A4, wherein R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group {the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, NR 3b C(O)R 3c , C(O)NR 3f R 3g , a cyano group, and a halogen atom}.
[Aspect A6] In aspect A4, X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, and R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect A7] The compound in Aspect A4, wherein X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group or a hydrogen atom, and R 11 is a phenyl group {the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, a C1-C3 alkoxy group substituted with one or more halogen atoms, a cyano group, and a halogen atom}.
[Aspect A8] In aspect A5, X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group, OR 14 , C(O)R 13 , C(O)OR 13 , or a hydrogen atom, R 11 is a phenyl group, a pyridyl group, or a pyrazolyl group {the phenyl group, the pyridyl group, and the pyrazolyl group are a cyclopropyl group optionally substituted with a cyano group, a C1-C3 alkyl group {the C1-C3 alkyl group may be substituted with one or more substituents selected from the group consisting of a cyclopropyl group, a cyano group, and a halogen atom}, OR 3a , S(O) m R 3k , a cyano group, and a halogen atom}, R 13 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyclopropyl group, or a hydrogen atom, and R Compounds in which 14 is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group {the phenyl moiety in the phenylmethyl group may be substituted with one or more halogen atoms}, or a hydrogen atom, R 3a is a C1-C3 alkyl group optionally substituted with one or more halogen atoms or a hydrogen atom, and R 3k is a C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a cyclopropyl group.
[Aspect A9] The compound in Aspect A5, wherein X is NR 10 C(O)R 11 , R 10 is a C1-C3 alkyl group or a hydrogen atom, and R 11 is a phenyl group {the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group substituted with one or more halogen atoms, a C1-C3 alkoxy group substituted with one or more halogen atoms, a cyano group, and a halogen atom}.

　次に、本発明化合物の製造法について説明する。 Next, we will explain the method for producing the compound of the present invention.

製造法１
　式（Ｉ－１）で示される化合物（以下、化合物（Ｉ－１）と記す）は、式（Ｉ－２）で示される化合物（以下、化合物（Ｉ－２）と記す）と式（Ｉ－３）で示される化合物（以下、化合物（Ｉ－３）と記す）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000013
〔式中、記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。溶媒としては、例えば、テトラヒドロフラン（以下、ＴＨＦと記す）、１，４－ジオキサン、１，２－ジメトキシエタン、メチルｔｅｒｔ－ブチルエーテル、ジエチルエーテル等のエーテル（以下、エーテル類と記す）；ジクロロメタン、クロロホルム等のハロゲン化炭化水素（以下、ハロゲン化炭化水素類と記す）；アセトニトリル等のニトリル（以下、ニトリル類と記す）；トルエン、キシレン等の芳香族炭化水素（以下、芳香族炭化水素類と記す）；Ｎ－メチルピロリドン（以下、ＮＭＰと記す）、Ｎ，Ｎ－ジメチルホルムアミド（以下、ＤＭＦと記す）等の非プロトン性極性溶媒（以下、非プロトン性極性溶媒類と記す）、及びこれらの混合物が挙げられる。
　反応は、必要に応じて塩基を使用することができる。塩基としては、例えば、トリエチルアミン、Ｎ，Ｎ－ジイソプロピルエチルアミン、ピリジン、４－（ジメチルアミノ）ピリジン等の有機塩基（以下、有機塩基類と記す）；及び炭酸ナトリウム、炭酸カリウム、炭酸セシウム等のアルカリ金属炭酸塩（以下、アルカリ金属炭酸塩類と記す）が挙げられる。
　反応には、化合物（Ｉ－２）１モルに対して、化合物（Ｉ－３）が通常１～１０モルの割合で用いられる。
　反応温度は、通常０℃～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－１）を得ることができる。
　化合物（Ｉ－３）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Manufacturing method 1
The compound represented by formula (I-1) (hereinafter referred to as compound (I-1)) can be produced by reacting a compound represented by formula (I-2) (hereinafter referred to as compound (I-2)) with a compound represented by formula (I-3) (hereinafter referred to as compound (I-3)).
Figure JPOXMLDOC01-appb-C000013
 (In the formula, the symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent, for example, ethers such as tetrahydrofuran (hereinafter referred to as THF), 1,4-dioxane, 1,2-dimethoxyethane, methyl tert-butyl ether, diethyl ether, etc. (hereinafter referred to as ethers), halogenated hydrocarbons such as dichloromethane, chloroform, etc. (hereinafter referred to as halogenated hydrocarbons), nitriles such as acetonitrile, etc. (hereinafter referred to as nitriles), aromatic hydrocarbons such as toluene, xylene, etc. (hereinafter referred to as aromatic hydrocarbons), aprotic polar solvents such as N-methylpyrrolidone (hereinafter referred to as NMP), N,N-dimethylformamide (hereinafter referred to as DMF), etc. (hereinafter referred to as aprotic polar solvents), and mixtures thereof.
The reaction can be carried out using a base as necessary, for example, organic bases such as triethylamine, N,N-diisopropylethylamine, pyridine, 4-(dimethylamino)pyridine (hereinafter referred to as organic bases), and alkali metal carbonates such as sodium carbonate, potassium carbonate, cesium carbonate (hereinafter referred to as alkali metal carbonates).
In the reaction, compound (I-3) is usually used in a ratio of 1 to 10 moles per mole of compound (I-2).
The reaction temperature is usually in the range of 0° C. to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-1).
Compound (I-3) is a commercially available compound or can be prepared using known methods.

製造法２
　式（Ｉ）で示される化合物（即ち、本発明化合物Ｎ）は、式（Ｉ－８）で示される化合物（以下、化合物（Ｉ－８）と記す）と式（Ｉ－Ｍ）で示される化合物（以下、化合物（Ｉ－Ｍ）と記す）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000014
〔式中、Ｘaは、塩素原子、臭素原子又はヨウ素原子を表し、ＭAは、９－ボラビシクロ［３．３．１］ノナン－９－イル基、ボロノ基、４，４，５，５－テトラメチル－１，３，２－ジオキサボロラン－２－イル基、又はトリブチルスタンニル基を表し、その他の記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。溶媒としては、例えば、エーテル類；芳香族炭化水素類；非プロトン性極性溶媒類；水及びこれらの２つ以上の混合物が挙げられる。
　金属触媒としては、テトラキス（トリフェニルホスフィン）パラジウム（０）、１，１’－ビス（ジフェニルホスフィノ）フェロセンパラジウム（ＩＩ）ジクロリド、トリス（ジベンジリデンアセトン）ジパラジウム（０）、酢酸パラジウム（ＩＩ）等のパラジウム触媒；ビス（シクロオクタジエン）ニッケル（０）、塩化ニッケル（ＩＩ）等のニッケル触媒；塩化鉄（ＩＩＩ）、アセチルアセトン鉄（ＩＩＩ）等の鉄触媒；ヨウ化銅（Ｉ）、塩化銅（Ｉ）等の銅触媒等及びこれらの２つ以上の組み合わせが挙げられる。
　反応には必要に応じて、配位子、塩基、及び／又は無機ハロゲン化物を用いてもよい。
　配位子としては、トリフェニルホスフィン、キサントホス、２，２’－ビス（ジフェニルホスフィノ）－１，１’－ビナフチル、１，１’－ビス（ジフェニルホスフィノ）フェロセン、２－ジシクロヘキシルホスフィノ－２’，４’，６’－トリイソプロピルビフェニル、２－ジシクロヘキシルホスフィノ－２’，６’－ジメトキシビフェニル、１，２－ビス（ジフェニルホスフィノ）エタン、２，２’－ビピリジン、２－アミノエタノール、８－ヒドロキシキノリン、及び１，１０－フェナントロリン等が挙げられる。
　塩基としては、アルカリ金属炭酸塩類及び有機塩基類が挙げられる。
　無機ハロゲン化物としては、フッ化カリウム、フッ化ナトリウム等のアルカリ金属フッ化物；及び塩化リチウム、塩化ナトリウム等のアルカリ金属塩化物が挙げられる。
　反応には、化合物（Ｉ－８）１モルに対して、化合物（Ｉ－Ｍ）が通常１～１０モルの割合、金属触媒が通常０．０１～０．５モルの割合で用いられる。反応に配位子が用いられる場合、化合物（Ｉ－８）１モルに対して、配位子が通常０．０１～１モルの割合で用いられる。反応に塩基が用いられる場合、化合物（Ｉ－８）１モルに対して、塩基が通常０．１～５モルの割合で用いられる。反応に無機ハロゲン化物が用いられる場合、化合物（Ｉ－８）１モルに対して、無機ハロゲン化物が通常０．１～５モルの割合で用いられる。
　反応温度は、通常－２０℃～２００℃の範囲である。反応時間は通常０．１～７２時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより本発明化合物Ｎを得ることができる。
　化合物（Ｉ―Ｍ）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。
　反応は例えば、国際公開第２０２０／０７００４９号のＥｘａｍｐｌｅ　Ｈ２に記載の方法に準じて実施することもできる。 Manufacturing Method 2
The compound represented by formula (I) (i.e., compound N of the present invention) can be produced by reacting a compound represented by formula (I-8) (hereinafter referred to as compound (I-8)) with a compound represented by formula (IM) (hereinafter referred to as compound (IM)).
Figure JPOXMLDOC01-appb-C000014
 [In the formula, X a represents a chlorine atom, a bromine atom, or an iodine atom, M A represents a 9-borabicyclo[3.3.1]nonan-9-yl group, a borono group, a 4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl group, or a tributylstannyl group, and the other symbols have the same meanings as above.]
The reaction is usually carried out in a solvent, such as ethers, aromatic hydrocarbons, aprotic polar solvents, water, and mixtures of two or more thereof.
Examples of the metal catalyst include palladium catalysts such as tetrakis(triphenylphosphine)palladium(0), 1,1'-bis(diphenylphosphino)ferrocenepalladium(II) dichloride, tris(dibenzylideneacetone)dipalladium(0), palladium(II) acetate, etc.; nickel catalysts such as bis(cyclooctadiene)nickel(0), nickel(II) chloride, etc.; iron catalysts such as iron(III) chloride, iron(III) acetylacetonate, etc.; copper catalysts such as copper(I) iodide, copper(I) chloride, etc.; and combinations of two or more of these.
The reaction may, if necessary, use a ligand, a base, and/or an inorganic halide.
Examples of the ligand include triphenylphosphine, xantphos, 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 1,1'-bis(diphenylphosphino)ferrocene, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',6'-dimethoxybiphenyl, 1,2-bis(diphenylphosphino)ethane, 2,2'-bipyridine, 2-aminoethanol, 8-hydroxyquinoline, and 1,10-phenanthroline.
The bases include alkali metal carbonates and organic bases.
Inorganic halides include alkali metal fluorides such as potassium fluoride and sodium fluoride; and alkali metal chlorides such as lithium chloride and sodium chloride.
In the reaction, compound (IM) is usually used in a ratio of 1 to 10 moles and metal catalyst is usually used in a ratio of 0.01 to 0.5 moles per mole of compound (I-8). When a ligand is used in the reaction, the ligand is usually used in a ratio of 0.01 to 1 mole per mole of compound (I-8). When a base is used in the reaction, the base is usually used in a ratio of 0.1 to 5 moles per mole of compound (I-8). When an inorganic halide is used in the reaction, the inorganic halide is usually used in a ratio of 0.1 to 5 moles per mole of compound (I-8).
The reaction temperature is usually in the range of −20° C. to 200° C. The reaction time is usually in the range of 0.1 to 72 hours.
After the reaction is completed, the compound N of the present invention can be obtained by carrying out post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer.
Compounds (IM) are commercially available compounds or can be prepared using known methods.
The reaction can also be carried out in accordance with, for example, the method described in Example H2 of WO 2020/070049.

製造法３
　式（Ｉ－１Ａ）で示される化合物（以下、化合物（Ｉ－１Ａ）と記す）は、式（Ｉ－２Ａ）で示される化合物（以下、化合物（Ｉ－２Ａ）と記す）と式（Ｍ－ｇ）で示される化合物（以下、化合物（Ｍ－ｇ）と記す）とを酸の存在下で反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000015
〔式中、ＸCは、塩素原子等の脱離基を表し、Ｂｏｃはｔｅｒｔ－ブトキシカルボニル基を表し、その他の記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。溶媒としては、エーテル類；ハロゲン化炭化水素類；芳香族炭化水素類；ニトリル類；非プロトン性極性溶媒類；水及びこれらの２つ以上の混合物が挙げられる。
　反応に用いられる酸としては、例えばトリフルオロ酢酸、及び塩化水素が挙げられる。塩化水素が用いられる場合、塩酸、塩化水素／メタノール溶液等の塩化水素の溶液を反応に供してもよい。
　反応は、例えば、まず、化合物（Ｉ－２Ａ）と酸とを混合し、その後、酸を留去し、化合物（Ｍ－ｇ）を混合することにより実施することができる。
　反応には、必要に応じて塩基を用いることができる。塩基としては、例えば有機塩基類が挙げられる。反応に塩基が用いられる場合、化合物（Ｉ－２Ａ）１モルに対して、塩基が通常１～１０モルの割合で用いられる。
　反応には、化合物（Ｉ－２Ａ）１モルに対して、化合物（Ｍ－ｇ）が通常１～２モルの割合、酸が通常１～１００モルの割合で用いられる。
　反応温度は通常－２０～２００℃の範囲内である。反応時間は通常０．１～２４時間の範囲内である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物（Ｉ－１Ａ）を得ることが出来る。
　化合物（Ｍ－ｇ）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Manufacturing Method 3
The compound represented by formula (I-1A) (hereinafter referred to as compound (I-1A)) can be produced by reacting a compound represented by formula (I-2A) (hereinafter referred to as compound (I-2A)) with a compound represented by formula (M-g) (hereinafter referred to as compound (M-g)) in the presence of an acid.
Figure JPOXMLDOC01-appb-C000015
 (In the formula, X represents a leaving group such as a chlorine atom, Boc represents a tert-butoxycarbonyl group, and the other symbols have the same meanings as above.)
The reaction is usually carried out in a solvent, which may include ethers, halogenated hydrocarbons, aromatic hydrocarbons, nitriles, aprotic polar solvents, water, and mixtures of two or more thereof.
The acid used in the reaction includes, for example, trifluoroacetic acid and hydrogen chloride. When hydrogen chloride is used, a solution of hydrogen chloride such as hydrochloric acid or a hydrogen chloride/methanol solution may be used in the reaction.
The reaction can be carried out, for example, by first mixing compound (I-2A) with an acid, then distilling off the acid, and mixing compound (Mg).
In the reaction, a base can be used as necessary. Examples of the base include organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (I-2A).
In the reaction, compound (Mg) is usually used in a ratio of 1 to 2 moles and acid is usually used in a ratio of 1 to 100 moles, relative to 1 mole of compound (I-2A).
The reaction temperature is usually within the range of −20 to 200° C. The reaction time is usually within the range of 0.1 to 24 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures are carried out to obtain compound (I-1A).
Compound (Mg) is a commercially available compound or can be prepared using known methods.

製造法４
　化合物（Ｉ－１Ａ）は、化合物（Ｉ－２Ａ）と式（Ｍ－ｅ）で示される化合物（以下、化合物（Ｍ－ｅ）と記す）とを縮合剤及び酸の存在下で反応させることにより製造することもできる。

Figure JPOXMLDOC01-appb-C000016
〔式中、記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。溶媒としては、エーテル類；ハロゲン化炭化水素類；芳香族炭化水素類；ニトリル類；酢酸エチル、酢酸ブチル等のエステル（以下、エステル類と記す）；非プロトン性極性溶媒類；ピリジン、ピコリン、ルチジン、キノリン等の含窒素芳香族化合物（以下、含窒素芳香族化合物類と記す）；及びこれらの２つ以上の混合物が挙げられる。
　反応に用いられる酸には、例えばトリフルオロ酢酸、及び塩化水素が挙げられる。
　塩化水素が用いられる場合、塩酸、塩化水素／メタノール溶液等の塩化水素の溶液を反応に供してもよい。
　反応は、例えば、まず、化合物（Ｉ－２Ａ）と酸とを混合し、その後、酸を留去し、化合物（Ｍ－ｅ）と縮合剤とを混合することにより実施することができる。
　反応に用いられる縮合剤としては、例えば１－エチル－３－［３－（ジメチルアミノ）プロピル］カルボジイミド塩酸塩、１，３－ジシクロヘキシルカルボジイミド等のカルボジイミド類が挙げられる。
　反応には、必要に応じて触媒を用いることができる。触媒としては、例えば１－ヒドロキシベンゾトリアゾールが挙げられる。反応に触媒が用いられる場合、化合物（Ｉ－２Ａ）１モルに対して、触媒が通常０．０１～０．５モルの割合で用いられる。
　反応には、必要に応じて塩基を用いることができる。塩基としては、例えば有機塩基類が挙げられる。反応に塩基が用いられる場合、化合物（Ｉ－２Ａ）１モルに対して、塩基が通常１～５モルの割合で用いられる。
　反応には、化合物（Ｉ－２Ａ）１モルに対して、化合物（Ｍ－ｅ）が通常１～２モルの割合、縮合剤が通常１～５モルの割合、酸が通常１～１００モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－１Ａ）を得ることができる。
　化合物（Ｍ－ｅ）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Manufacturing Method 4
Compound (I-1A) can also be produced by reacting compound (I-2A) with a compound represented by formula (Me) (hereinafter referred to as compound (Me)) in the presence of a condensing agent and an acid.
Figure JPOXMLDOC01-appb-C000016
 (In the formula, the symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent, which may include ethers, halogenated hydrocarbons, aromatic hydrocarbons, nitriles, esters such as ethyl acetate and butyl acetate (hereinafter referred to as esters), aprotic polar solvents, nitrogen-containing aromatic compounds such as pyridine, picoline, lutidine, and quinoline (hereinafter referred to as nitrogen-containing aromatic compounds), and mixtures of two or more of these.
The acid used in the reaction includes, for example, trifluoroacetic acid and hydrogen chloride.
When hydrogen chloride is used, a solution of hydrogen chloride such as hydrochloric acid or a hydrogen chloride/methanol solution may be subjected to the reaction.
The reaction can be carried out, for example, by first mixing compound (I-2A) with an acid, then distilling off the acid, and mixing compound (Me) with a condensing agent.
Condensing agents used in the reaction include, for example, carbodiimides such as 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride and 1,3-dicyclohexylcarbodiimide.
A catalyst may be used in the reaction, if necessary. An example of the catalyst is 1-hydroxybenzotriazole. When a catalyst is used in the reaction, the catalyst is usually used in a ratio of 0.01 to 0.5 moles per mole of compound (I-2A).
In the reaction, a base can be used as necessary. Examples of the base include organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 5 moles per mole of compound (I-2A).
In the reaction, compound (Me) is usually used in a ratio of 1 to 2 moles, a condensing agent is usually used in a ratio of 1 to 5 moles, and an acid is usually used in a ratio of 1 to 100 moles, relative to 1 mole of compound (I-2A).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-1A).
Compound (Me) is a commercially available compound or can be prepared using known methods.

製造法５
　化合物（Ｉ－１Ａ）は、式（Ｉ－１１）で示される化合物（以下、化合物（Ｉ－１１）と記す）と化合物（Ｉ－３）とを反応させることにより製造することもできる。

Figure JPOXMLDOC01-appb-C000017
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－２）に代えて化合物（Ｉ－１１）を用い、製造法１に準じて実施することができる。 Production method 5
Compound (I-1A) can also be produced by reacting a compound represented by formula (I-11) (hereinafter referred to as compound (I-11)) with compound (I-3).
Figure JPOXMLDOC01-appb-C000017
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 1, except that compound (I-11) is used in place of compound (I-2).

製造法６
　化合物（Ｉ－１Ａ）は、化合物（Ｉ－１１）と化合物（Ｍ－ｅ）とを縮合剤の存在下で反応させることにより製造することもできる。

Figure JPOXMLDOC01-appb-C000018
〔式中、記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば、エーテル類；ハロゲン化炭化水素類；芳香族炭化水素類；エステル類；ニトリル類；非プロトン性極性溶媒類；含窒素芳香族化合物類；及びこれらの２種類以上の混合物が挙げられる。
　反応に用いられる縮合剤としては、例えば１－エチル－３－［３－（ジメチルアミノ）プロピル］カルボジイミド塩酸塩、１，３－ジシクロヘキシルカルボジイミド等のカルボジイミド類が挙げられる。
　反応には、必要に応じて触媒を用いることができる。触媒としては、例えば１－ヒドロキシベンゾトリアゾールが挙げられる。反応に触媒が用いられる場合、化合物（Ｉ－１１）１モルに対して、触媒が通常０．０１～０．５モルの割合で用いられる。
　反応には、必要に応じて塩基を用いることができる。塩基としては、例えば有機塩基類が挙げられる。反応に塩基が用いられる場合、化合物（Ｉ－１１）１モルに対して、塩基が通常１～５モルの割合で用いられる。
　反応には、化合物（Ｉ－１１）１モルに対して、化合物（Ｍ－ｅ）が通常１～２モルの割合、縮合剤が通常１～５モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－１Ａ）を得ることができる。 Production method 6
Compound (I-1A) can also be produced by reacting compound (I-11) with compound (Me) in the presence of a condensing agent.
Figure JPOXMLDOC01-appb-C000018
 (In the formula, the symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, esters, nitriles, aprotic polar solvents, nitrogen-containing aromatic compounds, and mixtures of two or more of these.
Condensing agents used in the reaction include, for example, carbodiimides such as 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride and 1,3-dicyclohexylcarbodiimide.
A catalyst may be used in the reaction, if necessary. An example of the catalyst is 1-hydroxybenzotriazole. When a catalyst is used in the reaction, the catalyst is usually used in a ratio of 0.01 to 0.5 moles per mole of compound (I-11).
In the reaction, a base can be used as necessary. Examples of the base include organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 5 moles per mole of compound (I-11).
In the reaction, compound (Me) is usually used in a ratio of 1 to 2 moles and a condensing agent is usually used in a ratio of 1 to 5 moles, relative to 1 mole of compound (I-11).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-1A).

製造法７
　式（Ｉ－１Ｂ）で示される化合物（以下、化合物（Ｉ－１Ｂ）と記す）は、式（Ｉ－２Ｂ）で示される化合物（以下、化合物（Ｉ－２Ｂ）と記す）と化合物（Ｉ－３）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000019
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－２）に代えて化合物（Ｉ－２Ｂ）を用い、製造法１に準じて実施することができる。 Production method 7
The compound represented by formula (I-1B) (hereinafter referred to as compound (I-1B)) can be produced by reacting a compound represented by formula (I-2B) (hereinafter referred to as compound (I-2B)) with compound (I-3).
Figure JPOXMLDOC01-appb-C000019
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 1, except that compound (I-2B) is used in place of compound (I-2).

製造法８
　化合物（Ｉ－１Ｂ）は、化合物（Ｉ－２Ｂ）と化合物（Ｍ－ｅ）とを縮合剤の存在下で反応させることにより製造することもできる。

Figure JPOXMLDOC01-appb-C000020
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－１１）に代えて化合物（Ｉ－２Ｂ）を用い、製造法６に準じて実施することができる。 Production method 8
Compound (I-1B) can also be produced by reacting compound (I-2B) with compound (Me) in the presence of a condensing agent.
Figure JPOXMLDOC01-appb-C000020
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 6, except for using compound (I-2B) instead of compound (I-11).

製造法９
　化合物（Ｉ－１）は、式（Ｉ－２０）で示される化合物（以下、化合物（Ｉ－２０）と記す）と化合物（Ｉ－Ｍ）とを反応させることにより製造することもできる。

Figure JPOXMLDOC01-appb-C000021
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－８）に代えて化合物（Ｉ－２０）を用い、製造法２に準じて実施することができる。 Production method 9
Compound (I-1) can also be produced by reacting a compound represented by formula (I-20) (hereinafter referred to as compound (I-20)) with compound (IM).
Figure JPOXMLDOC01-appb-C000021
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 2, except that compound (I-20) is used in place of compound (I-8).

製造法１０
　式（ＩＩ－１）で示される化合物（以下、化合物（ＩＩ－１）と記す）は、式（ＩＩ－２）で示される化合物（以下、化合物（ＩＩ－２）と記す）と化合物（Ｉ－３）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000022
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－２）に代えて化合物（ＩＩ－２）を用い、製造法１に準じて実施することができる。 Production method 10
The compound represented by formula (II-1) (hereinafter referred to as compound (II-1)) can be produced by reacting a compound represented by formula (II-2) (hereinafter referred to as compound (II-2)) with compound (I-3).
Figure JPOXMLDOC01-appb-C000022
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 1, except that compound (II-2) is used in place of compound (I-2).

製造法１１
　化合物（ＩＩ－１）は、化合物（ＩＩ－２）と化合物（Ｍ－ｅ）とを縮合剤の存在下で反応させることにより製造することもできる。

Figure JPOXMLDOC01-appb-C000023
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－１１）に代えて化合物（ＩＩ－２）を用い、製造法６に準じて実施することができる。 Manufacturing Method 11
Compound (II-1) can also be produced by reacting compound (II-2) with compound (Me) in the presence of a condensing agent.
Figure JPOXMLDOC01-appb-C000023
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 6, except that compound (II-2) is used in place of compound (I-11).

製造法１２
　化合物（ＩＩ－１）は、式（ＩＩ－１９）で示される化合物（以下、化合物（ＩＩ－１９）と記す）と化合物（Ｉ－Ｍ）とを反応させることにより製造することもできる。

Figure JPOXMLDOC01-appb-C000024
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－８）に代えて化合物（ＩＩ－１９）を用い、製造法２に準じて実施することができる。 Manufacturing Method 12
Compound (II-1) can also be produced by reacting a compound represented by formula (II-19) (hereinafter referred to as compound (II-19)) with compound (IM).
Figure JPOXMLDOC01-appb-C000024
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 2, except that compound (II-19) is used in place of compound (I-8).

製造法１３
　式（ＩＩ－１Ａ）で示される化合物（以下、化合物（ＩＩ－１Ａ）と記す）は、式（ＩＩ－３Ａ）で示される化合物（以下、化合物（ＩＩ－３Ａ）と記す）と化合物（Ｉ－３）とを酸の存在下で反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000025
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－２Ａ）に代えて化合物（ＩＩ－３Ａ）を用い、さらに化合物（Ｍ－ｇ）に代えて化合物（Ｉ－３）を用いて、製造法３に準じて実施することができる。 Manufacturing Method 13
The compound represented by formula (II-1A) (hereinafter referred to as compound (II-1A)) can be produced by reacting a compound represented by formula (II-3A) (hereinafter referred to as compound (II-3A)) with compound (I-3) in the presence of an acid.
Figure JPOXMLDOC01-appb-C000025
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 3, except that compound (II-3A) is used in place of compound (I-2A) and compound (I-3) is used in place of compound (Mg).

　以下に製造中間体の製造法について記載する。 The manufacturing method for the intermediates is described below.

参考製造法１
　化合物（Ｉ－２）は式（Ｉ－４）で示される化合物（以下、化合物（Ｉ－４）と記す）から製造することができる。

Figure JPOXMLDOC01-appb-C000026
〔式中、記号は前記と同じ意味を表す。〕
　反応は例えば、Ｇｒｅｅｎ’ｓ　ＰＲＯＴＥＣＴＩＶＥ　ＧＲＯＵＰＳ　ｉｎ ＯＲＧＡＮＩＣ ＳＹＮＴＨＥＳＩＳ　ＦＯＲＴＨ　ＥＤＩＴＩＯＮ　Ｐ７２７. に記載の方法に準じて実施することができる。
　化合物（Ｉ－２）は、酸付加塩を形成することがある。酸付加塩を形成する酸としては、例えば、塩酸、硫酸等の無機酸；及び酢酸、トリフルオロ酢酸、安息香酸、ｐ－トルエンスルホン酸等の有機酸が挙げられる。 Reference Manufacturing Method 1
Compound (I-2) can be produced from a compound represented by formula (I-4) (hereinafter referred to as compound (I-4)).
Figure JPOXMLDOC01-appb-C000026
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION, p. 727.
Compound (I-2) may form an acid addition salt. Examples of acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.

参考製造法２
　化合物（Ｉ－４）は式（Ｉ－５）で示される化合物（以下、化合物（Ｉ－５）と記す）と化合物（Ｉ－Ｍ）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000027
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－８）に代えて化合物（Ｉ－５）を用い、製造法２に準じて実施することができる。 Reference Manufacturing Method 2
Compound (I-4) can be produced by reacting a compound represented by formula (I-5) (hereinafter referred to as compound (I-5)) with compound (IM).
Figure JPOXMLDOC01-appb-C000027
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 2, except that compound (I-5) is used in place of compound (I-8).

参考製造法３
　化合物（Ｉ－５）は式（Ｉ－６）で示される化合物（以下、化合物（Ｉ－６）と記す）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000028
〔式中、記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば、メタノール、エタノール等のアルコール（以下、アルコール類と記す）；ニトリル類；エーテル類、芳香族炭化水素類、非プロトン性極性溶媒類、ハロゲン化炭化水素類、水及びこれらの混合物が挙げられる。
　ハロゲン化剤としては、塩素、臭素、ヨウ素、Ｎ－クロロスクシンイミド、Ｎ－ブロモスクシンイミド、Ｎ－ヨードスクシンイミド（以下、ＮＩＳと記す）等が挙げられる。
　反応には、必要に応じて塩基を用いることができる。塩基としては、例えば、アルカリ金属炭酸塩類が挙げられる。反応に塩基を用いる場合、化合物（Ｉ－６）１モルに対して、塩基が通常１～１０モルの割合で用いられる。
　反応には、化合物（Ｉ－６）１モルに対して、ハロゲン化剤が通常１～１０モルの割合で用いられる。
　反応温度は、通常－２０℃～２００℃の範囲である。反応時間は通常０．１～７２時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－５）を得ることができる。 Reference Manufacturing Method 3
Compound (I-5) can be produced by reacting a compound represented by formula (I-6) (hereinafter referred to as compound (I-6)) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000028
 (In the formula, the symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent, for example, alcohols such as methanol and ethanol (hereinafter referred to as alcohols), nitriles, ethers, aromatic hydrocarbons, aprotic polar solvents, halogenated hydrocarbons, water, and mixtures thereof.
Examples of the halogenating agent include chlorine, bromine, iodine, N-chlorosuccinimide, N-bromosuccinimide, and N-iodosuccinimide (hereinafter referred to as NIS).
In the reaction, a base can be used as necessary. Examples of the base include alkali metal carbonates. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (I-6).
In the reaction, the halogenating agent is usually used in a ratio of 1 to 10 moles per mole of compound (I-6).
The reaction temperature is usually in the range of −20° C. to 200° C. The reaction time is usually in the range of 0.1 to 72 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-5).

参考製造法４
　化合物（Ｉ－６）は式（Ｉ－７）で示される化合物（以下、化合物（Ｉ－７）と記す）から製造することができる。

Figure JPOXMLDOC01-appb-C000029
〔式中、記号は前記と同じ意味を表す。〕
　反応は例えば、国際公開第２００７／１４７７９４号　Ｉｎｔｅｒｍｅｄｉａｔｅ２３に記載の方法、国際公開第２００３／０３７９００号　Ｅｘａｍｐｌｅ５に記載の方法に準じて実施することができる。
　化合物（Ｉ－７）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference Manufacturing Method 4
Compound (I-6) can be produced from a compound represented by formula (I-7) (hereinafter referred to as compound (I-7)).
Figure JPOXMLDOC01-appb-C000029
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out, for example, according to the method described in Intermediate 23 of WO 2007/147794 or Example 5 of WO 2003/037900.
Compound (I-7) is a commercially available compound or can be prepared using known methods.

参考製造法５
　化合物（Ｉ－９）は式（Ｉ－７Ａ）で示される化合物（以下、化合物（Ｉ－７Ａ）と記す）と式（Ｉ－Ａ）で示される化合物（以下、化合物（Ｉ－Ａ）と記す）とから製造することができる。

Figure JPOXMLDOC01-appb-C000030
〔式中、記号は前記と同じ意味を表す。〕
　反応は例えば、国際公開第２００７／１４７７９４号　Ｉｎｔｅｒｍｅｄｉａｔｅ２３に記載の方法に準じて実施することができる。 Reference Manufacturing Method 5
Compound (I-9) can be produced from a compound represented by formula (I-7A) (hereinafter referred to as compound (I-7A)) and a compound represented by formula (IA) (hereinafter referred to as compound (IA)).
Figure JPOXMLDOC01-appb-C000030
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out, for example, according to the method described in International Publication No. 2007/147794, Intermediate 23.

参考製造法６
　化合物（Ｉ－８）は、化合物（Ｉ－１０）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000031
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－６）に代えて化合物（Ｉ－１０）を用い、参考製造法３に準じて実施することができる。 Reference Manufacturing Method 6
Compound (I-8) can be produced by reacting compound (I-10) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000031
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 3, except for using compound (I-10) instead of compound (I-6).

参考製造法７
　化合物（Ｉ－１１）は、式（Ｉ－２Ａ）で示される化合物（以下、化合物（Ｉ－２Ａ）と記す）から製造することができる。

Figure JPOXMLDOC01-appb-C000032
〔式中、記号は前記と同じ意味を表す。〕
　反応は例えば、Ｇｒｅｅｎ’ｓ　ＰＲＯＴＥＣＴＩＶＥ　ＧＲＯＵＰＳ　ｉｎ ＯＲＧＡＮＩＣ ＳＹＮＴＨＥＳＩＳ　ＦＯＲＴＨ　ＥＤＩＴＩＯＮ　Ｐ７２７. に記載の方法に準じて実施することができる。
　化合物（Ｉ－１１）は、酸付加塩を形成することがある。酸付加塩を形成する酸としては、例えば、塩酸、硫酸等の無機酸；及び酢酸、トリフルオロ酢酸、安息香酸、ｐ－トルエンスルホン酸等の有機酸が挙げられる。 Reference Manufacturing Method 7
Compound (I-11) can be produced from a compound represented by formula (I-2A) (hereinafter referred to as compound (I-2A)).
Figure JPOXMLDOC01-appb-C000032
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION, p. 727.
Compound (I-11) may form an acid addition salt. Examples of acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.

参考製造法８
　化合物（Ｉ－２Ａ）は、式（Ｉ－１２）で示される化合物（以下、化合物（Ｉ－１２）と記す）と化合物（Ｉ－Ｍ）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000033
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－８）に代えて化合物（Ｉ－１２）を用い、製造法２に準じて実施することができる。 Reference Manufacturing Method 8
Compound (I-2A) can be produced by reacting a compound represented by formula (I-12) (hereinafter referred to as compound (I-12)) with compound (IM).
Figure JPOXMLDOC01-appb-C000033
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 2, except that compound (I-12) is used in place of compound (I-8).

参考製造法９
　化合物（Ｉ－１２）は、式（Ｉ－１３）で示される化合物（以下、化合物（Ｉ－１３）と記す）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000034
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－６）に代えて化合物（Ｉ－１３）を用い、参考製造法３に準じて実施することができる。
　化合物（Ｉ－１３）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference Manufacturing Method 9
Compound (I-12) can be produced by reacting a compound represented by formula (I-13) (hereinafter referred to as compound (I-13)) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000034
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 3, except for using compound (I-13) instead of compound (I-6).
Compound (I-13) is a commercially available compound or can be prepared using known methods.

参考製造法１－１
　化合物（Ｉ－２）は式（Ｉ－４Ｂ）で示される化合物（以下、化合物（Ｉ－４Ｂ）と記す）から製造することもできる。

Figure JPOXMLDOC01-appb-C000035
〔式中、Ｃｂｚは、ベンジルオキシカルボニル基を表し、その他の記号は前記と同じ意味を表す。〕
　反応は例えば、Ｇｒｅｅｎ’ｓ　ＰＲＯＴＥＣＴＩＶＥ　ＧＲＯＵＰＳ　ｉｎ ＯＲＧＡＮＩＣ ＳＹＮＴＨＥＳＩＳ　ＦＯＲＴＨ　ＥＤＩＴＩＯＮ　Ｐ．７５０ に記載の方法に準じて実施することができる。
　化合物（Ｉ－２）は、酸付加塩を形成することがある。酸付加塩を形成する酸としては、例えば、塩酸、硫酸等の無機酸；及び酢酸、トリフルオロ酢酸、安息香酸、ｐ－トルエンスルホン酸等の有機酸が挙げられる。 Reference Manufacturing Method 1-1
Compound (I-2) can also be produced from a compound represented by formula (I-4B) (hereinafter referred to as compound (I-4B)).
Figure JPOXMLDOC01-appb-C000035
 (In the formula, Cbz represents a benzyloxycarbonyl group, and the other symbols have the same meanings as defined above.)
The reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION p. 750.
Compound (I-2) may form an acid addition salt. Examples of acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.

参考製造法２－１
　化合物（Ｉ－４Ｂ）は式（Ｉ－５Ｂ）で示される化合物（以下、化合物（Ｉ－５Ｂ）と記す）と化合物（Ｉ－Ｍ）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000036
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－８）に代えて化合物（Ｉ－５Ｂ）を用い、製造法２に準じて実施することができる。 Reference Manufacturing Method 2-1
Compound (I-4B) can be produced by reacting a compound represented by formula (I-5B) (hereinafter referred to as compound (I-5B)) with compound (IM).
Figure JPOXMLDOC01-appb-C000036
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 2, except that compound (I-5B) is used in place of compound (I-8).

参考製造法３－１
　化合物（Ｉ－５Ｂ）は式（Ｉ－６Ｂ）で示される化合物（以下、化合物（Ｉ－６Ｂ）と記す）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000037
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－６）に代えて化合物（Ｉ－６Ｂ）を用い、参考製造法３に準じて実施することができる。 Reference Manufacturing Method 3-1
Compound (I-5B) can be produced by reacting a compound represented by formula (I-6B) (hereinafter referred to as compound (I-6B)) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000037
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 3, except for using compound (I-6B) instead of compound (I-6).

参考製造法４－１
　化合物（Ｉ－６Ｂ）は式（Ｉ－７Ｂ）で示される化合物（以下、化合物（Ｉ－７Ｂ）と記す）から製造することができる。

Figure JPOXMLDOC01-appb-C000038
〔式中、記号は前記と同じ意味を表す。〕
　反応は例えば、国際公開第２００７／１４７７９４号　Ｉｎｔｅｒｍｅｄｉａｔｅ２３に記載の方法、国際公開第２００３／０３７９００号　Ｅｘａｍｐｌｅ５に記載の方法、国際公開第２００７／１３４３６２号 　Ｅｘａｍｐｌｅ１に記載の方法、国際公開第２０２１／１５８６３４号  　Ｉｎｔｅｒｍｅｄｉａｔｅ　ＢＭＲ　ｓｔｅｐ　１に記載の方法、Ｈｕａｘｕｅ　Ｘｕｅｂａｏ　（２００５），　６３（９），　８５５－８６０．に記載の方法に準じて実施することができる。 Reference Manufacturing Method 4-1
Compound (I-6B) can be produced from a compound represented by formula (I-7B) (hereinafter referred to as compound (I-7B)).
Figure JPOXMLDOC01-appb-C000038
 (In the formula, the symbols have the same meanings as defined above.)
The reaction may be carried out, for example, according to the method described in WO 2007/147794 Intermediate 23, the method described in WO 2003/037900 Example 5, the method described in WO 2007/134362 Example 1, the method described in WO 2021/158634 Intermediate BMR step 1, or Huaxue Xuebao (2005), 63 (9), 855-860.

参考製造法１０－１
　化合物（Ｉ－７Ｂ）は式（Ｉ－１４Ｂ）で示される化合物（以下、化合物（Ｉ－１４Ｂ）と記す）から製造することができる。

Figure JPOXMLDOC01-appb-C000039
〔式中、記号は前記と同じ意味を表す。〕
　反応は例えば、国際公開第２０１６／１４８１４５号　実施例１－１　工程１－１－３に記載の方法に準じて実施することができる。 Reference Manufacturing Method 10-1
Compound (I-7B) can be produced from a compound represented by formula (I-14B) (hereinafter referred to as compound (I-14B)).
Figure JPOXMLDOC01-appb-C000039
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out, for example, in accordance with the method described in WO 2016/148145, Example 1-1, Step 1-1-3.

参考製造法１０－２
　化合物（Ｉ－１４Ｂ）は式（Ｉ－１４Ａ）で示される化合物（以下、化合物（Ｉ－１４Ａ）と記す）から製造することができる。

Figure JPOXMLDOC01-appb-C000040
〔式中、記号は前記と同じ意味を表す。〕
　反応は例えば、米国特許出願公開第２００２／６３８７９３８号　Ｉｎｖｅｎｔｉｖｅ　Ｅｘａｍｐｌｅ２５に記載の方法に準じて実施することができる。
　化合物（Ｉ－１４Ａ）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference Manufacturing Method 10-2
Compound (I-14B) can be produced from a compound represented by formula (I-14A) (hereinafter referred to as compound (I-14A)).
Figure JPOXMLDOC01-appb-C000040
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out, for example, according to the method described in Inventive Example 25 of US Patent Application Publication No. 2002/6387938.
Compound (I-14A) is a commercially available compound or can be prepared using known methods.

参考製造法１１
　化合物（Ｉ－２Ｂ）は式（Ｉ－１５）で示される化合物（以下、化合物（Ｉ－１５）にアミン類若しくはアンモニウム塩、及び還元剤を作用させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000041
〔式中、記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば、アルコール類；エーテル類；非プロトン性極性溶媒類；及びこれらの混合物が挙げられる。
　アミン類としては、メチルアミン、エチルアミン等が挙げられる。
　アンモニウム塩としては、酢酸アンモニウム等が挙げられる。
　反応には、必要に応じて酸を用いることができる。酸としては、例えば、酢酸等の有機酸が挙げられる。反応に酸を用いる場合、化合物（Ｉ－１５）１モルに対して、酸が通常０．１～１０モルの割合で用いられる。
　反応には、化合物（Ｉ－１５）１モルに対して、還元剤が通常１～１０モルの割合で用いられる。
　反応温度は、通常－２０℃～２００℃の範囲である。反応時間は通常０．１～７２時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－２Ｂ）を得ることができる。 Reference Manufacturing Method 11
Compound (I-2B) can be produced by reacting a compound represented by formula (I-15) (hereinafter, compound (I-15) with an amine or an ammonium salt, and a reducing agent.
Figure JPOXMLDOC01-appb-C000041
 (In the formula, the symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include alcohols, ethers, aprotic polar solvents, and mixtures thereof.
Examples of the amines include methylamine and ethylamine.
The ammonium salt includes ammonium acetate and the like.
In the reaction, an acid can be used as necessary. Examples of the acid include organic acids such as acetic acid. When an acid is used in the reaction, the acid is usually used in a ratio of 0.1 to 10 moles per mole of compound (I-15).
In the reaction, the reducing agent is usually used in a ratio of 1 to 10 moles per mole of compound (I-15).
The reaction temperature is usually in the range of −20° C. to 200° C. The reaction time is usually in the range of 0.1 to 72 hours.
After completion of the reaction, compound (I-2B) can be obtained by carrying out post-treatment operations such as adding water to the reaction mixture, extracting with an organic solvent, drying and concentrating the organic layer.

参考製造法１２
　化合物（Ｉ－１５）は式（Ｉ－１６）で示される化合物（以下、化合物（Ｉ－１６）と記す）と式（Ｍ－ｆ）で示される化合物（以下、化合物（Ｍ－ｆ）と記す）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000042
〔式中、Ｘｄは、塩素原子、臭素原子又はヨウ素原子を表し、その他の記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。溶媒としては、例えば、エーテル類；芳香族炭化水素類；非プロトン性極性溶媒類；及びこれらの２つ以上の混合物が挙げられる。
　反応には、化合物（Ｉ－１６）１モルに対して、化合物（Ｍ－ｆ）が通常１～１０モルの割合で用いられる。
　反応温度は、通常－２０℃～２００℃の範囲である。反応時間は通常０．１～７２時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－１５）を得ることができる。
　化合物（Ｍ－ｆ）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference Manufacturing Method 12
Compound (I-15) can be produced by reacting a compound represented by formula (I-16) (hereinafter referred to as compound (I-16)) with a compound represented by formula (M-f) (hereinafter referred to as compound (M-f)).
Figure JPOXMLDOC01-appb-C000042
 (In the formula, Xd represents a chlorine atom, a bromine atom, or an iodine atom, and the other symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent, such as, for example, ethers, aromatic hydrocarbons, aprotic polar solvents, and mixtures of two or more thereof.
In the reaction, compound (Mf) is usually used in a ratio of 1 to 10 moles per mole of compound (I-16).
The reaction temperature is usually in the range of −20° C. to 200° C. The reaction time is usually in the range of 0.1 to 72 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-15).
Compound (Mf) is a commercially available compound or can be prepared using known methods.

参考製造法１３
　化合物（Ｉ－１６）は式（Ｉ－１７）で示される化合物（以下、化合物（Ｉ－１７）と記す）と化合物（Ｉ－Ｍ）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000043
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－８）に代えて化合物（Ｉ－１７）を用い、製造法２に準じて実施することができる。 Reference Manufacturing Method 13
Compound (I-16) can be produced by reacting a compound represented by formula (I-17) (hereinafter referred to as compound (I-17)) with compound (IM).
Figure JPOXMLDOC01-appb-C000043
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 2, except that compound (I-17) is used in place of compound (I-8).

参考製造法１４
　化合物（Ｉ－１７）は式（Ｉ－１８）で示される化合物（以下、化合物（Ｉ－１８）と記す）と式（Ｍ－ｇ）で示される化合物（以下、化合物（Ｍ－ｇ）と記す）とを縮合剤の存在下で反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000044
〔式中、記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば、エーテル類；ハロゲン化炭化水素類；芳香族炭化水素類；エステル類；ニトリル類；非プロトン性極性溶媒類；含窒素芳香族化合物類；及びこれらの２種類以上の混合物が挙げられる。
　反応に用いられる縮合剤としては、例えば１－［ビス（ジメチルアミノ）メチレン］－１Ｈ－１，２，３－トリアゾロ［４，５－ｂ］ピリジニウム３－オキシドヘキサフルオロホスファート等が挙げられる。
　反応には、必要に応じて塩基を用いることができる。塩基としては、例えば有機塩基類が挙げられる。反応に塩基が用いられる場合、化合物（Ｉ－１８）１モルに対して、塩基が通常１～１０モルの割合で用いられる。
　反応には、化合物（Ｉ－１８）１モルに対して、化合物（Ｍ－ｇ）が通常１～３モルの割合、縮合剤が通常１～５モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－１７）を得ることができる。 Reference Manufacturing Method 14
Compound (I-17) can be produced by reacting a compound represented by formula (I-18) (hereinafter referred to as compound (I-18)) with a compound represented by formula (M-g) (hereinafter referred to as compound (M-g)) in the presence of a condensing agent.
Figure JPOXMLDOC01-appb-C000044
 (In the formula, the symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, esters, nitriles, aprotic polar solvents, nitrogen-containing aromatic compounds, and mixtures of two or more of these.
The condensing agent used in the reaction includes, for example, 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate.
In the reaction, a base can be used as necessary. Examples of the base include organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (I-18).
In the reaction, compound (Mg) is usually used in a ratio of 1 to 3 mol and a condensing agent is usually used in a ratio of 1 to 5 mol, relative to 1 mol of compound (I-18).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-17).

参考製造法１５
　化合物（Ｉ－１８）は式（Ｉ－１９）で示される化合物（以下、化合物（Ｉ－１９）と記す）を塩基の存在下で加水分解反応に付すことにより製造することができる。

Figure JPOXMLDOC01-appb-C000045
〔式中、ＲＸは、Ｃ１－Ｃ４アルキル基を表し、その他の記号は前記と同じ意味を表す。〕
　反応は、塩基の存在下、水及び有機溶媒の存在下で行われる。反応に用いられる溶媒としては例えば、エーテル類；ニトリル類；アルコール類；及びこれらの混合物が挙げられる。
　反応に用いられる塩基としては例えば、水酸化リチウム、水酸化ナトリウム、水酸化カリウム等のアルカリ金属水酸化物が挙げられる。
　反応の反応時間は、通常、５分間～７２時間の範囲である。反応の反応温度は、通常、０℃～１００℃の範囲である。
　反応に用いられる塩基の量は、化合物（Ｉ－１９）１モルに対して、通常は１モルから過剰量まで任意の割合で使用することができ、好ましくは１モル～５モルである。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－１８）を得ることができる。
　化合物（Ｉ－１９）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference Manufacturing Method 15
Compound (I-18) can be produced by subjecting a compound represented by formula (I-19) (hereinafter referred to as compound (I-19)) to hydrolysis reaction in the presence of a base.
Figure JPOXMLDOC01-appb-C000045
 (In the formula, R X represents a C1-C4 alkyl group, and the other symbols have the same meanings as defined above.)
The reaction is carried out in the presence of a base, water and an organic solvent, such as ethers, nitriles, alcohols, and mixtures thereof.
The base used in the reaction includes, for example, alkali metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide, etc.
The reaction time is usually in the range of 5 minutes to 72 hours, and the reaction temperature is usually in the range of 0° C. to 100° C.
The amount of the base used in the reaction can be any amount from 1 mole to an excess amount, and is preferably 1 to 5 moles, per mole of compound (I-19).
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-18).
Compound (I-19) is a commercially available compound or can be prepared using known methods.

参考製造法１６
　式（Ｉ－２０）で示される化合物（以下、化合物（Ｉ－２０）と記す）は式（Ｉ－２１）で示される化合物（以下、化合物（Ｉ－２１）と記す）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000046
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－６）に代えて化合物（Ｉ－２１）を用い、参考製造法３に準じて実施することができる。 Reference Manufacturing Method 16
The compound represented by formula (I-20) (hereinafter referred to as compound (I-20)) can be produced by reacting a compound represented by formula (I-21) (hereinafter referred to as compound (I-21)) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000046
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 3, except for using compound (I-21) instead of compound (I-6).

参考製造法１７
　化合物（Ｉ－２１）は式（Ｉ－２２）で示される化合物（以下、化合物（Ｉ－２２）と記す）と化合物（Ｉ－３）を反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000047
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－２）に代えて化合物（Ｉ－２２）を用い、製造法１に準じて実施することができる。 Reference Manufacturing Method 17
Compound (I-21) can be produced by reacting a compound represented by formula (I-22) (hereinafter referred to as compound (I-22)) with compound (I-3).
Figure JPOXMLDOC01-appb-C000047
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 1, except that compound (I-22) is used in place of compound (I-2).

参考製造法１８
　化合物（Ｉ－２１）は化合物（Ｉ－２２）と化合物（Ｍ－ｅ）とを縮合剤の存在下で反応させることにより製造することもできる。

Figure JPOXMLDOC01-appb-C000048
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－１１）に代えて化合物（Ｉ－２２）を用い、製造法６に準じて実施することができる。 Reference Manufacturing Method 18
Compound (I-21) can also be produced by reacting compound (I-22) with compound (Me) in the presence of a condensing agent.
Figure JPOXMLDOC01-appb-C000048
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 6, except that compound (I-22) is used in place of compound (I-11).

参考製造法１９
　化合物（Ｉ－２２）は式（Ｉ－２３）で示される化合物（以下、化合物（Ｉ－２３）にアミン類若しくはアンモニウム塩、及び還元剤を作用させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000049
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－１５）に代えて化合物（Ｉ－２３）を用い、参考製造法１１に準じて実施することができる。 Reference Manufacturing Method 19
Compound (I-22) can be produced by reacting a compound represented by formula (I-23) (hereinafter, compound (I-23) with an amine or an ammonium salt, and a reducing agent.
Figure JPOXMLDOC01-appb-C000049
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 11, except for using compound (I-23) instead of compound (I-15).

参考製造法２０
　化合物（Ｉ－２３）は式（Ｉ－２４）で示される化合物（以下、化合物（Ｉ－２４）と記す）と化合物（Ｍ－ｆ）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000050
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－１６）に代えて化合物（Ｉ－２４）を用い、参考製造法１２に準じて実施することができる。 Reference Manufacturing Method 20
Compound (I-23) can be produced by reacting a compound represented by formula (I-24) (hereinafter referred to as compound (I-24)) with compound (Mf).
Figure JPOXMLDOC01-appb-C000050
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 12, except for using compound (I-24) instead of compound (I-16).

参考製造法２１
　化合物（Ｉ－２４）は式（Ｉ－２５）で示される化合物（以下、化合物（Ｉ－２５）と記す）と化合物（Ｍ－ｇ）とをルイス酸の存在下で反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000051
〔式中、記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば、エーテル類；ハロゲン化炭化水素類；芳香族炭化水素類；非プロトン性極性溶媒類；及びこれらの２種類以上の混合物が挙げられる。
　反応に用いられるルイス酸としては、例えばトリメチルアルミニウム等が挙げられる。
　反応には、化合物（Ｉ－２５）１モルに対して、ルイス酸が通常０.１～５モルの割合で用いられる。
　反応には、化合物（Ｉ－２５）１モルに対して、化合物（Ｍ－ｇ）が通常１～５モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（Ｉ－２４）を得ることができる。
　化合物（Ｉ－２５）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。 Reference Manufacturing Method 21
Compound (I-24) can be produced by reacting a compound represented by formula (I-25) (hereinafter referred to as compound (I-25)) with compound (Mg) in the presence of a Lewis acid.
Figure JPOXMLDOC01-appb-C000051
 (In the formula, the symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, aprotic polar solvents, and mixtures of two or more of these.
The Lewis acid used in the reaction includes, for example, trimethylaluminum.
In the reaction, the Lewis acid is usually used in a proportion of 0.1 to 5 moles per mole of compound (I-25).
In the reaction, compound (Mg) is usually used in a ratio of 1 to 5 moles per mole of compound (I-25).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (I-24).
Compound (I-25) is a commercially available compound or can be prepared using known methods.

参考製造法２２
　化合物（ＩＩ－２）は式（ＩＩ－３）で示される化合物（以下、化合物（ＩＩ－３）と記す）から製造することができる。

Figure JPOXMLDOC01-appb-C000052
〔式中、ＰＧは、ｔｅｒｔ－ブトキシカルボニル基若しくはベンジルオキシカルボニル基を表し、その他の記号は前記と同じ意味を表す。〕
　反応は例えば、Ｇｒｅｅｎ’ｓ　ＰＲＯＴＥＣＴＩＶＥ　ＧＲＯＵＰＳ　ｉｎ ＯＲＧＡＮＩＣ ＳＹＮＴＨＥＳＩＳ　ＦＯＲＴＨ　ＥＤＩＴＩＯＮ　Ｐ．７２７若しくはＰ．７５０に記載の方法に準じて実施することができる。
　化合物（ＩＩ－２）は、酸付加塩を形成することがある。酸付加塩を形成する酸としては、例えば、塩酸、硫酸等の無機酸；及び酢酸、トリフルオロ酢酸、安息香酸、ｐ－トルエンスルホン酸等の有機酸が挙げられる。 Reference Manufacturing Method 22
Compound (II-2) can be produced from a compound represented by formula (II-3) (hereinafter referred to as compound (II-3)).
Figure JPOXMLDOC01-appb-C000052
 (In the formula, PG represents a tert-butoxycarbonyl group or a benzyloxycarbonyl group, and the other symbols have the same meanings as defined above.)
The reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION, p. 727 or p. 750.
Compound (II-2) may form an acid addition salt. Examples of acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.

参考製造法２３
　化合物（ＩＩ－３）は式（ＩＩ－４）で示される化合物（以下、化合物（ＩＩ－４）と記す）と式（Ｍ－ｈ）で示される化合物（以下、化合物（Ｍ－ｈ）と記す）とを酸の存在下で反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000053
〔式中、ＲｖはＣ１－Ｃ３アルキル基を表し、その他の記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば、エーテル類；ハロゲン化炭化水素類；芳香族炭化水素類；エステル類；ニトリル類；非プロトン性極性溶媒類；及びこれらの２種類以上の混合物が挙げられる。
　反応に用いられる酸としては、トリフルオロ酢酸や酢酸等の有機酸が挙げられる。
　反応には、化合物（ＩＩ－４）１モルに対して、酸が通常０.１～１００モルの割合で用いられる。
　反応には、必要に応じて塩基を用いることができる。塩基としては、例えば有機塩基類が挙げられる。反応に塩基が用いられる場合、化合物（ＩＩ－４）１モルに対して、塩基が通常１～１０モルの割合で用いられる。
　反応には、化合物（ＩＩ－４）１モルに対して、化合物（Ｍ－ｈ）が通常１～１０モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩ－３）を得ることができる。 Reference Manufacturing Method 23
Compound (II-3) can be produced by reacting a compound represented by formula (II-4) (hereinafter referred to as compound (II-4)) with a compound represented by formula (M-h) (hereinafter referred to as compound (M-h)) in the presence of an acid.
Figure JPOXMLDOC01-appb-C000053
 (In the formula, R v represents a C1-C3 alkyl group, and the other symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, esters, nitriles, aprotic polar solvents, and mixtures of two or more of these.
The acid used in the reaction includes organic acids such as trifluoroacetic acid and acetic acid.
In the reaction, the acid is usually used in a proportion of 0.1 to 100 moles per mole of compound (II-4).
In the reaction, a base can be used as necessary. Examples of the base include organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (II-4).
In the reaction, compound (Mh) is usually used in an amount of 1 to 10 moles per mole of compound (II-4).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-3).

参考製造法２４
　化合物（ＩＩ－４）は式（ＩＩ－５）で示される化合物（以下、化合物（ＩＩ－５）と記す）とヒドラジン類とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000054
〔式中、Ｘｂは塩素原子若しくは臭素原子を表し、その他の記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば、エーテル類；ハロゲン化炭化水素類；芳香族炭化水素類；アルコール類；非プロトン性極性溶媒類；水及びこれらの２種類以上の混合物が挙げられる。
　反応に用いられるヒドラジン類としては、無水ヒドラジン、ヒドラジン一水和物、ヒドラジン一塩酸塩等が挙げられる。
　反応には、化合物（ＩＩ－５）１モルに対して、ヒドラジン類が通常１～１０モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩ－４）を得ることができる。 Reference Manufacturing Method 24
Compound (II-4) can be produced by reacting a compound represented by formula (II-5) (hereinafter referred to as compound (II-5)) with a hydrazine.
Figure JPOXMLDOC01-appb-C000054
 [In the formula, Xb represents a chlorine atom or a bromine atom, and the other symbols have the same meanings as defined above.]
The reaction is usually carried out in a solvent, for example, ethers, halogenated hydrocarbons, aromatic hydrocarbons, alcohols, aprotic polar solvents, water, and mixtures of two or more of these.
The hydrazines used in the reaction include anhydrous hydrazine, hydrazine monohydrate, hydrazine monohydrochloride, and the like.
In the reaction, the hydrazine is usually used in an amount of 1 to 10 moles per mole of compound (II-5).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-4).

参考製造法２５
　化合物（ＩＩ－５）は式（ＩＩ－６）で示される化合物（以下、化合物（ＩＩ－６）と記す）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000055
〔式中、記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えば、エーテル類；ハロゲン化炭化水素類；芳香族炭化水素類；ニトリル類；非プロトン性極性溶媒類；含窒素芳香族化合物類；及びこれらの２種類以上の混合物が挙げられる。
　反応に用いられるハロゲン化剤としては、オキシ塩化リン等が挙げられる。
　反応には、化合物（ＩＩ－６）１モルに対して、ハロゲン化剤が通常１～１０モルの割合で用いられる。
　反応には、必要に応じて塩基を用いることができる。塩基としては、例えば有機塩基類が挙げられる。反応に塩基が用いられる場合、化合物（ＩＩ－６）１モルに対して、塩基が通常１～１０モルの割合で用いられる。
　反応には、必要に応じて第四級アンモニウム塩を用いることができる。第四級アンモニウム塩としては、例えばトリエチルベンジルアンモニウムクロリド等が挙げられる。反応に第四級アンモニウム塩が用いられる場合、化合物（ＩＩ－６）１モルに対して、第四級アンモニウム塩が通常０.１～５モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩ－５）を得ることができる。 Reference Manufacturing Method 25
Compound (II-5) can be produced by reacting a compound represented by formula (II-6) (hereinafter referred to as compound (II-6)) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000055
 (In the formula, the symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent. Examples of the solvent used in the reaction include ethers, halogenated hydrocarbons, aromatic hydrocarbons, nitriles, aprotic polar solvents, nitrogen-containing aromatic compounds, and mixtures of two or more of these.
The halogenating agent used in the reaction includes phosphorus oxychloride and the like.
In the reaction, the halogenating agent is usually used in a ratio of 1 to 10 moles per mole of compound (II-6).
In the reaction, a base can be used as necessary. Examples of the base include organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (II-6).
In the reaction, a quaternary ammonium salt can be used as necessary. Examples of the quaternary ammonium salt include triethylbenzylammonium chloride. When a quaternary ammonium salt is used in the reaction, the quaternary ammonium salt is usually used in a ratio of 0.1 to 5 moles per mole of compound (II-6).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-5).

参考製造法２６
　化合物（ＩＩ－６）は式（ＩＩ－７）で示される化合物（以下、化合物（ＩＩ－７）と記す）と化合物（Ｉ－Ｍ）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000056
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－８）に代えて化合物（ＩＩ－７）を用い、製造法２に準じて実施することができる。 Reference Manufacturing Method 26
Compound (II-6) can be produced by reacting a compound represented by formula (II-7) (hereinafter referred to as compound (II-7)) with compound (IM).
Figure JPOXMLDOC01-appb-C000056
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 2, except that compound (II-7) is used in place of compound (I-8).

参考製造法２７
　化合物（ＩＩ－７）は式（ＩＩ－８）で示される化合物（以下、化合物（ＩＩ－８）と記す）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000057
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－６）に代えて化合物（ＩＩ－８）を用い、参考製造法３に準じて実施することができる。 Reference Manufacturing Method 27
Compound (II-7) can be produced by reacting a compound represented by formula (II-8) (hereinafter referred to as compound (II-8)) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000057
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 3, except that compound (II-8) is used in place of compound (I-6).

参考製造法２８
　化合物（ＩＩ－８）は、式（ＩＩ－９）で示される化合物（以下、化合物（ＩＩ－９）と記す）と式（Ｍ－ｉ）で示される化合物（以下、化合物（Ｍ－ｉ）と記す）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000058
〔式中、Ｒｙは、Ｃ１－Ｃ４アルキル基を表し、その他の記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばアルコール類；エーテル類；芳香族炭化水素類；ニトリル類；非プロトン性極性溶媒；ハロゲン化炭化水素類；及びこれらの２種類以上の混合物が挙げられる。
　反応には、化合物（ＩＩ－９）１モルに対して、化合物（Ｍ－ｉ）が通常１～５モルの割合で用いられる。
　反応には、必要に応じて塩基を用いることができる。塩基としては、例えば、ナトリウムメトキシドやナトリウムエトキシド等のアルカリ金属アルコキシド類；アルカリ金属炭酸塩類；及び有機塩基類が挙げられる。反応に塩基を用いる場合、化合物（ＩＩ－９）１モルに対して、塩基が通常１～１０モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～２４時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩ－８）を得ることができる。
　化合物（Ｍ－ｉ）は、市販の化合物であるか、又は既知の方法を用いて製造することができる。
　化合物（ＩＩ－９）は、公知であるか、Ｔｅｔｒａｈｅｄｒｏｎ（２０１３）６９，１１０９２－１１１０８．等に記載の既知の方法に準じて製造することができる。 Reference Manufacturing Method 28
Compound (II-8) can be produced by reacting a compound represented by formula (II-9) (hereinafter referred to as compound (II-9)) with a compound represented by formula (Mi) (hereinafter referred to as compound (Mi)).
Figure JPOXMLDOC01-appb-C000058
 (In the formula, R y represents a C1-C4 alkyl group, and the other symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent, such as alcohols, ethers, aromatic hydrocarbons, nitriles, aprotic polar solvents, halogenated hydrocarbons, and mixtures of two or more of these.
In the reaction, compound (Mi) is usually used in a ratio of 1 to 5 moles per mole of compound (II-9).
In the reaction, a base can be used as necessary. Examples of the base include alkali metal alkoxides such as sodium methoxide and sodium ethoxide; alkali metal carbonates; and organic bases. When a base is used in the reaction, the base is usually used in a ratio of 1 to 10 moles per mole of compound (II-9).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 24 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-8).
Compounds (Mi) are commercially available compounds or can be prepared using known methods.
Compound (II-9) is publicly known, or can be produced according to a known method described in Tetrahedron (2013) 69, 11092-11108.

参考製造法２９
　式（ＩＩ－１０）で示される化合物（以下、化合物（ＩＩ－１０）と記す）は式（ＩＩ－１１）で示される化合物（以下、化合物（ＩＩ－１１）と記す）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000059
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－６）に代えて化合物（ＩＩ－１１）を用い、参考製造法３に準じて実施することができる。 Reference Manufacturing Method 29
The compound represented by formula (II-10) (hereinafter referred to as compound (II-10)) can be produced by reacting a compound represented by formula (II-11) (hereinafter referred to as compound (II-11)) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000059
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 3, except that compound (II-11) is used in place of compound (I-6).

参考製造法３０
　化合物（ＩＩ－１１）は式（ＩＩ－１２）で示される化合物（以下、化合物（ＩＩ－１２）と記す）と化合物（Ｍ－ｈ）とを酸の存在下で反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000060
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（ＩＩ－４）に代えて化合物（ＩＩ－１２）を用い、参考製造法２３に準じて実施することができる。 Reference Manufacturing Method 30
Compound (II-11) can be produced by reacting a compound represented by formula (II-12) (hereinafter referred to as compound (II-12)) with compound (Mh) in the presence of an acid.
Figure JPOXMLDOC01-appb-C000060
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 23, except for using compound (II-12) instead of compound (II-4).

参考製造法３１
　化合物（ＩＩ－１２）は式（ＩＩ－１３）で示される化合物（以下、化合物（ＩＩ－１３）と記す）とヒドラジン類とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000061
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（ＩＩ－５）に代えて化合物（ＩＩ－１３）を用い、参考製造法２４に準じて実施することができる。 Reference Manufacturing Method 31
Compound (II-12) can be produced by reacting a compound represented by formula (II-13) (hereinafter referred to as compound (II-13)) with a hydrazine.
Figure JPOXMLDOC01-appb-C000061
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 24, except for using compound (II-13) instead of compound (II-5).

参考製造法３２
　化合物（ＩＩ－１３）は化合物（ＩＩ－８）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000062
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（ＩＩ－６）に代えて化合物（ＩＩ－８）を用い、参考製造法２５に準じて実施することができる。 Reference Manufacturing Method 32
Compound (II-13) can be produced by reacting compound (II-8) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000062
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 25, except for using compound (II-8) instead of compound (II-6).

参考製造法３３
　化合物（ＩＩ－３Ａ）は式（ＩＩ－１４）で示される化合物（以下、化合物（ＩＩ－１４）と記す）と化合物（Ｉ－Ｍ）を反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000063
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－８）に代えて化合物（ＩＩ－１４）を用い、製造法２に準じて実施することができる。 Reference Manufacturing Method 33
Compound (II-3A) can be produced by reacting a compound represented by formula (II-14) (hereinafter referred to as compound (II-14)) with compound (IM).
Figure JPOXMLDOC01-appb-C000063
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 2, except that compound (II-14) is used in place of compound (I-8).

参考製造法３４
　化合物（ＩＩ－１４）は、式（ＩＩ－１５）で示される化合物（以下、化合物（ＩＩ－１５）と記す）と式（Ｍ－ｊ）で示される化合物（以下、化合物（Ｍ－ｊ）と記す）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000064
〔式中、Ｘｃは、塩素原子、臭素原子若しくはヨウ素原子を表し、Ｒｚは、Ｃ１－Ｃ３アルキル基を表し、その他の記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類；芳香族炭化水素類；非プロトン性極性溶媒；ハロゲン化炭化水素類；及びこれらの２種類以上の混合物が挙げられる。
　反応には、化合物（ＩＩ－１５）１モルに対して、化合物（Ｍ－ｊ）が通常１～５モルの割合で用いられる。
　反応には、必要に応じて酸を用いることができる。酸としては、例えば、酢酸やｐ－トルエンスルホン酸等の有機酸が挙げられる。反応に酸を用いる場合、化合物（ＩＩ－１５）１モルに対して、酸が通常０.１～１００モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩ－１４）を得ることができる。 Reference Manufacturing Method 34
Compound (II-14) can be produced by reacting a compound represented by formula (II-15) (hereinafter referred to as compound (II-15)) with a compound represented by formula (M-j) (hereinafter referred to as compound (M-j)).
Figure JPOXMLDOC01-appb-C000064
 (In the formula, Xc represents a chlorine atom, a bromine atom, or an iodine atom, Rz represents a C1-C3 alkyl group, and the other symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent, such as ethers, aromatic hydrocarbons, aprotic polar solvents, halogenated hydrocarbons, and mixtures of two or more of these.
In the reaction, compound (Mj) is usually used in a ratio of 1 to 5 moles per mole of compound (II-15).
In the reaction, an acid can be used as necessary. Examples of the acid include organic acids such as acetic acid and p-toluenesulfonic acid. When an acid is used in the reaction, the acid is usually used in a ratio of 0.1 to 100 moles per mole of compound (II-15).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-14).

参考製造法３５
　化合物（ＩＩ－１５）は、式（ＩＩ－１６）で示される化合物（以下、化合物（ＩＩ－１６）と記す）から製造することができる。

Figure JPOXMLDOC01-appb-C000065
〔式中、ＰＧ１は、２,４,６－トリメトキシフェニルメチル基、２,４－ジメトキシフェニルメチル基若しくは４－メトキシフェニルメチル基を表し、その他の記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類；アルコール類；芳香族炭化水素類；非プロトン性極性溶媒；ハロゲン化炭化水素類；水及びこれらの２種類以上の混合物が挙げられる。
　反応には、必要に応じて酸を用いることができる。酸としては、例えば、塩酸等の無機酸；トリフルオロ酢酸やｐ－トルエンスルホン酸等の有機酸が挙げられる。反応に酸を用いる場合、化合物（ＩＩ－１６）１モルに対して、酸が通常０.１～１００モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～７２時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩ－１５）を得ることができる。 Reference Manufacturing Method 35
Compound (II-15) can be produced from a compound represented by formula (II-16) (hereinafter referred to as compound (II-16)).
Figure JPOXMLDOC01-appb-C000065
 [In the formula, PG 1 represents a 2,4,6-trimethoxyphenylmethyl group, a 2,4-dimethoxyphenylmethyl group, or a 4-methoxyphenylmethyl group, and the other symbols have the same meanings as above.]
The reaction is usually carried out in a solvent, such as ethers, alcohols, aromatic hydrocarbons, aprotic polar solvents, halogenated hydrocarbons, water, and mixtures of two or more of these.
In the reaction, an acid can be used as necessary. Examples of the acid include inorganic acids such as hydrochloric acid, and organic acids such as trifluoroacetic acid and p-toluenesulfonic acid. When an acid is used in the reaction, the acid is usually used in a ratio of 0.1 to 100 moles per mole of compound (II-16).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 72 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-15).

参考製造法３６
　化合物（ＩＩ－１６）は、式（ＩＩ－１７）で示される化合物（以下、化合物（ＩＩ－１７）と記す）と式（Ｍ－ｋ）で示される化合物（以下、化合物（Ｍ－ｋ）と記す）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000066
〔式中、記号は前記と同じ意味を表す。〕
　反応は、通常溶媒中で行われる。反応に用いられる溶媒としては、例えばエーテル類；芳香族炭化水素類；非プロトン性極性溶媒；ニトリル類；ハロゲン化炭化水素類；及びこれらの２種類以上の混合物が挙げられる。
　反応には、化合物（ＩＩ－１７）１モルに対して、化合物（Ｍ－ｋ）が通常１～５モルの割合で用いられる。
　反応には、必要に応じて塩基を用いることができる。塩基としては、例えば、アルカリ金属炭酸塩類及び有機塩基類が挙げられる。反応に塩基を用いる場合、化合物（ＩＩ－１７）１モルに対して、塩基が通常０.１～１０モルの割合で用いられる。
　反応温度は、通常－２０～２００℃の範囲である。反応時間は通常０．１～４８時間の範囲である。
　反応終了後は、反応混合物に水を加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより化合物（ＩＩ－１６）を得ることができる。 Reference Manufacturing Method 36
Compound (II-16) can be produced by reacting a compound represented by formula (II-17) (hereinafter referred to as compound (II-17)) with a compound represented by formula (M-k) (hereinafter referred to as compound (M-k)).
Figure JPOXMLDOC01-appb-C000066
 (In the formula, the symbols have the same meanings as defined above.)
The reaction is usually carried out in a solvent, such as ethers, aromatic hydrocarbons, aprotic polar solvents, nitriles, halogenated hydrocarbons, and mixtures of two or more of these.
In the reaction, compound (Mk) is usually used in a ratio of 1 to 5 moles per mole of compound (II-17).
In the reaction, a base can be used as necessary. Examples of the base include alkali metal carbonates and organic bases. When a base is used in the reaction, the base is usually used in a ratio of 0.1 to 10 moles per mole of compound (II-17).
The reaction temperature is usually in the range of −20 to 200° C. The reaction time is usually in the range of 0.1 to 48 hours.
After the reaction is completed, the reaction mixture is added with water, extracted with an organic solvent, and the organic layer is dried and concentrated, and other post-treatment procedures can be carried out to obtain compound (II-16).

参考製造法３７
　化合物（ＩＩ－１７）は化合物（ＩＩ－７）とハロゲン化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000067
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（ＩＩ－６）に代えて化合物（ＩＩ－７）を用い、参考製造法２５に準じて実施することができる。 Reference Manufacturing Method 37
Compound (II-17) can be produced by reacting compound (II-7) with a halogenating agent.
Figure JPOXMLDOC01-appb-C000067
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Reference Production Method 25, except for using compound (II-7) instead of compound (II-6).

参考製造法３８
　式（ＩＩ－１８）で示される化合物（以下、化合物（ＩＩ－１８）と記す）は化合物（ＩＩ－１０）から製造することができる。

Figure JPOXMLDOC01-appb-C000068
〔式中、記号は前記と同じ意味を表す。〕
　反応は例えば、Ｇｒｅｅｎ’ｓ　ＰＲＯＴＥＣＴＩＶＥ　ＧＲＯＵＰＳ　ｉｎ ＯＲＧＡＮＩＣ ＳＹＮＴＨＥＳＩＳ　ＦＯＲＴＨ　ＥＤＩＴＩＯＮ　Ｐ．７２７若しくはＰ．７５０に記載の方法に準じて実施することができる。
　化合物（ＩＩ－１８）は、酸付加塩を形成することがある。酸付加塩を形成する酸としては、例えば、塩酸、硫酸等の無機酸；及び酢酸、トリフルオロ酢酸、安息香酸、ｐ－トルエンスルホン酸等の有機酸が挙げられる。 Reference Manufacturing Method 38
The compound represented by the formula (II-18) (hereinafter referred to as compound (II-18)) can be produced from compound (II-10).
Figure JPOXMLDOC01-appb-C000068
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out, for example, according to the method described in Green's PROTECTIVE GROUPS in ORGANIC SYNTHESIS FORTH EDITION, p. 727 or p. 750.
Compound (II-18) may form an acid addition salt. Examples of acids that form acid addition salts include inorganic acids such as hydrochloric acid and sulfuric acid; and organic acids such as acetic acid, trifluoroacetic acid, benzoic acid, and p-toluenesulfonic acid.

参考製造法３９
　化合物（ＩＩ－１９）は化合物（ＩＩ－１８）と化合物（Ｉ－３）を反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000069
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－２）に代えて化合物（ＩＩ－１８）を用い、製造法１に準じて実施することができる。 Reference Manufacturing Method 39
Compound (II-19) can be produced by reacting compound (II-18) with compound (I-3).
Figure JPOXMLDOC01-appb-C000069
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 1, except that compound (II-18) is used in place of compound (I-2).

参考製造法４０
　化合物（ＩＩ－３）は化合物（ＩＩ－１０）と化合物（Ｉ－Ｍ）とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-C000070
〔式中、記号は前記と同じ意味を表す。〕
　反応は、化合物（Ｉ－８）に代えて化合物（ＩＩ－１０）を用い、製造法２に準じて実施することができる。 Reference Manufacturing Method 40
Compound (II-3) can be produced by reacting compound (II-10) with compound (IM).
Figure JPOXMLDOC01-appb-C000070
 (In the formula, the symbols have the same meanings as defined above.)
The reaction can be carried out according to Production Method 2, except that compound (II-10) is used in place of compound (I-8).

　本発明化合物は、下記群（ａ）、群（ｂ）、群（ｃ）及び群（ｄ）からなる群より選ばれる１以上の成分（以下、本成分と記す）と混用又は併用することができる。
　前記混用又は併用とは、本発明化合物と本成分とを、同時に、別々に又は時間間隔をおいて使用することを意味する。
　本発明化合物と本成分とを同時に使用する場合、本発明化合物及び本成分が、それぞれ別個の製剤に含まれていてもよく、１つの製剤に含まれていてもよい。
　本発明の１つの側面は、群（ａ）、群（ｂ）、群（ｃ）及び群（ｄ）からなる群より選ばれる１以上の成分（すなわち、本成分）、並びに本発明化合物を含有する組成物（以下、組成物Ａと記す）である。 The compound of the present invention can be mixed or used in combination with one or more components (hereinafter referred to as the present components) selected from the group consisting of the following groups (a), (b), (c) and (d):
The above-mentioned mixed or concomitant use means that the compound of the present invention and the present ingredient are used simultaneously, separately or with an interval between them.
When the compound of the present invention and this ingredient are used simultaneously, the compound of the present invention and this ingredient may be contained in separate preparations or may be contained in a single preparation.
One aspect of the present invention is a composition (hereinafter referred to as Composition A) containing one or more components selected from the group consisting of Group (a), Group (b), Group (c), and Group (d) (i.e., the present components), and a compound of the present invention.

　群（ａ）は、アセチルコリンエステラーゼ阻害剤（例えばカーバメート系殺虫剤、有機リン系殺虫剤）、GABA作動性塩素イオンチャネルブロッカー（例えばフェニルピラゾール系殺虫剤）、ナトリウムチャネルモジュレーター（例えば、ピレスロイド系殺虫剤）、ニコチン性アセチルコリン受容体競合的モジュレーター（例えば、ネオニコチノイド系殺虫剤）、ニコチン性アセチルコリン受容体アロステリックモジュレーター、グルタミン酸作動性塩素イオンチャネルアロステリックモジュレーター（例えば、マクロライド系殺虫剤）、幼若ホルモンミミック、マルチサイト阻害剤、弦音器官TRPVチャネルモジュレーター、ダニ類生育阻害剤、微生物由来昆虫中腸内膜破壊剤、ミトコンドリアATP合成酵素阻害剤、酸化的リン酸化脱共役剤、ニコチン性アセチルコリン受容体チャネルブロッカー（例えば、ネライストキシン系殺虫剤）、キチン生合成阻害剤、脱皮阻害剤、エクダイソン受容体アゴニスト、オクトパミン受容体アゴニスト、ミトコンドリア電子伝達系複合体I, II, III及びIVの阻害剤、電位依存性ナトリウムチャネルブロッカー、アセチルCoAカルボキシラーゼ阻害剤、リアノジン受容体モジュレーター（例えば、ジアミド系殺虫剤）、弦音器官モジュレーター、微生物殺虫剤、並びにその他の殺虫活性成分、殺ダニ活性成分及び殺線虫活性成分からなる群である。これらは、IRACの作用機構に基づく分類に記載されている。 Group (a) includes acetylcholinesterase inhibitors (e.g., carbamate insecticides, organophosphate insecticides), GABAergic chloride channel blockers (e.g., phenylpyrazole insecticides), sodium channel modulators (e.g., pyrethroid insecticides), nicotinic acetylcholine receptor competitive modulators (e.g., neonicotinoid insecticides), nicotinic acetylcholine receptor allosteric modulators, glutamatergic chloride channel allosteric modulators (e.g., macrolide insecticides), juvenile hormone mimics, multisite inhibitors, chordotonal organ TRPV channel modulators, mite growth inhibitors, The group consists of microbial insect midgut membrane disruptors, mitochondrial ATP synthase inhibitors, oxidative phosphorylation uncouplers, nicotinic acetylcholine receptor channel blockers (e.g., nereistoxin insecticides), chitin biosynthesis inhibitors, molting inhibitors, ecdysone receptor agonists, octopamine receptor agonists, inhibitors of mitochondrial electron transport chain complexes I, II, III and IV, voltage-dependent sodium channel blockers, acetyl-CoA carboxylase inhibitors, ryanodine receptor modulators (e.g., diamide insecticides), chordotonal organ modulators, microbial insecticides, and other insecticidal, acaricidal and nematicidal active ingredients. These are described in the IRAC classification based on the mechanism of action.

　群（ｂ）は、核酸合成阻害剤（例えば、フェニルアミド系殺菌剤、アシルアミノ酸系殺菌剤）、細胞分裂及び細胞骨格阻害剤（例えば、MBC殺菌剤）、呼吸阻害剤（例えば、QoI殺菌剤、QiI殺菌剤）、アミノ酸合成及びタンパク質合成阻害剤（例えば、アニリノピリジン系殺菌剤）、シグナル伝達阻害剤、脂質合成及び膜合成阻害剤、ステロール生合成阻害剤（例えば、トリアゾール系などのDMI殺菌剤）、細胞壁生合成阻害剤、メラニン合成阻害剤、植物防御誘導剤、多作用点接触活性殺菌剤、微生物殺菌剤、及びその他の殺菌活性成分からなる群である。これらは、FRACの作用機構に基づく分類に記載されている。 Group (b) consists of nucleic acid synthesis inhibitors (e.g., phenylamide fungicides, acylamino acid fungicides), cell division and cytoskeleton inhibitors (e.g., MBC fungicides), respiratory inhibitors (e.g., QoI fungicides, QiI fungicides), amino acid synthesis and protein synthesis inhibitors (e.g., anilinopyridine fungicides), signal transduction inhibitors, lipid synthesis and membrane synthesis inhibitors, sterol biosynthesis inhibitors (e.g., DMI fungicides such as triazoles), cell wall biosynthesis inhibitors, melanin synthesis inhibitors, plant defense inducers, multisite contact active fungicides, microbial fungicides, and other fungicidal active ingredients. These are described in the classification based on the mechanism of action of FRAC.

　群（ｃ）は、植物成長調整成分（菌根菌及び根粒菌を含む）の群である。 Group (c) is a group of plant growth regulators (including mycorrhizal fungi and rhizobia).

　群（ｄ）は、忌避成分の群である。 Group (d) is a group of repellent components.

　以下に、本成分と本発明化合物との組合せの例を記載する。例えば、アラニカルブ(alanycarb) + SXはアラニカルブ(alanycarb)とSXとの組合せを意味する。
　なお、SXの略号は、化合物群SX1～SX1338及び本発明化合物１～５８から選ばれるいずれか１つの本発明化合物を意味する。また、以下に記載する本成分はいずれも公知の成分であり、市販の製剤から得るか、公知の方法により製造することができる。本成分が微生物の場合は、菌寄託機関から入手することもできる。なお、括弧内の数字はCAS RN（登録商標）を表す。 Examples of combinations of the present component and the compound of the present invention are described below. For example, alanycarb + SX means a combination of alanycarb and SX.
The abbreviation SX means any one of the compounds of the present invention selected from the compound group SX1 to SX1338 and the compounds of the present invention 1 to 58. The present components described below are all known components and can be obtained from commercially available preparations or produced by known methods. When the present components are microorganisms, they can also be obtained from a bacterial depository institution. The numbers in parentheses represent CAS RN (registered trademark).

　上記群（ａ）の本成分と本発明化合物との組合せ：
　アバメクチン(abamectin) + SX, アセフェート(acephate) + SX, アセキノシル(acequinocyl) + SX, アセタミプリド(acetamiprid) + SX, アセトプロール(acetoprole) + SX, アクリナトリン(acrinathrin) + SX, アシノナピル(acynonapyr) + SX, アフィドピロペン(afidopyropen) + SX, アフォキソラネル(afoxolaner) + SX, アラニカルブ(alanycarb) + SX, アルジカルブ(aldicarb) + SX, アレスリン(allethrin) + SX, アルファシペルメトリン(alpha-cypermethrin) + SX, アルファエンドスルファン(alpha-endosulfan) + SX, リン化アルミニウム(aluminium phosphide) + SX, アミトラズ(amitraz) + SX, アザジラクチン(azadirachtin) + SX, アザメチホス(azamethiphos) + SX, アジンホスエチル(azinphos-ethyl) + SX, アジンホスメチル(azinphos-methyl) + SX, アゾシクロチン(azocyclotin) + SX, Celastrus angulatus樹皮(bark of Celastrus angulatus) + SX, ベンダイオカルブ(bendiocarb) + SX, ベンフルトリン(benfluthrin) + SX, ベンフラカルブ(benfuracarb) + SX, ベンスルタップ(bensultap) + SX, ベンゾキシメート(benzoximate) + SX, ベンズピリモキサン(benzpyrimoxan) + SX, ベータシフルトリン(beta-cyfluthrin) + SX, べータシペルメトリン(beta-cypermethrin) + SX, ビフェナゼート(bifenazate) + SX, ビフェントリン(bifenthrin) + SX, ビオアレスリン(bioallethrin) + SX, ビオレスメトリン(bioresmethrin) + SX, ビストリフルロン(bistrifluron) + SX, ホウ砂(borax) + SX, ホウ酸(boric acid) + SX, ブロフラニリド(broflanilide) + SX, ブロモプロピレート(bromopropylate) + SX, ブプロフェジン(buprofezin) + SX, ブトカルボキシム(butocarboxim) + SX, ブトキシカルボキシム(butoxycarboxim) + SX, カズサホス(cadusafos) + SX, リン化カルシウム(calcium phosphide) + SX, カルバリル(carbaryl) + SX, カルボフラン(carbofuran) + SX, カルボスルファン(carbosulfan) + SX, カルタップ塩酸塩(cartap hydrochloride) + SX, カルタップ(cartap) + SX, キノメチオナート(chinomethionat) + SX, クロラントラニリプロール(chlorantraniliprole) + SX, クロルデン(chlordane) + SX, クロレトキシホス(chlorethoxyfos) + SX, クロルフェナピル(chlorfenapyr) + SX, クロルフェンビンホス(chlorfenvinphos) + SX, クロルフルアズロン(chlorfluazuron) + SX, クロルメホス(chlormephos) + SX, クロルピクリン(chloropicrin) + SX, クロルピリホス(chlorpyrifos) + SX, クロルピリホスメチル(chlorpyrifos-methyl) + SX, クロマフェノジド(chromafenozide) + SX, クロフェンテジン(clofentezine) + SX, クロチアニジン(clothianidin) + SX, コンカナマイシンＡ(concanamycin A) + SX, クマホス(coumaphos) + SX, クリオライト(cryolite) + SX, シアノホス(cyanophos) + SX, シアントラニリプロール(cyantraniliprole) + SX, シクラニリプロール(cyclaniliprole) + SX, シクロブトリフルラム(cyclobutrifluram) + SX, シクロプロトリン(cycloprothrin) + SX, シクロキサプリド(cycloxaprid) + SX, シエノピラフェン(cyenopyrafen) + SX, cyetpyrafen + SX, シフルメトフェン(cyflumetofen) + SX, シフルトリン(cyfluthrin) + SX, シハロジアミド(cyhalodiamide) + SX, シハロトリン(cyhalothrin) + SX, シヘキサチン(cyhexatin) + SX, シペルメトリン(cypermethrin) + SX, シフェノトリン(cyphenothrin) + SX, シプロフラニリド(cyproflanilide) + SX, シロマジン(cyromazine) + SX, ダゾメット(dazomet) + SX, デルタメトリン(deltamethrin) + SX, ジメトン－S－メチル(demeton-S-methyl) + SX, ジアフェンチウロン(diafenthiuron) + SX, ダイアジノン(diazinon) + SX, ジクロルボス(dichlorvos) + SX, ジクロロメゾチアズ(dicloromezotiaz) + SX, ジコホル(dicofol) + SX, ジクロトホス(dicrotophos) + SX, ジフロビダジン(diflovidazin) + SX, ジフルベンズロン(diflubenzuron) + SX, ジメフルトリン(dimefluthrin) + SX, ジメトエート(dimethoate) + SX, ジメチルビンホス(dimethylvinphos) + SX, ジンプロピリダズ(dimpropyridaz) + SX, ジノテフラン(dinotefuran) + SX, 八ホウ酸二ナトリウム(disodium octaborate) + SX, ジスルホトン(disulfoton) + SX, DNOC(2-methyl-4,6-dinitrophenol) + SX, ドラメクチン(doramectin) + SX, セイヨウオシダ乾燥葉(dried leaves of Dryopteris filix-mas) + SX, エマメクチン安息香酸塩(emamectin-benzoate) + SX, エンペントリン(empenthrin) + SX, エンドスルファン(endosulfan) + SX, EPN(O-ethyl O-(4-nitrophenyl) phenylphosphonothioate) + SX, イプシロンメトフルトリン(epsilon-metofluthrin) + SX, イプシロンモンフルオロトリン(epsilon-momfluorothrin) + SX, エスフェンバレレート(esfenvalerate) + SX, エチオフェンカルブ(ethiofencarb) + SX, エチオン(ethion) + SX, エチプロール(ethiprole) + SX, エトプロホス(ethoprophos) + SX, エトフェンプロックス(etofenprox) + SX, エトキサゾール(etoxazole) + SX, ニガヨモギ抽出物(extract of Artemisia absinthium) + SX, インドセンダン抽出物(extract of Azadirachta indica) + SX, Cassia nigricans抽出物(extract of Cassia nigricans) + SX, チョウマメ抽出物(extract of clitoria ternatea) + SX, ヒレハリソウ抽出物(extract of Symphytum officinale) + SX, アリタソウ抽出物(extract of Chenopodium ambrosioides) + SX, タンジー抽出物(extract of Tanacetum vulgare) + SX, セイヨウイラクサ抽出物(extract of Urtica dioica) + SX, ヤドリギ抽出物(extract of Viscum album) + SX, ファンフル(famphur) + SX, フェナミホス(fenamiphos) + SX, フェナザキン(fenazaquin) + SX, 酸化フェンブタスズ(fenbutatin oxide) + SX, フェニトロチオン(fenitrothion) + SX, フェンメゾジチアズ(fenmezoditiaz) + SX, フェノブカルブ(fenobucarb) + SX, フェノキシカルブ(fenoxycarb) + SX, フェンプロパトリン(fenpropathrin) + SX, フェンピロキシメート(fenpyroximate) + SX, フェンチオン(fenthion) + SX, フェンバレレート(fenvalerate) + SX, フィプロニル(fipronil) + SX, フロメトキン(flometoquin) + SX, フロニカミド(flonicamid) + SX, フルアクリピリム(fluacrypyrim) + SX, フルアザインドリジン(fluazaindolizine) + SX, フルアズロン(fluazuron) + SX, フルベンジアミド(flubendiamide) + SX, フルクロルジニリプロール(fluchlordiniliprole) + SX, フルシクロクスロン(flucycloxuron) + SX, フルシトリネート(flucythrinate) + SX, フルエンスルホン(fluensulfone) + SX, フルフェンプロックス(flufenoprox) + SX, フルフェノクスロン(flufenoxuron) + SX, フルフィプロール(flufiprole) + SX, フルメトリン(flumethrin) + SX, フルペンチオフェノックス(flupentiofenox) + SX, フルピラジフロン(flupyradifurone) + SX, フルピリミン(flupyrimin) + SX, フルピロキシストロビン(flupyroxystrobin) + SX, フルララネル(fluralaner) + SX, フルバリネート(fluvalinate) + SX, フルキサメタミド(fluxametamide) + SX, ホルメタネート(formetanate) + SX, ホスチアゼート(fosthiazate) + SX, フラメトリン(furamethrin) + SX, フラチオカルブ(furathiocarb) + SX, 
ガンマシハロトリン(gamma-cyhalothrin) + SX, GS-オメガ/カッパHXTX-Hv1aペプチド(GS-omega/kappa HXTX-Hv1a peptide) + SX, ハルフェンプロックス(halfenprox) + SX, ハロフェノジド(halofenozide) + SX, ヘプタフルトリン(heptafluthrin) + SX, ヘプテノホス(heptenophos) + SX, ヘキサフルムロン(hexaflumuron) + SX, ヘキシチアゾクス(hexythiazox) + SX, ホップベータ酸のカリウム塩(potassium salt of hop beta acid) + SX, ヒドラメチルノン(hydramethylnon) + SX, ヒドロプレン(hydroprene) + SX, イミシアホス(imicyafos) + SX, イミダクロプリド(imidacloprid) + SX, イミダクロチズ(imidaclothiz) + SX, イミプロトリン(imiprothrin) + SX, インダザピロキサメト(indazapyroxamet) + SX, インドキサカルブ(indoxacarb) + SX, イソシクロセラム(isocycloseram) + SX, イソフェンホス(isofenphos) + SX, イソプロカルブ(isoprocarb) + SX, イソプロピルＯ－(メトキシアミノチオホスホリル) サリチラート(isopropyl-O-(methoxyaminothiophosphoryl) salicylate) + SX, イソキサチオン(isoxathion) + SX, イベルメクチン(ivermectin) + SX, カデスリン(kadethrin) + SX, カッパテフルトリン(kappa-tefluthrin) + SX, カッパビフェントリン(kappa-bifenthrin) + SX, キノプレン(kinoprene) + SX, ラムダシハロトリン(lambda-cyhalothrin) + SX, レドプロナ(ledprona) + SX, レノレマイシン(lenoremycin) + SX, レピメクチン(lepimectin) + SX, 石灰硫黄合剤(lime sulfur) + SX, ロチラネル(lotilaner) + SX, ルフェヌロン(lufenuron) + SX, マシン油(machine oil) + SX, マラチオン(malathion) + SX, メカルバム(mecarbam) + SX, メペルフルトリン(meperfluthrin) + SX, メタフルミゾン(metaflumizone) + SX, メタム(metam) + SX, メタミドホス(methamidophos) + SX, メチダチオン(methidathion) + SX, メチオカルブ(methiocarb) + SX, メソミル(methomyl) + SX, メトプレン(methoprene) + SX, メトキシクロル(methoxychlor) + SX, メトキシフェノジド(methoxyfenozide) + SX, 臭化メチル(methyl bromide) + SX, メトフルトリン(metofluthrin) + SX, メトルカルブ(metolcarb) + SX, メトキサジアゾン(metoxadiazone) + SX, メビンホス(mevinphos) + SX, ミルベメクチン(milbemectin) + SX, ミルベマイシンオキシム(milbemycin oxime) + SX, ミボリラネル(mivorilaner) + SX, モドフラネル(modoflaner) + SX, モンフルオロトリン(momfluorothrin) + SX, モノクロトホス(monocrotophos) + SX, モキシデクチン(moxidectin) + SX, ナレッド(naled) + SX, ニコフルプロール(nicofluprole) + SX, ニコチン(nicotine) + SX, 硫酸ニコチン(nicotine-sulfate) + SX, ニテンピラム(nitenpyram) + SX, ノバルロン(novaluron) + SX, ノビフルムロン(noviflumuron) + SX, アメリカアリタソウ種子油(oil of the seeds of Chenopodium anthelminticum) + SX, オメトエート(omethoate) + SX, オキサミル(oxamyl) + SX, オキサゾスルフィル(oxazosulfyl) + SX, オキシジメトンメチル(oxydemeton-methyl) + SX, パラチオン(parathion) + SX, パラチオンメチル(parathion-methyl) + SX, ペルメトリン(permethrin) + SX, フェノトリン(phenothrin) + SX, フェントエート(phenthoate) + SX, ホレート(phorate) + SX, ホサロン(phosalone) + SX, ホスメット(phosmet) + SX, ホスファミドン(phosphamidon) + SX, ホスフィン(phosphine) + SX, ホキシム(phoxim) + SX, ピリミカーブ(pirimicarb) + SX, ピリミホスメチル(pirimiphos-methyl) + SX, プラレトリン(prallethrin) + SX, プロフェノホス(profenofos) + SX, プロフルトリン(profluthrin) + SX, プロパルギット(propargite) + SX, プロペタムホス(propetamphos) + SX, プロポキスル(propoxur) + SX, アルギニン酸プロピレングリコール(propylene glycol alginate) + SX, プロチオホス(prothiofos) + SX, ピフルブミド(pyflubumide) + SX, ピメトロジン(pymetrozine) + SX, ピラクロホス(pyraclofos) + SX, ピレトリン(pyrethrins) + SX, ピリダベン(pyridaben) + SX, ピリダリル(pyridalyl) + SX, ピリダフェンチオン(pyridaphenthion) + SX, ピリフルキナゾン(pyrifluquinazone) + SX, ピリミジフェン(pyrimidifen) + SX, ピリミノストロビン(pyriminostrobin) + SX, ピリプロール(pyriprole) + SX, ピリプロキシフェン(pyriproxyfen) + SX, キナルホス(quinalphos) + SX, レスメトリン(resmethrin) + SX, ロテノン(rotenone) + SX, リアノジン(ryanodine) + SX, サロラネル(sarolaner) + SX, セラメクチン(selamectin) + SX, シグマシペルメトリン(sigma-cypermethrin) + SX, シラフルオフェン(silafluofen) + SX, ホウ酸ナトリウム(sodium borate) + SX, メタホウ酸ナトリウム(sodium metaborate) + SX, スピドキサマト(spidoxamat) + SX, スピネトラム(spinetoram) + SX, スピノサド(spinosad) + SX, スピロブジフェン(spirobudifen) + SX, スピロジクロフェン(spirodiclofen) + SX, スピロメシフェン(spiromesifen) + SX, スピロピジオン(spiropidion) + SX, スピロテトラマト(spirotetramat) + SX, スルフィフルミン(sulfiflumin) + SX, スルフルラミド(sulfluramid) + SX, スルホテップ(sulfotep) + SX, スルホキサフロル(sulfoxaflor) + SX, 硫黄(sulfur) + SX, フッ化スルフリル(sulfuryl fluoride) + SX, 吐酒石(tartar emetic) + SX, タウフルバリネート(tau-fluvalinate) + SX, テブフェノジド(tebufenozide) + SX, テブフェンピラド(tebufenpyrad) + SX, テブピリムホス(tebupirimfos) + SX, テフルベンズロン(teflubenzuron) + SX, テフルトリン(tefluthrin) + SX, テメホス(temephos) + SX, テルブホス(terbufos) + SX, アリタソウから抽出したテルペン成分(terpene constituents of the extract of chenopodium ambrosioides near ambrosioides) + SX, テトラクロラントラニリプロール(tetrachlorantraniliprole) + SX, テトラクロルビンホス(tetrachlorvinphos) + SX, テトラジホン(tetradifon) + SX, テトラメトリン(tetramethrin) + SX, テトラメチルフルトリン(tetramethylfluthrin) + SX, テトラニリプロール(tetraniliprole) + SX, シータシペルメトリン(theta-cypermethrin) + SX, チアクロプリド(thiacloprid) + SX, チアメトキサム(thiamethoxam) + SX, チオシクラム(thiocyclam) + SX, チオジカルブ(thiodicarb) + SX, チオファノックス(thiofanox) + SX, チオメトン(thiometon) + SX, チオスルタップ二ナトリウム塩(thiosultap-disodium) + SX, チオスルタップ一ナトリウム塩(thiosultap-monosodium) + SX, チゴラネル(tigolaner) + SX, チオラントラニリプロール(tiorantraniliprole) + SX, チオキサザフェン(tioxazafen) + SX, トルフェンピラド(tolfenpyrad) + SX, トラロメトリン(tralomethrin) + SX, トランスフルトリン(transfluthrin) + SX, トリアザメート(triazamate) + SX, トリアゾホス(triazophos) + SX, トリクロルホン(trichlorfon) + SX, トリフルエンフロネート(trifluenfuronate) + SX, トリフルメゾピリム(triflumezopyrim) + SX, トリフルムロン(triflumuron) + SX, トリメタカルブ(trimethacarb) + SX, チクロピラゾフロル(tyclopyrazoflor) + SX, ウミフォキソラネル(umifoxolaner) + SX, バミドチオン(vamidothion) + SX, スリナムニガキ木材抽出物(wood extract of Quassia amara) + SX, XMC (3,5-dimethylphenyl N-methylcarbamate) + SX, キシリルカルブ(xylylcarb) + SX, ゼータシペルメトリン(zeta-cypermethrin) + SX, リン化亜鉛(zinc phosphide) + SX, 
4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide (1241050-20-3) + SX, 3-methoxy-N-(5-{5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}indan-1-yl)propanamide (1118626-57-5) + SX, N-{4-chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl}-1-methyl-4-(methanesulfonyl)-3-(1,1,2,2,2-pentafluoroethyl)-1H-pyrazole-3-carboxamide (1400768-21-9) + SX, N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl]-2-(methanesulfonyl)propanamide (2396747-83-2) + SX, N-[4-chloro-2-(pyridin-3-yl)-1,3-thiazol-5-yl]-N-ethyl-3-(methanesulfonyl)propanamide + SX, 1,4-dimethyl-2-[2-(pyridin-3-yl)-2H-indazol-5-yl]-1,2,4-triazolidine-3,5-dione (2171099-09-3) + SX, 2-isopropyl-5-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]-1,3,4-thiadiazole (2058052-95-0) + SX, N-({2-fluoro-4-[(2S,3S)-2-hydroxy-3-(3,4,5-trichlorophenyl)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl}methyl)cyclopropanecarboxamide + SX, 7-fluoro-N-[1-(methylsulfanyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfinyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfonyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, N-[1-(difluoromethyl)cyclopropyl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 2,9-dihydro-9-(methoxymethyl)-2-(pyridin-3-yl)-10H-pyrazolo[3,4-f]pyrido[2,3-b][1,4]oxazepin-10-one (2607927-97-7) + SX, 
BT作物のタンパク質Cry1Ab (BT crop protein Cry1Ab) + SX, BT作物のタンパク質Cry1Ac (BT crop protein Cry1Ac) + SX, BT作物のタンパク質Cry1Fa (BT crop protein Cry1Fa) + SX, BT作物のタンパク質Cry1A.105 (BT crop protein Cry1A.105) + SX, BT作物のタンパク質Cry2Ab (BT crop protein Cry2Ab) + SX, BT作物のタンパク質Vip3A (BT crop protein Vip3A) + SX, BT作物のタンパク質mCry3A (BT crop protein mCry3A) + SX, BT作物のタンパク質Cry3Ab (BT crop protein Cry3Ab) + SX, BT作物のタンパク質Cry3Bb (BT crop protein Cry3Bb) + SX, BT作物のタンパク質Cry34Ab1/Cry35Ab1 (BT crop protein Cry34Ab1/Cry35Ab1) + SX, アドクソフィエス・オラナ顆粒病ウイルスBV-0001株(Adoxophyes orana GV(granulovirus) strain BV-0001) + SX, アンチカルシア・ゲマタリス核多角体病ウイルス(Anticarsia gemmatalis MNPV(multiple nucleocapsid nucleopolyhedrovirus)) + SX, オートグラファ・カリフォルニア核多角体病ウイルス(Autographa californica MNPV) + SX, シジア・ポモネラ顆粒病ウイルスV15株(Cydia pomonella GV strain V15) + SX, シジア・ポモネラ顆粒病ウイルスV22株(Cydia pomonella GV strain V22) + SX, クリプトフレビア・ロイコトレタ顆粒病ウイルス(Cryptophlebia leucotreta GV) + SX, デンドロリムス・プンクタタス細胞質多面体ウイルス(Dendrolimus punctatus cypovirus) + SX, ヘリコベルパ・アルミゲラ核多角体病ウイルスBV-0003株(Helicoverpa armigera NPV(nucleopolyhedrovirus) strain BV-0003) + SX, ヘリコベルパ・ゼア核多角体病ウイルス(Helicoverpa zea NPV) + SX, リュマントリア・ディスパル核多角体病ウイルス(Lymantria dispar NPV) + SX, マメストラ・ブラシカエ核多角体病ウイルス(Mamestra brassicae NPV) + SX, マメストラ・コンフィグラタ核多角体病ウイルス(Mamestra configurata NPV) + SX, ネオディプリオン・アビエンティス核多角体病ウイルス(Neodiprion abietis NPV) + SX, ネオディプリオン・レコンテイ核多角体病ウイルス(Neodiprion lecontei NPV) + SX, ネオディプリオン・セルティファー核多角体病ウイルス(Neodiprion sertifer NPV) + SX, ノゼマ・ロクスタエ(Nosema locustae) + SX, オルギイア・プソイドツガタ核多角体病ウイルス(Orgyia pseudotsugata NPV) + SX, ピエリス・ラパエ顆粒病ウイルス(Pieris rapae GV) + SX, プロジア・インテルプンクテラ顆粒病ウイルス(Plodia interpunctella GV) + SX, スポドプテラ・エクシグア核多角体病ウイルス(Spodoptera exigua MNPV) + SX, スポドプテラ・リットラリス核多角体病ウイルス(Spodoptera littoralis MNPV) + SX, スポドプテラ・リツラ核多角体病ウイルス(Spodoptera litura NPV) + SX, Arthrobotrys dactyloides + SX, Bacillus firmus strain GB-126 + SX, Bacillus firmus strain I-1582 + SX, Bacillus firmus strain NCIM2637 + SX, Bacillus megaterium + SX, Bacillus sp. strain AQ175 + SX, Bacillus sp. strain AQ177 + SX, Bacillus sp. strain AQ178 + SX, Bacillus sphaericus strain 2362 serotype H5a5b + SX, Bacillus sphaericus strain ABTS1743 + SX, Bacillus thuringiensis strain AQ52 + SX, Bacillus thuringiensis strain BD#32 + SX, Bacillus thuringiensis strain CR-371 + SX, Bacillus thuringiensis subsp. Aizawai strain ABTS-1857 + SX, Bacillus thuringiensis subsp. Aizawai strain AM65-52 + SX, Bacillus thuringiensis subsp. Aizawai strain GC-91 + SX, Bacillus thuringiensis subsp. Aizawai strain NB200 + SX, Bacillus thuringiensis subsp. Aizawai Serotype strain H-7 + SX, Bacillus thuringiensis subsp. Kurstaki strain ABTS351 + SX, Bacillus thuringiensis subsp. Kurstaki strain BMP123 + SX, Bacillus thuringiensis subsp. Kurstaki strain CCT1306) + SX, Bacillus thuringiensis subsp. Kurstaki strain EG2348 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG7841 + SX, Bacillus thuringiensis subsp. Kurstaki strain EVB113-19 + SX, Bacillus thuringiensis subsp. Kurstaki strain F810 + SX, Bacillus thuringiensis subsp. Kurstaki strain HD-1 + SX, Bacillus thuringiensis subsp. Kurstaki strain PB54 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-11 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12 + SX, Bacillus thuringiensis subsp. Tenebriosis strain NB176 + SX, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002 + SX, Bacillus thuringiensis subsp. morrisoni + SX, Bacillus thuringiensis var. colmeri + SX, Bacillus thuringiensis var. darmstadiensis strain 24-91 + SX, Bacillus thuringiensis var. dendrolimus + SX, Bacillus thuringiensis var. galleriae + SX, Bacillus thuringiensis var. israelensis strain BMP144 + SX, Bacillus thuringiensis var. israelensis serotype strain H-14 + SX, Bacillus thuringiensis var. japonensis strain buibui + SX, Bacillus thuringiensis var. san diego strain M-7 + SX, Bacillus thuringiensis var. 7216 + SX, Bacillus thuringiensis var. aegypti + SX, Bacillus thuringiensis var. T36 + SX, Beauveria bassiana strain ANT-03 + SX, Beauveria bassiana strain ATCC74040 + SX, Beauveria bassiana strain GHA + SX, Beauveria brongniartii + SX, Burkholderia rinojensis strain A396 + SX, Chromobacterium subtsugae strain PRAA4-1T + SX, Dactyllela ellipsospora + SX, Dectylaria thaumasia + SX, Hirsutella minnesotensis + SX, Hirsutella rhossiliensis + SX, Hirsutella thompsonii + SX, Lagenidium giganteum + SX, Lecanicillium lecanii strain KV01 + SX, Lecanicillium lecanii conidia of strain DAOM198499 + SX, Lecanicillium lecanii conidia of strain DAOM216596 + SX, Lecanicillium muscarium strain Ve6 + SX, Metarhizium anisopliae strain F52 + SX, Metarhizium anisopliae var. acridum + SX, Metarhizium anisopliae var. anisopliae BIPESCO 5/F52 + SX, Metarhizium flavoviride + SX, Monacrosporium phymatopagum + SX, Paecilomyces fumosoroseus Apopka strain 97 + SX, Paecilomyces lilacinus strain 251 + SX, Paecilomyces tenuipes strain T1 + SX, Paenibacillus popilliae + SX, Pasteuria nishizawae strain Pn1 + SX, Pasteuria penetrans + SX, Pasteuria usgae + SX, Pasteuria thornei + SX, Serratia entomophila + SX, Verticillium chlamydosporium + SX, Verticillium lecani strain NCIM1312 + SX, Wolbachia pipientis + SX。 Combination of the present component of the above group (a) with the compound of the present invention:
abamectin + SX, acephate + SX, acequinocyl + SX, acetamiprid + SX, acetoprole + SX, acrinathrin + SX, acinonapyr + SX, afidopyropen + SX, afoxolaner + SX, alanycarb + SX, aldicarb + SX, allethrin + SX, alpha-cypermethrin + SX, alpha-endosulfan + SX, aluminium phosphide + SX, amitraz + SX, azadirachtin + SX, azamethiphos + SX, azinphos-ethyl + SX, azinphos-methyl + SX, azocyclotin + SX, bark of Celastrus angulatus + SX, bendiocarb + SX, benfluthrin + SX, benfuracarb + SX, bensultap + SX, benzoximate + SX, benzpyrimoxan + SX, beta-cyfluthrin + SX, beta-cypermethrin + SX, bifenazate + SX, bifenthrin + SX, bioallethrin + SX, bioresmethrin + SX, bistrifluron + SX, borax + SX, boric acid + SX, broflanilide + SX, bromopropylate + SX, buprofezin + SX, butocarboxim + SX, butoxycarboxim + SX, cadusafos + SX, calcium phosphide + SX, carbaryl + SX, carbofuran + SX, carbosulfan + SX, cartap hydrochloride + SX, cartap + SX, chinomethionat + SX, chlorantraniliprole + SX, chlordane + SX, chlorethoxyfos + SX, chlorfenapyr + SX, chlorfenvinphos + SX, chlorfluazuron + SX, chlormephos + SX, chloropicrin + SX, chlorpyrifos + SX, chlorpyrifos-methyl + SX, chromafenozide + SX, clofentezine + SX, clothianidin + SX, concanamycin A + SX, coumaphos + SX, cryolite + SX, cyanophos + SX, cyantraniliprole + SX, cyclaniliprole + SX, cyclobutrifluram + SX, cycloprothrin + SX, cycloxaprid + SX, cyenopyrafen + SX, cyetpyrafen + SX, cyflumetofen + SX, cyfluthrin + SX, cyhalodiamide + SX, cyhalothrin + SX, cyhexatin + SX, cypermethrin + SX, cyphenothrin + SX, cyproflanilide + SX, cyromazine + SX, dazomet + SX, deltamethrin + SX, demeton-S-methyl + SX, diafenthiuron + SX, diazinon + SX, dichlorvos + SX, dichloromezotiaz + SX, dicofol + SX, Dicrotophos + SX, diflovidazin + SX, diflubenzuron + SX, dimefluthrin + SX, dimethoate + SX, dimethylvinphos + SX, dimpropyridaz + SX, dinotefuran + SX, disodium octaborate + SX, disulfoton + SX, DNOC (2-methyl-4,6-dinitrophenol) + SX, doramectin + SX, dried leaves of Dryopteris filix-mas + SX, emamectin-benzoate + SX, empenthrin + SX, endosulfan + SX, EPN (O-ethyl O-(4-nitrophenyl) phenylphosphonothioate) + SX, epsilon-metofluthrin + SX, epsilon-momfluorothrin + SX, esfenvalerate + SX, ethiofencarb + SX, ethion + SX, ethiprole + SX, ethoprophos + SX, etofenprox + SX, etoxazole + SX, Artemisia absinthium extract + SX, Azadirachta extract indica + SX, extract of Cassia nigricans + SX, extract of clitoria ternatea + SX, extract of Symphytum officinale + SX, extract of Chenopodium ambrosioides + SX, extract of Tanacetum vulgare + SX, extract of Urtica dioica + SX, extract of Viscum album + SX, famphur + SX, fenamiphos + SX, fenazaquin + SX, fenbutatin oxide + SX, fenitrothion + SX, Fenmezoditiaz + SX, fenobucarb + SX, fenoxycarb + SX, fenpropathrin + SX, fenpyroximate + SX, fenthion + SX, fenvalerate + SX, fipronil + SX, flometoquin + SX, flonicamid + SX, fluacrypyrim + SX, fluazaindolizine + SX, fluazuron + SX, flubendiamide + SX, fluchlordiniliprole + SX, flucycloxuron + SX, flucythrinate + SX, fluensulfone + SX, flufenprox + SX, flufenoxuron + SX, flufiprole + SX, flumethrin + SX, flupentiofenox + SX, flupyradifurone + SX, flupyrimin + SX, flupyroxystrobin + SX, fluralaner + SX, fluvalinate + SX, fluxametamide + SX, formetanate + SX, fosthiazate + SX, furamethrin + SX, furathiocarb + SX,
gamma-cyhalothrin + SX, GS-omega/kappa HXTX-Hv1a peptide + SX, halfenprox + SX, halofenozide + SX, heptafluthrin + SX, heptenophos + SX, hexaflumuron + SX, hexythiazox + SX, potassium salt of hop beta acid + SX, hydramethylnon + SX, hydroprene + SX, imicyafos + SX, imidacloprid + SX SX, imidaclothiz + SX, imiprothrin + SX, indazapyroxamet + SX, indoxacarb + SX, isocycloseram + SX, isofenphos + SX, isoprocarb + SX, isopropyl-O-(methoxyaminothiophosphoryl) salicylate + SX, isoxathion + SX, ivermectin + SX, kadethrin + SX, kappa-tefluthrin + SX, kappa-bifenthrin + SX, kinoprene + SX, lambda-cyhalothrin + SX, ledprona + SX, lenoremycin + SX, lepimectin + SX, lime sulfur + SX, lotilaner + SX, lufenuron + SX, machine oil + SX, malathion + SX, mecarbam + SX, meperfluthrin + SX, metaflumizone + SX, metham + SX, methamidophos + SX, methidathion + SX, Methiocarb + SX, methomyl + SX, methoprene + SX, methoxychlor + SX, methoxyfenozide + SX, methyl bromide + SX, metofluthrin + SX, metolcarb + SX, metoxadiazone + SX, mevinphos + SX, milbemectin + SX, milbemycin oxime + SX, mivorilaner + SX, modoflaner + SX, momfluorothrin + SX, monocrotophos + SX, moxidectin + SX, naled + SX, nicofluprole + SX, nicotine + SX, nicotine-sulfate + SX, nitenpyram + SX, novaluron + SX, noviflumuron + SX, oil of the seeds of Chenopodium anthelminticum + SX, omethoate + SX, oxamyl + SX, oxazosulfyl + SX, oxydemeton-methyl + SX, parathion + SX, parathion-methyl + SX, permethrin + SX, phenothrin + SX, phenthoate + SX, phorate + SX, phosalone + SX, phosmet + SX, phosphamidon + SX, phosphine + SX, phoxim + SX, pirimicarb + SX, pirimiphos-methyl + SX, prallethrin + SX, profenofos + SX, profluthrin + SX, propargite + SX, propetamphos + SX, propoxur + SX, propylene glycol alginate + SX, prothiofos + SX, pyflubumide + SX, pymetrozine + SX, pyraclofos + SX, pyrethrins + SX, pyridaben + SX, pyridalyl + SX, pyridaphenthion + SX, pyrifluquinazone + SX, pyrimidifen + SX, pyriminostrobin + SX, pyriprole + SX, pyriproxyfen + SX, quinalphos + SX, resmethrin + SX, rotenone + SX, ryanodine + SX, sarolaner + SX, selamectin + SX, sigma-cypermethrin + SX, silafluofen + SX, sodium borate + SX, sodium metaborate + SX, spidoxamat + SX, spinetoram + SX, spinosad + SX, spirobudifen + SX, spirodiclofen + SX, spiromesifen + SX, spiropidion + SX, spirotetramat + SX, sulfiflumin + SX, sulfluramid + SX, sulfotep + SX, sulfoxaflor + SX, sulfur + SX, sulfuryl fluoride + SX, tartar emetic + SX, tau-fluvalinate + SX, tebufenozide + SX, tebufenpyrad + SX, tebupirimfos + SX, teflubenzuron + SX, tefluthrin + SX, temephos + SX, terbufos + SX, Terpene constituents of the extract of chenopodium ambrosioides near ambrosioides + SX, tetrachlorantraniliprole + SX, tetrachlorvinphos + SX, tetradifon + SX, tetramethrin + SX, tetramethylfluthrin + SX, tetraniliprole + SX, theta-cypermethrin + SX, thiacloprid + SX, thiamethoxam + SX, thiocyclam + SX, thiodicarb + SX, thiofanox + SX, Thiometon + SX, thiosultap-disodium + SX, thiosultap-monosodium + SX, tigolaner + SX, thiolanthraniliprole + SX, tioxazafen + SX, tolfenpyrad + SX, tralomethrin + SX, transfluthrin + SX, triazamate + SX, triazophos + SX, trichlorfon + SX, trifluenfuronate + SX, triflumezopyrim + SX, triflumuron + SX, trimethacarb + SX, tyclopyrazoflor + SX, umifoxolaner + SX, vamidothion + SX, wood extract of Quassia amara + SX, XMC (3,5-dimethylphenyl N-methylcarbamate) + SX, xylylcarb + SX, zeta-cypermethrin + SX, zinc phosphide + SX,
4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide (1241050-20-3) + SX, 3-methoxy-N-(5-{5-(trifluoromethyl)-5-[3-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}indan-1-yl)propanamide (1118626-57-5) + SX, N-{4-chloro-3-[(1-cyanocyclopropyl)carbamoyl]phenyl}-1-methyl-4-(methanesulfonyl)-3-(1,1,2,2,2-pentafluoroethyl)-1H-pyrazole-3-carboxamide (1400768-21-9) + SX, N-[3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl]-2-(methanesulfonyl)propanamide (2396747-83-2) + SX, N-[4-chloro-2-(pyridin-3-yl)-1,3-thiazol-5-yl]-N-ethyl-3-(methanesulfonyl)propanamide + SX, 1,4-dimethyl-2-[2-(pyridin-3-yl)-2H-indazol-5-yl]-1,2,4-triazolidine-3,5-dione (2171099-09-3) + SX, 2-isopropyl-5-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]-1,3,4-thiadiazole (2058052-95-0) + SX, N-({2-fluoro-4-[(2S,3S)-2-hydroxy-3-(3,4,5-trichlorophenyl)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl}methyl)cyclopropanecarboxamide + SX, 7-fluoro-N-[1-(methylsulfanyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfinyl)-2-methylpropan-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 7-fluoro-N-[1-(methanesulfonyl)-2-methylpropane-2-yl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, N-[1-(difluoromethyl)cyclopropyl]-2-(pyridin-3-yl)-2H-indazole-4-carboxamide + SX, 2,9-dihydro-9-(methoxymethyl)-2-(pyridin-3-yl)-10H-pyrazolo[3,4-f]pyrido[2,3-b][1,4]oxazepin-10-one (2607927-97-7) + SX,
BT crop protein Cry1Ab + SX, BT crop protein Cry1Ac + SX, BT crop protein Cry1Fa + SX, BT crop protein Cry1A.105 + SX, BT crop protein Cry2Ab + SX, BT crop protein Vip3A + SX, BT crop protein mCry3A + SX, BT crop protein Cry3Ab + SX, BT crop protein Cry3Bb + SX, BT crop protein Cry34Ab1/Cry35Ab1 + SX Cry34Ab1/Cry35Ab1 + SX, Adoxophyes orana GV (granulovirus) strain BV-0001 + SX, Anticarsia gemmatalis MNPV (multiple nucleocapsid nucleopolyhedrovirus) + SX, Autographa californica MNPV + SX, Cydia pomonella GV strain V15 + SX, Cydia pomonella GV strain V22 + SX, Cryptophlebia leucotreta granulosis virus + SX, leucotreta GV + SX, Dendrolimus punctatus cypovirus + SX, Helicoverpa armigera nucleopolyhedrovirus strain BV-0003 + SX, Helicoverpa zea NPV + SX, Lymantria dispar NPV + SX, Mamestra brassicae NPV + SX, Mamestra configurata NPV + SX, Neodiprion abietis NPV + SX, Neodiprion lecontei NPV + SX, Neodiprion sertifer NPV + SX, Nosema locustae + SX, Orgyia pseudotsugata NPV + SX, Pieris rapae GV + SX, Plodia interpunctella GV + SX, Spodoptera exigua MNPV + SX, Spodoptera littoralis MNPV + SX, Spodoptera litura NPV + SX, Arthrobotrys dactyloides + SX, Bacillus firmus strain GB-126 + SX, Bacillus firmus strain I-1582 + SX, Bacillus firmus strain NCIM2637 + SX, Bacillus megaterium + SX, Bacillus sp. strain AQ175 + SX, Bacillus sp. strain AQ177 + SX, Bacillus sp. strain AQ178 + SX, Bacillus sphaericus strain 2362 serotype H5a5b + SX, Bacillus sphaericus strain ABTS1743 + SX, Bacillus thuringiensis strain AQ52 + SX, Bacillus thuringiensis strain BD#32 + SX, Bacillus thuringiensis strain CR-371 + SX, Bacillus thuringiensis subsp. Aizawai strain ABTS-1857 + SX, Bacillus thuringiensis subsp. Aizawai strain AM65-52 + SX, Bacillus thuringiensis subsp. Aizawai strain GC-91 + SX, Bacillus thuringiensis subsp. Aizawai strain NB200 + SX, Bacillus thuringiensis subsp. Aizawai Serotype strain H-7 + SX, Bacillus thuringiensis subsp. Kurstaki strain ABTS351 + SX, Bacillus thuringiensis subsp. Kurstaki strain BMP123 + SX, Bacillus thuringiensis subsp. Kurstaki strain CCT1306) + SX, Bacillus thuringiensis subsp. Kurstaki strain EG2348 + SX, Bacillus thuringiensis subsp. Kurstaki strain EG7841 + SX, Bacillus thuringiensis subsp. Kurstaki strain EVB113-19 + SX, Bacillus thuringiensis subsp. Kurstaki strain F810 + SX, Bacillus thuringiensis subsp. Kurstaki strain HD-1 + SX, Bacillus thuringiensis subsp. Kurstaki strain PB54 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-11 + SX, Bacillus thuringiensis subsp. Kurstaki strain SA-12 + SX, Bacillus thuringiensis subsp. Tenebriosis strain NB176 + SX, Bacillus thuringiensis subsp. Thuringiensis strain MPPL002 + SX, Bacillus thuringiensis subsp. morrisoni + SX, Bacillus thuringiensis var. colmeri + SX, Bacillus thuringiensis var. darmstadiensis strain 24-91 + SX, Bacillus thuringiensis var. dendrolimus + SX, Bacillus thuringiensis var. galleriae + SX, Bacillus thuringiensis var. israelensis strain BMP144 + SX, Bacillus thuringiensis var. israelensis serotype strain H-14 + SX, Bacillus thuringiensis var. japonensis strain buibui + SX, Bacillus thuringiensis var. san diego strain M-7 + SX, Bacillus thuringiensis var. 7216 + SX, Bacillus aegypti + SX, Bacillus thuringiensis var. T36 + SX, Beauveria bassiana strain ANT-03 + SX, Beauveria bassiana strain ATCC74040 + SX, Beauveria bassiana strain GHA + SX, Beauveria brongniartii + SX, Burkholderia rinojensis strain A396 + SX, Chromobacterium subtsugae strain PRAA4-1T + SX, Dactyllela ellipsospora + SX, Dectylaria thaumasia + SX, Hirsutella minnesotensis + SX, Hirsutella rhossiliensis + SX, Hirsutella thompsonii + SX, Lagenidium giganteum + SX, Lecanicillium lecanii strain KV01 + SX, Lecanicillium acridum + SX, Metarhizium anisopliae var. anisopliae BIPESCO 5/F52 + SX, Metarhizium flavoviride + SX, Monacrosporium phymatopagum + SX, Paecilomyces fumosoroseus Apopka strain 97 + SX, Paecilomyces lilacinus strain 251 + SX, Paecilomyces tenuipes strain T1 + SX, Paenibacillus popilliae + SX, Pasteuria nishizawae strain Pn1 + SX, Pasteuria penetrans + SX, Pasteuria usgae + SX, Pasteuria thornei + SX, Serratia entomophila + SX, Verticillium chlamydosporium + SX, Verticillium lecani strain NCIM1312 + SX, Wolbachia pipientis + SX.

　上記群（ｂ）の本成分と本発明化合物との組合せ：
　アシベンゾラルSメチル(acibenzolar-S-methyl) + SX, アルジモルフ(aldimorph) + SX, アメトクトラジン(ametoctradin) + SX, アミノピリフェン(aminopyrifen) + SX, アミスルブロム(amisulbrom) + SX, アニラジン(anilazine) + SX, アザコナゾール(azaconazole) + SX, アゾキシストロビン(azoxystrobin) + SX, 塩基性硫酸銅(basic copper sulfate) + SX, ベナラキシル(benalaxyl) + SX, ベナラキシルM(benalaxyl-M) + SX, ベノダニル(benodanil) + SX, ベノミル(benomyl) + SX, ベンチアバリカルブ(benthiavalicarb) + SX, ベンチアバリカルブイソプロピル(benthiavalicarb-isopropyl) + SX, ベンゾビンジフルピル(benzovindiflupyr) + SX, ビナパクリル(binapacryl) + SX, ビフェニル(biphenyl) + SX, ビテルタノール(bitertanol) + SX, ビキサフェン(bixafen) + SX, ブラストサイジンS(blasticidin-S) + SX, ボルドー液(Bordeaux mixture) + SX, ボスカリド(boscalid) + SX, ブロモタロニル(bromothalonil) + SX, ブロムコナゾール(bromuconazole) + SX, ブピリメート(bupirimate) + SX, キャプタホール(captafol) + SX, キャプタン(captan) + SX, カルベンダジム(carbendazim) + SX, カルボキシン(carboxin) + SX, カルプロパミド(carpropamid) + SX, キノメチオナート(chinomethionat) + SX, キチン(chitin) + SX, クロロインコナジド(chloroinconazide) + SX, クロロネブ(chloroneb) + SX, クロロタロニル(chlorothalonil) + SX, クロゾリネート(chlozolinate) + SX, コレトクロリンＢ(colletochlorin B) + SX, 酢酸銅(II) (copper(II) acetate) + SX, 水酸化銅(II) (copper(II) hydroxide) + SX, 塩基性塩化銅(copper oxychloride) + SX, 硫酸銅(II) (copper(II) sulfate) + SX, クモキシストロビン(coumoxystrobin) + SX, シアゾファミド(cyazofamid) + SX, シフルフェナミド(cyflufenamid) + SX, シモキサニル(cymoxanil) + SX, シプロコナゾール(cyproconazole) + SX, シプロジニル(cyprodinil) + SX, ジクロベンチアゾクス(dichlobentiazox) + SX, ジクロフルアニド(dichlofluanid) + SX, ジクロシメット(diclocymet) + SX, ジクロメジン(diclomezine) + SX, ジクロラン(dicloran) + SX, ジエトフェンカルブ(diethofencarb) + SX, ジフェノコナゾール(difenoconazole) + SX, ジフルメトリム(diflumetorim) + SX, ジメタクロン(dimethachlone) + SX, ジメチリモール(dimethirimol) + SX, ジメトモルフ(dimethomorph) + SX, ジモキシストロビン(dimoxystrobin) + SX, ジニコナゾール(diniconazole) + SX, ジニコナゾールM(diniconazole-M) + SX, ジノカップ(dinocap) + SX, 亜リン酸水素二カリウム(dipotassium hydrogenphosphite) + SX, ジピメチトロン(dipymetitrone) + SX, ジチアノン(dithianon) + SX, ドデシルベンゼンスルホン酸ビスエチレンジアミン銅(II)錯塩(dodecylbenzenesulphonic acid bisethylenediamine copper(II) salt) + SX, ドデモルフ(dodemorph) + SX, ドジン(dodine) + SX, エジフェンホス(edifenphos) + SX, エノキサストロビン(enoxastrobin) + SX, エポキシコナゾール(epoxiconazole) + SX, エタコナゾール(etaconazole) + SX, エタボキサム(ethaboxam) + SX, エチリモール(ethirimol) + SX, エトリジアゾール(etridiazole) + SX, ニンニク抽出物(extract of Allium sativum) + SX, ハウチワマメ苗木の子葉の抽出物(extract of the cotyledons of lupine plantlets ("BLAD")) + SX, スギナ抽出物(extract of Equisetum arvense) + SX, ティーツリー抽出物(extract of Melaleuca alternifolia) + SX, オオイタドリ抽出物(extract of Reynoutria sachalinensis) + SX, キンレンカ抽出物(extract of Tropaeolum majus) + SX, ファモキサドン(famoxadone) + SX, フェンアミドン(fenamidone) + SX, フェナミンストロビン(fenaminstrobin) + SX, フェナリモル(fenarimol) + SX, フェンブコナゾール(fenbuconazole) + SX, フェンフラム(fenfuram) + SX, フェンヘキサミド(fenhexamid) + SX, フェノキサニル(fenoxanil) + SX, フェンピクロニル(fenpiclonil) + SX, フェンピコキサミド(fenpicoxamid) + SX, フェンプロピジン(fenpropidin) + SX, フェンプロピモルフ(fenpropimorph) + SX, フェンピラザミン(fenpyrazamine) + SX, 酢酸トリフェニル錫(fentin acetate) + SX, 塩化トリフェニル錫(fentin chloride) + SX, 水酸化トリフェニル錫(fentin hydroxide) + SX, フェルバム(ferbam) + SX, フェリムゾン(ferimzone) + SX, フロリルピコキサミド(florylpicoxamid) + SX, フルアジナム(fluazinam) + SX, フルベネテラム(flubeneteram) + SX, フルジオキソニル(fludioxonil) + SX, フルフェノキサジアザム(flufenoxadiazam) + SX, フルフェノキシストロビン(flufenoxystrobin) + SX, フルインダピル(fluindapyr) + SX, フルメチルスルホリム(flumetylsulforim) + SX, フルモルフ(flumorph) + SX, フルオピコリド(fluopicolide) + SX, フルオピラム(fluopyram) + SX, フルオピモミド(fluopimomide) + SX, フルオルイミド(fluoroimide) + SX, フルオキサピプロリン(fluoxapiprolin) + SX, フルオキサストロビン(fluoxastrobin) + SX, フルオキシチオコナゾール(fluoxytioconazole) + SX, フルキンコナゾール(fluquinconazole) + SX, フルシラゾール(flusilazole) + SX, フルスルファミド(flusulfamide) + SX, フルチアニル(flutianil) + SX, フルトラニル(flutolanil) + SX, フルトリアホール(flutriafol) + SX, フルキサピロキサド(fluxapyroxad) + SX, ホルペット(folpet) + SX, ホセチル(fosetyl) + SX, ホセチルアルミニウム(fosetyl-aluminium) + SX, フベリダゾール(fuberidazole) + SX, フララキシル(furalaxyl) + SX, フラメトピル(furametpyr) + SX, グアザチン(guazatine) + SX, ヘキサコナゾール(hexaconazole) + SX, ヒメキサゾール(hymexazole) + SX, 
イマザリル(imazalil) + SX, イミベンコナゾール(imibenconazole) + SX, イミノクタジン(iminoctadine) + SX, イミノクタジン酢酸塩(iminoctadine triacetate) + SX, インピルフルキサム(inpyrfluxam) + SX, ヨードカルブ(iodocarb) + SX, イプコナゾール(ipconazole) + SX, イプフェントリフルコナゾール(ipfentrifluconazole) + SX, イプフルフェノキン(ipflufenoquin) + SX, イプロベンホス(iprobenfos) + SX, イプロジオン(iprodione) + SX, イプロバリカルブ(iprovalicarb) + SX, イソフェタミド(isofetamid) + SX, イソフルシプラム(isoflucypram) + SX, イソプロチオラン(isoprothiolane) + SX, イソピラザム(isopyrazam) + SX, イソチアニル(isotianil) + SX, カスガマイシン(kasugamycin) + SX, クレソキシムメチル(kresoxim-methyl) + SX, ラミナリン(laminarin) + SX, オークの葉及び樹皮(leaves and bark of Quercus) + SX, マンコゼブ(mancozeb) + SX, マンデストロビン(mandestrobin) + SX, マンジプロパミド(mandipropamid) + SX, マンネブ(maneb) + SX, メフェントリフルコナゾール(mefentrifluconazole) + SX, メパニピリム(mepanipyrim) + SX, メプロニル(mepronil) + SX, メプチルジノカップ(meptyldinocap) + SX, メタラキシル(metalaxyl) + SX, メタラキシルM(metalaxyl-M) + SX, メタリルピコキサミド(metarylpicoxamid) + SX, メトコナゾール(metconazole) + SX, メタスルホカルブ(methasulfocarb) + SX, メチラム(metiram) + SX, メトミノストロビン(metominostrobin) + SX, メトラフェノン(metrafenone) + SX, メチルテトラプロール(metyltetraprole) + SX, ミクロブタニル(myclobutanil) + SX, ナフチフィン(naftifine) + SX, ヌアリモール(nuarimol) + SX, オクチリノン(octhilinone) + SX, オフラセ(ofurace) + SX, オリサストロビン(orysastrobin) + SX, オキサジキシル(oxadixyl) + SX, オキサチアピプロリン(oxathiapiprolin) + SX, oxine-copper + SX, オキソリニック酸(oxolinic acid) + SX, オキスポコナゾール(oxpoconazole) + SX, オキスポコナゾールフマル酸塩(oxpoconazole fumarate) + SX, オキシカルボキシン(oxycarboxin) + SX, オキシテトラサイクリン(oxytetracycline) + SX, ペフラゾエート(pefurazoate) + SX, ペンコナゾール(penconazole) + SX, ペンシクロン(pencycuron) + SX, ペンフルフェン(penflufen) + SX, ペンチオピラド(penthiopyrad) + SX, フェナマクリル(phenamacril) + SX, 亜リン酸(phosphorous acid) + SX, フサライド(phthalide) + SX, ピカルブトラゾクス(picarbutrazox) + SX, ピコキシストロビン(picoxystrobin) + SX, ピペラリン(piperalin) + SX, ポリオキシン(polyoxins) + SX, 炭酸水素カリウム(potassium hydrogencarbonate) + SX, 亜リン酸二水素カリウム(potassium dihydrogenphosphite) + SX, プロベナゾール(probenazole) + SX, プロクロラズ(prochloraz) + SX, プロシミドン(procymidone) + SX, プロパミジン(propamidine) + SX, プロパモカルブ(propamocarb) + SX, プロピコナゾール(propiconazole) + SX, プロピネブ(propineb) + SX, プロキナジド(proquinazid) + SX, プロチオカルブ(prothiocarb) + SX, プロチオコナゾール(prothioconazole) + SX, ピジフルメトフェン(pydiflumetofen) + SX, ピラクロストロビン(pyraclostrobin) + SX, ピラメトストロビン(pyrametostrobin) + SX, ピラオキシストロビン(pyraoxystrobin) + SX, ピラプロポイン(pyrapropoyne) + SX, ピラジフルミド(pyraziflumid) + SX, ピラゾホス(pyrazophos) + SX, ピリベンカルブ(pyribencarb) + SX, ピリブチカルブ(pyributicarb) + SX, ピリダクロメチル(pyridachlometyl) + SX, ピリフェノックス(pyrifenox) + SX, ピリメタニル(pyrimethanil) + SX, ピリモルフ(pyrimorph) + SX, ピリオフェノン(pyriofenone) + SX, ピリソキサゾール(pyrisoxazole) + SX, ピロキロン(pyroquilon) + SX, キラヤ科植物抽出物(Quillaja extract) + SX, キンコナゾール(quinconazole) + SX, キノフメリン(quinofumelin) + SX, キノキシフェン(quinoxyfen) + SX, キントゼン(quintozene) + SX, キヌアのサポニン(Saponins of Chenopodium quinoa) + SX, セボクチラミン(seboctylamine) + SX, セダキサン(sedaxane) + SX, シルチオファム(silthiofam) + SX, シメコナゾール(simeconazole) + SX, 炭酸水素ナトリウム(sodium hydrogencarbonate) + SX, スピロキサミン(spiroxamine) + SX, ストレプトマイシン(streptomycin) + SX, 硫黄(sulfur) + SX, テブコナゾール(tebuconazole) + SX, テブフロキン(tebufloquin) + SX, テクロフタラム(teclofthalam) + SX, テクナゼン(tecnazene) + SX, テルビナフィン(terbinafine) + SX, テトラコナゾール(tetraconazole) + SX, チアベンダゾール(thiabendazole) + SX, チフルザミド(thifluzamide) + SX, チオファネート(thiophanate) + SX, チオファネートメチル(thiophanate-methyl) + SX, チウラム(thiram) + SX, チモール(thymol) + SX, チアジニル(tiadinil) + SX, トルクロホスメチル(tolclofos-methyl) + SX, トルフェンピラド(tolfenpyrad) + SX, トルプロカルブ(tolprocarb) + SX, トリルフルアニド(tolylfluanid) + SX, トリアジメホン(triadimefon) + SX, トリアジメノール(triadimenol) + SX, トリアゾキシド(triazoxide) + SX, トリクロピリカルブ(triclopyricarb) + SX, トリシクラゾール(tricyclazole) + SX, トリデモルフ(tridemorph) + SX, トリフロキシストロビン(trifloxystrobin) + SX, トリフルミゾール(triflumizole) + SX, トリホリン(triforine) + SX, トリチコナゾール(triticonazole) + SX, バリダマイシン(validamycin) + SX, バリフェナレート(valifenalate) + SX, ビンクロゾリン(vinclozolin) + SX, マスタードパウダー(yellow mustard powder) + SX, zinc thiazole + SX, ジネブ(zineb) + SX, ジラム(ziram) + SX, ゾキサミド(zoxamide) + SX, 
N'-[4-({3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide (1202781-91-6) + SX, N'-{4-[(4,5-dichlorothiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylmethanimidamide (929908-57-6) + SX, N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylmethanimidamide (1052688-31-9) + SX, N'-[5-chloro-4-(2-fluorophenoxy)-2-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055589-28-9) + SX, N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055756-21-1) + SX, N'-(2-chloro-4-phenoxy-5-methylphenyl)-N-ethyl-N-methylmethanimidamide (2062599-39-5) + SX, N'-[4-(1-hydroxy-1-phenyl-2,2,2-trifluoroethyl)-2-methyl-5-methoxyphenyl]-N-isopropyl-N-methylmethanimidamide (2101814-55-3) + SX, N'-[5-bromo-6-(1-methyl-2-propoxyethoxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylmethanimidamide (1817828-69-5) + SX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (1362477-26-6) + SX, 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (1257056-97-5) + SX, ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate (39491-78-6) + SX, N-[(2-chlorothiazol-5-yl)methyl]-N-ethyl-6-methoxy-3-nitropyridin-2-amine (1446247-98-8) + SX, 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-11-4) + SX, (1R, 2S, 5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-06-2) + SX, (1S, 2R, 5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-07-3) + SX, 2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-13-6) + SX, (1R, 2S, 5S)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-08-4) + SX, (1S, 2R, 5R)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-09-5) + SX, methyl 3-[(4-chlorophenyl)methyl]-2-hydroxy-1-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-carboxylate (1791398-02-1) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-bromo-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-86-0) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-chloro-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-84-8) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018316-13-5) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2,3-difluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018317-25-2) + SX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082661-43-4) + SX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082660-27-1) + SX, methyl ({2-methyl-5-[1-(4-methoxy-2-methylphenyl)-1H-pyrazol-3-yl]phenyl}methyl)carbamate (1605879-98-8) + SX, 2-(difluoromethyl)-N-[1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1616239-21-4) + SX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-02-9) + SX, 2-(difluoromethyl)-N-[3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-05-2) + SX, (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-27-0) + SX, (2E,3Z)-5-{[1-(2,4-dichlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-54-3) + SX, 5-chloro-4-({2-[6-(4-chlorophenoxy)pyridin-3-yl]ethyl}amino)-6-methylpyrimidine (1605340-92-8) + SX, N-(1-benzyl-1,3-dimethylbutyl)-8-fluoroquinoline-3-carboxamide (2132414-04-9) + SX, N-(1-benzyl-3,3,3-trifluoro-1-methylpropyl)-8-fluoroquinoline-3-carboxamide (2132414-00-5) + SX, 4,4-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-25-1) + SX, 5,5-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-26-2) + SX, N-ethyl-2-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N,2-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-methoxy-N'-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N'-ethyl-N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N'-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-acetyl-2-(ethanesulfonyl)-N-[2-(methoxycarbonyl)-4-(trifluoromethoxy)phenyl]-4-(trifluoromethyl)benzamide (2043675-28-9) + SX, 
3-(4-bromo-7-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromoindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromo-4-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)acetamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)butanamide + SX, N-methoxy-N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N-diethyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX, 4-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)morpholin-3-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one + SX, 3,3-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1,2-oxazinan-3-one + SX, 1-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)azepan-2-one + SX, 4,4-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 5-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, ethyl 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxylate + SX, N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-propyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxy-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-methoxy-N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N,N-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-1,2,4-triazol-3-amine + SX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + SX, methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, ethyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, methyl 2-[2-(trifluoromethyl)-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, 1-(2,3-dimethylpyridin-5-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-[2-(difluoromethyl)-3-methylpyridin-5-yl]-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 2,2-difluoro-N-[6-({[1-(1-methyl-1H-tetrazol-5-yl)benzimidazol-2-yl]oxy}methyl)pyridin-2-yl]-2-phenoxyacetamide + SX, 1-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile + SX, ethyl 1-[(4-{[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, ethyl 1-[(4-{[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoroethyl]-3-(3-cyclopropyl-2-fluorophenoxy)-5-methylpyridazine-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(spiro[3.4]octan-1-yl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-hexyl-5-methylthiazole-4-carboxamide + SX, 2-[acetyl(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methoxyacetyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methylpropanoyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxetan-3-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxolan-3-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxan-4-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(3,5-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(6-chloropyridin-3-yl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluoro-3-methoxyphenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-{[1-(2,6-difluorophenyl)cyclopropyl]oxy}pyrimidine + SX, 3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(4-bromo-2-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5R)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}-3-methylbutan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}-3-methylbutan-2-yl)-2,2-dimethylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-(2-cyanoethoxy)ethyl]-5-[1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, 
methyl ({5-[1-(2,6-difluoro-4-isopropylphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl ({5-[1-(2,6-difluoro-4-cyclopropylphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl ({5-[1-(2,6-difluoro-4-methoxyphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl (Z)-2-(5-cyclopentyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-[(3-isopropyl-1H-pyrazol-1-yl)-2-methylphenoxy]-3-methoxyprop-2-enoate + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-6-fluoro-3,3-dimethylisoquinolin-4(3H)-one + SX, methyl (2Z)-3-methoxy-2-[(4-methyl[1,1'-biphenyl]-3-yl)oxy]prop-2-enoate + SX, Agrobacterium radiobactor strain K1026 + SX, Agrobacterium radiobactor strain K84 + SX, Bacillus amyloliquefaciens strain PTA-4838 (Aveo(商標) EZ Nematicide) + SX, Bacillus amyloliquefaciens strain AT332 + SX, Bacillus amyloliquefaciens strain B3 + SX, Bacillus amyloliquefaciens strain D747 + SX, Bacillus amyloliquefaciens strain DB101 + SX, Bacillus amyloliquefaciens strain DB102 + SX, Bacillus amyloliquefaciens strain GB03 + SX, Bacillus amyloliquefaciens strain FZB24 + SX, Bacillus amyloliquefaciens strain FZB42 + SX, Bacillus amyloliquefaciens strain IN937a + SX, Bacillus amyloliquefaciens strain MBI600 + SX, Bacillus amyloliquefaciens strain QST713 + SX, Bacillus amyloliquefaciens isolate strain B246 + SX, Bacillus amyloliquefaciens strain F727 + SX, Bacillus amyloliquefaciens subsp. plantarum strain D747 + SX, Bacillus licheniformis strain HB-2 + SX, Bacillus licheniformis strain SB3086 + SX, Bacillus pumilus strain AQ717 + SX, Bacillus pumilus strain BUF-33 + SX, Bacillus pumilus strain GB34 + SX, Bacillus pumilus strain QST2808 + SX, Bacillus simplex strain CGF2856 + SX, Bacillus subtilis strain AQ153 + SX, Bacillus subtilis strain AQ743 + SX, Bacillus subtilis strain BU1814 + SX, Bacillus subtilis strain D747 + SX, Bacillus subtilis strain DB101 + SX, Bacillus subtilis strain FZB24 + SX, Bacillus subtilis strain GB03 + SX, Bacillus subtilis strain HAI0404 + SX, Bacillus subtilis strain IAB/BS03 + SX, Bacillus subtilis strain MBI600 + SX, Bacillus subtilis strain QST30002/AQ30002 + SX, Bacillus subtilis strain QST30004/AQ30004 + SX, Bacillus subtilis strain QST713 + SX, Bacillus subtilis strain QST714 + SX, Bacillus subtilis var. Amyloliquefaciens strain FZB24 + SX, Bacillus subtilis strain Y1336 + SX, Burkholderia cepacia + SX, Burkholderia cepacia type Wisconsin strain J82 + SX, Burkholderia cepacia type Wisconsin strain M54 + SX, Candida oleophila strain O + SX, Candida saitoana + SX, Chaetomium cupreum + SX, Clonostachys rosea + SX, Coniothyrium minitans strain CGMCC8325 + SX, Coniothyrium minitans strain CON/M/91-8 + SX, cryptococcus albidus + SX, Erwinia carotovora subsp. carotovora strain CGE234M403 + SX, Fusarium oxysporum strain Fo47 + SX, Gliocladium catenulatum strain J1446 + SX, Paenibacillus polymyxa strain AC-1 + SX, Paenibacillus polymyxa strain BS-0105 + SX, Pantoea agglomerans strain E325 + SX, Phlebiopsis gigantea strain VRA1992 + SX, Pseudomonas aureofaciens strain TX-1 + SX, Pseudomonas chlororaphis strain 63-28 + SX, Pseudomonas chlororaphis strain AFS009 + SX, Pseudomonas chlororaphis strain MA342 + SX, Pseudomonas fluorescens strain 1629RS + SX, Pseudomonas fluorescens strain A506 + SX, Pseudomonas fluorescens strain CL145A + SX, Pseudomonas fluorescens strain G7090 + SX, Pseudomonas sp. strain CAB-02 + SX, Pseudomonas syringae strain 742RS + SX, Pseudomonas syringae strain MA-4 + SX, Pseudozyma flocculosa strain PF-A22UL + SX, Pseudomonas rhodesiae strain HAI-0804 + SX, Pythium oligandrum strain DV74 + SX, Pythium oligandrum strain M1 + SX, Streptomyces griseoviridis strain K61 + SX, Streptomyces lydicus strain WYCD108US + SX, Streptomyces lydicus strain WYEC108 + SX, Talaromyces flavus strain SAY-Y-94-01 + SX, Talaromyces flavus strain V117b + SX, Trichoderma asperellum strain ICC012 + SX, Trichoderma asperellum SKT-1 + SX, Trichoderma asperellum strain T25 + SX, Trichoderma asperellum strain T34 + SX, Trichoderma asperellum strain TV1 + SX, Trichoderma atroviride strain CNCM 1-1237 + SX, Trichoderma atroviride strain LC52 + SX, Trichoderma atroviride strain IMI 206040 + SX, Trichoderma atroviride strain SC1 + SX, Trichoderma atroviride strain SKT-1 + SX, Trichoderma atroviride strain T11 + SX, Trichoderma gamsii strain ICC080 + SX, Trichoderma harzianum strain 21 + SX, Trichoderma harzianum strain DB104 + SX, Trichoderma harzianum strain DSM 14944 + SX, Trichoderma harzianum strain ESALQ-1303 + SX, Trichoderma harzianum strain ESALQ-1306 + SX, Trichoderma harzianum strain IIHR-Th-2 + SX, Trichoderma harzianum strain ITEM908 + SX, Trichoderma harzianum strain kd + SX, Trichoderma harzianum strain MO1 + SX, Trichoderma harzianum strain SF + SX, Trichoderma harzianum strain T22 + SX, Trichoderma harzianum strain T39 + SX, Trichoderma harzianum strain T78 + SX, Trichoderma harzianum strain TH35 + SX, Trichoderma polysporum strain IMI206039 + SX, trichoderma stromaticum + SX, Trichoderma virens strain G-41 + SX, Trichoderma virens strain GL-21 + SX, Trichoderma viride + SX, Variovorax paradoxus strain CGF4526 + SX, Harpin protein + SX。 Combination of the present component of the above group (b) with the compound of the present invention:
acibenzolar-S-methyl + SX, aldimorph + SX, ametoctradin + SX, aminopyrifen + SX, amisulbrom + SX, anilazine + SX, azaconazole + SX, azoxystrobin + SX, basic copper sulfate + SX, benalaxyl + SX, benalaxyl-M + SX, benodanil + SX, benomyl + SX, benthiavalicarb + SX, benthiavalicarb-isopropyl + SX, benzovindiflupyr + SX, binapacryl + SX, biphenyl + SX, bitertanol + SX, bixafen + SX, blasticidin-S + SX, Bordeaux mixture + SX, boscalid + SX, bromothalonil + SX, bromuconazole + SX, bupirimate + SX, captafol + SX, captan + SX, carbendazim + SX, carboxin + SX, carpropamid + SX, chinomethionat + SX, chitin + SX, chloroinconazide + SX, chloroneb + SX, chlorothalonil + SX, chlozolinate + SX, colletochlorin B + SX, copper(II) acetate + SX, copper(II) hydroxide + SX, copper oxychloride + SX, copper(II) sulfate + SX, coumoxystrobin + SX, cyazofamid + SX, cyflufenamid + SX, cymoxanil + SX, cyproconazole + SX, cyprodinil + SX, dichlobentiazox + SX, dichlofluanid + SX, diclocymet + SX, diclomezine + SX, dicloran + SX, diethofencarb + SX, difenoconazole + SX, diflumetorim + SX, dimethachlone + SX, dimethirimol + SX, dimethomorph + SX, dimoxystrobin + SX, diniconazole + SX, diniconazole-M + SX, dinocap + SX, dipotassium hydrogenphosphite + SX, dipymetitrone + SX, dithianon + SX, dodecylbenzenesulphonic acid bisethylenediamine copper(II) salt + SX, dodemorph + SX, dodine + SX, edifenphos + SX, enoxastrobin + SX, epoxiconazole + SX, etaconazole + SX, ethaboxam + SX, ethirimol + SX, etridiazole + SX, extract of Allium sativum + SX, extract of the cotyledons of lupine plantlets ("BLAD") + SX, extract of Equisetum arvense + SX, extract of Melaleuca alternifolia + SX, extract of Reynoutria sachalinensis + SX, extract of Tropaeolum majus + SX, famoxadone + SX, fenamidone + SX, fenaminstrobin + SX, fenarimol + SX, fenbuconazole + SX, fenfuram + SX, fenhexamid + SX, fenoxanil + SX, fenpiclonil + SX, fenpicoxamid + SX, fenpropidin + SX, fenpropimorph + SX, fenpyrazamine + SX, fentin acetate + SX, fentin chloride + SX, fentin hydroxide + SX, ferbam + SX, ferimzone + SX, florylpicoxamid + SX, fluazinam + SX, flubeneteram + SX, fludioxonil + SX, flufenoxadiazam + SX, flufenoxystrobin + SX, fluindapyr + SX, flumetylsulforim + SX, flumorph + SX, fluopicolide + SX, fluopyram + SX, fluopimomide + SX, fluoroimide + SX, fluoxapiprolin + SX, fluoxastrobin + SX, Fluoxytioconazole + SX, Fluquinconazole + SX, Flusilazole + SX, Flusulfamide + SX, Flutianil + SX, Flutolanil + SX, Flutriafol + SX, Fluxapyroxad + SX, Folpet + SX, Fosetyl + SX, Fosetyl-aluminium + SX, Fuberidazole + SX, Furalaxyl + SX, Furamethpyr + SX, Guazatine + SX, Hexaconazole + SX, hymexazole + SX,
imazalil + SX, imibenconazole + SX, iminoctadine + SX, iminoctadine triacetate + SX, inpyrfluxam + SX, iodocarb + SX, ipconazole + SX, ipfentrifluconazole + SX, ipflufenoquin + SX, iprobenfos + SX, iprodione + SX, iprovalicarb + SX, isofetamide + SX, isoflucipram + SX, isoprothiolane + SX, Isopyrazam + SX, Isotianil + SX, Kasugamycin + SX, Kresoxim-methyl + SX, Laminarin + SX, Leaves and bark of Quercus + SX, Mancozeb + SX, Mandestrobin + SX, Mandipropamid + SX, Maneb + SX, Mefentrifluconazole + SX, Mepanipyrim + SX, Mepronil + SX, Meptyldinocap + SX, Metalaxyl + SX, Metalaxyl-M + SX, metarylpicoxamid + SX, metconazole + SX, methasulfocarb + SX, metiram + SX, metominostrobin + SX, metrafenone + SX, metyltetraprole + SX, myclobutanil + SX, naftifine + SX, nuarimol + SX, octhilinone + SX, ofurace + SX, orysastrobin + SX, oxadixyl + SX, oxathiapiprolin + SX, oxine-copper + SX, oxolinic acid + SX, oxpoconazole + SX, oxpoconazole fumarate + SX, oxycarboxin + SX, oxytetracycline + SX, pefurazoate + SX, penconazole + SX, pencycuron + SX, penflufen + SX, penthiopyrad + SX, phenamacril + SX, phosphorous acid + SX, phthalide + SX, picarbutrazox + SX, Picoxystrobin + SX, Piperalin + SX, Polyoxins + SX, Potassium hydrogencarbonate + SX, Potassium dihydrogenphosphite + SX, Probenazole + SX, Prochloraz + SX, Procymidone + SX, Propamidine + SX, Propamocarb + SX, Propiconazole + SX, Propineb + SX, Proquinazid + SX, Prothiocarb + SX, Prothioconazole + SX, Pydiflumetofen + SX, pyraclostrobin + SX, pyrametostrobin + SX, pyraoxystrobin + SX, pyrapropoyne + SX, pyraziflumid + SX, pyrazophos + SX, pyribencarb + SX, pyributicarb + SX, pyridaclomethyl + SX, pyrifenox + SX, pyrimethanil + SX, pyrimorph + SX, pyriophenone + SX, pyrisoxazole + SX, pyroquilon + SX, Quillaja extract + SX, quinconazole + SX, quinofumelin + SX, quinoxyfen + SX, quintozene + SX, saponins of Chenopodium quinoa + SX, seboctylamine + SX, sedaxane + SX, silthiofam + SX, simeconazole + SX, sodium hydrogencarbonate + SX, spiroxamine + SX, streptomycin + SX, sulfur + SX, tebuconazole + SX, tebufloquin + SX, teclofthalam + SX, tecnazene + SX, terbinafine + SX, tetraconazole + SX, thiabendazole + SX, thifluzamide + SX, thiophanate + SX, thiophanate-methyl + SX, thiram + SX, thymol + SX, tiadinil + SX, tolclofos-methyl + SX, tolfenpyrad + SX, tolprocarb + SX, tolylfluanid + SX, triadimefon + SX, triadimenol + SX, triazoxide + SX, triclopyricarb + SX, tricyclazole + SX, tridemorph + SX, trifloxystrobin + SX, triflumizole + SX, triforine + SX, triticonazole + SX, validamycin + SX, valifenalate + SX, vinclozolin + SX, yellow mustard powder + SX, zinc thiazole + SX, zineb + SX, ziram + SX, Zoxamide + SX,
N'-[4-({3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl}oxy)-2,5-dimethylphenyl]-N-ethyl-N-methylmethanimidamide (1202781-91-6) + SX, N'-{4-[(4,5-dichlorothiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methylmethanimidamide (929908-57-6) + SX, N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methylmethanimidamide (1052688-31-9) + SX, N'-[5-chloro-4-(2-fluorophenoxy)-2-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055589-28-9) + SX, N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylmethanimidamide (2055756-21-1) + SX, N'-(2-chloro-4-phenoxy-5-methylphenyl)-N-ethyl-N-methylmethanimidamide (2062599-39-5) + SX, N'-[4-(1-hydroxy-1-phenyl-2,2,2-trifluoroethyl)-2-methyl-5-methoxyphenyl]-N-isopropyl-N-methylmethanimidamide (2101814-55-3) + SX, N'-[5-bromo-6-(1-methyl-2-propoxyethoxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylmethanimidamide (1817828-69-5) + SX, 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine (1362477-26-6) + SX, 2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazoline (1257056-97-5) + SX, ethyl (2Z)-3-amino-2-cyano-3-phenylacrylate (39491-78-6) + SX, N-[(2-chlorothiazol-5-yl)methyl]-N-ethyl-6-methoxy-3-nitropyridin-2-amine (1446247-98-8) + SX, 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-11-4) + SX, (1R, 2S, 5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-06-2) + SX, (1S, 2R, 5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-07-3) + SX, 2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1394057-13-6) + SX, (1R, 2S, 5S)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-08-4) + SX, (1S, 2R, 5R)-2-(chloromethyl)-5-(4-fluorobenzyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol (1801930-09-5) + SX, methyl 3-[(4-chlorophenyl)methyl]-2-hydroxy-1-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)cyclopentan-1-carboxylate (1791398-02-1) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-bromo-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-86-0) + SX, 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)-1-[1-(4-chloro-2,6-difluorophenoxy)cyclopropyl]ethanol (2019215-84-8) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018316-13-5) + SX, 1-[2-(1-chlorocyclopropyl)-3-(2,3-difluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile (2018317-25-2) + SX, 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082661-43-4) + SX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)pyridin-3-yl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol (2082660-27-1) + SX, methyl ({2-methyl-5-[1-(4-methoxy-2-methylphenyl)-1H-pyrazol-3-yl]phenyl}methyl)carbamate (1605879-98-8) + SX, 2-(difluoromethyl)-N-[1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1616239-21-4) + SX, 2-(difluoromethyl)-N-[3-ethyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-02-9) + SX, 2-(difluoromethyl)-N-[3-propyl-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl]pyridine-3-carboxamide (1847460-05-2) + SX, (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-27-0) + SX, (2E,3Z)-5-{[1-(2,4-dichlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide (1445331-54-3) + SX, 5-chloro-4-({2-[6-(4-chlorophenoxy)pyridin-3-yl]ethyl}amino)-6-methylpyrimidine (1605340-92-8) + SX, N-(1-benzyl-1,3-dimethylbutyl)-8-fluoroquinoline-3-carboxamide (2132414-04-9) + SX, N-(1-benzyl-3,3,3-trifluoro-1-methylpropyl)-8-fluoroquinoline-3-carboxamide (2132414-00-5) + SX, 4,4-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-25-1) + SX, 5,5-dimethyl-2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one (2098918-26-2) + SX, N-ethyl-2-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N,2-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-methoxy-N'-methyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N'-ethyl-N-methoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N'-dimethoxy-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-acetyl-2-(ethanesulfonyl)-N-[2-(methoxycarbonyl)-4-(trifluoromethoxy)phenyl]-4-(trifluoromethyl)benzamide (2043675-28-9) + SX,
3-(4-bromo-7-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromoindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(7-bromo-4-fluoroindol-1-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, 3-(3,5-dichloropyridin-2-yl)butan-2-yl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-[(3-acetoxy-4-methoxypyridin-2-yl)carbonyl]-L-alaninate + SX, (1S)-1-[1-(naphthalen-1-yl)cyclopropyl]ethyl N-{[3-(acetoxymethoxy)-4-methoxypyridin-2-yl]carbonyl}-L-alaninate + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)cyclopropanecarboxamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)acetamide + SX, N-allyl-N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, 3,3,3-trifluoro-N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)propanamide + SX, N-({2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)butanamide + SX, N-methoxy-N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N,N-diethyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, N-methyl-N'-({ 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)urea + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX, 4-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)morpholin-3-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)isoxazolidin-3-one + SX, 3,3-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)piperidin-2-one + SX, 2-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1,2-oxazinan-3-one + SX, 1-({3-fluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)azepan-2-one + SX, 4,4-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, 5-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)pyrrolidin-2-one + SX, ethyl 1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxylate + SX, N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N-propyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide+SX, + SX, N-methoxy-N-methyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-pyrazole-4-carboxamide + SX, N,N-dimethyl-1-({4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}methyl)-1H-1,2,4-triazol-3-amine + SX, N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + SX, methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, ethyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, methyl 2-[2-(trifluoromethyl)-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propanoate + SX, 1-(2,3-dimethylpyridin-5-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-[2-(difluoromethyl)-3-methylpyridin-5-yl]-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 2,2-difluoro-N-[6-({[1-(1-methyl-1H-tetrazol-5-yl)benzimidazol-2-yl]oxy}methyl)pyridin-2-yl]-2-phenoxyacetamide + SX, 1-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]-1H-imidazole-5-carbonitrile + SX, ethyl 1-[(4-{[2-(trifluoromethyl)-1,3-dioxolan-2-yl]methoxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, ethyl 1-[(4-{[(1Z)-2-ethoxy-3,3,3-trifluoro-1-propen-1-yl]oxy}phenyl)methyl]-1H-pyrazole-4-carboxylate + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide + SX, 6-chloro-N-[2-(2-chloro-4-methylphenyl)-2,2-difluoroethyl]-3-(3-cyclopropyl-2-fluorophenoxy)-5-methylpyridazine-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-(spiro[3.4]octan-1-yl)-5-methylthiazole-4-carboxamide + SX, 2-[cyano(2,6-difluoropyridin-4-yl)amino]-N-hexyl-5-methylthiazole-4-carboxamide + SX, 2-[acetyl(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methoxyacetyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2-methylpropanoyl)(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-[(2,6-difluoropyridin-4-yl)amino]-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxetan-3-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxolan-3-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 2-{[(oxan-4-yl)carbonyl](2,6-difluoropyridin-4-yl)amino}-N-(2,2-dimethylcyclobutyl)-5-methylthiazole-4-carboxamide + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(3,5-difluorophenyl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(6-chloropyridin-3-yl)ethyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2,6-difluorophenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-N-[1-(2-fluoro-3-methoxyphenyl)cyclopropyl]pyrimidin-2-amine + SX, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-{[1-(2,6-difluorophenyl)cyclopropyl]oxy}pyrimidine + SX, 3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(4-bromo-2-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, 3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, (5R)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine + SX, SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}-3-methylbutan-2-yl)-2,2-dimethylpropanamide + SX, N-((2S)-1-{3-[2-(5-fluoro-2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, N-((2S)-1-{3-[2-(2-methoxyphenyl)-2-hydroxyethyl]-5-[(E)-1-(isopropoxyimino)ethyl]-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl}propan-2-yl)-2-methylpropanamide + SX, SX,
methyl ({5-[1-(2,6-difluoro-4-isopropylphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl ({5-[1-(2,6-difluoro-4-methoxyphenyl)-1H-pyrazol-3-yl]-2-methylphenyl}methyl)carbamate + SX, methyl (Z)-2-(5-cyclopentyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxyprop-2-enoate + SX, methyl (Z)-2-[(3-isopropyl-1H-pyrazol-1-yl)-2-methylphenoxy]-3-methoxyprop-2-enoate + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(4,5-dimethyl-1H-benzimidazol-1-yl)-4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(pyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline + SX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-6-fluoro-3,3-dimethylisoquinolin-4(3H)-one + SX, methyl (2Z)-3-methoxy-2-[(4-methyl[1,1'-biphenyl]-3-yl)oxy]prop-2-enoate + SX, Agrobacterium radiobactor strain K1026 + SX. Bacillus amyloliquefaciens strain DB101 + SX, Bacillus amyloliquefaciens strain DB102 + SX, Bacillus amyloliquefaciens strain GB03 + SX, Bacillus amyloliquefaciens strain FZB24 + SX, Bacillus amyloliquefaciens strain FZB42 + SX, Bacillus amyloliquefaciens strain IN937a + SX, Bacillus amyloliquefaciens strain MBI600 + SX, Bacillus amyloliquefaciens strain QST713 + SX, Bacillus amyloliquefaciens isolate strain B246 + SX, Bacillus amyloliquefaciens strain F727 + SX, Bacillus amyloliquefaciens subsp. plantarum strain D747 + SX, Bacillus licheniformis strain HB-2 + SX, Bacillus licheniformis strain SB3086 + SX, Bacillus pumilus strain AQ717 + SX, Bacillus pumilus strain BUF-33 + SX, Bacillus pumilus strain GB34 + SX, Bacillus pumilus strain QST2808 + SX, Bacillus simplex strain CGF2856 + SX, Bacillus subtilis strain AQ153 + SX, Bacillus subtilis strain AQ743 + SX, Bacillus subtilis strain BU1814 + SX, Bacillus subtilis strain D747 + SX, Bacillus subtilis strain DB101 + SX, Bacillus subtilis strain FZB24 + SX, Bacillus subtilis strain GB03 + SX, Bacillus subtilis strain HAI0404 + SX, Bacillus subtilis strain IAB/BS03 + SX, Bacillus subtilis strain MBI600 + SX, Bacillus subtilis strain QST30002/AQ30002 + SX, Bacillus subtilis strain QST30004/AQ30004 + SX, Bacillus subtilis strain QST713 + SX, Bacillus subtilis strain QST714 + SX, Bacillus subtilis var. Amyloliquefaciens strain FZB24 + SX, Bacillus subtilis strain Y1336 + SX, Burkholderia cepacia + SX, Burkholderia cepacia type strain Wisconsin J82 + SX, Burkholderia cepacia type Wisconsin strain M54 + SX, Candida oleophila strain O + SX, Candida saitoana + SX, Chaetomium cupreum + carotovora strain CGE234M403 + SX, Fusarium oxysporum strain Fo47 + SX, Gliocladium catenulatum strain J1446 + SX, Paenibacillus polymyxa strain AC-1 + SX, Paenibacillus polymyxa strain BS-0105 + SX, Pantoea agglomerans strain E325 + SX, Phlebiopsis gigantea strain VRA1992 + SX, Pseudomonas aureofaciens strain TX-1 + SX, Pseudomonas chlororaphis strain 63-28+ SX, Pseudomonas chlororaphis strain AFS009 + SX, Pseudomonas chlororaphis strain MA342 + SX, Pseudomonas fluorescens strain 1629RS + SX, Pseudomonas fluorescens strain A506 + SX, Pseudomonas fluorescens strain CL145A + SX, Pseudomonas fluorescens strain strain G7090 + SX, Pseudomonas sp. strain CAB-02 + SX, Pseudomonas syringae strain 742RS + SX, Pseudomonas syringae strain MA-4 + SX, Pseudozyma flocculosa strain PF-A22UL + SX, Pseudomonas rhodesiae strain HAI-0804 + SX, Pythium oligandrum strain DV74 + SX, Pythium oligandrum strain M1 + SX, Streptomyces griseoviridis strain K61 + SX, Streptomyces lydicus strain WYCD108US + SX, Streptomyces lydicus strain WYEC108 + SX, Talaromyces flavus strain SAY-Y-94-01 + SX, Talaromyces flavus strain V117b + SX, Trichoderma asperellum strain ICC012 + SX, Trichoderma asperellum SKT-1 + SX, Trichoderma asperellum strain T25 + SX, Trichoderma asperellum strain T34 + SX, Trichoderma asperellum strain TV1 + SX, Trichoderma atroviride strain CNCM 1-1237 + SX, Trichoderma atroviride strain LC52 + SX, Trichoderma atroviride strain IMI 206040 + SX, Trichoderma atroviride strain SC1 + SX, Trichoderma atroviride strain SKT-1 + SX, Trichoderma atroviride strain T11 + SX, Trichoderma gamsii strain ICC080 + SX, Trichoderma harzianum strain 21 + SX, Trichoderma harzianum strain DB104 + SX, Trichoderma harzianum strain DSM 14944 + SX, Trichoderma harzianum strain ESALQ-1303 + SX, Trichoderma harzianum strain ESALQ-1306 + SX, Trichoderma harzianum strain IIHR-Th-2 + SX, Trichoderma harzianum strain ITEM908 + SX, Trichoderma harzianum strain kd + SX, Trichoderma harzianum strain MO1 + SX, Trichoderma harzianum strain SF + SX, Trichoderma harzianum strain T22 + SX, Trichoderma harzianum strain T39 + SX, Trichoderma harzianum strain T78 + SX, Trichoderma harzianum strain TH35 + SX, Trichoderma polysporum strain IMI206039 + SX, trichoderma stromaticum + SX, Trichoderma virens strain G-41 + SX, Trichoderma virens strain GL-21 + SX, Trichoderma viride + SX, Variovorax paradoxus strain CGF4526 + SX, Harpin protein + SX.

　上記群（ｃ）の本成分と本発明化合物との組合せ：
　１－メチルシクロプロペン(1-methylcyclopropene) + SX, １，３－ジフェニルウレア(1,3-diphenylurea) + SX, ２，３，５－トリヨード安息香酸(2,3,5-triiodobenzoic acid) + SX, IAA ((1H-indol-3-yl)acetic acid) + SX, IBA (4-(1H-indol-3-yl)butyric acid) + SX, MCPA (2-(4-chloro-2-methylphenoxy)acetic acid) + SX, MCPB (4-(4-chloro-2-methylphenoxy)butyric acid) + SX, 4-CPA (4-chlorophenoxyacetic acid) + SX, ５－アミノレブリン酸塩酸塩(5-aminolevulinic acid hydrochloride) + SX, ６－ベンジルアミノプリン(6-benzylaminopurine) + SX, アブシシン酸(abscisic acid) + SX, AVG (aminoethoxyvinylglycine) + SX, アニシフルプリン(anisiflupurin) + SX, アンシミドール(ancymidol) + SX, ブトルアリン(butralin) + SX, 炭酸カルシウム(calcium carbonate) + SX, 塩化カルシウム(calcium chloride) + SX, ギ酸カルシウム(calcium formate) + SX, 過酸化カルシウム(calcium peroxide) + SX, 石灰硫黄(calcium polysulfide) + SX, 硫酸カルシウム(calcium sulfate) + SX, クロルメコートクロリド(chlormequat-chloride) + SX, クロロプロファム(chlorpropham) + SX, 塩化コリン(choline chloride) + SX, クロプロップ(cloprop) + SX, シアナミド(cyanamide) + SX, シクラニリド(cyclanilide) + SX, ダミノジッド(daminozide) + SX, デカン－１－オール(decan-1-ol) + SX, ジクロルプロップ(dichlorprop) + SX, ジケグラック(dikegulac) + SX, ジメチピン(dimethipin) + SX, ジクワット(diquat) + SX, エテホン(ethephon) + SX, エチクロゼート(ethychlozate) + SX, フルメトラリン(flumetralin) + SX, フルルプリミドール(flurprimidol) + SX, ホルクロルフェヌロン(forchlorfenuron) + SX, ホルモノネチン(formononetin) + SX, ジベレリンＡ(Gibberellin A) + SX, ジベレリンＡ３(Gibberellin A3) + SX, イナベンフィド(inabenfide) + SX, カイネチン(Kinetin) + SX, lipochitooligosaccharide SP104 + SX, マレイン酸ヒドラジド(maleic hydrazide) + SX, メフルイジド(mefluidide) + SX, メピコートクロリド(mepiquat-chloride) + SX, 酸化型グルタチオン(oxidized glutathione) + SX, パクロブトラゾール(paclobutrazol) + SX, ペンディメタリン(pendimethalin) + SX, プロヘキサジオンカルシウム(prohexadione-calcium) + SX, プロヒドロジャスモン(prohydrojasmon) + SX, ピラフルフェンエチル(pyraflufen-ethyl) + SX, シントフェン(sintofen) + SX, １－ナフタレン酢酸ナトリウム(sodium 1-naphthaleneacetate) + SX, シアン酸ナトリウム(sodium cyanate) + SX, チジアズロン(thidiazuron) + SX, トリアペンテノール(triapenthenol) + SX, トリブホス(tribufos) + SX, トリネキサパックエチル(trinexapac-ethyl) + SX, ウニコナゾールP (uniconazole-P) + SX, ２－（ナフタレン－１－イル）アセトアミド(2-(naphthalen-1-yl)acetamide) + SX, ［４－オキソ－４－（２－フェニルエチル）アミノ］酪酸 + SX, ５－（トリフルオロメチル）ベンゾ［b］チオフェン－２－カルボン酸メチル + SX, ３－［（６－クロロ－４－フェニルキナゾリン－２－イル）アミノ］プロパン－１－オール + SX, Claroideoglomus etunicatum + SX, Claroideoglomus claroideum + SX, Funneliformis mosseae + SX, Gigaspora margarita + SX, Gigaspora rosea + SX, Glomus aggregatum + SX, Glomus deserticola + SX, Glomus monosporum + SX, Paraglomus brasillianum + SX, Rhizophagus clarus + SX, Rhizophagus intraradices RTI-801 + SX, Rhizophagus irregularis DAOM 197198 + SX, Azorhizobium caulinodans + SX, Azospirillum amazonense + SX, Azospirillum brasilense XOH + SX, Azospirillum brasilense Ab-V5 + SX, Azospirillum brasilense Ab-V6 + SX, Azospirillum caulinodans + SX, Azospirillum halopraeferens + SX, Azospirillum irakense + SX, Azospirillum lipoferum + SX, Bradyrhizobium elkanii SEMIA 587 + SX, Bradyrhizobium elkanii SEMIA 5019 + SX, Bradyrhizobium japonicum TA-11 + SX, Bradyrhizobium japonicum USDA 110 + SX, Bradyrhizobium liaoningense + SX, Bradyrhizobium lupini + SX, Delftia acidovorans RAY209 + SX, Mesorhizobium ciceri + SX, Mesorhizobium huakii + SX, Mesorhizobium loti + SX, Rhizobium etli + SX, Rhizobium galegae + SX, Rhizobium leguminosarum bv. Phaseoli + SX, Rhizobium leguminosarum bv. Trifolii + SX, Rhizobium leguminosarum bv. Viciae + SX, Rhizobium trifolii + SX, Rhizobium tropici + SX, Sinorhizobium fredii + SX, Sinorhizobium meliloti + SX, Zucchini Yellow Mosaik Virus weak strain + SX。 Combination of the present component of the above group (c) with the compound of the present invention:
1-methylcyclopropene + SX, 1,3-diphenylurea + SX, 2,3,5-triiodobenzoic acid + SX, IAA ((1H-indol-3-yl)acetic acid) + SX, IBA (4-(1H-indol-3-yl)butyric acid) + SX, MCPA (2-(4-chloro-2-methylphenoxy)acetic acid) + SX, MCPB (4-(4-chloro-2-methylphenoxy)butyric acid) + SX, 4-CPA (4-chlorophenoxyacetic acid) + SX, 5-aminolevulinic acid hydrochloride + SX, 6-benzylaminopurine + SX, abscisic acid + SX, AVG (aminoethoxyvinylglycine) + SX, anisiflupurin + SX, ancymidol + SX, butralin + SX, calcium carbonate + SX, calcium chloride + SX, calcium formate + SX, calcium peroxide + SX, calcium polysulfide + SX, calcium sulfate + SX, chlormequat-chloride + SX, chlorpropham + SX, choline chloride + SX, cloprop + SX, cyanamide + SX, cyclanilide + SX, Daminozide + SX, Decane-1-ol + SX, Dichlorprop + SX, Dikegulac + SX, Dimethipin + SX, Diquat + SX, Ethephon + SX, Ethychlozate + SX, Flumetralin + SX, Flurprimidol + SX, Forchlorfenuron + SX, Formononetin + SX, Gibberellin A + SX, Gibberellin A3 + SX, Inabenfide + SX, Kinetin + SX, lipochitooligosaccharide SP104 + SX, maleic hydrazide + SX, mefluidide + SX, mepiquat-chloride + SX, oxidized glutathione + SX, paclobutrazol + SX, pendimethalin + SX, prohexadione-calcium + SX, prohydrojasmon + SX, pyraflufen-ethyl + SX, sintophen + SX, sodium 1-naphthaleneacetate + SX, sodium cyanate + SX, Thidiazuron + SX, Triapenthenol + SX, Tribufos + SX, Trinexapac-ethyl + SX, Uniconazole-P + SX, 2-(naphthalen-1-yl)acetamide + SX, [4-oxo-4-(2-phenylethyl)amino]butyric acid + SX, Methyl 5-(trifluoromethyl)benzo[b]thiophene-2-carboxylate + SX, 3-[(6-chloro-4-phenylquinazolin-2-yl)amino]propan-1-ol + SX, Claroideoglomus etunicatum + SX, Claroideoglomus claroideum + SX, Funneliformis mosseae + SX, Gigaspora margarita + SX, Gigaspora rosea + SX, Glomus aggregatum + SX, Glomus deserticola + SX, Glomus monosporum + SX, Paraglomus brasillianum + SX, Rhizophagus clarus + SX, Rhizophagus intraradices RTI-801 + SX, Rhizophagus irregularis DAOM 197198 + SX, Azorhizobium caulinodans + SX, Azospirillum amazonense + SX, Azospirillum brasilense XOH + SX, Azospirillum brasilense Ab-V5 + SX, Azospirillum brasilense Ab-V6 + SX, Azospirillum caulinodans + SX, Azospirillum halopraeferens + SX, Azospirillum irakense + SX, Azospirillum lipoferum + SX, Bradyrhizobium elkanii SEMIA 587 + SX, Bradyrhizobium elkanii SEMIA 5019 + SX, Bradyrhizobium japonicum TA-11 + SX, Bradyrhizobium japonicum USDA 110 + SX, Bradyrhizobium liaoningense + SX, Bradyrhizobium lupini + SX, Delftia acidovorans RAY209 + SX, Mesorhizobium ciceri + SX, Mesorhizobium huakii + SX, Mesorhizobium loti + SX, Rhizobium etli + SX, Rhizobium galegae + SX, Rhizobium leguminosarum bv. Phaseoli + SX, Rhizobium leguminosarum bv. Trifolii + SX, Rhizobium leguminosarum bv. Viciae + SX, Rhizobium trifolii + SX, Rhizobium tropici + SX, Sinorhizobium fredii + SX, Sinorhizobium meliloti + SX, Zucchini Yellow Mosaik Virus weak strain + SX.

　上記群（ｄ）の本成分と本発明化合物との組合せ：
　アントラキノン(anthraquinone) + SX, ディート(deet) + SX, イカリジン(icaridin) + SX。 Combination of the component of the above group (d) with the compound of the present invention:
Anthraquinone + SX, deet + SX, icaridin + SX.

　本発明化合物と本成分との比は、特に限定されるものではないが、重量比（本発明化合物：本成分）で１０００：１～１：１０００、５００：１～１：５００、１００：１～１：１００、５０：１、２０：１、１０：１、９：１、８：１、７：１、６：１、５：１、４：１、３：１、２：１、１：１、１：２、１：３、１：４、１：５、１：６、１：７、１：８、１：９、１：１０、１：２０、１：５０等が挙げられる。 The ratio of the compound of the present invention to this component is not particularly limited, but examples of the ratio by weight (compound of the present invention: this component) include 1000:1 to 1:1000, 500:1 to 1:500, 100:1 to 1:100, 50:1, 20:1, 10:1, 9:1, 8:1, 7:1, 6:1, 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, 1:10, 1:20, and 1:50.

　本発明化合物は、有害昆虫や有害ダニ類等の有害節足動物、有害線虫、及び有害軟体動物に対して効力を有する。有害節足動物、有害線虫、及び有害軟体動物としては、例えば以下のものが挙げられる。 The compound of the present invention is effective against harmful arthropods such as harmful insects and harmful mites, harmful nematodes, and harmful mollusks. Examples of harmful arthropods, harmful nematodes, and harmful mollusks include the following:

　半翅目(Hemiptera)：ヒメトビウンカ(Laodelphax striatellus)、トビイロウンカ(Nilaparvata lugens)、セジロウンカ(Sogatella furcifera)、トウモロコシウンカ(Peregrinus maidis)、キタウンカ(Javesella pellucida)、クロフツノウンカ(Perkinsiella saccharicida)、Tagosodes orizicolus、Stenocranus pacificus等のウンカ科(Delphacidae)；ツマグロヨコバイ(Nephotettix cincticeps)、タイワンツマグロヨコバイ(Nephotettix virescens)、クロスジツマグロヨコバイ(Nephotettix nigropictus)、イナズマヨコバイ(Recilia dorsalis)、チャノミドリヒメヨコバイ(Empoasca onukii)、ジャガイモヒメヨコバイ(Empoasca fabae)、コーンリーフホッパー(Dalbulus maidis)、シロオオヨコバイ(Cofana spectra)、Amrasca biguttula biguttula等のヨコバイ科(Cicadellidae)；ヨーロピアンスピトルバグ(Philaenus spumarius)等のアワフキムシ科(Aphrophoridae); Mahanarva posticata、Mahanarva fimbriolata等のコガシラアワフキムシ科(Cercopidae)；マメクロアブラムシ(Aphis fabae)、ダイズアブラムシ(Aphis glycines)、ワタアブラムシ(Aphis gossypii)、ヨーロッパリンゴアブラムシ(Aphis pomi)、ユキヤナギアブラムシ(Aphis spiraecola)、モモアカアブラムシ(Myzus persicae)、ムギワラギクオマルアブラムシ(Brachycaudus helichrysi)、ダイコンアブラムシ(Brevicoryne brassicae)、rosy apple aphid(Dysaphis plantaginea)、ニセダイコンアブラムシ(Lipaphis erysimi)、チューリップヒゲナガアブラムシ(Macrosiphum euphorbiae)、ジャガイモヒゲナガアブラムシ(Aulacorthum solani)、レタスヒゲナガアブラムシ(Nasonovia ribisnigri)、ムギクビレアブラムシ(Rhopalosiphum padi)、トウモロコシアブラムシ(Rhopalosiphum maidis)、ミカンクロアブラムシ(Toxoptera citricida)、モモコフキアブラムシ(Hyalopterus pruni)、ヒエノアブラムシ(Melanaphis sacchari)、オカボノクロアブラムシ(Tetraneura nigriabdominalis)、カンシャワタアブラムシ(Ceratovacuna lanigera)、リンゴワタムシ(Eriosoma lanigerum)、イングリッシュグレインエイフィッド（Sitobion avenae）等のアブラムシ科(Aphididae)；ブドウネアブラムシ(Daktulosphaira vitifoliae)、ピーカンフィロキセラ(Phylloxera devastatrix)、ピーカンリーフフィロキセラ (Phylloxera notabilis)、サウザンピーカンリーフフィロキセラ(Phylloxera russelae)等のネアブラムシ科(Phylloxeridae)；ツガカサアブラムシ(Adelges tsugae)、バルサムウーリーアフィッド(Adelges piceae)、ヒメカサアブラムシ(Aphrastasia pectinatae)等のカサアブラムシ科(Adelgidae)；イネクロカメムシ(Scotinophara lurida)、ブラックパディーバグ(Scotinophara coarctata)、アオクサカメムシ(Nezara antennata)、トゲシラホシカメムシ(Eysarcoris aeneus)、オオトゲシラホシカメムシ(Eysarcoris lewisi)、シラホシカメムシ(Eysarcoris ventralis)、ムラサキシラホシカメムシ(Eysarcoris annamita)、クサギカメムシ(Halyomorpha halys)、ミナミアオカメムシ(Nezara viridula)、ブラウンスティンクバグ(Euschistus heros)、レッドバンデッドスティンクバグ(Piezodorus guildinii)、Oebalus pugnax、Dichelops melacanthus、イチモンジカメムシ(Piezodorus hybneri)等のカメムシ科(Pentatomidae)；Scaptocoris castanea等のツチカメムシ科(Cydnidae)；ホソヘリカメムシ(Riptortus clavatus)、クモヘリカメムシ(Leptocorisa chinensis)、ホソクモヘリカメムシ(Leptocorisa acuta)等のホソヘリカメムシ科(Alydidae)；ホソハリカメムシ(Cletus punctiger)、アシビロヘリカメムシ(Leptoglossus australis)等のヘリカメムシ科(Coreidae)；カンシャコバネナガカメムシ(Cavelerius saccharivorus)、コバネヒョウタンナガカメムシ(Togo hemipterus)、アメリカコバネナガカメムシ(Blissus leucopterus)等のナガカメムシ科(Lygaeidae)；アカヒゲホソミドリカスミカメ(Trigonotylus caelestialium)、アカスジカスミカメ(Stenotus rubrovittatus)、フタトゲムギカスミカメ(Stenodema calcarata)、サビイロカスミカメ(Lygus lineolaris)等のカスミカメムシ科(Miridae)；オンシツコナジラミ(Trialeurodes vaporariorum)、タバココナジラミ(Bemisia tabaci)、ミカンコナジラミ(Dialeurodes citri)、ミカントゲコナジラミ(Aleurocanthus spiniferus)、チャトゲコナジラミ(Aleurocanthus camelliae)、ヒサカキワタフキコナジラミ(Pealius euryae)等のコナジラミ科(Aleyrodidae)；シュロマルカイガラムシ(Abgrallaspis cyanophylli)、アカマルカイガラムシ(Aonidiella aurantii)、ナシマルカイガラムシ(Diaspidiotus perniciosus)、クワシロカイガラムシ(Pseudaulacaspis pentagona)、ヤノネカイガラムシ(Unaspis yanonensis)、ニセヤノネカイガラムシ(Unaspis citri)等のマルカイガラムシ科(Diaspididae)；ルビーロウムシ(Ceroplastes rubens)等のカタカイガラムシ科(Coccidae)；イセリアカイガラムシ(Icerya purchasi)、キイロワタフキカイガラムシ(Icerya seychellarum)等のワタフキカイガラムシ科(Margarodidae)；ナスコナガイガラムシ(Phenacoccus solani)、クロテンコナカイガラムシ(Phenacoccus solenopsis)、フジコナカイガラムシ(Planococcus kraunhiae)、クワコナカイガラムシ(Pseudococcus comstocki)、ミカンコナカイガラムシ(Planococcus citri)、ガハニコナカイガラムシ(Pseudococcus calceolariae)、ナガオコナカイガラムシ(Pseudococcus longispinus)、タトルミーリーバグ(Brevennia rehi)等のコナカイガラムシ科(Pseudococcidae)；ミカンキジラミ(Diaphorina citri)、ミカントガリキジラミ(Trioza erytreae)、ナシキジラミ(Cacopsylla pyrisuga)、チュウゴクナシキジラミ(Cacopsylla chinensis)、ジャガイモトガリキジラミ(Bactericera cockerelli)、ピアプシラ(Cacopsylla pyricola)等のキジラミ科(Psyllidae)；プラタナスグンバイ(Corythucha ciliata)、アワダチソウグンバイ(Corythucha marmorata)、ナシグンバイ(Stephanitis nashi)、ツツジグンバイ(Stephanitis pyrioides)等のグンバイムシ科(Tingidae)；トコジラミ(Cimex lectularius)、ネッタイトコジラミ(Cimex hemipterus)等のトコジラミ科(Cimicidae)；Quesada gigas等のセミ科(Cicadidae)；ブラジルサシガメ(Triatoma infestans)、オオサシガメ（Triatoma rubrofasciata）、Triatoma dimidiata、ベネズエラサシガメ(Rhodonius prolixus)等のサシガメ科(Reduviidae)。 Hemiptera: Delphacids, such as Laodelphax striatellus, Nilaparvata lugens, Sogatella furcifera, Peregrinus maidis, Javesella pellucida, Perkinsiella saccharicida, Tagosodes orizicolus, and Stenocranus pacificus. ae); green rice leafhopper (Nephotettix cincticeps), Taiwan green rice leafhopper (Nephotettix virescens), black-striped green rice leafhopper (Nephotettix nigropictus), lightning leafhopper (Recilia dorsalis), tea green leafhopper (Empoasca onukii), potato leafhopper (Empoasca fabae), corn leafhopper (Dalbulus maidis), white giant leafhopper (Cofana spectrum), Amras Cicadellidae (Cicadellidae), such as ca biguttula biguttula; Aphrophoridae (Aphrophoridae), such as European spittlebug (Philaenus spumaris); Cercopidae (Cercopidae), such as Mahanarva posticata and Mahanarva fimbriolata; Bean aphid (Aphis fabae), soybean aphid (Aphis glycines), cotton aphid (Aphis gossypii), European apple aphid (Aphis spp.), etc. Aphis pomi, snow willow aphid (Aphis spiraecola), green peach aphid (Myzus persicae), strawberry aphid (Brachycaudus helichrysi), radish aphid (Brevicoryne brassicae), rosy apple aphid (Dysaphis plantaginea), false radish aphid (Lipaphis erysimi), tulip long-horn aphid (Macrosiphum euphorbiae), oats Aulacorthum solani, lettuce aphid (Nasonovia ribisnigri), wheat curl aphid (Rhopalosiphum padi), corn aphid (Rhopalosiphum maidis), citrus black aphid (Toxoptera citricida), peach buttercup aphid (Hyalopterus pruni), barnyard millet aphid (Melanaphis sacchari), and Japanese black aphid (Tetraneura nigriabd) ominalis, candy cotton aphid (Ceratovacuna lanigera), apple aphid (Eriosoma lanigerum), English grain aphid (Sitobion avenae); grapevine aphid (Daktulosphaira vitifoliae), pecan phylloxera (Phylloxera devastatrix), pecan leaf phylloxera (Phylloxera notabilis), southern pecan leaf phylloxera (P Phylloxeridae, such as hylloxera russelae; Adelgidae, such as Adelges tsugae, Adelges piceae, Aphrastasia pectinatae; Scotinophara lurida, black paddy bug, Nezara antennata, spiny star bug Stink bug (Eysarcoris aeneus), large spurred spotted bug (Eysarcoris lewisi), white spotted bug (Eysarcoris ventralis), purple spotted bug (Eysarcoris annamita), brown stink bug (Halyomorpha halys), southern green stink bug (Nezara viridula), brown stink bug (Euschistus heros), red banded stink bug (Piezodorus guildinii), Oebalus pugna x, Dichelops melacanthus, Piezodorus hybneri and other members of the Pentatomidae family; Scaptocoris castanea and other members of the Cydnidae family; Riptortus clavatus, Leptocorisa chinensis, Leptocorisa acuta and other members of the Alydidae family; Cletus punctiger, Coreidae, such as the foot-striped long-horned bug (Leptoglossus australis); Lygaeidae, such as the rice-winged long-horned bug (Cavelerius saccharivorus), the rice-winged long-horned bug (Togo hemipterus), and the American long-horned bug (Blissus leucopterus); Trigonotylus caelestialium, Stenotus rubrovittat, and other long-horned bugs. us, Stenodema calcarata, Lygus lineolaris and other Miridae family; Trialeurodes vaporariorum, Bemisia tabaci, Dialeurodes citri, Aleurocanthus spiniferus, Aleurocanthus camelliae, Japanese cotton grasshopper The family Aleyrodidae, such as the whitefly (Pealius euryae); the family Coccinellidae, such as the palm scale insect (Abgrallaspis cyanophylli), the red scale insect (Aonidiella aurantii), the pear scale insect (Diaspidiotus perniciosus), the mulberry scale insect (Pseudaulacaspis pentagona), the Yanon scale insect (Unaspis yanonensis), and the false Yanon scale insect (Unaspis citri). (Diaspididae); Coccidae, such as Ceroplastes rubens; Margarodidae, such as Icerya purchasi and Icerya seychellarum; Phenacoccus solani, Phenacoccus solenopsis, and Planococcus kraunhiae Mealybugs (Pseudococcidae) such as mulberry mealybug (Pseudococcus comstocki), citrus mealybug (Planococcus citri), calceolariae mealybug (Pseudococcus calceolariae), longispinus mealybug (Pseudococcus longispinus), and Brevennia rehi; citrus psyllid (Diaphorina citri), Trioza erytreae, and pear pheasant (Citrus spp.) Psyllidae, including Cacopsylla pyrisuga, Cacopsylla chinensis, Bactericera cockerelli, and Cacopsylla pyricola; Corythucha ciliata, Corythucha marmorata, Stephanitis nashi, and Stephanitis pyrio the Tingidae family, such as the bedbug Cimex lectularius and the net bug Cimex hempterus; the Cimicidae family, such as the Quesada gigas; the Reduviidae family, such as the Brazilian assassin bug Triatoma infestans, the giant assassin bug Triatoma rubrofasciata, Triatoma dimidiata, and the Venezuelan assassin bug Rhodonius prolixus.

　鱗翅目(Lepidoptera)：ニカメイガ(Chilo suppressalis)、ダークヘディドステムボーラー(Chilo polychrysus)、ホワイトステムボーラー(Scirpophaga innotata)、イッテンオオメイガ(Scirpophaga incertulas)、Rupela albina、コブノメイガ(Cnaphalocrocis medinalis)、Marasmia patnalis、イネハカジノメイガ(Marasmia exigua)、ワタノメイガ(Notarcha derogata)、アワノメイガ(Ostrinia furnacalis)、ヨーロピアンコーンボーラー(Ostrinia nubilalis)、ハイマダラノメイガ(Hellula undalis)、モンキクロノメイガ(Herpetogramma luctuosale)、シバツトガ(Parapediasia teterrellus)、ライスケースワーム(Nymphula depunctalis)、シュガーケーンボーラー(Diatraea saccharalis)、エッグプラントフルーツボーラー（Leucinodes orbonalis）等のツトガ科(Crambidae)；モロコシマダラメイガ(Elasmopalpus lignosellus)、ノシメマダラメイガ(Plodia interpunctella)、フタモンマダラノメイガ(Euzophera batangensis)、スジマダラメイガ(Cadra cautella)等のメイガ科(Pyralidae)；ハスモンヨトウ(Spodoptera litura)、シロイチモジヨトウ(Spodoptera exigua)、アワヨトウ(Mythimna separata)、ヨトウガ(Mamestra brassicae)、イネヨトウ(Sesamia inferens)、シロナヨトウ(Spodoptera mauritia)、フタオビコヤガ(Naranga aenescens)、ツマジロクサヨトウ(Spodoptera frugiperda)、アフリカシロナヨトウ(Spodoptera exempta)、Spodoptera cosmioides、セミトロピカルアーミーワーム（Spodoptera eridania）、タマナヤガ(Agrotis ipsilon)、カブラヤガ(Agrotis segetum)、タマナギンウワバ(Autographa nigrisigna)、イネキンウワバ(Plusia festucae)、Soybean looper(Chrysodeixis includens)、トリコプルシア属(Trichoplusia spp.)、ニセアメリカタバコガ(Heliothis virescens)等のヘリオティス属(Heliothis spp.)、オオタバコガ(Helicoverpa armigera)、コーンイヤワーム(Helicoverpa zea)等のヘリコベルパ属(Helicoverpa spp.)、ベルベットビーンキャタピラー(Anticarsia gemmatalis)、コットンリーフワーム(Alabama argillacea)、ホップワインボーラー(Hydraecia immanis)等のヤガ科(Noctuidae)；モンシロチョウ(Pieris rapae)等のシロチョウ科(Pieridae)；ナシヒメシンクイ(Grapholita molesta)、スモモヒメシンクイ(Grapholita dimorpha)、マメシンクイガ(Leguminivora glycinivorella)、アズキサヤムシガ(Matsumuraeses azukivora)、リンゴコカクモンハマキ(Adoxophyes orana fasciata)、チャノコカクモンハマキ(Adoxophyes honmai)、チャハマキ(Homona magnanima)、ミダレカクモンハマキ(Archips fuscocupreanus)、コドリングモス(Cydia pomonella)、カンシャシンクイハマキ(Tetramoera schistaceana)、ビーンシュートボーラ(Epinotia aporema)、シトラスフルーツボーラー(Citripestis sagittiferella)、ヨーロピアングレープワインモス（Lobesia botrana）等のハマキガ科(Tortricidae)；チャノホソガ(Caloptilia theivora)、キンモンホソガ(Phyllonorycter ringoniella)等のホソガ科(Gracillariidae)；モモシンクイガ(Carposina sasakii)等のシンクイガ科(Carposinidae)；コーヒーリーフマイナー(Leucoptera coffeella)、モモハモグリガ(Lyonetia clerkella)、ギンモンハモグリガ(Lyonetia prunifoliella)等のハモグリガ科(Lyonetiidae)；マイマイガ(Lymantria dispar)等のリマントリア属(Lymantria spp.)、チャドクガ(Euproctis pseudoconspersa)等のユープロクティス属(Euproctis spp.)等のドクガ科(Lymantriidae)；コナガ(Plutella xylostella)等のコナガ科(Plutellidae)；モモキバガ(Anarsia lineatella)、イモキバガ(Helcystogramma triannulella)、ワタアカミムシガ(Pectinophora gossypiella)、ジャガイモガ(Phthorimaea operculella)、トマトキバガ(Tuta absoluta)等のキバガ科(Gelechiidae)；アメリカシロヒトリ(Hyphantria cunea)等のヒトリガ科(Arctiidae)；ジャイアントシュガーケーンボーラー(Telchin licus)等のカストニアガ科(Castniidae)；ヒメボクトウ（Cossus insularis）等のボクトウガ科（Cossidae）；ヨモギエダシャク(Ascotis selenaria)等のシャクガ科(Geometridae)；ヒロヘリアオイラガ(Parasa lepida)等のイラガ科(Limacodidae)；カキノヘタムシガ(Stathmopoda masinissa)等のニセマイコガ科(Stathmopodidae)；クロメンガタスズメ(Acherontia lachesis)等のスズメガ科(Sphingidae)；キクビスカシバ(Nokona feralis)、コスカシバ(Synanthedon hector)、ヒメコスカシバ(Synanthedon tenuis)等のスカシバガ科(Sesiidae)；イネツトムシ(Parnara guttata)等のセセリチョウ科(Hesperiidae)；イガ(Tinea translucens)、コイガ(Tineola bisselliella)等のヒロズコガ科(Tineidae)。 Lepidoptera: Chilo suppressalis, Dark headed stem borer, Chilo polychrysus, White stem borer, Scirpophaga innotata, Scirpophaga incertulas, Rupela albina, Cnaphalocrocis medinalis, Marasmia patnalis, Marasmia exigua, Notarcha derogata, Ostrinia furnacalis, European corn borer, Hellula undalis, Herpetogramma luct Crambidae, such as the Japanese bush moth (Parapediasia teterrellus), the rice case worm (Nymphula depunctalis), the sugar cane borer (Diatraea saccharalis), and the eggplant fruit borer (Leucinodes orbonalis); Pyralidae, such as the corn moth (Elasmopalpus lignosellus), the Indian meal moth (Plodia interpunctella), the two-spotted moth (Euzophera batangensis), and the striped moth (Cadra cautella); Spodoptera litura, Spodoptera exigua, and the armyworm moth (Mythimna se parata), armyworm moth (Mamestra brassicae), rice armyworm moth (Sesamia inferens), armyworm moth (Spodoptera mauritia), two-banded cutworm moth (Naranga aenescens), leaf fall armyworm (Spodoptera frugiperda), African armyworm moth (Spodoptera exempta), Spodoptera cosmioides, semi-tropical armyworm (Spodoptera eridania), cutworm moth (Agrotis ipsilon), turnip cutworm moth (Agrotis segetum), silver looper moth (Autographa nigrisigna), rice yellow looper moth (Plusia festucae), soybean looper (Chrysodeixis includens), trichople Trichoplusia spp., Heliothis spp. such as Heliothis virescens, Helicoverpa spp. such as Helicoverpa armigera, corn earworm (Helicoverpa zea), Noctuidae such as Velvet bean caterpillar (Anticarsia gemmatalis), cotton leafworm (Alabama argillacea), hop wine borer (Hydraecia immanis), Pieridae such as Pieris rapae, pear fruit moth (Grapholita molesta), plum fruit moth (Grapholita dimorpha), bean cicada (Coleoptera pedunculidae), etc. Tortricidae, such as the grass moth (Leguminivora glycinivorella), the bean pea moth (Matsumuraeses azukivora), the smaller apple tortrix moth (Adoxophyes orana fasciata), the smaller tea tortrix moth (Adoxophyes honmai), the tea tortrix moth (Homona magnima), the common tortrix moth (Archips fuscocupreanus), the codling moth (Cydia pomonella), the sugar candy moth (Tetramoera schistaceana), the bean shoot borer (Epinotia aporema), the citrus fruit borer (Citripestis sagittiferella), and the European grape wine moth (Lobesia botrana); the Gracilariidae family, such as the tea leaf moth (Caloptilia theivora) and the golden leaf moth (Phyllonorycter ringoniella); the Carposinidae family, such as the peach fruit moth (Carposina sasakii); the Lyonetiidae family, such as the coffee leaf miner (Leucoptera coffeeella), the peach leafminer (Lyonetia clerkella) and the golden leafminer (Lyonetia prunifoliella); the Lymantriidae family, such as the gypsy moth (Lymantria dispar) and the Euproctis spp. such as the brown tussock moth (Euproctis pseudoconspersa); The family Plutellidae includes the diamondback moth (Plutella xylostella); the family Gelechiidae includes the peach leaf moth (Anarsia lineatella), the potato leaf moth (Helcystogramma triannulella), the red cotton moth (Pectinophora gossypiella), the potato tuber moth (Pthorimaea operculella), and the tomato leaf moth (Tuta absoluta); the family Arctiidae includes the fall webworm (Hyphantria cunea); the family Castniidae includes the giant sugarcane borer (Telchin licus); the family Cossidae includes the lesser cotton candy (Cossus insularis); the family Ascotis selenari Geometridae such as Parasa lepida; Limacodidae such as Stathmopoda masinissa; Sphingidae such as Acherontia lachesis; Sesiidae such as Nokona feralis, Synanthedon hector, and Synanthedon tenuis; Hesperiidae such as Parnara guttata; Tineidae such as Tinea translucens and Tineola bisselliella.

　総翅目(Thysanoptera)：ミカンキイロアザミウマ(Frankliniella occidentalis)、ミナミキイロアザミウマ(Thrips palmi)、チャノキイロアザミウマ(Scirtothrips dorsalis)、ネギアザミウマ(Thrips tabaci)、ヒラズハナアザミウマ(Frankliniella intonsa)、イネアザミウマ(Stenchaetothrips biformis)、モトジロアザミウマ(Echinothrips americanus)、アボカドスリプス（Scirtothrips perseae）等のアザミウマ科(Thripidae)；イネクダアザミウマ(Haplothrips aculeatus)等のクダアザミウマ科(Phlaeothripidae)。 Thysanoptera: Thripidae, such as Frankliniella occidentalis, Thrips palmi, Scirtothrips dorsalis, Thrips tabaci, Frankliniella intonsa, Stenchaetothrips biformis, Echinothrips americanus, Scirtothrips perseae; Phlaeothripidae, such as Haplothrips aculeatus.

　双翅目(Diptera)：タネバエ(Delia platura)、タマネギバエ(Delia antiqua)、テンサイモグリハナバエ(Pegomya cunicularia)等のハナバエ科(Anthomyiidae)；シュガービートルートマゴット(Tetanops myopaeformis)等のハネフリバエ科(Ulidiidae)；イネハモグリバエ(Agromyza oryzae)、トマトハモグリバエ(Liriomyza sativae)、マメハモグリバエ(Liriomyza trifolii)、ナモグリバエ(Chromatomyia horticola)等のハモグリバエ科(Agromyzidae)；イネキモグリバエ(Chlorops oryzae)等のキモグリバエ科(Chloropidae)；ウリミバエ(Bactrocera cucurbitae)、ミカンコミバエ(Bactrocera dorsalis)、ナスミバエ(Bactrocera latifrons)、オリーブミバエ(Bactrocera oleae)、クインスランドミバエ(Bactrocera tryoni)、チチュウカイミバエ(Ceratitis capitata)、アップルマゴット(Rhagoletis pomonella)、オウトウハマダラミバエ(Rhacochlaena japonica)等のミバエ科(Tephritidae)；イネヒメハモグリバエ(Hydrellia griseola)、トウヨウイネクキミギワバエ(Hydrellia philippina)、イネクキミギワバエ(Hydrellia sasakii)等のミギワバエ科(Ephydridae)；オウトウショウジョウバエ(Drosophila suzukii)、キイロショウジョウバエ（Drosophila melanogaster）等のショウジョウバエ科(Drosophilidae)；オオキモンノミバエ(Megaselia spiracularis)等のノミバエ科(Phoridae)；オオチョウバエ(Clogmia albipunctata)等のチョウバエ科(Psychodidae)；チビクロバネキノコバエ(Bradysia difformis)、ネギネクロバネキノコバエ(Bradysia odoriphaga)等のクロバネキノコバエ科(Sciaridae)；ヘシアンバエ(Mayetiola destructor)、イネノシントメタマバエ(Orseolia oryzae)等のタマバエ科(Cecidomyiidae)；Diopsis macrophthalma等のシュモクバエ科(Diopsidae)；Glossina palpalis、Glossina morsitans等のツェツェバエ科 (Glossinidae)；アシマダラブユ（Simulium japonicum）、Simulium damnosum等のブユ科(Simuliidae)；サシチョウバエ亜科(Phlebotominae)；キリウジガガンボ(Tipula aino)、コモンクレーンフライ(Tipula oleracea)、ヨーロピアンクレーンフライ(Tipula paludosa)等のガガンボ科(Tipulidae)；アカイエカ(Culex pipiens pallens)、コガタアカイエカ(Culex tritaeniorhynchus)、チカイエカ(Culex pipiens f. molestus)、ネッタイイエカ(Culex quinquefasciatus)、トビイロイエカ(Culex pipiens pipiens)、ニセシロハシイエカ(Culex vishnui)、ヒトスジシマカ(Aedes albopictus)、ネッタイシマカ(Aedes aegypti)、シナハマダラカ(Anopheles sinensis)、ガンビエハマダラカ(Anopheles gambiae)、ステフェンスハマダラカ(Anopheles stephensi)、Anopheles coluzzii、Anopheles albimanus、Anopheles sundaicus、Anopheles arabiensis、Anopheles funestus、Anopheles darlingi、Anopheles farauti、Anopheles minimus等のカ科(Culicidae)；キアシオオブユ(Prosimulium yezoensis)、ツメ卜ゲブユ(Simulium ornatum)等のブユ科(Simulidae)；ウシアブ(Tabanus trigonus)等のアブ科(Tabanidae)；イエバエ(Musca domestica)、オオイエバエ(Muscina stabulans)、サシバエ(Stomoxys calcitrans)、ノサシバエ(Haematobia irritans)等のイエバエ科(Muscidae)；クロバエ科(Calliphoridae)；ニクバエ科(Sarcophagidae)；オオユスリカ(Chironomus plumosus)、セスジユスリカ(Chironomus yoshimatsui)、ハイイロユスリカ(Glyptotendipes tokunagai)等のユスリカ科(Chironomidae)；ヒメイエバエ科(Fannidae)。 Diptera: Anthomyiidae such as Delia platura, Delia antiqua, Pegomyia cunicularia, etc.; Ulidiidae such as Tetanops myopaeformis, etc.; Agromyza oryzae, Liriomyza sativae, Liriomyza trifolii, Chromatomyia horticola, etc. Agromyzidae (Agromyzidae); Chloropidae (Chlorops oryzae), etc.; Bactrocera cucurbitae (Melon fly), Bactrocera dorsalis (Oriental fruit fly), Bactrocera latifrons (Eastern fruit fly), Bactrocera oleae (Olive fruit fly), Bactrocera tryoni (Queensland fruit fly), Ceratitis capitata (Mediterranean fruit fly), Rhagoletis pomonella (Apple maggot), Rhagoletis suzukii (Sugar apple fly), Rhagoletis japonica (Chrysocarpus japonica), Rhagoletis japonica (Rhagoletis ... Tephritidae, such as Hacochlaena japonica; Ephydridae, such as Hydrellia griseola, Hydrellia philippina, and Hydrellia sasakii; Drosophilidae, such as Drosophila suzukii and Drosophila melanogaster; Megaselia spiracularis ), Psychodidae, such as Clogmia albipunctata, Sciaridae, such as Bradysia difformis and Bradysia odoriphaga, Cecidomyiidae, such as Mayetiola destructor and Orseolia oryzae, Diopsidae, such as Diopsis macrophthalma, Glos Family Glossinidae, such as Glossina sina palpalis and Glossina morsitans; Family Simuliidae, such as Simulium japonicum and Simulium damnosum; Subfamily Phlebotominae; Family Tipulidae, such as Tipula aino, Common crane fly (Tipula oleracea), European crane fly (Tipula paludosa); Family Culex pipiens pallens, Culex tritaeniorhynchus, Culex pipiens pallens ... x tritaeniorhynchus, Culex pipiens f. molestus, Culex quinquefasciatus, Culex pipiens pipiens, Culex vishnui, Aedes albopictus, Aedes aegypti, Anopheles sinensis, Anopheles gambiae, Anopheles stephensi, Anop Culicidae (Anopheles heles coluzzii, Anopheles albimanus, Anopheles sundaicus, Anopheles arabiensis, Anopheles funestus, Anopheles darlingi, Anopheles farauti, Anopheles minimus, etc.); Simulidae (Prosimulium yezoensis, Simulium ornatum, etc.); Tabanidae (Tabanus trigonus, etc.); Musc Family Muscidae, such as Musca domestica, Muscina stabulans, Stomoxys calcitrans, and Haematobia irritans; Family Calliphoridae; Family Sarcophagidae; Family Chironomidae, such as Chironomus plumosus, Chironomus yoshimatsui, and Glyptotendipes tokunagai; Family Fannidae.

　鞘翅目(Coleoptera)：ダイアブロティカ属(Diabrotica spp.、例えば、ウエスタンコーンルートワーム(Diabrotica virgifera virgifera)、サザンコーンルートワーム(Diabrotica undecimpunctata howardi)、ノーザンコーンルートワーム(Diabrotica barberi)、メキシカンコーンルートワーム(Diabrotica virgifera zeae)、バンデッドキューカンバービートル(Diabrotica balteata)、キューカビットビートル(Diabrotica speciosa)等）、ビーンリーフビートル(Cerotoma trifurcata)、クビアカクビホソハムシ(Oulema melanopus)、ウリハムシ(Aulacophora femoralis)、キスジノミハムシ(Phyllotreta striolata)、キャベッジフリービートル(Phyllotreta cruciferae)、ウエスタンブラックフリービートル(Phyllotreta pusilla)、キャベッジステムフリービートル(Psylliodes chrysocephala)、ホップフリービートル(Psylliodes punctulata)、コロラドハムシ(Leptinotarsa decemlineata)、イネドロオイムシ(Oulema oryzae)、グレープコラスピス(Colaspis brunnea)、コーンフリービートル(Chaetocnema pulicaria)、サツマイモヒサゴトビハムシ(Chaetocnema confinis)、ポテトフリービートル(Epitrix cucumeris)、イネトゲハムシ(Dicladispa armigera)、サザンコーンリーフビートル(Myochrous denticollis)、ヨツモンカメノコハムシ(Laccoptera quadrimaculata)、タバコノミハムシ(Epitrix hirtipennis)、ダイコンサルハムシ(Phaedon brassicae)、フタスジヒメハムシ(Medythia nigrobilineata)等のハムシ科(Chrysomelidae)；シードコーンビートル(Stenolophus lecontei)、スレンダーシードコーンビートル(Clivina impressifrons)等のオサムシ科(Carabidae)；ドウガネブイブイ(Anomala cuprea)、ヒメコガネ(Anomala rufocuprea)、アオドウガネ(Anomala albopilosa)、マメコガネ(Popillia japonica)、ナガチャコガネ(Heptophylla picea)、ヨーロピアンチェーファー(Rhizotrogus majalis)、クロマルコガネ(Tomarus gibbosus)、クロコガネ属(Holotrichia spp.)、ジューン・ビートル(Phyllophaga crinita)等のフィロファガ属(Phyllophaga spp.)、Diloboderus abderus等のディロボデルス属(Diloboderus spp.)等のコガネムシ科(Scarabaeidae)；ワタミヒゲナガゾウムシ(Araecerus coffeae)等のヒゲナガゾウムシ科（Anthriibidae);アリモドキゾウムシ(Cylas formicarius)等のホソクチゾウムシ科(Aponidae)；ブラジルマメゾウムシ(Zabrotes subfasciatus)等のマメゾウムシ科(Bruchidae)；マツノキクイムシ(Tomicus piniperda)、コーヒーベリーボーラー(Hypothenemus hampei)等のキクイムシ科(Scolytidae)；イモゾウムシ(Euscepes postfasciatus)、アルファルファタコゾウムシ(Ｈypera postica)、コクゾウムシ(Sitophilus zeamais)、ココクゾウムシ(Sitophilus oryzae)、グラナリアコクゾウムシ(Sitophilus granarius)、イネゾウムシ(Echinocnemus squameus)、イネミズゾウムシ(Lissorhoptrus oryzophilus)、シロスジオサゾウムシ(Rhabdoscelus lineaticollis)、ワタミハナゾウムシ(Anthonomus grandis)、シバオサゾウムシ(Sphenophorus venatus)、サザンコーンビルバグ(Sphenophorus callosus)、ソイビーンストークウィービル(Sternechus subsignatus)、シュガーケーンウィービル(Sphenophorus levis)、サビヒョウタンゾウムシ(Scepticus griseus)、トビイロヒョウタンゾウムシ(Scepticus uniformis)、Aracanthus mourei等のAracanthus属(Aracanthus spp.)、コットンルートボーラー (Eutinobothrus brasiliensis)等のゾウムシ科(Curculionidae)；コクヌストモドキ(Tribolium castaneum)、ヒラタコクヌストモドキ(Tribolium confusum)、ガイマイゴミムシダマシ(Alphitobius diaperinus)等のゴミムシダマシ科(Tenebrionidae)；ニジュウヤホシテントウ(Epilachna vigintioctopunctata)等のテントウムシ科(Coccinellidae)；ヒラタキクイムシ(Lyctus brunneus)、コナナガシンクイ(Rhizopertha dominica)等のナガシンクイムシ科(Bostrychidae)；ヒョウホンムシ科(Ptinidae)；ゴマダラカミキリ(Anoplophora malasiaca)、Migdolus fryanus、クビアカツヤカミキリ（Aromia bungii）等のカミキリムシ科(Cerambycidae)；オキナワカンシャクシコメツキ(Melanotus okinawensis)、トビイロムナボソコメツキ(Agriotes fuscicollis)、クシコメツキ(Melanotus legatus)、アシブトコメツキ属(Anchastus spp.)、コノデルス属(Conoderus spp.)、クテニセラ属(Ctenicera spp.)、リモニウス属(Limonius spp.)、アエオルス属(Aeolus spp.)等のコメツキムシ科(Elateridae)；アオバアリガタハネカクシ(Paederus fuscipes)等のハネカクシ科(Staphylinidae)；ヒメマルカツオブシムシ(Anthrenus verbasci)、ハラジロカツオブシムシ(Dermestes maculates)、ヒメアカカツオブシムシ(Trogoderma granarium)等のカツオブシムシ科(Dermestidae)；タバコシバンムシ(Lasioderma serricorne)、ジンサンシバンムシ(Stegobium paniceum)等のシバンムシ科(Anobiidae)；アカチビヒラタムシ(Cryptolestes ferrugineus)等のチビヒラタムシ科(Laemophloeidae)；ノコギリヒラタムシ(Oryzaephilus surinamensis)等のホソヒラタムシ科(Silvanidae)、ブロッサムビートル（Brassicogethes aeneus）等のケシキスイムシ科（Nitidulidae）。 Coleoptera: Diabrotica spp. (e.g. Western corn rootworm (Diabrotica virgifera virgifera), Southern corn rootworm (Diabrotica undecimpunctata howardi), Northern corn rootworm (Diabrotica barberi), Mexican corn rootworm (Diabrotica virgifera zeae), Banded cucumber beetle (Diabrotica balteata), Cucumber beetle (Diabrotica speciosa), etc.), Bean leaf beetle (Cerotoma trifurcata), Red-necked leaf beetle (Oulema melanopus), Cucumber leaf beetle (Aulacophora femoralis), Striped flea beetle (Phyllotreta striolat a), cabbage free beetle (Phyllotreta cruciferae), western black free beetle (Phyllotreta pusilla), cabbage stem free beetle (Psylliodes chrysocephala), hop free beetle (Psylliodes punctulata), Colorado potato beetle (Leptinotarsa decemlineata), rice leaf beetle (Oulema oryzae), grape colaspis (Colaspis brunnea), corn free beetle (Chaetocnema pulicaria), sweet potato leaf beetle (Chaetocnema confinis), potato free beetle (Epitrix cucumeris), rice thorn beetle (Dicladispa armigera), southern corn leaf beetle (Myochrous denticollis), four-legged turtle The Chrysomelidae family includes the saw beetle (Laccoptera quadrimaculata), the tobacco flea beetle (Epitrix hirtipennis), the Chinese radish beetle (Phaedon brassicae), and the two-striped beetle (Medythia nigrobilineata); the Carabidae family includes the seed corn beetle (Stenolophus lecontei) and the slender seed corn beetle (Clivina impressifrons); the cuprea beetle (Anomala cuprea), the dung beetle (Anomala rufocuprea), the green beetle (Anomala albopilosa), the Japanese beetle (Popillia japonica), the long-legged beetle (Heptophylla picea), the European chafer (Rhizotrogus majalis), the black chafer (Tom arus gibbosus, Phyllophaga spp. such as the black scarab beetle (Holotrichia spp.), Phyllophaga spp. such as the June beetle (Phyllophaga crinita), Scarabaeidae such as Diloboderus spp. such as Diloboderus abderus; fungus weevils such as Araecerus coffeee Family Anthriibidae; Family Aponidae such as sweet potato weevil (Cylas formicarius); Family Bruchidae such as Brazilian bean weevil (Zabrotes subfasciatus); Family Scolytidae such as pine bark beetle (Tomicus piniperda) and coffee berry borer (Hypothenemus hampei); Family Scolytidae such as potato weevil (Hypothenemus hampei); Bug (Euscepes postfasciatus), Alfalfa weevil (Hypera postica), Maize weevil (Sitophilus zeamais), Rice weevil (Sitophilus oryzae), Granary maize weevil (Sitophilus granarius), Rice weevil (Echinocnemus squameus), Rice water weevil (Lissorhoptrus oryzophilus), White grain weevil (Rhabdoscelus lineaticollis), Boll weevil (Anthonomus grandis), Grass banded weevil (Sphenophorus venatus), Southern cornbill bug (Sphenophorus callosus), Soybean stalk weevil (Sternechus subsignatus), Sugar cane weevil (Sphenophorus levii). is, Aracanthus spp. such as the rust gourd weevil (Scepticus griseus), the brown gourd weevil (Scepticus uniformis), Aracanthus mourei, and the cotton root borer (Eutinobothrus brasiliensis); eum, Tribolium confusum, Alphitobius diaperinus and other Tenebrionidae; Epilachna vigintioctopunctata and other Coccinellidae; Lyctus brunneus, Rhizope rtha dominica; Ptinidae; Cerambycidae; Anoplophora malasiaca, Migdolus fryanus, Aromia bungii; Melanotus okinawensis, Brown-necked wire beetle; Elateridae, including Agriotes fuscicollis, Melanotus legatus, Anchastus spp., Conoderus spp., Ctenicera spp., Limonius spp., Aeolus spp., etc.; Paederus spp. fuscipes; Dermestidae; Lasioderma serricorne, Stegobium nigricans, Anthrenus verbasci, Dermestes maculates, Trogoderma granarium, Lasioderma serricorne, Stegobium paniceum and other Anobiidae; Cryptolestes ferrugineus and other Laemophloeidae; Oryzaephilus surinamensis and other Silvanidae; and Brassicogethes aeneus and other Blossom Beetles.

　直翅目(Orthoptera)：トノサマバッタ(Locusta migratoria)、モロッコトビバッタ(Dociostaurus maroccanus)、オーストラリアトビバッタ(Chortoicetes terminifera)、アカトビバッタ(Nomadacris septemfasciata)、ブラウンローカスト(Locustana pardalina)、ツリーローカスト(Anacridium melanorhodon)、イタリアンローカスト(Calliptamus italicus)、ディファレンシャルグラスホッパー(Melanoplus differentialis)、ツーストライプドグラスホッパー(Melanoplus bivittatus)、マイグレトリーグラスホッパー(Melanoplus sanguinipes)、レッドレッグドグラスホッパー(Melanoplus femurrubrum)、クリアウィングドグラスホッパー(Camnula pellucida)、サバクワタリバッタ(Schistocerca gregaria)、イエローウィングドローカスト(Gastrimargus musicus)、スパースローテッドローカスト(Austracris guttulosa)、コバネイナゴ(Oxya yezoensis)、ハネナガイナゴ(Oxya japonica)、タイワンツチイナゴ(Patanga succincta)等のバッタ科(Acrididae)；ケラ(Gryllotalpa orientalis)等のケラ科(Gryllotalpidae)；ヨーロッパイエコオロギ(Acheta domestica)、エンマコオロギ(Teleogryllus emma)等のコオロギ科(Gryllidae)；モルモンクリケット(Anabrus simplex)等のキリギリス科(Tettigoniidae)。 Orthoptera: Migratory grasshopper (Locusta migratoria), Moroccan grasshopper (Dociostaurus maroccanus), Australian grasshopper (Chortoicetes terminifera), Red grasshopper (Nomadacris septemfasciata), Brown locust (Locustana pardalina), Tree locust (Anacridium melanorhodon), Italian locust (Calliptamus italicus), Differential grasshopper (Melanoplus differentialis), Two-striped grasshopper (Melanoplus bivittatus), Migratory grasshopper (Melanoplus sanguinipes), Red-legged grasshopper (Melanoplus femurrubru) m), Clearwing Grasshopper (Camnula pellucida), Desert Locust (Schistocerca gregaria), Yellowwing Locust (Gastrimargus musicus), Sparse-throated Locust (Austracris guttulosa), Oriental Locust (Oxya yezoensis), Long-winged Locust (Oxya japonica), Formosan Ground Locust (Patanga succincta), and other grasshoppers (Acrididae); mole crickets (Gryllotalpidae) such as the mole cricket (Gryllotalpa orientalis); crickets (Gryllidae) such as the European house cricket (Acheta domestica) and the field cricket (Teleogryllus emma); and katydids (Tettigoniidae) such as the Mormon cricket (Anabrus simplex).

　膜翅目(Hymenoptera)：カブラハバチ(Athalia rosae)、ニホンカブラバチ(Athalia japonica)等のハバチ科(Tenthredinidae)；ヒアリ(Solenopsis invicta)、アカカミアリ(Solenopsis geminata)等のトフシアリ属(Solenopsis spp.)、ブラウンリーフカッティングアント(Atta capiguara)等のハキリアリ属(Atta spp.)、ヒメハキリアリ属(Acromyrmex spp.)、サシハリアリ(Paraponera clavata)、ルリアリ(Ochetellus glaber)、イエヒメアリ(Monomorium pharaonis)、アルゼンチンアリ(Linepithema humile)、クロヤマアリ(Formica japonica)、アミメアリ(Pristomyrmex punctutus)、オオズアリ(Pheidole noda)、ツヤオオズアリ(Pheidole megacephala)、クロオオアリ(Camponotus japonicus)、ムネアカオオアリ(Camponotus obscuripes)等のオオアリ属(Camponotus spp.)、オキシデンタリスシュウカクアリ(Pogonomyrmex occidentalis)等のシュウカクアリ属(Pogonomyrmex spp.)、コカミアリ(Wasmania auropunctata)等のコカミアリ属(Wasmania spp.)、アシナガキアリ(Anoplolepis gracilipes)等のアリ科(Formicidae)；オオスズメバチ(Vespa mandarinia)、ケブカスズメバチ(Vespa simillima)、コガタスズメバチ(Vespa analis)、ツマアカスズメバチ(Vespa velutina)、セグロアシナガバチ(Polistes jokahamae)等のスズメバチ科(Vespidae)；モミノオオキバチ(Urocerus gigas)等のキバチ科(Siricidae)；アリガタバチ科(Bethylidae)。 Hymenoptera: Tenthredinidae such as Athalia rosae and Athalia japonica; Solenopsis spp. such as Solenopsis invicta and Solenopsis geminata; Atta spp. such as Atta capiguara and Acrom yrmex spp.), Paraponera clavata, Ochetellus glaber, Monomorium pharaonis, Argentine ant (Linepithema humile), Formica japonica, Pristomyrmex punctutus, Pheidole noda, Pheidole megacephala, Camponotus spp., such as the Japanese camponotus (Camponotus japonicus), Camponotus spp., such as the red-breasted camponotus (Camponotus obscuripes), Pogonomyrmex spp., such as Pogonomyrmex occidentalis, Wasmania spp., such as Wasmania auropunctata, and Anoplolepis gracilipinas. es); Vespidae (Hornets) such as the giant hornet (Vespa mandarinia), the hairy hornet (Vespa simillima), the small hornet (Vespa analis), the red hornet (Vespa velutina), and the Japanese paper wasp (Polistes jokahamae); Siricidae (Wasps) such as the fir wasp (Urocerus gigas); and Bethylidae (Hornets).

　ゴキブリ目(Blattodea)：チャバネゴキブリ(Blattella germanica)等のチャバネゴキブリ科(Ectobiidae)；クロゴキブリ(Periplaneta fuliginosa)、ワモンゴキブリ(Periplaneta americana)、コワモンゴキブリ（Periplaneta australasiae）、トビイロゴキブリ(Periplaneta brunnea)、トウヨウゴキブリ(Blatta orientalis)等のゴキブリ科(Blattidae)；ヤマトシロアリ(Reticulitermes speratus)、イエシロアリ(Coptotermes formosanus)、アメリカカンザイシロアリ(Incisitermes minor)、ダイコクシロアリ(Cryptotermes domesticus)、タイワンシロアリ(Odontotermes formosanus)、コウシュンシロアリ(Neotermes koshunensis)、サツマシロアリ(Glyptotermes satsumensis)、ナカジマシロアリ(Glyptotermes nakajimai)、カタンシロアリ(Glyptotermes fuscus)、オオシロアリ(Hodotermopsis sjostedti)、コウシュウイエシロアリ(Coptotermes guangzhouensis)、アマミシロアリ(Reticulitermes amamianus)、ミヤタケシロアリ(Reticulitermes miyatakei)、カンモンシロアリ(Reticulitermes kanmonensis)、タカサゴシロアリ(Nasutitermes takasagoensis)、ニトベシロアリ(Pericapritermes nitobei)、ムシャシロアリ(Sinocapritermes mushae)、Cornitermes cumulans等のシロアリ科(Termitidae)。 　Order Blattodea: Family Ectobiidae, such as the German cockroach (Blattella germanica); Family Blattidae, such as the Siberian cockroach (Periplaneta fuliginosa), the American cockroach (Periplaneta americana), the American cockroach (Periplaneta australiae), the brown cockroach (Periplaneta brunnea), and the Asian cockroach (Blatta orientalis); Family Reticulitermes speratus, Formosan termite (Coptotermes formosanus), Formosan dry wood termite (Incisitermes minor), Formosan termite (Cryptotermes domesticus), Formosan termite (Odontotermes formosanus), and Formosan termite (Neotermes Termites of the family Termitidae, such as Glyptotermes satsumensis, Glyptotermes nakajimai, Glyptotermes fuscus, Hodotermopsis sjostedti, Coptotermes guangzhouensis, Reticulitermes amamianus, Reticulitermes miyatakei, Reticulitermes kanmonensis, Nasutitermes takasagoensis, Pericapritermes nitobei, Sinocapritermes mushae, and Cornitermes cumulans.

　ノミ目(Siphonaptera): ヒトノミ(Pulex irritans)、ネコノミ(Ctenocephalides felis)、イヌノミ(Ctenocephalides canis)、ケオプスネズミノミ(Xenopsylla cheopis) 、ニワトリノミ(Echidnophaga gallinacea)等のヒトノミ科（Pulicidae）；スナノミ(Tunga penetrans)等のスナノミ科（Hectopsyllidae）；ヨーロッパネズミノミ(Nosopsyllus fasciatus)等のナガノミ科（Ceratophyllidae）。 　Order Siphonaptera: Family Pulicidae such as the human flea (Pulex irritans), cat flea (Ctenocephalides felis), dog flea (Ctenocephalides canis), rat flea (Xenopsylla cheopis), chicken flea (Echidnophaga gallinacea), etc.; Family Hectopsyllidae such as the sand flea (Tunga penetrans); Family Ceratophyllidae such as the European rat flea (Nosopsyllus fasciatus).

　咀顎目(Psocodae)：アタマジラミ(Pediculus humanus capitis)等のヒトジラミ科（Pediculidae）；ケジラミ(Pthirus pubis)等のケジラミ科（Pthiridae）；ウシジラミ(Haematopinus eurysternus)、ブタジラミ(Haematopinus suis)等のケモノジラミ科（Haematopinidae）；ウシホソジラミ(Linognathus vituli)、ヒツジ体幹寄生ホソジラミ(Linognathus ovillus)、ケブカウシジラミ(Solenopotes capillatus)等のケモノホソジラミ科（Linognathidae）；ウシハジラミ(Bovicola bovis)、ヒツジジラミ(Bovicola ovis)、Bovicola breviceps、Damalinia forficula、ウェルネッキエラ属(Werneckiella spp.)等のボビコラ科（Bovicoliidae）；イヌハジラミ(Trichodectes canis)、ネコハジラミ(Felicola subrostratus)等のケモノハジラミ科（Trichodectidae）；ニワトリハジラミ(Menopon gallinae)、ニワトリオオハジラミ(Menacanthus stramineus)、トリノトン属(Trinoton spp.)等のタンカクハジラミ科（Menoponidae）；クミングシア属(Cummingsia spp.)等のケモノタンカクハジラミ科（Trimenoponidae）；コナチャタテ(Trogium pulsatorium)等のコチャタテ科(Trogiidae)；ウスグロチャタテ(Liposcelis corrodens)、ヒラタチャタテ(Liposcelis bostrychophila)、ソウメンチャタテ(Liposcelis pearmani)、カツブシチャタテ(Liposcelis entomophila)等のコナチャタテ科(Liposcelidae又はLiposcelididae)。 　Psocodae: Family Pediculidae such as head lice (Pediculus humanus capitis); Family Pthiridae such as pubic lice (Pthirus pubis); Family Haematopinidae such as cow lice (Haematopinus eurysternus) and pig lice (Haematopinus suis); Family Linognathus vituli, Sheep trunk lice Family Linognathidae, such as body lice (Linognathus ovillus) and cow lice (Solenopotes capillatus); Family Bovicoliidae, such as cow lice (Bovicola bovis), sheep lice (Bovicola ovis), Bovicola breviceps, Damalinia forficula, and Werneckiella spp.; Family Bovicoliidae, such as dog lice (T Family Trichodectidae, such as richodectes canis and Felicola subrostratus; Family Menoponidae, such as chicken lice (Menopon gallinae), chicken big lice (Menacanthus stramineus) and Trinoton spp.; Family Trinotonidae, such as Cummingsia spp. enoponidae); Trogiidae, such as Trogium pulsatorium; Liposcelidae or Liposcelididae, such as Liposcelis corrodens, Liposcelis bostrychophila, Liposcelis pearmani, and Liposcelis entomophila.

　シミ目(Thysanura):ヤマトシミ(Ctenolepisma villosa)、セイヨウシミ(Lepisma saccharina)等のシミ科(Lepismatidae)。 　Order Thysanura: Family Lepismatidae, including the Japanese silverfish (Ctenolepisma villosa) and the European silverfish (Lepisma saccharina).

　ダニ目(Acari)：ナミハダニ(Tetranychus urticae)、カンザワハダニ(Tetranychus kanzawai)、ミツユビナミハダニ(Tetranychus evansi)、ミカンハダニ(Panonychus citri)、リンゴハダニ(Panonychus ulmi)、オリゴニカス属(Oligonychus spp.)等のハダニ科(Tetranychidae)；ミカンサビダニ(Aculops pelekassi)、リュウキュウミカンサビダニ(Phyllocoptruta citri)、トマトサビダニ(Aculops lycopersici)、チャノサビダニ(Calacarus carinatus)、チャノナガサビダニ(Acaphylla theavagrans)、ニセナシサビダニ(Eriophyes chibaensis)、リンゴサビダニ(Aculus schlechtendali)、カキサビダニ(Aceria diospyri)、Aceria tosichella、シソサビダニ(Shevtchenkella sp.)等のフシダニ科(Eriophyidae)；チャノホコリダニ(Polyphagotarsonemus latus)等のホコリダニ科(Tarsonemidae)；ミナミヒメハダニ(Brevipalpus phoenicis)等のヒメハダニ科(Tenuipalpidae)；ケナガハダニ科(Tuckerellidae)；フタトゲチマダニ(Haemaphysalis longicornis)、キチマダニ(Haemaphysalis flava)、ヤマトマダニ(Haemaphysalis japonica)、ツリガネチマダニ(Haemaphysalis campanulata)、アメリカイヌカクマダニ(Dermacentor variabilis)、タイワンカクマダニ(Dermacentor taiwanensis)、ロッキーマウンテンウッドチック(Dermacentor andersoni)、アミメカクマダニ（Dermacentor reticulatus）、ヤマトマダニ(Ixodes ovatus)、シュルツマダニ(Ixodes persulcatus)、ブラックレッグドチック(Ixodes scapularis)、西部クロアシマダニ(Ixodes pacificus)、Ixodes holocyclus、Ixodes ricinus、ローンスターチック(Amblyomma americanum)、ガルフコーストチック(Amblyomma maculatum)、オウシマダニ(Rhipicephalus microplus)、キャトルチック(Rhipicephalus annulatus)、クリイロコイタマダニ(Rhipicephalus sanguineus)、Rhipicephalus appendiculatus、Rhipicephalus decoloratus等のマダニ科（Ixodidae）；ナガヒメダニ(Argas persicus)、Ornithodoros hermsi、Ornithodoros turicata等のヒメダニ科(Argasidae)；ケナガコナダニ(Tyrophagus putrescentiae)、ホウレンソウケナガコナダニ(Tyrophagus similis)等のコナダニ科(Acaridae)；コナヒョウヒダニ(Dermatophagoides farinae)、ヤケヒョウヒダニ(Dermatophagoides pteronyssinus)等のチリダニ科(Pyroglyphidae)；ホソツメダニ(Cheyletus eruditus)、クワガタツメダニ(Cheyletus malaccensis)、ミナミツメダニ(Chelacaropsis moorei)、イヌツメダニ(Cheyletiella yasguri)等のツメダニ科(Cheyletidae)；ヒツジキュウセンヒゼンダニ(Psoroptes ovis)、ウマキュウセンヒゼンダニ(Psoroptes equi)、Knemidocoptes mutans、ミミヒゼンダニ(Otodectes cynotis)、ショクヒヒゼンダニ属(Chorioptes spp.)等のキュウセン科(Psoroptidae)；ネコショウセンコウヒゼンダニ(Notoedres cati)、ネズミショウセンコウヒゼンダニ(Notoedres muris)、センコウヒゼンダニ(Sarcoptes scabiei)等のヒゼンダニ科(Sarcoptidae)；ウサギズツキダニ(Listrophorus gibbus)等のズツキダニ科(Listrophoridae)；ワクモ(Dermanyssus gallinae)等のサシダニ科(Dermanyssidae)；トリサシダニ(Ornithonyssus sylviarum)、イエダニ(Ornithonyssus bacoti)等のオオサシダニ科(Macronyssidae)；ミツバチヘギイタダニ(Varroa jacobsoni)等のヘギイタダニ科(Varroidae)；イヌニキビダニ(Demodex canis)、ネコニキビダニ(Demodex cati)等のニキビダニ科(Demodicidae)；アカツツガムシ(Leptotrombidium akamushi)、フトゲツツガムシ(Leptotrombidium pallidum)、タテツツガムシ(Leptotrombidium scutellare)等のツツガムシ科(Trombiculidae)。 　Acari: Tetranychus urticae, Tetranychus kanzawai, Tetranychus evansi, Panonychus citri, Panonychus ulmi, Oligonychus spp., etc.; Aculops pelekassi, Phyllocoptruta citri, Aculops lycopersici, Calaminella spp., etc. Eriophyidae, such as Acarus carinatus, Acaphylla theavagrans, Eriophyes chibaensis, Aculus schlechtendali, Aceria diospyri, Aceria tosichella, Shevtchenkella sp.; Tarsonemidae, such as Polyphagotarsonemus latus; Deutzia purpurea, such as Brevipalpus phoenicis. (Tenuipalpidae); Tuckerellidae; Haemaphysalis longicornis, Haemaphysalis flava, Haemaphysalis japonica, Haemaphysalis campanulata, Dermacentor variabilis, Dermacentor taiwanensis, Dermacentor andersoni, Dermacentor reticulatus), Ixodes ovatus, Ixodes persulcatus, Black-legged tick (Ixodes scapularis), Western black-legged tick (Ixodes pacificus), Ixodes holocyclus, Ixodes ricinus, Lone Star tick (Amblyomma americanum), Gulf Coast tick (Amblyomma maculatum), Bullfinch tick (Rhipicephalus microplus), Cattle tick (Rhipicephalus annulatus), Brown dog tick (Rhi Ixodidae, such as Rhipicephalus appendiculatus, Rhipicephalus decoloratus; Argasidae, such as Argas persicus, Ornithodoros hermsi, Ornithodoros turicata; Acaridae, such as Tyrophagus putrescentiae and Tyrophagus similis; Dermatophagoides farinae, burnt mites, Pyroglyphidae family, such as Dermatophagoides pteronyssinus; Cheyletidae family, such as Cheyletus eruditus, Cheyletus malaccensis, Chelacaropsis moorei, and Cheyletiella yasguri; Psoroptes ovis, Psoroptes equi, Knemidocoptes mutans, and Otodectes cy Psoroptidae such as Notoedres notis and Chorioptes spp.; Sarcoptidae such as Notoedres cati, Notoedres muris and Sarcoptes scabiei; Listrophoridae such as Listrophorus gibbus; Demanyssidae such as Dermanyssus gallinae; Ornithonyssus sylvia rum), and the Macronyssidae family, such as the house mite (Ornithonyssus bacoti); the Varroidae family, such as the Varroa jacobsoni mite; the Demodex canis family, such as the Demodex cati mite; the Trombiculidae family, such as the Leptotrombidium akamushi, Leptotrombidium pallidum, and Leptotrombidium scutellare mite.

　クモ目(Araneae)：カバキコマチグモ(Cheiracanthium japonicum)等のコマチグモ科(Eutichuridae)；セアカゴケグモ(Latrodectus hasseltii)等のヒメグモ科(Theridiidae)。
　オビヤスデ目(Polydesmida)：ヤケヤスデ(Oxidus gracilis)、アカヤスデ(Nedyopus tambanus)等のヤケヤスデ科(Paradoxosomatidae)。
　等脚目(Isopoda)：オカダンゴムシ(Armadillidium vulgare)等のオカダンゴムシ科(Armadillidiidae)。
　唇脚綱(Chilopoda)：ゲジ(Thereuonema hilgendorfi)等のゲジ科(Scutigeridae)；トビズムカデ(Scolopendra subspinipes)等のオオムカデ科(Scolopendridae)；イッスンムカデ(Bothropolys rugosus)等のイッスンムカデ科(Ethopolyidae)。
　腹足綱(Gastropoda)：チャコウラナメクジ(Limax marginatus)、キイロコウラナメクジ(Limax flavus)等のコウラナメクジ科(Limacidae)；ナメクジ(Meghimatium bilineatum)等のナメクジ科(Philomycidae)；スクミリンゴガイ(Pomacea canaliculata)等のリンゴガイ科(Ampullariidae)；ヒメモノアラガイ(Austropeplea ollula)等のモノアラガイ科(Lymnaeidae)。 Order Araneae: Family Eutichuridae such as Cheiracanthium japonicum; Family Theridiidae such as Latrodectus hasseltii.
Polydesmida: Paradoxosomatidae, including Oxidus gracilis, Nedyopus tambanus, etc.
Isopoda: Family Armadillidiidae, including Armadillidium vulgare.
Chilopoda: Scutigeridae such as Thereuonema hilgendorfi; Scolopendridae such as Scolopendra subspinipes; Ethopolyidae such as Bothropolys rugosus.
Class Gastropoda: Family Limacidae such as the brown slug (Limax marginatus) and the yellow slug (Limax flavus); Family Philomycidae such as the slug (Meghimatium bilineatum); Family Ampullariidae such as the apple snail (Pomacea canaliculata); Family Lymnaeidae such as the lymnae snail (Austropeplea ollula).

　線虫類(Nematoda)：イネシンガレセンチュウ(Aphelenchoides besseyi)等のアフェレンコイデス科(Aphelenchoididae)；ミナミネグサレセンチュウ(Pratylenchus coffeae)、Pratylenchus brachyurus、ムギネグサレセンチュウ(Pratylenchus neglectus)、Radopholus similis等のプラティレンクス科(Pratylenchidae)；ジャワネコブセンチュウ(Meloidogyne javanica)、サツマイモネコブセンチュウ(Meloidogyne incognita)、guava root-knot nematodes (Meloidogyne enterolobii)、キタネコブセンチュウ(Meloidogyne hapla)、ダイズシストセンチュウ(Heterodera glycines)、ジャガイモシストセンチュウ(Globodera rostochiensis)、ジャガイモシロシストセンチュウ(Globodera pallida)、コロンビアネコブセンチュウ(Meloidogyne chitwoodi)等のヘテロデラ科(Heteroderidae)；Rotylenchulus reniformis等のホプロライムス科(Hoplolaimidae)；イチゴメセンチュウ(Nothotylenchus acris)、ナミクキセンチュウ(Ditylenchus dipsaci)等のアングイナ科(Anguinidae)；ミカンネセンチュウ(Tylenchulus semipenetrans)等のティレンクルス科(Tylenchulidae)；ブドウオオハリセン(Xiphinema index)等のロンギドルス科(Longidoridae)；トリコドルス科(Trichodoridae)；マツノザイセンチュウ(Bursaphelenchus xylophilus)等のパラシタアフェレンクス科(Parasitaphelenchidae)。 Nematoda: Aphelenchoididae, such as Aphelenchoides besseyi; Pratylenchidae, such as Pratylenchus coffeee, Pratylenchus brachyurus, Pratylenchus neglectus, and Radopholus similis Java root-knot nematode (Meloidogyne javanica), sweet potato root-knot nematode (Meloidogyne incognita), guava root-knot nematodes (Meloidogyne enterolobii), northern root-knot nematode (Meloidogyne hapla), soybean cyst nematode (Heterodera glycines), potato cyst nematode (Globodera rostochien sis, Globodera pallida, Meloidogyne chitwoodi, etc. from the Heteroderidae; Rotylenchulus reniformis, etc. from the Hoplolaimidae; Nothotylenchus acris, Ditylenchus dipsaci, etc. from the Anguinidae Anguinidae; Tylenchulidae such as Tylenchulus semipenetrans; Longidoridae such as Xiphinema index; Trichodoridae; Parasitaphelenchidae such as Bursaphelenchus xylophilus.

　有害昆虫、有害ダニ類等の有害節足動物、有害軟体動物及び有害線虫は、殺虫剤、殺ダニ剤、殺軟体動物剤又は殺線虫剤に薬剤感受性の低下した、又は薬剤抵抗性の発達した有害昆虫、有害ダニ類等の有害節足動物、有害軟体動物及び有害線虫であってもよい。 The harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes may be harmful insects, harmful arthropods such as harmful mites, harmful mollusks, and harmful nematodes that have reduced sensitivity to insecticides, acaricides, molluscicides, or nematocides, or that have developed resistance to the insecticides, acaricides, molluscicides, or nematocides.

　本発明の有害節足動物防除方法としては、本発明化合物又は組成物Ａの有効量を、有害節足動物に直接、及び／又は、有害節足動物の生息場所（植物、土壌、家屋内、動物等）に施用することにより行われる。本発明の有害節足動物の防除方法としては、例えば、茎葉処理、土壌処理、根部処理、シャワー処理、燻煙処理、水面処理及び種子処理が挙げられる。 The method for controlling harmful arthropods of the present invention is carried out by applying an effective amount of the compound of the present invention or composition A directly to the harmful arthropods and/or to the habitat of the harmful arthropods (plants, soil, inside a house, animals, etc.). Examples of the method for controlling harmful arthropods of the present invention include foliage treatment, soil treatment, root treatment, shower treatment, fumigation treatment, water surface treatment and seed treatment.

　本発明化合物又は組成物Ａは、通常、固体担体、液体担体、ガス状担体等の不活化担体と界面活性剤等を混合し、必要に応じて結合剤、分散剤、安定剤等の製剤用補助剤を添加して、水性懸濁製剤、油性懸濁製剤、油剤、乳剤、エマルション製剤、マイクロエマルション製剤、マイクロカプセル製剤、水和剤、顆粒水和剤、粉剤、粒剤、錠剤、エアゾール剤、樹脂製剤等に製剤化して用いる。これらの製剤に限らず、Manual on development and use of FAO and WHO Specifications for pesticides, FAO Plant Production and Protection Papers-271～276, prepared by the FAO/WHO Joint Meeting on Pesticide Specifications, 2016, ISSN:0259-2517に記載の剤型に製剤化して用いることができる。
　これらの製剤には本発明化合物又は組成物Ａが重量比で通常０．０００１～９９％含有される。 The compound of the present invention or composition A is usually mixed with an inactivated carrier such as a solid carrier, a liquid carrier, or a gaseous carrier and a surfactant, and formulation auxiliary agents such as a binder, a dispersant, or a stabilizer are added as necessary to prepare an aqueous suspension preparation, an oil suspension preparation, an oil solution, an emulsion, an emulsion preparation, a microemulsion preparation, a microcapsule preparation, a wettable powder, a wettable granule, a dust, a granule, a tablet, an aerosol, a resin preparation, etc. It can be used by formulating it into a dosage form described in the Manual on development and use of FAO and WHO Specifications for pesticides, FAO Plant Production and Protection Papers-271 to 276, prepared by the FAO/WHO Joint Meeting on Pesticide Specifications, 2016, ISSN:0259-2517, without being limited to these formulations.
These preparations usually contain the compound of the present invention or composition A in an amount of 0.0001 to 99% by weight.

　固体担体としては、例えば、クレー（パイロフィライトクレー、カオリンクレー等）、タルク、炭酸カルシウム、珪藻土、ゼオライト、ベントナイト、酸性白土、アタパルジャイト、ホワイトカーボン、硫酸アンモニウム、バーミキュライト、パーライト、軽石、硅砂、化学肥料（硫安、燐安、硝安、尿素、塩安等）の微粉末及び粒状物、並びに樹脂（ポリエチレン、ポリプロピレン、ポリエステル、ポリウレタン、ポリアミド、ポリ塩化ビニル等）が挙げられる。 Solid carriers include, for example, clay (pyrophyllite clay, kaolin clay, etc.), talc, calcium carbonate, diatomaceous earth, zeolite, bentonite, acid clay, attapulgite, white carbon, ammonium sulfate, vermiculite, perlite, pumice, silica sand, fine powders and granules of chemical fertilizers (ammonium sulfate, ammonium phosphate, ammonium nitrate, urea, ammonium chloride, etc.), and resins (polyethylene, polypropylene, polyester, polyurethane, polyamide, polyvinyl chloride, etc.).

　液体担体としては、例えば、水、アルコール類（エタノール、シクロヘキサノール、ベンジルアルコール、プロピレングリコール、ポリエチレングリコール等）、ケトン類（アセトン、シクロヘキサノン等）、芳香族炭化水素（キシレン、フェニルキシリルエタン、メチルナフタレン等）、脂肪族炭化水素類（ヘキサン、シクロヘキサン等）、エステル類（酢酸エチル、オレイン酸メチル、炭酸プロピレン等）、ニトリル類（アセトニトリル等）、エーテル類（エチレングリコールジメチルエーテル等）、アミド類（Ｎ，Ｎ－ジメチルホルムアミド、Ｎ，Ｎ－ジメチルオクタンアミド等）、スルホキシド類（ジメチルスルホキシド等）、ラクタム類（Ｎ－メチルピロリドン、Ｎ－オクチルピロリドン等）、脂肪酸類（オレイン酸等）、植物油（大豆油等）が挙げられる。 Liquid carriers include, for example, water, alcohols (ethanol, cyclohexanol, benzyl alcohol, propylene glycol, polyethylene glycol, etc.), ketones (acetone, cyclohexanone, etc.), aromatic hydrocarbons (xylene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, etc.), esters (ethyl acetate, methyl oleate, propylene carbonate, etc.), nitriles (acetonitrile, etc.), ethers (ethylene glycol dimethyl ether, etc.), amides (N,N-dimethylformamide, N,N-dimethyloctanamide, etc.), sulfoxides (dimethyl sulfoxide, etc.), lactams (N-methylpyrrolidone, N-octylpyrrolidone, etc.), fatty acids (oleic acid, etc.), and vegetable oils (soybean oil, etc.).

　ガス状担体としては、例えば、フルオロカーボン、ブタンガス、ＬＰＧ（液化石油ガス）、ジメチルエーテル、窒素、及び炭酸ガスが挙げられる。 Gaseous carriers include, for example, fluorocarbons, butane gas, LPG (liquefied petroleum gas), dimethyl ether, nitrogen, and carbon dioxide.

　界面活性剤としては、例えば、非イオン界面活性剤（ポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルアリールエーテル、ポリエチレングリコール脂肪酸エステル等）及び陰イオン界面活性剤（アルキルスルホン酸塩、アルキルアリールスルホン酸塩、アルキル硫酸塩等）が挙げられる。 Surfactants include, for example, nonionic surfactants (polyoxyethylene alkyl ethers, polyoxyethylene alkylaryl ethers, polyethylene glycol fatty acid esters, etc.) and anionic surfactants (alkyl sulfonates, alkylaryl sulfonates, alkyl sulfates, etc.).

　その他の製剤用補助剤としては、結合剤、分散剤、着色剤及び安定剤等が挙げられ、具体的には例えば、多糖類（デンプン、アラビアガム、セルロース誘導体、アルギン酸等）、リグニン誘導体、合成水溶性高分子（ポリビニルアルコール、ポリビニルピロリドン、ポリアクリル酸類等）、酸性リン酸イソプロピル、及びジブチルヒドロキシトルエンが挙げられる。 Other formulation adjuvants include binders, dispersants, colorants, and stabilizers, and specific examples include polysaccharides (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin derivatives, synthetic water-soluble polymers (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acids, etc.), acid isopropyl phosphate, and dibutylhydroxytoluene.

　また、本発明化合物の持つ効力を高めたり補助したりする成分としてアジュバントを用いることができる。具体的には、Nimbus（登録商標）、Assist（登録商標）、Aureo（登録商標）、Iharol（登録商標）、Silwet L-77（登録商標）、BreakThru（登録商標）、SundanceII（登録商標）、Induce（登録商標）、Penetrator（登録商標）、AgriDex（登録商標）、Lutensol A8（登録商標）、NP-7（登録商標）、Triton（登録商標）、Nufilm（登録商標）、Emulgator NP7（登録商標）、Emulad（登録商標）、TRITON X 45（登録商標）、AGRAL 90（登録商標）、AGROTIN（登録商標）、ARPON（登録商標）、EnSpray N（登録商標）、及びBANOLE（登録商標）等が挙げられる。 Additionally, adjuvants can be used as components that enhance or support the efficacy of the compounds of the present invention. Specific examples include Nimbus (registered trademark), Assist (registered trademark), Aureo (registered trademark), Iharol (registered trademark), Silwet L-77 (registered trademark), BreakThru (registered trademark), SundanceII (registered trademark), Induce (registered trademark), Penetrator (registered trademark), AgriDex (registered trademark), Lutensol A8 (registered trademark), NP-7 (registered trademark), Triton (registered trademark), Nufilm (registered trademark), Emulgator NP7 (registered trademark), Emulad (registered trademark), TRITON X 45 (registered trademark), AGRAL 90 (registered trademark), AGROTIN (registered trademark), ARPON (registered trademark), EnSpray N (registered trademark), and BANOLE (registered trademark).

　本発明において、植物としては、植物全体、茎葉、花、穂、果実、樹幹、枝、樹冠、種子、栄養生殖器官及び苗が挙げられる。 In the present invention, plants include whole plants, stems and leaves, flowers, spikes, fruits, trunks, branches, crowns, seeds, vegetative reproductive organs, and seedlings.

　栄養生殖器官とは、植物の根、茎、葉等のうち、その部位を本体から切り離して土壌に設置した場合に、成長する能力を持つものを意味する。栄養生殖器官としては、例えば、塊根（tuberous root）、横走根（creeping root）、鱗茎（bulb）、球茎（corm又はsolid bulb）、塊茎（tuber）、根茎（rhizome）、匍匐枝（stolon）、担根体（rhizophore）、茎断片（cane cuttings）、むかご（propagule）及びつる（vine cutting）が挙げられる。なお、匍匐枝は、ランナー（runner）と呼ばれることもあり、むかごは、珠芽とも呼ばれ、肉芽（broad bud）、鱗芽（bulbil）に分けられる。つるとは、サツマイモやヤマノイモ等の苗条（葉及び茎の総称、shoot）を意味する。鱗茎、球茎、塊茎、根茎、茎断片、担根体又は塊根を総称して、球根とも呼ばれている。イモの栽培は塊茎を土壌に植え付けることで始めるが、用いられる塊茎は一般に種芋と呼ばれる。 A vegetative reproductive organ is a part of a plant, such as a root, stem, or leaf, that has the ability to grow when it is separated from the main body and placed in soil. Examples of vegetative reproductive organs include tuberous roots, creeping roots, bulbs, corms (or solid bulbs), tubers, rhizomes, stolons, rhizophores, cane cuttings, propagules, and vine cuttings. Stolons are sometimes called runners, and bulbils are also called bulbils and are divided into broad buds and bulbils. Vines refer to shoots (a collective term for leaves and stems) of sweet potatoes, Chinese yams, etc. Bulbs are a collective term for bulbs, corms, tubers, rhizomes, stem fragments, rhizophores, or tuberous roots. Potato cultivation begins with planting tubers in the soil, and the tubers used are generally called seed potatoes.

　本発明化合物又は組成物Ａの有効量を土壌に施用して有害節足動物を防除する方法としては、例えば、植物を植えつける前又は植えつけた後の土壌に本発明化合物又は組成物Ａの有効量を施用する方法が挙げられる。より具体的には、例えば、植穴処理（植穴散布、植穴処理土壌混和）、株元処理（株元散布、株元土壌混和、株元灌注、育苗期後半株元処理）、植溝処理（植溝散布、植溝土壌混和）、作条処理（作条散布、作条土壌混和、生育期作条散布）、播種時作条処理（播種時作条散布、播種時作条土壌混和）、全面処理（全面土壌散布、全面土壌混和）、側条処理、水面処理（水面施用、湛水後水面施用）、その他土壌散布処理（生育期粒剤葉面散布、樹冠下または主幹周辺散布、土壌表面散布、土壌表面混和、播穴散布、畦部地表面散布、株間散布）、その他灌注処理（土壌灌注、育苗期灌注、薬液注入処理、地際部灌注、薬液ドリップイリゲーション、ケミゲーション）、育苗箱処理（育苗箱散布、育苗箱灌注、育苗箱薬液湛水）、育苗トレイ処理（育苗トレイ散布、育苗トレイ灌注、育苗トレイ薬液湛水）、苗床処理（苗床散布、苗床灌注、水苗代苗床散布、苗浸漬）、床土混和処理（床土混和、播種前床土混和、播種時覆土前散布、播種時覆土後散布、覆土混和）、及びその他処理（培土混和、鋤き込み、表土混和、雨落ち部土壌混和、植位置処理、粒剤花房散布、ペースト肥料混和）が挙げられる。 An example of a method for controlling harmful arthropods by applying an effective amount of the compound of the present invention or composition A to soil is a method of applying an effective amount of the compound of the present invention or composition A to the soil before or after planting a plant. More specifically, for example, planting hole treatment (spraying in planting holes, mixing soil for planting hole treatment), plant base treatment (spraying at the plant base, mixing soil at the plant base, irrigation at the plant base, plant base treatment in the latter half of the seedling raising period), planting furrow treatment (spraying in planting furrow, mixing soil in planting furrow), crop row treatment (spraying in crop row, mixing soil in crop row, crop row spray during the growing season), crop row treatment at the time of sowing (crop row spraying at the time of sowing, mixing soil in crop row at the time of sowing), overall treatment (overall soil spray, overall soil mixing), side row treatment, water surface treatment (water surface application, water surface application after flooding), other soil spray treatments (foliar spraying of granules during the growing season, spraying under the tree crown or around the main trunk, soil surface spraying, soil surface mixing, seeding hole spraying, ridge ground surface spraying, inter-plant spraying), and so on. Other irrigation treatments include (soil irrigation, seedling irrigation, chemical injection treatment, ground level irrigation, chemical drip irrigation, chemigation), seedling box treatments (seedling box spraying, seedling box irrigation, seedling box flooding with chemicals), seedling tray treatments (seedling tray spraying, seedling tray irrigation, seedling tray flooding with chemicals), seedbed treatments (seedling bed spraying, seedling bed irrigation, water seedling bed spraying, seedling immersion), bed soil mixing treatments (bed soil mixing, bed soil mixing before sowing, spraying before soil cover at sowing, spraying after soil cover at sowing, soil cover mixing), and other treatments (mixing culture soil, plowing in, mixing topsoil, mixing soil from areas that have fallen off due to rain, planting position treatment, spraying granular inflorescences, mixing paste fertilizer).

　種子処理としては、例えば、種子又は栄養生殖器官への本発明化合物又は組成物Ａの処理が挙げられ、詳しくは、例えば、本発明化合物又は組成物Ａの懸濁液を霧状にして種子表面又は栄養生殖器官表面に吹きつける吹きつけ処理、本発明化合物又は組成物Ａを種子又は栄養生殖器官に塗布する塗沫処理、本発明化合物又は組成物Ａの薬液に一定時間種子又は栄養生殖器官を浸漬する浸漬処理、本発明化合物又は組成物Ａを含有する担体で種子又は栄養生殖器官をコートする方法（フィルムコート処理、ペレットコート処理等）が挙げられる。上記の栄養生殖器官としては、特に種芋が挙げられる。
　組成物Ａを種子又は栄養生殖器官に処理する場合、組成物Ａを１つの製剤として種子又は栄養生殖器官に処理することもできるし、組成物Ａを異なる複数の製剤として複数回に分けて種子又は栄養生殖器官に処理することもできる。組成物Ａを異なる複数の製剤として複数回に分けて処理する方法としては、例えば、有効成分として本発明化合物のみを含む製剤を処理し、種子又は栄養生殖器官を風乾させた後、本成分を含む製剤を処理する方法；及び、有効成分として本発明化合物及び本成分を含む製剤を処理し、種子又は栄養生殖器官を風乾させた後、処理済みの本成分以外の本成分を含む製剤を処理する方法、が挙げられる。
　本発明における本発明化合物又は組成物Ａを保持している種子又は栄養生殖器官とは、種子又は栄養生殖器官の表面に、本発明化合物又は組成物Ａが付着している状態のものを意味する。上記の本発明化合物又は組成物Ａを保持している種子又は栄養生殖器官は、種子又は栄養生殖器官へ本発明化合物又は組成物Ａが付着される前後に、本発明化合物又は組成物Ａ以外の資材が付着されていてもよい。
　また、組成物Ａが種子又は栄養生殖器官の表面に層となって付着している場合、該層は、１つの層又は複数の層からなる。また、複数の層からなる場合、各々の層は、１以上の有効成分を含んでいる層であるか、又は、１以上の有効成分を含んでいる層と有効成分を含んでいない層とからなる。
　本発明化合物又は組成物Ａを保持している種子又は栄養生殖器官は、例えば、本発明化合物又は組成物Ａを含む製剤を前記の種子処理の方法により、種子又は栄養生殖器官に施用することによって得ることができる。 Examples of seed treatment include treatment of seeds or vegetative reproductive organs with the compound of the present invention or composition A. More specifically, examples of the treatment include spraying treatment in which a suspension of the compound of the present invention or composition A is misted and sprayed onto the surface of a seed or vegetative reproductive organ, smearing treatment in which the compound of the present invention or composition A is applied to the seed or vegetative reproductive organ, immersion treatment in which the seed or vegetative reproductive organ is immersed in a liquid of the compound of the present invention or composition A for a certain period of time, and a method of coating the seed or vegetative reproductive organ with a carrier containing the compound of the present invention or composition A (film coating treatment, pellet coating treatment, etc.). The above-mentioned vegetative reproductive organ particularly includes seed potatoes.
When applying composition A to seeds or vegetative reproductive organs, composition A can be applied to the seeds or vegetative reproductive organs as one formulation, or composition A can be applied to the seeds or vegetative reproductive organs in multiple separate applications as different formulations. Examples of the method of applying composition A in multiple separate applications as different formulations include a method of applying a formulation containing only the compound of the present invention as an active ingredient, air-drying the seeds or vegetative reproductive organs, and then applying a formulation containing this component; and a method of applying a formulation containing the compound of the present invention and this component as active ingredients, air-drying the seeds or vegetative reproductive organs, and then applying a formulation containing this component other than the component that has already been applied.
In the present invention, the seed or vegetative reproductive organ carrying the compound of the present invention or composition A means a seed or vegetative reproductive organ having the compound of the present invention or composition A attached to its surface. The seed or vegetative reproductive organ carrying the compound of the present invention or composition A may have a material other than the compound of the present invention or composition A attached thereto before or after the compound of the present invention or composition A is attached to the seed or vegetative reproductive organ.
When composition A is attached to the surface of a seed or a vegetative reproductive organ in the form of a layer, the layer may consist of one or more layers. When the composition A consists of multiple layers, each layer may contain one or more active ingredients, or each layer may consist of a layer containing one or more active ingredients and a layer containing no active ingredients.
Seeds or vegetative reproductive organs carrying the compound of the present invention or composition A can be obtained, for example, by applying a formulation containing the compound of the present invention or composition A to the seeds or vegetative reproductive organs by the seed treatment methods described above.

　本発明化合物又は組成物Ａを農業分野の有害節足動物防除に用いる場合、その施用量は、１００００ｍ2あたりの本発明化合物の量で通常１～１００００ｇである。種子又は栄養生殖器官に処理する場合は、種子又は栄養生殖器官１Ｋｇに対して、本発明化合物の量が、通常０．００１～１００ｇの範囲で施用される。本発明化合物又は組成物Ａが乳剤、水和剤、フロアブル剤等に製剤化されている場合は、通常、有効成分濃度が０．０１～１００００ｐｐｍとなるように水で希釈して施用し、粒剤、粉剤等は、通常、そのまま施用する。 When the compound of the present invention or composition A is used for controlling harmful arthropods in the agricultural field, the application amount is usually 1 to 10,000 g of the compound of the present invention per 10,000 m2 . When treating seeds or vegetative reproductive organs, the compound of the present invention is usually applied in an amount of 0.001 to 100 g per 1 kg of seeds or vegetative reproductive organs. When the compound of the present invention or composition A is formulated as an emulsifiable concentrate, wettable powder, flowable agent, or the like, it is usually applied after diluting with water so that the active ingredient concentration is 0.01 to 10,000 ppm, and granules, dusts, and the like are usually applied as is.

　また、本発明化合物又は組成物Ａは、シート状やひも状に加工した樹脂製剤を作物に巻き付ける、作物近傍に張り渡す、株元土壌に敷く等の方法により処理することもできる。 The compound or composition A of the present invention can also be applied by wrapping the resin preparation in a sheet or string shape around the crop, stretching it near the crop, or spreading it on the soil around the base of the plant.

　本発明化合物又は組成物Ａを家屋内に生息する有害節足動物の防除に用いる場合、その施用量は、面上に処理する場合は処理面積１ｍ2あたりの本発明化合物の量で、通常、０．０１～１０００ｍｇであり、空間に処理する場合は処理空間１ｍ3あたりの本発明化合物の量で、通常、０．０１～５００ｍｇである。本発明化合物又は組成物Ａが乳剤、水和剤、フロアブル剤等に製剤化されている場合は、通常、有効成分濃度が０．１～１００００ｐｐｍとなるように水で希釈して施用し、油剤、エアゾール剤、燻煙剤、毒餌剤等はそのまま施用する。 When the compound of the present invention or composition A is used for controlling harmful arthropods living in houses, the application amount is usually 0.01 to 1000 mg of the compound of the present invention per 1 m2 of treatment area when applied on a surface, and usually 0.01 to 500 mg of the compound of the present invention per 1 m3 of treatment space when applied in a space. When the compound of the present invention or composition A is formulated as an emulsifiable concentrate, wettable powder, flowable agent, etc., it is usually applied after diluting with water so that the active ingredient concentration is 0.1 to 10000 ppm, and when it is an oil agent, aerosol agent, fumigation agent, poison bait, etc., it is applied as it is.

　本発明化合物又は組成物Ａをウシ、ウマ、ブタ、ヒツジ、ヤギ、ニワトリ等の家畜、イヌ、ネコ、ラット、マウス等の小動物の外部寄生虫防除に用いる場合は、獣医学的に公知の方法で動物に使用することができる。具体的な使用方法としては、全身抑制を目的にする場合には、例えば錠剤、飼料混入、坐薬、注射（筋肉内、皮下、静脈内、腹腔内等）により投与され、非全身的抑制を目的とする場合には、例えば油剤若しくは水性液剤を噴霧する、ポアオン処理若しくはスポットオン処理を行う、シャンプー製剤で動物を洗う又は樹脂製剤を首輪や耳札にして動物に付ける等の方法により用いられる。動物に投与する場合の本発明化合物又は組成物Ａの量は、通常、動物の体重１ｋｇに対して、０．１～１０００ｍｇの範囲である。 When the compound of the present invention or composition A is used for controlling external parasites in livestock such as cows, horses, pigs, sheep, goats, and chickens, and small animals such as dogs, cats, rats, and mice, it can be administered to animals by methods known in veterinary medicine. Specific methods of use include, for example, administration by tablet, inclusion in feed, suppository, or injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) for systemic inhibition, and for non-systemic inhibition, for example, spraying an oil or aqueous liquid, pour-on treatment, or spot-on treatment, washing the animal with a shampoo preparation, or attaching a resin preparation to the animal as a collar or ear tag. The amount of the compound of the present invention or composition A when administered to an animal is usually in the range of 0.1 to 1000 mg per 1 kg of the animal's body weight.

　本発明化合物又は組成物Ａは、畑、水田、芝生、果樹園等の農耕地における有害節足動物の防除剤として使用することができる。植物としては、例えば以下のものが挙げられる。 The compound of the present invention or composition A can be used as an agent for controlling harmful arthropods in agricultural land such as fields, paddy fields, lawns, orchards, etc. Examples of plants include the following.

　トウモロコシ（馬歯種、硬粒種、軟粒種、爆裂種、糯種、甘味種、フィールドコーン）、イネ（長粒種、短粒種、中粒種、ジャポニカ種、熱帯ジャポニカ種、インディカ種、ジャワニカ種、水稲、陸稲、浮稲、直播、移植、糯米）、コムギ（パンコムギ（硬質、軟質、中質、赤コムギ、白コムギ）、デュラムコムギ、スペルトコムギ、クラブコムギ、それぞれの冬コムギ型、春コムギ型）、オオムギ（二条オオムギ（＝ビールムギ）、六条オオムギ、ハダカムギ、もち麦、それぞれの冬オオムギ型、春オオムギ型）、ライムギ（冬ライムギ型、春ライムギ型）、トリティカーレ（冬トリティカーレ型、春トリティカーレ型）、エンバク（冬エンバク型、春エンバク型）、ソルガム、ワタ（アップランド種、ピマ種）、ダイズ（完熟種子収穫品種、枝豆品種、青刈り品種、それぞれの無限伸育型、有限伸育型、半有限伸育型）、ピーナッツ、ソバ、テンサイ（製糖用、飼料用、根菜、葉菜、燃料）、ナタネ（冬ナタネ型、春ナタネ型）、カノーラ（冬カノーラ型、春カノーラ型）、ヒマワリ（搾油用、食用、観賞用）、サトウキビ、タバコ、チャノキ、クワ、ナス科野菜（ナス、トマト、ピーマン、トウガラシ、ジャガイモ等）、ウリ科野菜（キュウリ、カボチャ、ズッキーニ、スイカ、メロン等）、アブラナ科野菜（ダイコン、カブ、セイヨウワサビ、コールラビ、ハクサイ、キャベツ、カラシナ、ブロッコリー、カリフラワー等）、キク科野菜（ゴボウ、シュンギク、アーティチョーク、レタス等）、ユリ科野菜（ネギ、タマネギ、ニンニク、アスパラガス等）、セリ科野菜（ニンジン、パセリ、セロリ、アメリカボウフウ等）、アカザ科野菜（ホウレンソウ、フダンソウ等）、シソ科野菜（シソ、ミント、バジル等）、イチゴ、サツマイモ、ヤマノイモ、サトイモ、仁果類（リンゴ、セイヨウナシ、ニホンナシ、チュウゴクナシ、カリン、マルメロ等）、核果類（モモ、スモモ、ネクタリン、ウメ、オウトウ、アンズ、プルーン等）、カンキツ類（ウンシュウミカン、オレンジ、レモン、ライム、グレープフルーツ等）、堅果類（クリ、クルミ、ハシバミ、アーモンド、ピスタチオ、カシューナッツ、マカダミアナッツ等）、液果類（ブルーベリー、クランベリー、ブラックベリー、ラズベリー等）、ブドウ、カキ、イチジク、オリーブ、ビワ、バナナ、コーヒー、ナツメヤシ、ココヤシ、観賞植物、森林植物、シバ類、牧草類。 　Corn (horse-tooth, hard, soft, bursting, glutinous, sweet, field corn), rice (long, short, medium, japonica, tropical japonica, indica, javanica, paddy, upland, floating, direct-seeded, transplanted, glutinous), wheat (bread wheat (hard, soft, medium, red, white), durum, spelt, club, each winter and spring type), barley (two-rowed barley (= beer barley), six-rowed barley, naked barley, waxy barley, each winter and spring type), rye (winter rye type, spring rye type) ), triticale (winter triticale type, spring triticale type), oats (winter oat type, spring oat type), sorghum, cotton (upland type, pima type), soybean (fully harvested varieties, edamame varieties, green-cut varieties, indeterminate, determinate, semi-determinate types), peanuts, buckwheat, sugar beet (sugar, animal feed, root, leafy, fuel), rapeseed (winter rapeseed type, spring rapeseed type), canola (winter canola type, spring canola type), sunflower (oil extraction, food, ornamental), sugarcane, tobacco, tea plant, mulberry, solanaceous vegetables (eggplant, tomato, bell pepper, chili pepper, potato) potatoes, etc.), Cucurbitaceae vegetables (cucumbers, pumpkins, zucchinis, watermelons, melons, etc.), Cruciferous vegetables (radishes, turnips, horseradish, kohlrabi, Chinese cabbage, cabbage, mustard, broccoli, cauliflower, etc.), Asteraceae vegetables (burdock, chrysanthemums, artichokes, lettuce, etc.), Liliaceae vegetables (leeks, onions, garlic, asparagus, etc.), Apiaceae vegetables (carrots, parsley, celery, parsley, etc.), Chenopodiaceae vegetables (spinach, Swiss chard, etc.), Lamiaceae vegetables (perilla, mint, basil, etc.), strawberries, sweet potatoes, Chinese yams, taro, pome fruits fruits (apples, European pears, Japanese pears, Chinese pears, quince, quince, etc.), stone fruits (peaches, plums, nectarines, plums, cherries, apricots, prunes, etc.), citrus fruits (Satsuma mandarins, oranges, lemons, limes, grapefruits, etc.), nuts (chestnuts, walnuts, hazels, almonds, pistachios, cashew nuts, macadamia nuts, etc.), berries (blueberries, cranberries, blackberries, raspberries, etc.), grapes, persimmons, figs, olives, loquats, bananas, coffee, dates, coconuts, ornamental plants, forest plants, turf grasses, pasture grasses.

　上記植物は、一般的に栽培される品種であれば特に限定はない。上記植物には、自然交配で作出しうる植物、突然変異により発生しうる植物、F1ハイブリッド植物、及び遺伝子組換え作物も含まれる。遺伝子組換え作物としては、例えばイソキサフルトール等のHPPD（４－ヒドロキシフェニルピルビン酸ジオキシゲナーゼ酵素）阻害剤、イマゼタピル、チフェンスルフロンメチル等のALS（アセト乳酸合成酵素）阻害剤、EPSP（５－エノールピルビルシキミ酸－３－リン酸合成酵素）阻害剤、グルタミン合成酵素阻害剤、PPO（プロトポルフィリノーゲン酸化酵素）阻害剤、ブロモキシニル、又はジカンバ等の除草剤に対する耐性が付与された植物；バチルス・チューリンゲンシス（Bacillus thuringiensis）などのバチルス属で知られている選択的毒素等を合成することが可能となった植物；有害昆虫由来の内在性遺伝子に部分的に一致する遺伝子断片等を合成し、標的有害昆虫体内でジーンサイレンシング（RNAi；RNA interference）を誘導することにより特異的な殺虫活性を付与することができる植物が挙げられる。 The above plants are not particularly limited as long as they are varieties that are commonly cultivated. The above plants also include plants that can be produced by natural crossbreeding, plants that can be generated by mutation, F1 hybrid plants, and genetically modified crops. Examples of genetically modified crops include plants that have been given resistance to herbicides such as HPPD (4-hydroxyphenylpyruvate dioxygenase enzyme) inhibitors such as isoxaflutole, ALS (acetolactate synthase) inhibitors such as imazethapyr and thifensulfuron methyl, EPSP (5-enolpyruvylshikimate-3-phosphate synthase) inhibitors, glutamine synthetase inhibitors, PPO (protoporphyrinogen oxidase) inhibitors, bromoxynil, or dicamba; plants that are able to synthesize selective toxins known from the Bacillus genus, such as Bacillus thuringiensis; and plants that can be given specific insecticidal activity by synthesizing gene fragments that partially match endogenous genes derived from harmful insects and inducing gene silencing (RNAi; RNA interference) in the target harmful insect body.

　以下、本発明を製造例、製剤例及び試験例等によりさらに詳しく説明するが、本発明はこれらの例のみに限定されるものではない。
　本明細書中、Meはメチル基を表し、Etはエチル基を表し、Bocはｔｅｒｔ－ブトキシカルボニル基を表し、Cbzはベンジルオキシカルボニル基を表す。 The present invention will be explained in more detail below with reference to Production Examples, Formulation Examples, Test Examples and the like, but the present invention is not limited to these examples.
In this specification, Me represents a methyl group, Et represents an ethyl group, Boc represents a tert-butoxycarbonyl group, and Cbz represents a benzyloxycarbonyl group.

　まず、本発明化合物及びその製造中間体の製造例を示す。 First, we will show examples of the production of the compound of the present invention and its production intermediates.

　化合物の物性値を液体クロマトグラフィー／質量分析（以下、ＬＣＭＳと記す）で測定した場合には、測定された分子イオン値［Ｍ＋Ｈ］+又は［Ｍ－Ｈ］-及び保持時間（以下、ＲＴと記す）を記す。液体クロマトグラフィー（以下、ＬＣと記す）及び質量分析（以下、ＭＳと記す）の条件は以下の通りである。 When the physical properties of the compound were measured by liquid chromatography/mass spectrometry (hereinafter referred to as LCMS), the measured molecular ion value [M+H] + or [M-H] - and retention time (hereinafter referred to as RT) are recorded. The conditions for liquid chromatography (hereinafter referred to as LC) and mass spectrometry (hereinafter referred to as MS) are as follows.

［ＬＣ条件］
カラム：Ｌ－ｃｏｌｕｍｎ２　ＯＤＳ、内径４．６ｍｍ、長さ３５ｍｍ、粒子径３μｍ（一般財団法人化学物質評価研究機構）
ＵＶ測定波長：２５２ｎｍ
移動相：Ａ液：０．１％ギ酸水溶液、Ｂ液：０．１％ギ酸アセトニトリル
流速：２．０ｍＬ／分
グラジエント条件：［表ＬＣ１］に記載の濃度勾配で送液する。 [LC conditions]
Column: L-column 2 ODS, inner diameter 4.6 mm, length 35 mm, particle size 3 μm (Chemicals Evaluation and Research Institute, Japan)
UV measurement wavelength: 252nm
Mobile phase: Solution A: 0.1% formic acid aqueous solution, Solution B: 0.1% formic acid acetonitrile Flow rate: 2.0 mL/min Gradient conditions: The solution was delivered at the concentration gradient shown in [Table LC1].

Figure JPOXMLDOC01-appb-T000071
Figure JPOXMLDOC01-appb-T000071

［ＭＳ条件］
検出器：ＬＣＭＳ－２０２０（島津製作所製）
イオン化法：ＤＵＩＳ法（ＥＳＩ、ＡＰＣＩ） [MS conditions]
Detector: LCMS-2020 (Shimadzu Corporation)
Ionization method: DUIS method (ESI, APCI)

参考製造例１
　特開２０１８－７６２３４号公報の実施例１－１に記載の方法に準じて製造した、ｔｅｒｔ-ブチル [（１Ｓ）－１－（５－アミノ－１Ｈ－ピラゾール－３－イル）エチル]（メチル）カルバマート０．５０ｇに、１，１，３，３－テトラメトキシプロパン０．４１ｇ及び酢酸８．３ｍＬを加え、加熱還流下で３時間攪拌した。反応液を室温まで放冷し、Ｎ－ヨードスクシンイミド０．４６ｇを加えて、さらに１６時間攪拌した。得られた混合物を氷冷した飽和炭酸水素ナトリウム水溶液へ注ぎ、クロロホルムを用いて抽出した。得られた有機層を飽和チオ硫酸ナトリウム水溶液、水、及び飽和食塩水により順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、濃縮した。
　得られた残渣に、２－トリブチルスタンニルピリミジン０．５２ｇ、テトラキストリフェニルホスフィンパラジウム０．１６ｇ、ヨウ化銅（Ｉ）０．０５ｇ、塩化リチウム０．０６ｇ及び１、４‐ジオキサン７．１ｍＬを加え、１００℃で１２時間攪拌した。得られた混合物を室温まで放冷し、水を加えてクロロホルムを用いて抽出した。得られた有機層を水、飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体１を０．１３ｇ得た。

Figure JPOXMLDOC01-appb-C000072
中間体１：1H-NMR (CDCl3) δ: 8.87(2H, d), 8.74(1H, d), 8.71(1H, dd), 7.11(1H, s), 6.93(1H, t), 6.51-6.40(1H, m), 2.84-2.67(3H, m), 1.65(3H, d), 1.40-1.33(9H, m). Reference Manufacturing Example 1
0.41 g of 1,1,3,3-tetramethoxypropane and 8.3 mL of acetic acid were added to 0.50 g of tert-butyl [(1S)-1-(5-amino-1H-pyrazol-3-yl)ethyl] (methyl)carbamate produced according to the method described in Example 1-1 of JP 2018-76234 A, and the mixture was stirred under heating and reflux for 3 hours. The reaction solution was allowed to cool to room temperature, and 0.46 g of N-iodosuccinimide was added and stirred for another 16 hours. The resulting mixture was poured into an ice-cooled saturated aqueous sodium hydrogen carbonate solution and extracted with chloroform. The resulting organic layer was washed successively with a saturated aqueous sodium thiosulfate solution, water, and saturated saline. The resulting organic layer was dried over sodium sulfate and concentrated.
To the resulting residue, 0.52 g of 2-tributylstannylpyrimidine, 0.16 g of tetrakistriphenylphosphine palladium, 0.05 g of copper (I) iodide, 0.06 g of lithium chloride, and 7.1 mL of 1,4-dioxane were added and stirred at 100°C for 12 hours. The resulting mixture was allowed to cool to room temperature, water was added, and extraction was performed using chloroform. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.13 g of intermediate 1 represented by the following formula.
Figure JPOXMLDOC01-appb-C000072
 Intermediate 1: 1 H-NMR (CDCl 3 ) δ: 8.87(2H, d), 8.74(1H, d), 8.71(1H, dd), 7.11(1H, s), 6.93(1H, t), 6.51-6.40(1H, m), 2.84-2.67(3H, m), 1.65(3H, d), 1.40-1.33(9H, m).

参考製造例２
　国際公開第２０１６／０２０７８６号のＥｘａｍｐｌｅ　５に記載の方法に準じて製造した３－ブロモイミダゾ［１，２－ｂ］ピリダジン－２－カルボン酸エチル２．７９ｇ及びＴＨＦ６．０ｍＬの混合物に、１ｍｏｌ／Ｌの水酸化ナトリウム水溶液１２.０ｍＬを加え、室温で２時間攪拌した。得られた混合物に氷冷下で１ｍｏｌ／Ｌの塩酸を加えて中和した後、析出した固体をろ取して、減圧下で乾燥し、次式で示される中間体２を２．４４ｇ得た。

Figure JPOXMLDOC01-appb-C000073
中間体２：1H-NMR (DMSO-D6) δ: 8.78 (1H, d), 8.26 (1H, d), 7.46-7.44 (1H, m). Reference Manufacturing Example 2
To a mixture of 2.79 g of ethyl 3-bromoimidazo[1,2-b]pyridazine-2-carboxylate produced according to the method described in Example 5 of WO 2016/020786 and 6.0 mL of THF, 12.0 mL of 1 mol/L aqueous sodium hydroxide solution was added and stirred at room temperature for 2 hours. The resulting mixture was neutralized by adding 1 mol/L hydrochloric acid under ice-cooling, and the precipitated solid was filtered and dried under reduced pressure to obtain 2.44 g of intermediate 2 represented by the following formula.
Figure JPOXMLDOC01-appb-C000073
 Intermediate 2: 1 H-NMR (DMSO-D 6 ) δ: 8.78 (1H, d), 8.26 (1H, d), 7.46-7.44 (1H, m).

参考製造例３
　０．５６ｇの中間体２及びＤＭＦ７．７ｍＬの混合物に、Ｎ，Ｎ－ジイソプロピルエチルアミン２．１ｍＬ、１－［ビス（ジメチルアミノ）メチレン］－１Ｈ－１，２，３－トリアゾロ［４，５－ｂ］ピリジニウム３－オキシドヘキサフルオロホスファート２．６４ｇ、及びＮ，Ｏ－ジメチルヒドロキシルアミン塩酸塩０．２９ｇを順次加え、室温で４時間攪拌した。得られた混合物に水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、中間体３を０．６３ｇ得た。

Figure JPOXMLDOC01-appb-C000074
中間体３：1H-NMR (CDCl3) δ: 8.53-8.52 (1H, m), 8.00-7.98 (1H, m), 7.20-7.17 (1H, m), 3.81 (3H, s), 3.48 (3H, s). Reference Manufacturing Example 3
To a mixture of 0.56 g of intermediate 2 and 7.7 mL of DMF, 2.1 mL of N,N-diisopropylethylamine, 2.64 g of 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate, and 0.29 g of N,O-dimethylhydroxylamine hydrochloride were added in that order, and the mixture was stirred at room temperature for 4 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated saline in that order. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.63 g of intermediate 3.
Figure JPOXMLDOC01-appb-C000074
 Intermediate 3: 1 H-NMR (CDCl 3 ) δ: 8.53-8.52 (1H, m), 8.00-7.98 (1H, m), 7.20-7.17 (1H, m), 3.81 (3H, s), 3.48 (3H, s).

参考製造例４
　０．５０ｇの中間体３、０．７１ｇの２－トリブチルスタンニルピリミジン、０．２１ｇのテトラキストリフェニルホスフィンパラジウム（０）、０．０７ｇのヨウ化銅（Ｉ）、０．０７ｇの塩化リチウム及び５．８ｍＬの１，４‐ジオキサンの混合物を１００℃で１８時間攪拌した。得られた混合物を室温まで放冷して減圧下で濃縮した後に、クロロホルムに溶解した。セライトろ過を行った後に、得られた溶液を減圧下で濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、中間体４を０．１３ｇ得た。

Figure JPOXMLDOC01-appb-C000075
中間体４：1H-NMR (CDCl3) δ: 8.90 (2H, d), 8.65 (1H, dd), 8.10 (1H, dd), 7.25-7.22 (2H, m), 3.55 (3H, s), 3.41 (3H, s). Reference Production Example 4
A mixture of 0.50 g of intermediate 3, 0.71 g of 2-tributylstannylpyrimidine, 0.21 g of tetrakistriphenylphosphinepalladium(0), 0.07 g of copper(I) iodide, 0.07 g of lithium chloride, and 5.8 mL of 1,4-dioxane was stirred at 100° C. for 18 hours. The resulting mixture was allowed to cool to room temperature, concentrated under reduced pressure, and then dissolved in chloroform. After filtration through Celite, the resulting solution was concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 0.13 g of intermediate 4.
Figure JPOXMLDOC01-appb-C000075
 Intermediate 4: 1 H-NMR (CDCl 3 ) δ: 8.90 (2H, d), 8.65 (1H, dd), 8.10 (1H, dd), 7.25-7.22 (2H, m), 3.55 (3H, s), 3.41 (3H, s).

参考製造例５
　０．１３ｇの中間体４及びＴＨＦ４．６ｍＬの混合物に、氷冷下でメチルマグネシウムクロリド（３．０ｍｏｌ／ＬのＴＨＦ溶液）０．２４ｍＬを加え、氷冷下で３時間攪拌した。得られた混合物に飽和塩化アンモニウム水溶液を加えてクロロホルムを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮し、中間体５を０．１１ｇ得た。

Figure JPOXMLDOC01-appb-C000076
中間体５：1H-NMR (CDCl3) δ: 8.99 (2H, d), 8.45 (1H, dd), 8.11 (1H, dd), 7.43 (1H, t), 7.21 (1H, dd), 2.74 (3H, s). Reference Production Example 5
To a mixture of 0.13 g of intermediate 4 and 4.6 mL of THF, 0.24 mL of methylmagnesium chloride (3.0 mol/L THF solution) was added under ice cooling, and the mixture was stirred for 3 hours under ice cooling. A saturated aqueous solution of ammonium chloride was added to the resulting mixture, and the mixture was extracted with chloroform. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated to obtain 0.11 g of intermediate 5.
Figure JPOXMLDOC01-appb-C000076
 Intermediate 5: 1 H-NMR (CDCl 3 ) δ: 8.99 (2H, d), 8.45 (1H, dd), 8.11 (1H, dd), 7.43 (1H, t), 7.21 (1H, dd), 2.74 (3H, s).

参考製造例６
　０．１１ｇの中間体５、０．３６ｇの酢酸アンモニウム、及び９．２ｍＬのメタノールの混合物を６５℃で２時間攪拌した。得られた混合物を室温まで放冷した後に、０．０８７ｇのシアノ水素化ホウ素ナトリウム及び０．１ｍＬの酢酸を加えて６５℃で２時間攪拌した。得られた混合物を室温まで放冷した後に、水及びクロロホルムを加えて抽出した。得られた水層に３ｍｏｌ／Ｌの水酸化ナトリウム水溶液を加えてｐＨ１２として、クロロホルムを用いて抽出した。得られた有機層を硫酸ナトリウムで乾燥した後に、ろ過して濃縮し、中間体６を０．０５８ｇ得た。

Figure JPOXMLDOC01-appb-C000077
中間体６：1H-NMR (CDCl3) δ: 8.96 (2H, d), 8.53 (1H, dd), 8.04 (1H, dd), 7.25 (1H, m), 7.17 (1H, dd), 4.81 (1H, m), 1.61 (3H, d). Reference Production Example 6
A mixture of 0.11 g of intermediate 5, 0.36 g of ammonium acetate, and 9.2 mL of methanol was stirred at 65° C. for 2 hours. The resulting mixture was allowed to cool to room temperature, and then 0.087 g of sodium cyanoborohydride and 0.1 mL of acetic acid were added and stirred at 65° C. for 2 hours. The resulting mixture was allowed to cool to room temperature, and then extracted with water and chloroform. A 3 mol/L aqueous solution of sodium hydroxide was added to the resulting aqueous layer to adjust the pH to 12, and the mixture was extracted with chloroform. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated to obtain 0.058 g of intermediate 6.
Figure JPOXMLDOC01-appb-C000077
 Intermediate 6: 1 H-NMR (CDCl 3 ) δ: 8.96 (2H, d), 8.53 (1H, dd), 8.04 (1H, dd), 7.25 (1H, m), 7.17 (1H, dd), 4.81 (1H, m), 1.61 (3H, d).

参考製造例７
　１．１２ｇの中間体５、１．２６ｍＬのチタン(IV)エトキシド及び３０ｍＬのメタノールの混合物に、１．４２ｍＬのメチルアミン（約４０％のメタノール溶液）を加え、４０℃で２時間撹拌した。得られた混合物を室温まで放冷した後に、０．１７５ｇの水素化ホウ素ナトリウムを加えて室温で２時間撹拌した。得られた混合物を氷水に注ぎこみ、酢酸エチルを加えて抽出した。得られた水層に１ｍｏｌ／Ｌの水酸化ナトリウム水溶液を加えてｐＨ１２として、クロロホルムを用いて抽出した。得られた有機層を硫酸ナトリウムで乾燥し、濃縮し、次式で示される中間体７を０．５７３ｇ得た。

Figure JPOXMLDOC01-appb-C000078
中間体７：1H-NMR (CDCl3) δ: 8.96 (2H, d), 8.55-8.52 (1H, m), 8.03 (1H, dd), 7.34 (1H, s), 7.25 (1H, t), 7.16 (1H, dd), 4.64 (1H, q), 2.29 (3H, s), 1.55 (3H, d). Reference Production Example 7
To a mixture of 1.12 g of intermediate 5, 1.26 mL of titanium (IV) ethoxide, and 30 mL of methanol, 1.42 mL of methylamine (about 40% methanol solution) was added and stirred at 40° C. for 2 hours. The resulting mixture was allowed to cool to room temperature, and then 0.175 g of sodium borohydride was added and stirred at room temperature for 2 hours. The resulting mixture was poured into ice water, and ethyl acetate was added for extraction. A 1 mol/L aqueous solution of sodium hydroxide was added to the resulting aqueous layer to adjust the pH to 12, and the mixture was extracted with chloroform. The resulting organic layer was dried over sodium sulfate and concentrated to obtain 0.573 g of intermediate 7 represented by the following formula.
Figure JPOXMLDOC01-appb-C000078
 Intermediate 7: 1 H-NMR (CDCl 3 ) δ: 8.96 (2H, d), 8.55-8.52 (1H, m), 8.03 (1H, dd), 7.34 (1H, s), 7.25 (1H, t), 7.16 (1H, dd), 4.64 (1H, q), 2.29 (3H, s), 1.55 (3H, d).

参考製造例８
　６．１１ｇのＮ，Ｏ－ジメチルヒドロキシルアミン塩酸塩及び１２０ｍＬのＴＨＦの混合物に、氷冷下で３５ｍＬのトリメチルアルミニウム（１５％のトルエン溶液）を滴下し、氷冷下で３０分間撹拌した。反応液に、４．００ｇのピラゾロ［１，５－ａ］ピリミジン－２－カルボン酸エチルとＴＨＦ３０ｍＬの混合物を加えて、室温まで昇温し、２時間撹拌した。得られた混合物を１ｍｏｌ/Ｌ塩酸に注ぎ、クロロホルムを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体８を１．５６ｇ得た。

Figure JPOXMLDOC01-appb-C000079
中間体８：1H-NMR (CDCl3) δ: 8.74-8.73 (1H, m), 8.56 (1H, dd), 7.19 (1H, d), 6.93 (1H, dd), 3.79 (3H, s), 3.49 (3H, s). Reference Production Example 8
To a mixture of 6.11 g of N,O-dimethylhydroxylamine hydrochloride and 120 mL of THF, 35 mL of trimethylaluminum (15% toluene solution) was added dropwise under ice cooling, and the mixture was stirred for 30 minutes under ice cooling. To the reaction solution, a mixture of 4.00 g of ethyl pyrazolo[1,5-a]pyrimidine-2-carboxylate and 30 mL of THF was added, and the mixture was warmed to room temperature and stirred for 2 hours. The resulting mixture was poured into 1 mol/L hydrochloric acid and extracted with chloroform. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 1.56 g of intermediate 8 represented by the following formula.
Figure JPOXMLDOC01-appb-C000079
 Intermediate 8: 1 H-NMR (CDCl 3 ) δ: 8.74-8.73 (1H, m), 8.56 (1H, dd), 7.19 (1H, d), 6.93 (1H, dd), 3.79 (3H, s), 3.49 (3H, s).

参考製造例９
　中間体４に代えて中間体８を使用し、参考製造例５に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000080
中間体９：1H-NMR (CDCl3) δ: 8.71-8.69 (1H, m), 8.57 (1H, dd), 7.20 (1H, m), 6.96 (1H, dd), 2.73 (3H, s). Reference Production Example 9
The compound prepared according to Reference Production Example 5 using Intermediate 8 instead of Intermediate 4 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000080
 Intermediate 9: 1 H-NMR (CDCl 3 ) δ: 8.71-8.69 (1H, m), 8.57 (1H, dd), 7.20 (1H, m), 6.96 (1H, dd), 2.73 (3H, s).

参考製造例１０
　中間体５に代えて中間体９を使用し、参考製造例６に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000081
中間体１０：1H-NMR (CDCl3) δ: 8.61-8.60 (1H, m), 8.44 (1H, dd), 6.77 (1H, dd), 6.61 (1H, s), 4.36 (1H, q), 1.55 (3H, d). Reference Production Example 10
The compound prepared according to Reference Production Example 6 using Intermediate 9 instead of Intermediate 5 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000081
 Intermediate 10: 1 H-NMR (CDCl 3 ) δ: 8.61-8.60 (1H, m), 8.44 (1H, dd), 6.77 (1H, dd), 6.61 (1H, s), 4.36 (1H, q), 1.55 (3H, d).

参考製造例１１
　０．０５８ｇの中間体１０及びＤＭＦ３．０ｍＬの混合物に、Ｎ，Ｎ－ジイソプロピルエチルアミン０．３２ｍＬ及び３，５－ビス（トリフルオロメチル）ベンゾイルクロリド０．０９９ｇを順次加え、室温で４時間攪拌した。得られた混合物に水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体１１を０．０５２ｇ得た。

Figure JPOXMLDOC01-appb-C000082
中間体１１：1H-NMR (CDCl3) δ: 8.65-8.63 (1H, m), 8.50 (1H, dd), 8.29 (2H, s), 8.02 (1H, s), 7.12-7.10 (1H, m), 6.84 (1H, dd), 6.66 (1H, s), 5.65-5.58 (1H, m), 1.75 (3H, d). Reference Production Example 11
To a mixture of 0.058 g of intermediate 10 and 3.0 mL of DMF, 0.32 mL of N,N-diisopropylethylamine and 0.099 g of 3,5-bis(trifluoromethyl)benzoyl chloride were added in that order, and the mixture was stirred at room temperature for 4 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated saline in that order. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.052 g of intermediate 11 represented by the following formula.
Figure JPOXMLDOC01-appb-C000082
 Intermediate 11: 1 H-NMR (CDCl 3 ) δ: 8.65-8.63 (1H, m), 8.50 (1H, dd), 8.29 (2H, s), 8.02 (1H, s), 7.12-7.10 (1H, m), 6.84 (1H, dd), 6.66 (1H, s), 5.65-5.58 (1H, m), 1.75 (3H, d).

参考製造例１２
　０．４８５ｇの中間体１１に、酢酸２．０ｍＬ、クロロホルム２．０ｍＬ及び０．３２５ｇのＮ－ヨードスクシンイミドを加え、室温で５時間撹拌した。得られた混合物に水を加え、クロロホルムを用いて抽出した。得られた有機層を飽和炭酸水素ナトリウム水溶液、飽和チオ硫酸ナトリウム水溶液、水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体１２を０．５００ｇ得た。

Figure JPOXMLDOC01-appb-C000083
中間体１２：1H-NMR (CDCl3) δ: 8.63 (1H, dd), 8.59 (1H, dd), 8.30 (2H, s), 8.03 (1H, s), 7.20 (1H, d), 6.92 (1H, dd), 5.68-5.60 (1H, m), 1.73 (3H, d). Reference Manufacturing Example 12
2.0 mL of acetic acid, 2.0 mL of chloroform, and 0.325 g of N-iodosuccinimide were added to 0.485 g of intermediate 11, and the mixture was stirred at room temperature for 5 hours. Water was added to the resulting mixture, and the mixture was extracted with chloroform. The resulting organic layer was washed successively with a saturated aqueous solution of sodium hydrogen carbonate, a saturated aqueous solution of sodium thiosulfate, water, and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.500 g of intermediate 12 represented by the following formula.
Figure JPOXMLDOC01-appb-C000083
 Intermediate 12: 1 H-NMR (CDCl 3 ) δ: 8.63 (1H, dd), 8.59 (1H, dd), 8.30 (2H, s), 8.03 (1H, s), 7.20 (1H, d), 6.92 (1H, dd), 5.68-5.60 (1H, m), 1.73 (3H, d).

参考製造例１３－１
　１８．７ｇのシアノ酢酸に、２９３ｍＬのアセトニトリル、６１．３ｍＬのトリエチルアミン及び５５．９ｇの塩化マグネシウムを順次加え、室温で２３時間撹拌して混合物Ａを得た。３４．８ｇのＮ－メチル－Ｎ－(フェニルメトキシカルボニル) －Ｌ－アラニン及び２００ｍＬのＴＨＦの混合物に、２８．５ｇの１，１´－カルボニルジイミダゾール、３．５８ｇの４－ジメチルアミノピリジンを順次加え、室温で４時間撹拌して混合物Ｂを得た。混合物Ａに混合物Ｂを滴下し、室温で４４時間撹拌した。得られた混合物に１ｍｏｌ/Ｌ塩酸を加え、酢酸エチルを用いて抽出した。得られた有機層を水、飽和炭酸水素ナトリウム水溶液、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮し、次式で示される中間体１３－１を２７．８ｇ得た。

Figure JPOXMLDOC01-appb-C000084
中間体１３－１：：ＬＣＭＳ：２５９［Ｍ－Ｈ］―、ＲＴ＝１．６５分 Reference Manufacturing Example 13-1
293 mL of acetonitrile, 61.3 mL of triethylamine, and 55.9 g of magnesium chloride were added to 18.7 g of cyanoacetic acid in this order, and the mixture was stirred at room temperature for 23 hours to obtain mixture A. 28.5 g of 1,1'-carbonyldiimidazole and 3.58 g of 4-dimethylaminopyridine were added to a mixture of 34.8 g of N-methyl-N-(phenylmethoxycarbonyl)-L-alanine and 200 mL of THF in this order, and the mixture was stirred at room temperature for 4 hours to obtain mixture B. Mixture B was added dropwise to mixture A, and the mixture was stirred at room temperature for 44 hours. 1 mol/L hydrochloric acid was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was washed successively with water, a saturated aqueous solution of sodium bicarbonate, and a saturated aqueous solution of sodium chloride. The obtained organic layer was dried over sodium sulfate, filtered, and concentrated to obtain 27.8 g of intermediate 13-1 represented by the following formula.
Figure JPOXMLDOC01-appb-C000084
 Intermediate 13-1::LCMS:259 [MH] - , RT = 1.65 min

参考製造例１３－２
　２２．８ｇの中間体１３－１を、１７５ｍＬのエタノール、１７５ｍＬの酢酸及び１２．８ｍＬのヒドラジン一水和物の混合物に加え、室温で４時間撹拌した。得られた混合物に水を加え、クロロホルムを用いて抽出した。得られた有機層を飽和炭酸水素ナトリウム水溶液、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮し、次式で示される中間体１３－２を２２．０ｇ得た。

Figure JPOXMLDOC01-appb-C000085
中間体１３－２：ＬＣＭＳ：２７５［Ｍ＋Ｈ］+、ＲＴ＝１．１７分 Reference Manufacturing Example 13-2
22.8 g of intermediate 13-1 was added to a mixture of 175 mL of ethanol, 175 mL of acetic acid, and 12.8 mL of hydrazine monohydrate, and stirred at room temperature for 4 hours. Water was added to the resulting mixture, and the mixture was extracted with chloroform. The resulting organic layer was washed successively with a saturated aqueous solution of sodium bicarbonate and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated to obtain 22.0 g of intermediate 13-2 represented by the following formula.
Figure JPOXMLDOC01-appb-C000085
 Intermediate 13-2: LCMS: 275 [M+H] + , RT = 1.17 min

参考製造例１４
　２２．０ｇの中間体１３、１５.８ｍＬの１，１，３，３－テトラメトキシプロパン及び４０．１ｍLの酢酸の混合物を９０℃で５時間撹拌した。得られた混合物を室温まで放冷して濃縮し、残渣に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルを用いて抽出した。得られた有機層を飽和食塩水洗浄し、硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体１４を１１．６ｇ得た。

Figure JPOXMLDOC01-appb-C000086
中間体１４：1H-NMR (CDCl3) δ: 8.64-8.62 (1H, m), 8.45 (1H, dd), 7.41-7.33 (5H, m), 6.78 (1H, dd), 6.58-6.53 (1H, m), 5.81-5.67 (1H, m), 5.25-5.17 (2H, m), 2.79 (3H, s), 1.64 (3H, d). Reference Production Example 14
A mixture of 22.0 g of intermediate 13, 15.8 mL of 1,1,3,3-tetramethoxypropane, and 40.1 mL of acetic acid was stirred at 90° C. for 5 hours. The resulting mixture was allowed to cool to room temperature and concentrated, and a saturated aqueous solution of sodium hydrogen carbonate was added to the residue, followed by extraction with ethyl acetate. The resulting organic layer was washed with saturated saline, dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 11.6 g of intermediate 14 represented by the following formula.
Figure JPOXMLDOC01-appb-C000086
 Intermediate 14: 1 H-NMR (CDCl 3 ) δ: 8.64-8.62 (1H, m), 8.45 (1H, dd), 7.41-7.33 (5H, m), 6.78 (1H, dd), 6.58-6.53 (1H, m), 5.81-5.67 (1H, m), 5.25-5.17 (2H, m), 2.79 (3H, s), 1.64 (3H, d).

参考製造例１５
　６．３０ｇの中間体１４に、クロロホルム２０ｍＬ及び４．８０ｇのＮ－ヨードスクシンイミドを加え、室温で６時間撹拌した。得られた混合物に水を加え、クロロホルムを用いて抽出した。得られた有機層を飽和炭酸水素ナトリウム水溶液、飽和チオ硫酸ナトリウム水溶液、水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体１５を６．６１ｇ得た。

Figure JPOXMLDOC01-appb-C000087
中間体１５：1H-NMR (CDCl3) δ: 8.61-8.59 (1H, m), 8.54 (1H, dd), 7.42-7.30 (5H, m), 6.85 (1H, dd), 5.80-5.61 (1H, m), 5.25-5.23 (2H, m), 2.75-2.69 (3H, m), 1.65 (3H, d). Reference Production Example 15
20 mL of chloroform and 4.80 g of N-iodosuccinimide were added to 6.30 g of intermediate 14, and the mixture was stirred at room temperature for 6 hours. Water was added to the resulting mixture, and the mixture was extracted with chloroform. The resulting organic layer was washed successively with a saturated aqueous solution of sodium hydrogen carbonate, a saturated aqueous solution of sodium thiosulfate, water, and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 6.61 g of intermediate 15 represented by the following formula.
Figure JPOXMLDOC01-appb-C000087
 Intermediate 15: 1 H-NMR (CDCl 3 ) δ: 8.61-8.59 (1H, m), 8.54 (1H, dd), 7.42-7.30 (5H, m), 6.85 (1H, dd), 5.80-5.61 (1H, m), 5.25-5.23 (2H, m), 2.75-2.69 (3H, m), 1.65 (3H, d).

参考製造例１６
　中間体３に代えて中間体１５を使用し、参考製造例４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000088
中間体１６：1H-NMR (CDCl3) δ: 8.75-8.74 (1H, m), 8.69-8.64 (3H, m), 7.33-7.31 (5H, m), 6.99 (1H, t), 6.95-6.93 (1H, m), 6.58-6.53 (1H, m), 5.12-5.09 (2H, m), 2.81-2.76 (3H, m), 1.68 (3H, d). Reference Production Example 16
The compound prepared according to Reference Production Example 4 using Intermediate 15 instead of Intermediate 3 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000088
 Intermediate 16: 1 H-NMR (CDCl 3 ) δ: 8.75-8.74 (1H, m), 8.69-8.64 (3H, m), 7.33-7.31 (5H, m), 6.99 (1H, t), 6.95-6.93 (1H, m), 6.58-6.53 (1H, m), 5.12-5.09 (2H, m), 2.81-2.76 (3H, m), 1.68 (3H, d).

参考製造例１７
　０．４４ｇの中間体１６にトリフルオロ酢酸を５ｍＬ加え、７０℃で３時間撹拌した。反応液を室温まで放冷し、濃縮した。残渣に１ｍｏｌ/Ｌの塩酸を加え、メチルｔｅｒｔ－ブチルエーテルで抽出した。得られた水層に１ｍｏｌ／Ｌの水酸化ナトリウム水溶液を加えてｐＨ１０として、クロロホルムを用いて抽出した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮し、次式で示される中間体１７を０．２２６ｇ得た。

Figure JPOXMLDOC01-appb-C000089
中間体１７：1H-NMR (CDCl3) δ: 8.89 (2H, d), 8.77-8.76 (1H, m), 8.73-8.71 (1H, m), 7.14 (1H, t), 6.94 (1H, dd), 4.72 (1H, q), 2.36 (3H, s), 1.55 (3H, d). Reference Production Example 17
5 mL of trifluoroacetic acid was added to 0.44 g of intermediate 16, and the mixture was stirred at 70° C. for 3 hours. The reaction solution was allowed to cool to room temperature and concentrated. 1 mol/L of hydrochloric acid was added to the residue, and the mixture was extracted with methyl tert-butyl ether. 1 mol/L of aqueous sodium hydroxide solution was added to the obtained aqueous layer to adjust the pH to 10, and the mixture was extracted with chloroform. The obtained organic layer was dried over sodium sulfate, filtered, and concentrated to obtain 0.226 g of intermediate 17 represented by the following formula.
Figure JPOXMLDOC01-appb-C000089
 Intermediate 17: 1 H-NMR (CDCl 3 ) δ: 8.89 (2H, d), 8.77-8.76 (1H, m), 8.73-8.71 (1H, m), 7.14 (1H, t), 6.94 (1H, dd), 4.72 (1H, q), 2.36 (3H, s), 1.55 (3H, d).

参考製造例１８
　１，１，３，３－テトラメトキシプロパンに代えてアセチルアセトンを使用し、参考製造例１４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000090
中間体１８：1H-NMR (CDCl3) δ: 7.39-7.31 (5H, m), 6.52 (1H, s), 6.41 (1H, s), 5.78-5.65 (1H, m), 5.21 (2H, s), 2.79 (3H, s), 2.70 (3H, s), 2.54 (3H, s), 1.62 (3H, d). Reference Production Example 18
The compound and its physical properties produced according to Reference Production Example 14 are shown below, except that acetylacetone was used instead of 1,1,3,3-tetramethoxypropane.
Figure JPOXMLDOC01-appb-C000090
 Intermediate 18: 1 H-NMR (CDCl 3 ) δ: 7.39-7.31 (5H, m), 6.52 (1H, s), 6.41 (1H, s), 5.78-5.65 (1H, m), 5.21 (2H, s), 2.79 (3H, s), 2.70 (3H, s), 2.54 (3H, s), 1.62 (3H, d).

参考製造例１９
　１，１，３，３－テトラメトキシプロパンに代えて２－クロロマロンアルデヒドを使用し、参考製造例１４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000091
中間体１９：1H-NMR (CDCl3) δ: 8.67-8.65 (1H, m), 8.39 (1H, d), 7.39-7.34 (5H, m), 6.61-6.55 (1H, m), 5.79-5.63 (1H, m), 5.21 (2H, s), 2.79-2.77 (3H, m), 1.62 (3H, d). Reference Production Example 19
The compound and its physical properties are shown below, which were produced according to Reference Production Example 14, except that 2-chloromalonaldehyde was used instead of 1,1,3,3-tetramethoxypropane.
Figure JPOXMLDOC01-appb-C000091
 Intermediate 19: 1 H-NMR (CDCl 3 ) δ: 8.67-8.65 (1H, m), 8.39 (1H, d), 7.39-7.34 (5H, m), 6.61-6.55 (1H, m), 5.79-5.63 (1H, m), 5.21 (2H, s), 2.79-2.77 (3H, m), 1.62 (3H, d).

参考製造例２０
　１，１，３，３－テトラメトキシプロパンに代えて１，１，３，３－テトラエトキシ－２－メチルプロパンを使用し、参考製造例１４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000092
中間体２０：1H-NMR (CDCl3) δ: 8.42 (1H, s), 8.33 (1H, d), 7.39-7.32 (5H, m), 6.52-6.47 (1H, m), 5.77-5.70 (1H, m), 5.21 (2H, s), 2.77 (3H, s), 2.36 (3H, s), 1.62 (3H, d). Reference Production Example 20
A compound produced according to Reference Production Example 14 using 1,1,3,3-tetraethoxy-2-methylpropane instead of 1,1,3,3-tetramethoxypropane and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000092
 Intermediate 20: 1 H-NMR (CDCl 3 ) δ: 8.42 (1H, s), 8.33 (1H, d), 7.39-7.32 (5H, m), 6.52-6.47 (1H, m), 5.77-5.70 (1H, m), 5.21 (2H, s), 2.77 (3H, s), 2.36 (3H, s), 1.62 (3H, d).

参考製造例２１
　１，１，３，３－テトラメトキシプロパンに代えて１－ジメチルアミノ－１－ブテン－３－オンを使用し、参考製造例１４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000093
中間体２１：1H-NMR (CDCl3) δ: 8.34 (1H, d), 7.37-7.32 (5H, m), 6.65-6.64 (1H, m), 6.56-6.52 (1H, m), 5.81-5.68 (1H, m), 5.21 (2H, s), 2.82-2.80 (3H, m), 2.75 (3H, s), 1.64 (3H, d). Reference Production Example 21
Compounds prepared according to Reference Production Example 14 using 1-dimethylamino-1-buten-3-one instead of 1,1,3,3-tetramethoxypropane and their physical properties are shown below.
Figure JPOXMLDOC01-appb-C000093
 Intermediate 21: 1 H-NMR (CDCl 3 ) δ: 8.34 (1H, d), 7.37-7.32 (5H, m), 6.65-6.64 (1H, m), 6.56-6.52 (1H, m), 5.81-5.68 (1H, m), 5.21 (2H, s), 2.82-2.80 (3H, m), 2.75 (3H, s), 1.64 (3H, d).

参考製造例２２
　中間体１４に代えて中間体１８、中間体１９、中間体２０又は中間体２１を使用し、参考製造例１５に準じて製造した化合物及びその物性値を以下に示す。
　式（Ｂ－１）

Figure JPOXMLDOC01-appb-C000094
で示される化合物において、Ｒ3q1、Ｒ3q2及びＲ3q3の組合せが［表Ｂ－１］に記載のいずれかの組合せである化合物。 Reference Production Example 22
Compounds produced according to Reference Production Example 15 using Intermediate 18, Intermediate 19, Intermediate 20 or Intermediate 21 instead of Intermediate 14 and their physical properties are shown below.
Formula (B-1)
Figure JPOXMLDOC01-appb-C000094
 In the compound represented by the following formula (1), the combination of R 3q1 , R 3q2 and R 3q3 is any of the combinations described in [Table B-1].

Figure JPOXMLDOC01-appb-T000095
中間体２２：1H-NMR (CDCl3) δ: 7.40-7.32 (5H, m), 6.57 (1H, s), 5.75-5.62 (1H, m), 5.25-5.20 (2H, m), 2.76-2.71 (6H, m), 2.61 (3H, s), 1.63 (3H, d).
中間体２３：1H-NMR (CDCl3) δ: 8.67-8.63 (1H, m), 8.46 (1H, d), 7.40-7.34 (5H, m), 5.72-5.61 (1H, m), 5.23-5.21 (2H, m), 2.75-2.72 (3H, m), 1.63-1.62 (3H, m).
中間体２４：1H-NMR (CDCl3) δ: 8.40 (2H, s), 7.38-7.33 (5H, m), 5.76-5.61 (1H, m), 5.25-5.22 (2H, m), 2.73-2.70 (3H, m), 2.39 (3H, s), 1.63 (3H, d).
中間体２５：1H-NMR (CDCl3) δ: 8.44 (1H, d), 7.42-7.30 (5H, m), 6.71 (1H, d), 5.81-5.62 (1H, m), 5.26-5.17 (2H, m), 2.80-2.77 (3H, m), 2.76-2.74 (3H, m), 1.65 (3H, d).
Figure JPOXMLDOC01-appb-T000095
 Intermediate 22: 1 H-NMR (CDCl 3 ) δ: 7.40-7.32 (5H, m), 6.57 (1H, s), 5.75-5.62 (1H, m), 5.25-5.20 (2H, m), 2.76-2.71 (6H, m), 2.61 (3H, s), 1.63 (3H, d).
Intermediate 23: 1 H-NMR (CDCl 3 ) δ: 8.67-8.63 (1H, m), 8.46 (1H, d), 7.40-7.34 (5H, m), 5.72-5.61 (1H, m), 5.23-5.21 (2H, m), 2.75-2.72 (3H, m), 1.63-1.62 (3H, m).
Intermediate 24: 1 H-NMR (CDCl 3 ) δ: 8.40 (2H, s), 7.38-7.33 (5H, m), 5.76-5.61 (1H, m), 5.25-5.22 (2H, m), 2.73-2.70 (3H, m), 2.39 (3H, s), 1.63 (3H, d).
Intermediate 25: 1 H-NMR (CDCl 3 ) δ: 8.44 (1H, d), 7.42-7.30 (5H, m), 6.71 (1H, d), 5.81-5.62 (1H, m), 5.26-5.17 (2H, m), 2.80-2.77 (3H, m), 2.76-2.74 (3H, m), 1.65 (3H, d).

参考製造例２３
　参考製造例４に準じて製造した化合物及びその物性値を以下に示す。
　式（Ｂ－２）

Figure JPOXMLDOC01-appb-C000096
で示される化合物において、Ｒ3q1、Ｒ3q2及びＲ3q3の組合せが［表Ｂ－２］に記載のいずれかの組合せである化合物。 Reference Production Example 23
The compounds prepared according to Reference Preparation Example 4 and their physical properties are shown below.
Formula (B-2)
Figure JPOXMLDOC01-appb-C000096
 In the compound represented by the following formula (1), the combination of R 3q1 , R 3q2 and R 3q3 is any of the combinations described in [Table B-2].

Figure JPOXMLDOC01-appb-T000097
中間体２６：1H-NMR (CDCl3) δ: 8.68-8.59 (2H, m), 7.34-7.30 (5H, m), 6.96-6.94 (1H, m), 6.67-6.65 (1H, m), 6.55-6.42 (1H, m), 5.12-5.10 (2H, m), 2.81-2.76 (3H, m), 2.75-2.73 (3H, m), 2.68 (3H, s), 1.67 (3H, d).
中間体２７：1H-NMR (CDCl3) δ: 8.76-8.61 (4H, m), 7.33-7.31 (5H, m), 7.02 (1H, t), 6.52 (1H, q), 5.10-5.07 (2H, m), 2.83-2.78 (3H, m), 1.67 (3H, d).
中間体２８：1H-NMR (CDCl3) δ: 8.71-8.70 (1H, m), 8.61-8.59 (2H, m), 8.51-8.49 (1H, m), 7.31-7.30 (5H, m), 6.96 (1H, t), 6.54-6.51 (1H, m), 5.14-5.11 (2H, m), 2.79-2.74 (3H, m), 2.42 (3H, d), 1.67 (3H, d).
中間体２９：1H-NMR (CDCl3) δ: 8.73-8.72 (1H, m), 8.64-8.63 (2H, m), 7.32-7.26 (5H, m), 6.98 (1H, t), 6.81-6.79 (1H, m), 6.61-6.54 (1H, m), 5.16-5.08 (2H, m), 2.87-2.82 (6H, m), 1.69 (3H, d).
Figure JPOXMLDOC01-appb-T000097
 Intermediate 26: 1 H-NMR (CDCl 3 ) δ: 8.68-8.59 (2H, m), 7.34-7.30 (5H, m), 6.96-6.94 (1H, m), 6.67-6.65 (1H, m), 6.55-6.42 (1H, m), 5.12-5.10 (2H, m), 2.81-2.76 (3H, m), 2.75-2.73 (3H, m), 2.68 (3H, s), 1.67 (3H, d).
Intermediate 27: 1 H-NMR (CDCl 3 ) δ: 8.76-8.61 (4H, m), 7.33-7.31 (5H, m), 7.02 (1H, t), 6.52 (1H, q), 5.10-5.07 (2H, m), 2.83-2.78 (3H, m), 1.67 (3H, d).
Intermediate 28: 1 H-NMR (CDCl 3 ) δ: 8.71-8.70 (1H, m), 8.61-8.59 (2H, m), 8.51-8.49 (1H, m), 7.31-7.30 (5H, m), 6.96 (1H, t), 6.54-6.51 (1H, m), 5.14-5.11 (2H, m), 2.79-2.74 (3H, m), 2.42 (3H, d), 1.67 (3H, d).
Intermediate 29: 1 H-NMR (CDCl 3 ) δ: 8.73-8.72 (1H, m), 8.64-8.63 (2H, m), 7.32-7.26 (5H, m), 6.98 (1H, t), 6.81-6.79 (1H, m), 6.61-6.54 (1H, m), 5.16-5.08 (2H, m), 2.87-2.82 (6H, m), 1.69 (3H, d).

参考製造例２４
　参考製造例１７に準じて製造した化合物及びその物性値を以下に示す。
　式（Ｂ－３）

Figure JPOXMLDOC01-appb-C000098
で示される化合物において、Ｒ3q1、Ｒ3q2及びＲ3q3の組合せが［表Ｂ－３］に記載のいずれかの組合せである化合物。 Reference Production Example 24
The compounds prepared according to Reference Preparation Example 17 and their physical properties are shown below.
Formula (B-3)
Figure JPOXMLDOC01-appb-C000098
 In the compound represented by the following formula (1), the combination of R 3q1 , R 3q2 and R 3q3 is any of the combinations described in [Table B-3].

Figure JPOXMLDOC01-appb-T000099
中間体３０：1H-NMR (CDCl3) δ: 8.85 (2H, d), 7.09 (1H, t), 6.67-6.67 (1H, m), 4.62 (1H, q), 2.79-2.78 (3H, m), 2.69 (3H, s), 2.36 (3H, s), 1.53 (3H, d).
中間体３１：1H-NMR (CDCl3) δ: 8.91 (2H, d), 8.76 (1H, d), 8.69 (1H, d), 7.18 (1H, t), 4.75 (1H, q), 2.38 (3H, s), 1.57 (3H, d).
中間体３２：1H-NMR (CDCl3) δ: 8.88 (2H, d), 8.64-8.63 (1H, m), 8.51-8.51 (1H, m), 7.12 (1H, t), 4.70 (1H, q), 2.43-2.43 (3H, m), 2.36 (3H, s), 1.56 (3H, d).
中間体３３：1H-NMR (CDCl3) δ: 8.89 (2H, d), 8.65 (1H, d), 7.11 (1H, t), 6.81-6.80 (1H, m), 4.70 (1H, q), 2.85-2.85 (3H, m), 2.38 (3H, s), 1.56 (3H, d).
Figure JPOXMLDOC01-appb-T000099
 Intermediate 30: 1 H-NMR (CDCl 3 ) δ: 8.85 (2H, d), 7.09 (1H, t), 6.67-6.67 (1H, m), 4.62 (1H, q), 2.79-2.78 (3H, m), 2.69 (3H, s), 2.36 (3H, s), 1.53 (3H, d).
Intermediate 31: 1 H-NMR (CDCl 3 ) δ: 8.91 (2H, d), 8.76 (1H, d), 8.69 (1H, d), 7.18 (1H, t), 4.75 (1H, q), 2.38 (3H, s), 1.57 (3H, d).
Intermediate 32: 1 H-NMR (CDCl 3 ) δ: 8.88 (2H, d), 8.64-8.63 (1H, m), 8.51-8.51 (1H, m), 7.12 (1H, t), 4.70 (1H, q), 2.43-2.43 (3H, m), 2.36 (3H, s), 1.56 (3H, d).
Intermediate 33: 1 H-NMR (CDCl 3 ) δ: 8.89 (2H, d), 8.65 (1H, d), 7.11 (1H, t), 6.81-6.80 (1H, m), 4.70 (1H, q), 2.85-2.85 (3H, m), 2.38 (3H, s), 1.56 (3H, d).

参考製造例２５
　２．００ｇの３－アミノピリダジンに、１０ｍＬのエタノール及び５．１９ｇの２－クロロ－３－オキソペンタン酸メチルを加え、８０℃で８時間撹拌した。反応液を室温まで放冷し濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体３４を０．４７３ｇ得た。

Figure JPOXMLDOC01-appb-C000100
中間体３４：1H-NMR (CDCl3) δ: 8.55 (1H, dd), 7.98 (1H, dd), 7.21 (1H, dd), 4.02 (3H, s), 3.17 (2H, q), 1.38 (3H, t). Reference Production Example 25
10 mL of ethanol and 5.19 g of methyl 2-chloro-3-oxopentanoate were added to 2.00 g of 3-aminopyridazine, and the mixture was stirred at 80° C. for 8 hours. The reaction solution was allowed to cool to room temperature and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.473 g of intermediate 34 represented by the following formula.
Figure JPOXMLDOC01-appb-C000100
 Intermediate 34: 1 H-NMR (CDCl 3 ) δ: 8.55 (1H, dd), 7.98 (1H, dd), 7.21 (1H, dd), 4.02 (3H, s), 3.17 (2H, q), 1.38 (3H, t).

参考製造例２６
　０．４７３ｇの中間体３４に、１５ｍＬのクロロホルム、０．０３８ｇの２，２´－アゾビス（イソブチロニトリル）及び０．４９１ｇのＮ－ブロモスクシンイミドを加え、６５℃で５時間撹拌した。反応液を室温まで放冷し、飽和チオ硫酸ナトリウム水溶液を加えてクロロホルムを用いて抽出した。得られた有機層を飽和炭酸水素ナトリウム水溶液、及び飽和食塩水で順次洗浄し、硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体３５を０．４７５ｇ得た。

Figure JPOXMLDOC01-appb-C000101
中間体３５：1H-NMR (CDCl3) δ: 8.59 (1H, dd), 8.07 (1H, dd), 7.27 (1H, dd), 6.10 (1H, q), 4.06 (3H, s), 2.19 (3H, d). Reference Production Example 26
15 mL of chloroform, 0.038 g of 2,2'-azobis(isobutyronitrile) and 0.491 g of N-bromosuccinimide were added to 0.473 g of intermediate 34, and the mixture was stirred at 65°C for 5 hours. The reaction solution was allowed to cool to room temperature, and a saturated aqueous solution of sodium thiosulfate was added and extracted with chloroform. The resulting organic layer was washed successively with a saturated aqueous solution of sodium bicarbonate and saturated saline, dried over sodium sulfate, filtered and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.475 g of intermediate 35 represented by the following formula.
Figure JPOXMLDOC01-appb-C000101
 Intermediate 35: 1 H-NMR (CDCl 3 ) δ: 8.59 (1H, dd), 8.07 (1H, dd), 7.27 (1H, dd), 6.10 (1H, q), 4.06 (3H, s), 2.19 (3H, d).

参考製造例２７
　０．２３７ｇの中間体３５に、１ｍＬのメタノール及び０．５０５ｍＬのメチルアミン（約４０％のメタノール溶液）を加えて室温で３０時間撹拌した。反応液を濃縮し、次式で示される中間体３６を０．２４１ｇ得た。

Figure JPOXMLDOC01-appb-C000102
中間体３６：1H-NMR (CDCl3) δ: 8.54 (1H, dd), 8.13 (1H, dd), 7.31 (1H, dd), 4.79 (1H, q), 3.49 (1H, s), 3.11 (3H, d), 2.50 (3H, s), 1.72 (3H, d). Reference Production Example 27
1 mL of methanol and 0.505 mL of methylamine (about 40% methanol solution) were added to 0.237 g of intermediate 35, and the mixture was stirred at room temperature for 30 hours. The reaction solution was concentrated to obtain 0.241 g of intermediate 36 represented by the following formula.
Figure JPOXMLDOC01-appb-C000102
 Intermediate 36: 1 H-NMR (CDCl 3 ) δ: 8.54 (1H, dd), 8.13 (1H, dd), 7.31 (1H, dd), 4.79 (1H, q), 3.49 (1H, s), 3.11 (3H, d), 2.50 (3H, s), 1.72 (3H, d).

参考製造例２８
　５．００ｇの３，５－ジヒドロキシ安息香酸エチルに、７０ｍＬのＴＨＦ、９．６ｍＬのトリエチルアミン及び７．４４ｍＬのメタンスルホニルクロリドを順次加え、室温で１８時間撹拌した。反応液に水を加えて酢酸エチルを用いて抽出した。得られた有機層を飽和食塩水で洗浄し、硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体３７を９．３２ｇ得た。

Figure JPOXMLDOC01-appb-C000103
中間体３７：1H-NMR (CDCl3) δ: 7.92 (2H, d), 7.47 (1H, t), 4.42 (2H, q), 3.23 (6H, s), 1.41 (3H, t). Reference Production Example 28
70 mL of THF, 9.6 mL of triethylamine, and 7.44 mL of methanesulfonyl chloride were added to 5.00 g of ethyl 3,5-dihydroxybenzoate in that order, and the mixture was stirred at room temperature for 18 hours. Water was added to the reaction solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated saline, dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 9.32 g of intermediate 37 represented by the following formula.
Figure JPOXMLDOC01-appb-C000103
 Intermediate 37: 1 H-NMR (CDCl 3 ) δ: 7.92 (2H, d), 7.47 (1H, t), 4.42 (2H, q), 3.23 (6H, s), 1.41 (3H, t).

参考製造例２９
　３．００ｇの３－ブロモ－５－ヒドロキシ安息香酸メチルに、２０ｍＬのＴＨＦ、２．０ｍＬのトリエチルアミン及び１．２３ｍＬのメタンスルホニルクロリドを順次加え、室温で１時間撹拌した。反応液に水を加えて酢酸エチルを用いて抽出した。得られた有機層を飽和食塩水で洗浄し、硫酸ナトリウムで乾燥し、ろ過して濃縮して、次式で示される中間体３８を４．５３ｇ得た。

Figure JPOXMLDOC01-appb-C000104
中間体３８：1H-NMR (CDCl3) δ: 8.16 (1H, t), 7.87 (1H, t), 7.66 (1H, t), 3.95 (3H, s), 3.22 (3H, s). Reference Production Example 29
20 mL of THF, 2.0 mL of triethylamine, and 1.23 mL of methanesulfonyl chloride were added to 3.00 g of methyl 3-bromo-5-hydroxybenzoate in this order, and the mixture was stirred at room temperature for 1 hour. Water was added to the reaction solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated saline, dried over sodium sulfate, filtered, and concentrated to obtain 4.53 g of intermediate 38 represented by the following formula.
Figure JPOXMLDOC01-appb-C000104
 Intermediate 38: 1 H-NMR (CDCl 3 ) δ: 8.16 (1H, t), 7.87 (1H, t), 7.66 (1H, t), 3.95 (3H, s), 3.22 (3H, s).

参考製造例３０
　１．００ｇの３－ブロモ－５－ヨード安息香酸メチルに、０．４５ｇのシクロプロパンスルフィン酸ナトリウム、０．０５５ｇのヨウ化銅（Ｉ）、０．０６７ｇのＬ－プロリン、０．０４０ｇの炭酸カリウム及び２．９ｍＬのＤＭＳＯを加え、１１５℃で７時間撹拌した。反応液に水を加えて酢酸エチルを用いて抽出した。得られた有機層を飽和食塩水で洗浄し、硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体３９を０．２８７ｇ得た。

Figure JPOXMLDOC01-appb-C000105
中間体３９：1H-NMR (CDCl3) δ: 8.47 (1H, t), 8.42 (1H, dd), 8.21 (1H, t), 3.98 (3H, s), 2.52-2.48 (1H, m), 1.42-1.37 (2H , m), 1.13-1.07 (2H, m). Reference Manufacturing Example 30
To 1.00 g of methyl 3-bromo-5-iodobenzoate, 0.45 g of sodium cyclopropanesulfinate, 0.055 g of copper(I) iodide, 0.067 g of L-proline, 0.040 g of potassium carbonate, and 2.9 mL of DMSO were added, and the mixture was stirred at 115° C. for 7 hours. Water was added to the reaction solution, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated saline, dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.287 g of intermediate 39 represented by the following formula.
Figure JPOXMLDOC01-appb-C000105
 Intermediate 39: 1 H-NMR (CDCl 3 ) δ: 8.47 (1H, t), 8.42 (1H, dd), 8.21 (1H, t), 3.98 (3H, s), 2.52-2.48 (1H, m), 1.42-1.37 (2H , m), 1.13-1.07 (2H, m).

参考製造例３１
　０．４９５ｇの３－ブロモ－５－（シアノメチル）安息香酸メチルに、５ｍＬのＤＭＳＯ、０．１９３ｇの水素化ナトリウム　（６０％、流動パラフィンに分散）を加え、室温で１５分間撹拌した。反応液に０．６０５ｇの１，２－ジブロモエタンを加えて、さらに室温で７．５時間撹拌した。得られた混合物に飽和塩化アンモニウム水溶液を加えてメチルｔｅｒｔ－ブチルエーテルを用いて抽出した。得られた有機層を飽和食塩水で洗浄し、硫酸マグネシウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体４０を０．０８５ｇ得た。

Figure JPOXMLDOC01-appb-C000106
中間体４０：1H-NMR (CDCl3) δ: 8.10 (1H, t), 7.81 (1H, t), 7.70 (1H, t), 3.94 (3H, s), 1.82-1.80 (2H, m), 1.48-1.46 (2H, m). Reference Production Example 31
0.495 g of methyl 3-bromo-5-(cyanomethyl)benzoate was added with 5 mL of DMSO and 0.193 g of sodium hydride (60%, dispersed in liquid paraffin) and stirred at room temperature for 15 minutes. 0.605 g of 1,2-dibromoethane was added to the reaction solution and further stirred at room temperature for 7.5 hours. A saturated aqueous solution of ammonium chloride was added to the resulting mixture and extracted with methyl tert-butyl ether. The resulting organic layer was washed with saturated saline, dried over magnesium sulfate, filtered and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.085 g of intermediate 40 represented by the following formula.
Figure JPOXMLDOC01-appb-C000106
 Intermediate 40: 1 H-NMR (CDCl 3 ) δ: 8.10 (1H, t), 7.81 (1H, t), 7.70 (1H, t), 3.94 (3H, s), 1.82-1.80 (2H, m), 1.48-1.46 (2H, m).

参考製造例３２
　１．００ｇの中間体３７に、１０ｍＬのＴＨＦ、５ｍＬの水を加え、氷冷下で０．１８６ｇの水酸化リチウム一水和物を加えて室温３０分間撹拌した。塩酸を加えてｐＨ２として、酢酸エチルを用いて抽出した。得られた有機層を飽和食塩水で洗浄し、硫酸ナトリウムで乾燥し、ろ過して濃縮して、次式で示される中間体４１を０．８１８ｇ得た。

Figure JPOXMLDOC01-appb-C000107
中間体４１：1H-NMR (CDCl3) δ: 7.98 (2H, d), 7.53 (1H, t), 3.25 (6H, s). Reference Production Example 32
10 mL of THF and 5 mL of water were added to 1.00 g of intermediate 37, and 0.186 g of lithium hydroxide monohydrate was added under ice cooling and stirred at room temperature for 30 minutes. Hydrochloric acid was added to adjust the pH to 2, and extraction was performed using ethyl acetate. The obtained organic layer was washed with saturated saline, dried over sodium sulfate, filtered and concentrated to obtain 0.818 g of intermediate 41 represented by the following formula.
Figure JPOXMLDOC01-appb-C000107
 Intermediate 41: 1 H-NMR (CDCl 3 ) δ: 7.98 (2H, d), 7.53 (1H, t), 3.25 (6H, s).

参考製造例３２－１
　中間体３７に代えて中間体３８、中間体３９又は中間体４０を使用し、参考製造例３２に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000108
中間体４２：1H-NMR (CDCl3) δ: 8.21 (1H, t), 7.93 (1H, dd), 7.73 (1H, t), 3.24 (3H, s).
Figure JPOXMLDOC01-appb-C000109
 中間体４３：1H-NMR (CDCl3) δ: 8.52 (1H, t), 8.47 (1H, t), 8.25 (1H, t), 2.54-2.48 (1H, m), 1.42-1.40 (2H, m), 1.13-1.10 (2H, m).
Figure JPOXMLDOC01-appb-C000110
 中間体４４：1H-NMR (CDCl3) δ: 8.16 (1H, t), 7.87 (1H, t), 7.76 (1H, t), 1.85-1.81 (2H, m), 1.51-1.47 (2H, m). Reference Manufacturing Example 32-1
Compounds prepared according to Reference Production Example 32 using Intermediate 38, Intermediate 39 or Intermediate 40 instead of Intermediate 37 and their physical properties are shown below.
Figure JPOXMLDOC01-appb-C000108
 Intermediate 42: 1 H-NMR (CDCl 3 ) δ: 8.21 (1H, t), 7.93 (1H, dd), 7.73 (1H, t), 3.24 (3H, s).
Figure JPOXMLDOC01-appb-C000109
 Intermediate 43: 1 H-NMR (CDCl 3 ) δ: 8.52 (1H, t), 8.47 (1H, t), 8.25 (1H, t), 2.54-2.48 (1H, m), 1.42-1.40 (2H, m), 1.13-1.10 (2H, m).
Figure JPOXMLDOC01-appb-C000110
 Intermediate 44: 1 H-NMR (CDCl 3 ) δ: 8.16 (1H, t), 7.87 (1H, t), 7.76 (1H, t), 1.85-1.81 (2H, m), 1.51-1.47 (2H, m).

参考製造例３３
　非特許文献Ｔｅｔｒａｈｅｄｒｏｎ（２０１３）６９，１１０９２－１１１０８．に記載の方法に準じて製造した（Ｓ）－４－［Ｎ－（ベンジルオキシカルボニル）アミノ］－３－オキソペンタン酸メチル１５ｇ及びメタノール１０７ｍＬの混合物に、アセトアミジン塩酸塩５．５９ｇを加えた後、ナトリウムメトキシド（２８重量％メタノール溶液）２１．８ｇを加え、室温で１８時間攪拌した。得られた混合物を濃縮し、水を加えてクロロホルムで抽出した。得られた水層にクエン酸をｐＨ５になるまで加えた後、クロロホルムで抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥した後に、ろ過して濃縮し、次式で示される中間体４５を１２．１ｇ得た。

Figure JPOXMLDOC01-appb-C000111
中間体４５：1H-NMR (CDCl3) δ: 7.36-7.32 (5H, m), 6.26 (1H, s), 5.51 (1H, d), 5.13-5.08 (2H, m), 4.69-4.64 (1H, m), 2.45 (3H, s), 1.41 (3H, d). Reference Production Example 33
To a mixture of 15 g of methyl (S)-4-[N-(benzyloxycarbonyl)amino]-3-oxopentanoate produced according to the method described in non-patent document Tetrahedron (2013) 69, 11092-11108. and 107 mL of methanol, 5.59 g of acetamidine hydrochloride was added, and then 21.8 g of sodium methoxide (28 wt % methanol solution) was added and stirred at room temperature for 18 hours. The resulting mixture was concentrated, water was added, and the mixture was extracted with chloroform. Citric acid was added to the resulting aqueous layer until the pH was 5, and the mixture was extracted with chloroform. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated to obtain 12.1 g of intermediate 45 represented by the following formula.
Figure JPOXMLDOC01-appb-C000111
 Intermediate 45: 1 H-NMR (CDCl 3 ) δ: 7.36-7.32 (5H, m), 6.26 (1H, s), 5.51 (1H, d), 5.13-5.08 (2H, m), 4.69-4.64 (1H, m), 2.45 (3H, s), 1.41 (3H, d).

参考製造例３４
　５．０ｇの中間体４５及びＴＨＦ８７ｍＬの混合物に、ヨウ素８．８３ｇ及び炭酸カリウム５．０４ｇを加え、加熱還流下で７時間攪拌した。得られた混合物を室温まで放冷し、水を加えてクロロホルムを用いて抽出した。得られた有機層を飽和チオ硫酸ナトリウム水溶液、水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥した後に、ろ過して濃縮し、次式で示される中間体４６を３．３７ｇ得た。

Figure JPOXMLDOC01-appb-C000112
中間体４６：1H-NMR (CDCl3) δ: 7.36-7.32 (5H, m), 5.90 (1H, d), 5.19-5.11 (3H, m), 2.47 (3H, s), 1.37 (3H, d). Reference Production Example 34
To a mixture of 5.0 g of intermediate 45 and 87 mL of THF, 8.83 g of iodine and 5.04 g of potassium carbonate were added, and the mixture was stirred under heating and reflux for 7 hours. The resulting mixture was allowed to cool to room temperature, water was added, and the mixture was extracted with chloroform. The resulting organic layer was washed successively with a saturated aqueous solution of sodium thiosulfate, water, and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated to obtain 3.37 g of intermediate 46 represented by the following formula.
Figure JPOXMLDOC01-appb-C000112
 Intermediate 46: 1 H-NMR (CDCl 3 ) δ: 7.36-7.32 (5H, m), 5.90 (1H, d), 5.19-5.11 (3H, m), 2.47 (3H, s), 1.37 (3H, d).

参考製造例３５
　中間体３に代えて中間体４６を使用し、参考製造例４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000113
中間体４７：1H-NMR (CDCl3) δ: 8.90 (2H, d), 7.33-7.31 (6H, m), 5.94-5.92 (1H, m), 5.06-5.02 (2H, m), 4.81 (1H, s), 2.44 (3H, s), 1.37 (3H, d). Reference Production Example 35
The compound prepared according to Reference Production Example 4 using Intermediate 46 instead of Intermediate 3 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000113
 Intermediate 47: 1 H-NMR (CDCl 3 ) δ: 8.90 (2H, d), 7.33-7.31 (6H, m), 5.94-5.92 (1H, m), 5.06-5.02 (2H, m), 4.81 (1H, s), 2.44 (3H, s), 1.37 (3H, d).

参考製造例３６
　０．８４ｇの中間体４７及びトルエン４．６ｍＬの混合物に、０．６４ｍＬの塩化ホスホリルを加えて１１０℃で３時間攪拌した。得られた混合物を室温まで放冷し、１ｍｏｌ／Ｌの水酸化ナトリウム水溶液加えて３０分間攪拌した後に、クロロホルムを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、中間体４８を０．１４ｇ得た。

Figure JPOXMLDOC01-appb-C000114
中間体４８：1H-NMR (CDCl3) δ: 8.92 (2H, d), 7.40 (1H, t), 7.37-7.31 (5H, m), 6.05 (1H, d), 5.06-5.04 (2H, m), 4.84-4.79 (1H, m), 2.76 (3H, s), 1.33 (3H, d). Reference Production Example 36
To a mixture of 0.84 g of intermediate 47 and 4.6 mL of toluene, 0.64 mL of phosphoryl chloride was added and stirred at 110° C. for 3 hours. The resulting mixture was allowed to cool to room temperature, and 1 mol/L aqueous sodium hydroxide solution was added and stirred for 30 minutes, after which it was extracted with chloroform. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.14 g of intermediate 48.
Figure JPOXMLDOC01-appb-C000114
 Intermediate 48: 1 H-NMR (CDCl 3 ) δ: 8.92 (2H, d), 7.40 (1H, t), 7.37-7.31 (5H, m), 6.05 (1H, d), 5.06-5.04 (2H, m), 4.84-4.79 (1H, m), 2.76 (3H, s), 1.33 (3H, d).

参考製造例３７
　０．１４ｇの中間体４８及びエタノール３．５ｍＬの混合物に、０．０５ｍＬのヒドラジン一水和物を加えて室温で１５時間攪拌した。得られた混合物に水を加えた後、析出した固体をろ取して、減圧下で乾燥し、次式で示される中間体４９を０．０５９ｇ得た。

Figure JPOXMLDOC01-appb-C000115
中間体４９：1H-NMR (CDCl3) δ: 8.84 (2H, d), 7.36-7.28 (5H, m), 7.22 (1H, t), 6.36 (1H, d), 5.69-5.67 (1H, m), 5.08-5.02 (2H, m), 4.15 (2H, d), 2.56 (3H, s), 1.50 (3H, d). Reference Production Example 37
To a mixture of 0.14 g of intermediate 48 and 3.5 mL of ethanol, 0.05 mL of hydrazine monohydrate was added and stirred at room temperature for 15 hours. Water was added to the resulting mixture, and the precipitated solid was collected by filtration and dried under reduced pressure to obtain 0.059 g of intermediate 49 represented by the following formula.
Figure JPOXMLDOC01-appb-C000115
 Intermediate 49: 1 H-NMR (CDCl 3 ) δ: 8.84 (2H, d), 7.36-7.28 (5H, m), 7.22 (1H, t), 6.36 (1H, d), 5.69-5.67 (1H, m), 5.08-5.02 (2H, m), 4.15 (2H, d), 2.56 (3H, s), 1.50 (3H, d).

参考製造例３８
　０．０５９ｇの中間体４９及びクロロホルム３．２ｍＬの混合物に、０．０５ｍＬのオルトぎ酸トリメチル及び０．０４ｍＬのトリフルオロ酢酸を加え、室温で１５時間攪拌した。得られた混合物に飽和炭酸水素ナトリウム水溶液を加えてクロロホルムを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮し、中間体５０を０．０６５ｇ得た。

Figure JPOXMLDOC01-appb-C000116
中間体５０：1H-NMR (CDCl3) δ: 9.00 (2H, d), 8.42 (1H, s), 7.40 (1H, t), 7.34-7.31 (5H, m), 5.95 (1H, d), 5.38-5.35 (1H, m), 5.06-5.01 (2H, m), 3.05 (3H, s), 1.55 (3H, d). Reference Production Example 38
To a mixture of 0.059 g of intermediate 49 and 3.2 mL of chloroform, 0.05 mL of trimethyl orthoformate and 0.04 mL of trifluoroacetic acid were added and stirred at room temperature for 15 hours. A saturated aqueous solution of sodium bicarbonate was added to the resulting mixture and extracted with chloroform. The resulting organic layer was washed with water and saturated saline in sequence. The resulting organic layer was dried over sodium sulfate, filtered and concentrated to obtain 0.065 g of intermediate 50.
Figure JPOXMLDOC01-appb-C000116
 Intermediate 50: 1 H-NMR (CDCl 3 ) δ: 9.00 (2H, d), 8.42 (1H, s), 7.40 (1H, t), 7.34-7.31 (5H, m), 5.95 (1H, d), 5.38-5.35 (1H, m), 5.06-5.01 (2H, m), 3.05 (3H, s), 1.55 (3H, d).

参考製造例３９
　０．０６５ｇの中間体５０、酢酸エチル３．２ｍＬ及びメタノール１．６ｍＬの混合物に、１０％パラジウム／活性炭素（約５５％含水）０．０７ｇを加えて、反応容器内を水素雰囲気下として室温で６時間攪拌した。得られた混合物をセライトろ過した後に、得られた溶液を減圧下で濃縮し、中間体５１を０．１３ｇ得た。

Figure JPOXMLDOC01-appb-C000117
中間体５１：1H-NMR (CDCl3) δ: 8.99 (2H, d), 8.39 (1H, s), 7.40 (1H, t), 4.28 (1H, q), 3.07 (3H, s), 1.46 (3H, d). Reference Production Example 39
To a mixture of 0.065 g of intermediate 50, 3.2 mL of ethyl acetate, and 1.6 mL of methanol, 0.07 g of 10% palladium/activated carbon (about 55% water content) was added, and the inside of the reaction vessel was placed under a hydrogen atmosphere and stirred at room temperature for 6 hours. The mixture was filtered through Celite, and the resulting solution was concentrated under reduced pressure to obtain 0.13 g of intermediate 51.
Figure JPOXMLDOC01-appb-C000117
 Intermediate 51: 1 H-NMR (CDCl 3 ) δ: 8.99 (2H, d), 8.39 (1H, s), 7.40 (1H, t), 4.28 (1H, q), 3.07 (3H, s), 1.46 (3H, d).

参考製造例４０
　アセトアミジン塩酸塩に代えてホルムアミジン酢酸塩を使用し、参考製造例３３に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000118
中間体５２：1H-NMR (CDCl3) δ: 8.10 (1H, s), 7.36-7.30 (5H, m), 6.42 (1H, s), 5.40 (1H, d), 5.12-5.09 (2H, m), 4.69-4.67 (1H, m), 1.43 (3H, d). Reference Production Example 40
Compounds prepared according to Reference Production Example 33 using formamidine acetate instead of acetamidine hydrochloride and their physical properties are shown below.
Figure JPOXMLDOC01-appb-C000118
 Intermediate 52: 1 H-NMR (CDCl 3 ) δ: 8.10 (1H, s), 7.36-7.30 (5H, m), 6.42 (1H, s), 5.40 (1H, d), 5.12-5.09 (2H, m), 4.69-4.67 (1H, m), 1.43 (3H, d).

参考製造例４１
　４．０ｇの中間体５２、３．３３ｇのトリエチルベンジルアンモニウムクロリド、１．８４ｍＬのジメチルアニリン及び４９ｍＬのアセトニトリルの混合物に、２．０４ｍＬの塩化ホスホリルを加え、６０℃で２時間攪拌した。得られた混合物を室温まで放冷して減圧下で濃縮した後に、飽和炭酸水素ナトリウム水溶液を加えて３０分間攪拌し、酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、中間体５３を３．７ｇ得た。

Figure JPOXMLDOC01-appb-C000119
中間体５３：1H-NMR (CDCl3) δ: 8.93 (1H, s), 7.36-7.34 (6H, m), 5.60 (1H, d), 5.13-5.09 (2H, m), 4.89-4.84 (1H, m), 1.49 (3H, d). Reference Production Example 41
To a mixture of 4.0 g of intermediate 52, 3.33 g of triethylbenzylammonium chloride, 1.84 mL of dimethylaniline and 49 mL of acetonitrile, 2.04 mL of phosphoryl chloride was added and stirred at 60° C. for 2 hours. The resulting mixture was allowed to cool to room temperature and concentrated under reduced pressure, and then a saturated aqueous solution of sodium bicarbonate was added and stirred for 30 minutes, followed by extraction with ethyl acetate. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered and concentrated. The residue was subjected to silica gel column chromatography to obtain 3.7 g of intermediate 53.
Figure JPOXMLDOC01-appb-C000119
 Intermediate 53: 1 H-NMR (CDCl 3 ) δ: 8.93 (1H, s), 7.36-7.34 (6H, m), 5.60 (1H, d), 5.13-5.09 (2H, m), 4.89-4.84 (1H, m), 1.49 (3H, d).

参考製造例４２
　中間体４８に代えて中間体５３を使用し、参考製造例３７に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000120
中間体５４：1H-NMR (CDCl3) δ: 8.52 (1H, s), 7.36-7.31 (5H, m), 6.64 (1H, s), 6.24 (1H, s), 5.77 (1H, d), 5.12-5.10 (2H, m), 4.76-4.71 (1H, m), 3.81 (2H, s), 1.45 (3H, d). Reference Production Example 42
The compound prepared according to Reference Production Example 37 using Intermediate 53 instead of Intermediate 48 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000120
 Intermediate 54: 1 H-NMR (CDCl 3 ) δ: 8.52 (1H, s), 7.36-7.31 (5H, m), 6.64 (1H, s), 6.24 (1H, s), 5.77 (1H, d), 5.12-5.10 (2H, m), 4.76-4.71 (1H, m), 3.81 (2H, s), 1.45 (3H, d).

参考製造例４３
　中間体４９に代えて中間体５４を使用し、参考製造例３８に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000121
中間体５５：1H-NMR (CDCl3) δ: 9.36 (1H, s), 8.42 (1H, s), 7.64 (1H, s), 7.35-7.34 (5H, m), 5.47 (1H, d), 5.13-5.07 (2H, m), 5.00-4.99 (1H, m), 1.54 (3H, d). Reference Production Example 43
The compound prepared according to Reference Production Example 38 using Intermediate 54 instead of Intermediate 49 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000121
 Intermediate 55: 1 H-NMR (CDCl 3 ) δ: 9.36 (1H, s), 8.42 (1H, s), 7.64 (1H, s), 7.35-7.34 (5H, m), 5.47 (1H, d), 5.13-5.07 (2H, m), 5.00-4.99 (1H, m), 1.54 (3H, d).

参考製造例４４
　２．４２ｇの中間体５５及び酢酸１６．３ｍＬの混合液に、Ｎ－ブロモスクシンイミド２．９０ｇを加え、室温で２１時間攪拌した。得られた混合物に水を加えてクロロホルムを用いて抽出した。得られた有機層を飽和炭酸水素ナトリウム水溶液、飽和チオ硫酸ナトリウム水溶液、水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体５６を１．６６ｇ得た。

Figure JPOXMLDOC01-appb-C000122
中間体５６：1H-NMR (CDCl3) δ: 9.29 (1H, s), 8.45 (1H, s), 7.37-7.34 (5H, m), 5.79 (1H, d), 5.51-5.49 (1H, m), 5.13-5.06 (2H, m), 1.49 (3H, d). Reference Production Example 44
To a mixture of 2.42 g of intermediate 55 and 16.3 mL of acetic acid, 2.90 g of N-bromosuccinimide was added and stirred at room temperature for 21 hours. Water was added to the resulting mixture, and the mixture was extracted with chloroform. The resulting organic layer was washed successively with a saturated aqueous solution of sodium hydrogen carbonate, a saturated aqueous solution of sodium thiosulfate, water, and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 1.66 g of intermediate 56 represented by the following formula.
Figure JPOXMLDOC01-appb-C000122
 Intermediate 56: 1 H-NMR (CDCl 3 ) δ: 9.29 (1H, s), 8.45 (1H, s), 7.37-7.34 (5H, m), 5.79 (1H, d), 5.51-5.49 (1H, m), 5.13-5.06 (2H, m), 1.49 (3H, d).

参考製造例４５
　中間体３に代えて中間体５６を使用し、参考製造例４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000123
中間体５７：1H-NMR (CDCl3) δ: 9.45 (1H, s), 9.01 (2H, d), 8.46 (1H, s), 7.43 (1H, t), 7.33-7.31 (5H, m), 5.82 (1H, d), 5.38-5.37 (1H, m), 5.05-4.99 (2H, m), 1.57 (3H, d). Reference Production Example 45
The compound prepared according to Reference Production Example 4 using Intermediate 56 instead of Intermediate 3 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000123
 Intermediate 57: 1 H-NMR (CDCl 3 ) δ: 9.45 (1H, s), 9.01 (2H, d), 8.46 (1H, s), 7.43 (1H, t), 7.33-7.31 (5H, m), 5.82 (1H, d), 5.38-5.37 (1H, m), 5.05-4.99 (2H, m), 1.57 (3H, d).

参考製造例４６
　中間体５０に代えて中間体５７を使用し、参考製造例３９に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000124
中間体５８：ＬＣＭＳ：２４２［Ｍ＋Ｈ］+、ＲＴ＝０．２６分 Reference Production Example 46
The compound prepared according to Reference Production Example 39 using Intermediate 57 instead of Intermediate 50 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000124
 Intermediate 58: LCMS: 242 [M+H] + , RT = 0.26 min

参考製造例４７
　中間体５２に代えて中間体４６を使用し、参考製造例４１に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000125
中間体５９：1H-NMR (CDCl3) δ: 7.36-7.32 (5H, m), 6.05 (1H, d), 5.31-5.27 (1H, m), 5.13-5.10 (2H, m), 2.64 (3H, s), 1.42 (3H, d). Reference Production Example 47
The compound prepared according to Reference Production Example 41 using Intermediate 46 instead of Intermediate 52 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000125
 Intermediate 59: 1 H-NMR (CDCl 3 ) δ: 7.36-7.32 (5H, m), 6.05 (1H, d), 5.31-5.27 (1H, m), 5.13-5.10 (2H, m), 2.64 (3H, s), 1.42 (3H, d).

参考製造例４８
　１．０ｇの中間体５９及びアセトニトリル１１．６ｍＬの混合液に、２，４，６－トリメトキシフェニルメチルアミン０．６９ｇ及び炭酸カリウム０．６４ｇを加え、室温で２１時間攪拌した。得られた混合物に水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体６０を１．３１ｇ得た。

Figure JPOXMLDOC01-appb-C000126
中間体６０：1H-NMR (CDCl3) δ: 7.36-7.31 (5H, m), 6.32 (1H, d), 6.16 (2H, s), 6.03-6.02 (1H, m), 5.12-5.09 (2H, m), 5.04-4.99 (1H, m), 4.69-4.62 (2H, m), 3.86 (6H, s), 3.82 (3H, s), 2.48 (3H, s), 1.35 (3H, d). Reference Production Example 48
To a mixture of 1.0 g of intermediate 59 and 11.6 mL of acetonitrile, 0.69 g of 2,4,6-trimethoxyphenylmethylamine and 0.64 g of potassium carbonate were added and stirred at room temperature for 21 hours. Water was added to the resulting mixture and extracted with ethyl acetate. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered and concentrated. The residue was subjected to silica gel column chromatography to obtain 1.31 g of intermediate 60 represented by the following formula.
Figure JPOXMLDOC01-appb-C000126
 Intermediate 60: 1 H-NMR (CDCl 3 ) δ: 7.36-7.31 (5H, m), 6.32 (1H, d), 6.16 (2H, s), 6.03-6.02 (1H, m), 5.12-5.09 (2H, m), 5.04-4.99 (1H, m), 4.69-4.62 (2H, m), 3.86 (6H, s), 3.82 (3H, s), 2.48 (3H, s), 1.35 (3H, d).

参考製造例４９
　０．５０ｇの中間体６０に塩化水素（５－１０重量％メタノール溶液）を８．４ｍＬ加え、９０℃で１５時間攪拌した。得られた混合物を室温まで放冷した後に濃縮し、４．２ｍＬのＤＭＦ、４．２ｍＬのブロモアセトアルデヒドジメチルアセタール及び１．０ｍＬの酢酸を加え、８０℃で１５時間攪拌した。得られた混合物に水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体６１を０．１０ｇ得た。

Figure JPOXMLDOC01-appb-C000127
中間体６１：1H-NMR (CDCl3) δ: 7.73 (1H, d), 7.61 (1H, s), 7.36-7.32 (5H, m), 5.96 (1H, d), 5.41-5.36 (1H, m), 5.14-5.09 (2H, m), 2.79 (3H, s), 1.44 (3H, d). Reference Production Example 49
8.4 mL of hydrogen chloride (5-10 wt % methanol solution) was added to 0.50 g of intermediate 60, and the mixture was stirred at 90° C. for 15 hours. The resulting mixture was allowed to cool to room temperature and then concentrated, and 4.2 mL of DMF, 4.2 mL of bromoacetaldehyde dimethyl acetal, and 1.0 mL of acetic acid were added, and the mixture was stirred at 80° C. for 15 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated saline in that order. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.10 g of intermediate 61 represented by the following formula.
Figure JPOXMLDOC01-appb-C000127
 Intermediate 61: 1 H-NMR (CDCl 3 ) δ: 7.73 (1H, d), 7.61 (1H, s), 7.36-7.32 (5H, m), 5.96 (1H, d), 5.41-5.36 (1H, m), 5.14-5.09 (2H, m), 2.79 (3H, s), 1.44 (3H, d).

参考製造例５０
　中間体３に代えて中間体６１を使用し、参考製造例４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000128
中間体６２：1H-NMR (CDCl3) δ: 8.98 (2H, d), 7.72 (1H, d), 7.54 (1H, d), 7.37-7.37 (1H, m), 7.34-7.31 (5H, m), 6.00 (1H, d), 5.14-5.13 (1H, m), 5.05-5.03 (2H, m), 2.86 (3H, s), 1.49 (3H, d). Reference Manufacturing Example 50
The compound prepared according to Reference Production Example 4 using Intermediate 61 instead of Intermediate 3 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000128
 Intermediate 62: 1 H-NMR (CDCl 3 ) δ: 8.98 (2H, d), 7.72 (1H, d), 7.54 (1H, d), 7.37-7.37 (1H, m), 7.34-7.31 (5H, m), 6.00 (1H, d), 5.14-5.13 (1H, m), 5.05-5.03 (2H, m), 2.86 (3H, s), 1.49 (3H, d).

参考製造例５１
　６．０ｇの中間体５６及びトリフルオロ酢酸３１．９ｍＬの混合液を、７０℃で４時間攪拌した。得られた混合物を室温まで放冷した後に濃縮し、メチルｔｅｒｔ－ブチルエーテル及び水を加えて抽出した。得られた水層に飽和炭酸水素ナトリウムを加えてｐＨ１０とした後、クロロホルム（２０容量％イソプロパノール含有）で抽出した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。
　得られた残渣及びＴＨＦ３５．５ｍＬの混合物に、氷冷下でＮ，Ｎ－ジイソプロピルエチルアミン１０．０ｍＬ及び３，５－ビス（トリフルオロメチル）ベンゾイルクロリド５．９４ｇを順次加え、室温で４時間攪拌した。得られた混合物に水を加えてクロロホルムを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される中間体６３を６．８４ｇ得た。

Figure JPOXMLDOC01-appb-C000129
中間体６３：1H-NMR (CDCl3) δ: 9.38 (1H, s), 8.50 (1H, s), 8.27 (2H, s), 8.04 (1H, s), 7.34 (1H, d), 5.93-5.91 (1H, m), 1.65 (3H, d). Reference Production Example 51
A mixture of 6.0 g of Intermediate 56 and 31.9 mL of trifluoroacetic acid was stirred at 70° C. for 4 hours. The resulting mixture was allowed to cool to room temperature, concentrated, and extracted with methyl tert-butyl ether and water. Saturated sodium bicarbonate was added to the resulting aqueous layer to adjust the pH to 10, and then extracted with chloroform (containing 20% by volume of isopropanol). The resulting organic layer was dried over sodium sulfate, filtered, and concentrated.
To a mixture of the obtained residue and 35.5 mL of THF, 10.0 mL of N,N-diisopropylethylamine and 5.94 g of 3,5-bis(trifluoromethyl)benzoyl chloride were added in this order under ice cooling, and the mixture was stirred at room temperature for 4 hours. Water was added to the obtained mixture, and the mixture was extracted with chloroform. The obtained organic layer was washed with water and saturated saline in this order. The obtained organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 6.84 g of intermediate 63 represented by the following formula.
Figure JPOXMLDOC01-appb-C000129
 Intermediate 63: 1 H-NMR (CDCl 3 ) δ: 9.38 (1H, s), 8.50 (1H, s), 8.27 (2H, s), 8.04 (1H, s), 7.34 (1H, d), 5.93-5.91 (1H, m), 1.65 (3H, d).

参考製造例５２
　中間体３に代えて中間体６３を使用し、さらに２－トリブチルスタンニルピリミジンに代えてトリブチル（１－エトキシビニル）スタンナンを使用して、参考製造例４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000130
中間体６４：1H-NMR (CDCl3) δ: 9.41 (1H, s), 8.44 (1H, s), 8.25 (2H, s), 8.02 (1H, s), 7.30 (1H, d), 5.87-5.84 (1H, m), 4.87 (1H, d), 4.81 (1H, d), 4.13-4.09 (2H, m), 1.64 (3H, d), 1.45 (3H, t). Reference Production Example 52
The compound and its physical properties are shown below, which were produced according to Reference Production Example 4, except that Intermediate 63 was used instead of Intermediate 3, and tributyl(1-ethoxyvinyl)stannane was used instead of 2-tributylstannylpyrimidine.
Figure JPOXMLDOC01-appb-C000130
 Intermediate 64: 1 H-NMR (CDCl 3 ) δ: 9.41 (1H, s), 8.44 (1H, s), 8.25 (2H, s), 8.02 (1H, s), 7.30 (1H, d), 5.87-5.84 (1H, m), 4.87 (1H, d), 4.81 (1H, d), 4.13-4.09 (2H, m), 1.64 (3H, d), 1.45 (3H, t).

参考製造例５３
　Ｎ－（ｔｅｒｔ－ブトキシカルボニル）－Ｎ－メチル－Ｌ－アラニン３０ｇ及びクロロホルム３００ｍＬの混合物に１，１´－カルボニルジイミダゾール２３．９ｇを加えて室温で１時間攪拌した。マロノニトリル９．３ｍＬを加えて更に室温で４時間攪拌し、得られた混合物を濃縮した。
　得られた残渣及び１，４－ジオキサン４９０ｍＬの混合物に、炭酸ナトリウム８６ｇ及びジメチル硫酸５６ｍＬを順次加え、８５℃で８時間攪拌した。ジメチル硫酸を２８ｍＬ加えて更に９時間攪拌し、ジメチル硫酸２８ｍＬ及び炭酸ナトリウム２４．７ｇを加えて更に３時間攪拌した。得られた混合物を室温まで放冷した後、綿栓ろ過して得られたろ液に水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、中間体６５を１２．２ｇ得た。

Figure JPOXMLDOC01-appb-C000131
中間体６５：1H-NMR (CDCl3) δ: 5.02-4.88 (1H, m), 4.36 (3H, s), 2.89 (3H, s), 1.48 (9H, s), 1.43 (3H, d). Reference Production Example 53
To a mixture of 30 g of N-(tert-butoxycarbonyl)-N-methyl-L-alanine and 300 mL of chloroform, 23.9 g of 1,1'-carbonyldiimidazole was added and stirred at room temperature for 1 hour. 9.3 mL of malononitrile was added and stirred at room temperature for an additional 4 hours, and the resulting mixture was concentrated.
To a mixture of the obtained residue and 490 mL of 1,4-dioxane, 86 g of sodium carbonate and 56 mL of dimethyl sulfate were added in that order, and the mixture was stirred at 85° C. for 8 hours. 28 mL of dimethyl sulfate was added and the mixture was stirred for an additional 9 hours, and 28 mL of dimethyl sulfate and 24.7 g of sodium carbonate were added and the mixture was stirred for an additional 3 hours. The obtained mixture was allowed to cool to room temperature, and then filtered through a cotton plug to obtain a filtrate, to which water was added and the mixture was extracted with ethyl acetate. The obtained organic layer was washed successively with water and saturated saline. The obtained organic layer was dried over sodium sulfate, filtered and concentrated. The obtained residue was subjected to silica gel column chromatography to obtain 12.2 g of intermediate 65.
Figure JPOXMLDOC01-appb-C000131
 Intermediate 65: 1 H-NMR (CDCl 3 ) δ: 5.02-4.88 (1H, m), 4.36 (3H, s), 2.89 (3H, s), 1.48 (9H, s), 1.43 (3H, d).

参考製造例５４
　１２．２ｇの中間体６５及びエタノール５０ｍＬの混合物に、ヒドラジン一水和物４．５ｍＬを順次加え、６０℃で８時間攪拌した。得られた混合物を室温まで放冷した後、水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。
　得られた残渣に１，１，３，３－テトラメトキシプロパン１５ｍＬ及び酢酸５０ｍＬを加え、８０℃で６時間攪拌した。得られた混合物を室温まで放冷した後、飽和炭酸水素ナトリウム水溶液を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。得られた残渣をシリカゲルカラムクロマトグラフィーに付し、中間体６６を１０．０ｇ得た。

Figure JPOXMLDOC01-appb-C000132
中間体６６：1H-NMR (CDCl3) δ: 8.71-8.69 (2H, m), 7.05 (1H, s), 5.77-5.67 (1H, m), 2.83 (3H, s), 1.67 (3H, d), 1.51 (9H, s). Reference Production Example 54
To a mixture of 12.2 g of intermediate 65 and 50 mL of ethanol, 4.5 mL of hydrazine monohydrate was added in sequence, and the mixture was stirred at 60° C. for 8 hours. The mixture was allowed to cool to room temperature, and then water was added and extracted with ethyl acetate. The organic layer obtained was washed with water and saturated saline in sequence. The organic layer obtained was dried over sodium sulfate, filtered, and concentrated.
To the resulting residue, 15 mL of 1,1,3,3-tetramethoxypropane and 50 mL of acetic acid were added, and the mixture was stirred at 80° C. for 6 hours. The resulting mixture was allowed to cool to room temperature, and then a saturated aqueous solution of sodium hydrogen carbonate was added, followed by extraction with ethyl acetate. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The resulting residue was subjected to silica gel column chromatography, and 10.0 g of intermediate 66 was obtained.
Figure JPOXMLDOC01-appb-C000132
 Intermediate 66: 1 H-NMR (CDCl 3 ) δ: 8.71-8.69 (2H, m), 7.05 (1H, s), 5.77-5.67 (1H, m), 2.83 (3H, s), 1.67 (3H, d), 1.51 (9H, s).

参考製造例６６
　０．３０ｇの中間体６６及び塩化水素／１，４－ジオキサン溶液（４ｍｏｌ／Ｌ）５．０ｍＬの混合物を室温で１５時間攪拌し、得られた混合物を濃縮した。
　得られた残渣及びＴＨＦ５．０ｍＬの混合溶液に、トリエチルアミン０．３７ｍＬ及び３，５－ビス（トリフルオロメチル）ベンゾイルクロリド０．２７ｍＬを順次加え、室温で１時間攪拌した。得られた混合物に水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、中間体７８を０．１５ｇ得た。

Figure JPOXMLDOC01-appb-C000133
中間体７８：1H-NMR (CDCl3) δ: 8.75-8.73 (2H, m), 8.08 (2H, s), 7.96 (1H, s), 7.13-7.11 (1H, m), 6.28 (1H, s), 3.04-2.93 (3H, m), 1.84 (3H, d). Reference Manufacturing Example 66
A mixture of 0.30 g of Intermediate 66 and 5.0 mL of a hydrogen chloride/1,4-dioxane solution (4 mol/L) was stirred at room temperature for 15 hours, and the resulting mixture was concentrated.
To a mixed solution of the obtained residue and 5.0 mL of THF, 0.37 mL of triethylamine and 0.27 mL of 3,5-bis(trifluoromethyl)benzoyl chloride were added in that order, and the mixture was stirred at room temperature for 1 hour. Water was added to the obtained mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was washed with water and saturated saline in that order. The obtained organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.15 g of intermediate 78.
Figure JPOXMLDOC01-appb-C000133
 Intermediate 78: 1 H-NMR (CDCl 3 ) δ: 8.75-8.73 (2H, m), 8.08 (2H, s), 7.96 (1H, s), 7.13-7.11 (1H, m), 6.28 (1H, s), 3.04-2.93 (3H, m), 1.84 (3H, d).

参考製造例５５
　中間体４９に代えて中間体５４を使用し、さらにオルトギ酸トリメチルに代えてオルト酢酸トリメチルを使用して、参考製造例３８に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000134
中間体６７：ＬＣＭＳ：３１２［Ｍ＋Ｈ］+、ＲＴ＝１．４４分 Reference Production Example 55
A compound prepared according to Reference Production Example 38 by using Intermediate 54 instead of Intermediate 49 and trimethyl orthoacetate instead of trimethyl orthoformate is shown below, and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000134
 Intermediate 67: LCMS: 312 [M+H] + , RT = 1.44 min

参考製造例５６
　中間体５５に代えて中間体６７を使用し、参考製造例４４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000135
中間体６８：1H-NMR (CDCl3) δ: 9.15 (1H, s), 7.37-7.31 (5H, m), 5.81 (1H, d), 5.47-5.45 (1H, m), 5.13-5.07 (2H, m), 2.65 (3H, s), 1.47 (3H, d). Reference Production Example 56
The compound prepared according to Reference Production Example 44 using Intermediate 67 instead of Intermediate 55 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000135
 Intermediate 68: 1 H-NMR (CDCl 3 ) δ: 9.15 (1H, s), 7.37-7.31 (5H, m), 5.81 (1H, d), 5.47-5.45 (1H, m), 5.13-5.07 (2H, m), 2.65 (3H, s), 1.47 (3H, d).

参考製造例５７
　中間体３に代えて中間体６８を使用し、参考製造例４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000136
中間体６９：1H-NMR (CDCl3) δ: 9.32 (1H, s), 9.00 (2H, d), 7.41 (1H, t), 7.35-7.31 (5H, m), 5.84 (1H, d), 5.29-5.28 (1H, m), 5.05-5.00 (2H, m), 2.64 (3H, s), 1.53 (3H, d). Reference Production Example 57
The compound prepared according to Reference Production Example 4 using Intermediate 68 instead of Intermediate 3 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000136
 Intermediate 69: 1 H-NMR (CDCl 3 ) δ: 9.32 (1H, s), 9.00 (2H, d), 7.41 (1H, t), 7.35-7.31 (5H, m), 5.84 (1H, d), 5.29-5.28 (1H, m), 5.05-5.00 (2H, m), 2.64 (3H, s), 1.53 (3H, d).

参考製造例５８
　１．０ｇの中間体６９及びトリフルオロ酢酸５．１ｍＬの混合液を、７０℃で４時間攪拌した。得られた混合物を室温まで放冷した後に濃縮し、メチルｔｅｒｔ－ブチルエーテル及び水を加えて抽出した。得られた水層に飽和炭酸水素ナトリウムを加えてｐＨ１０とした後、クロロホルム（２０容量％イソプロパノール含有）で抽出した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮し、中間体７０を０．５４ｇ得た。

Figure JPOXMLDOC01-appb-C000137
中間体７０：1H-NMR (CDCl3) δ: 9.35 (1H, s), 8.99 (2H, d), 7.41 (1H, t), 4.20 (1H, q), 2.63 (3H, s), 1.45 (3H, d). Reference Production Example 58
A mixture of 1.0 g of intermediate 69 and 5.1 mL of trifluoroacetic acid was stirred at 70° C. for 4 hours. The resulting mixture was allowed to cool to room temperature, concentrated, and extracted with methyl tert-butyl ether and water. Saturated sodium bicarbonate was added to the resulting aqueous layer to adjust the pH to 10, and then extracted with chloroform (containing 20% by volume of isopropanol). The resulting organic layer was dried over sodium sulfate, filtered, and concentrated to obtain 0.54 g of intermediate 70.
Figure JPOXMLDOC01-appb-C000137
 Intermediate 70: 1 H-NMR (CDCl 3 ) δ: 9.35 (1H, s), 8.99 (2H, d), 7.41 (1H, t), 4.20 (1H, q), 2.63 (3H, s), 1.45 (3H, d).

参考製造例５９
　（Ｓ）－４－［Ｎ－（ベンジルオキシカルボニル）アミノ］－３－オキソペンタン酸メチルに代えて非特許文献Ｔｅｔｒａｈｅｄｒｏｎ（２０１３）６９，１１０９２－１１１０８．に記載の方法に準じて製造した（Ｓ）－４－［Ｎ－（ベンジルオキシカルボニル）－Ｎ－メチルアミノ］－３－オキソペンタン酸メチルを使用し、さらにアセトアミジン塩酸塩に代えてホルムアミジン酢酸塩を使用して、参考製造例３３に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000138
中間体７１：ＬＣＭＳ：２８８［Ｍ＋Ｈ］+、ＲＴ＝１．３５分 Reference Production Example 59
The compound and its physical properties are shown below, which were produced in accordance with Reference Production Example 33 using methyl (S)-4-[N-(benzyloxycarbonyl)-N-methylamino]-3-oxopentanoate produced in accordance with the method described in non-patent document Tetrahedron (2013) 69, 11092-11108 instead of methyl (S)-4-[N-(benzyloxycarbonyl)amino]-3-oxopentanoate, and using formamidine acetate instead of acetamidine hydrochloride.
Figure JPOXMLDOC01-appb-C000138
 Intermediate 71: LCMS: 288 [M+H] + , RT = 1.35 min

参考製造例６０
　中間体５２に代えて中間体７１を使用し、参考製造例４１に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000139
中間体７２：ＬＣＭＳ：３０６［Ｍ＋Ｈ］+、ＲＴ＝１．８８分 Reference Manufacturing Example 60
The compound prepared according to Reference Production Example 41 using Intermediate 71 instead of Intermediate 52 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000139
 Intermediate 72: LCMS: 306 [M+H] + , RT = 1.88 min

参考製造例６１
　中間体４８に代えて中間体７２を使用し、参考製造例３７に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000140
中間体７３：1H-NMR (CDCl3) δ: 8.55 (1H, s), 7.36-7.32 (5H, m), 6.53 (1H, d), 6.24 (1H, s), 5.41-5.10 (3H, m), 3.79-3.72 (2H, m), 2.86 (3H, s), 1.54 (3H, d). Reference Manufacturing Example 61
The compound prepared according to Reference Production Example 37 using Intermediate 72 instead of Intermediate 48 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000140
 Intermediate 73: 1 H-NMR (CDCl 3 ) δ: 8.55 (1H, s), 7.36-7.32 (5H, m), 6.53 (1H, d), 6.24 (1H, s), 5.41-5.10 (3H, m), 3.79-3.72 (2H, m), 2.86 (3H, s), 1.54 (3H, d).

参考製造例６２
　中間体４９に代えて中間体７３を使用し、参考製造例３８に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000141
中間体７４：ＬＣＭＳ：３１２［Ｍ＋Ｈ］+、ＲＴ＝１．５６分 Reference Manufacturing Example 62
The compound prepared according to Reference Production Example 38 using Intermediate 73 instead of Intermediate 49 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000141
 Intermediate 74: LCMS: 312 [M+H] + , RT = 1.56 min

参考製造例６３
　中間体５６に代えて中間体７４を使用し、参考製造例４４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000142
中間体７５：ＬＣＭＳ：３９０／３９２［Ｍ＋Ｈ］+、ＲＴ＝１．７０分 Reference Production Example 63
The compound prepared according to Reference Production Example 44 using Intermediate 74 instead of Intermediate 56 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000142
 Intermediate 75: LCMS: 390/392 [M+H] + , RT = 1.70 min

参考製造例６４
　中間体３に代えて中間体７５を使用し、参考製造例４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000143
中間体７６：ＬＣＭＳ：３９０［Ｍ＋Ｈ］+、ＲＴ＝１．４９分 Reference Production Example 64
The compound prepared according to Reference Production Example 4 using Intermediate 75 instead of Intermediate 3 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000143
 Intermediate 76: LCMS: 390 [M+H] + , RT = 1.49 min

参考製造例６５
　中間体５０に代えて中間体７６を使用し、参考製造例３９に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000144
中間体７７：1H-NMR (CDCl3) δ: 9.48 (1H, s), 9.00 (2H, d), 8.43 (1H, s), 7.43 (1H, t), 4.00 (1H, q), 2.18 (3H, s), 1.45 (3H, d).  Reference Manufacturing Example 65
The compound prepared according to Reference Production Example 39 using Intermediate 76 instead of Intermediate 50 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000144
 Intermediate 77: 1 H-NMR (CDCl 3 ) δ: 9.48 (1H, s), 9.00 (2H, d), 8.43 (1H, s), 7.43 (1H, t), 4.00 (1H, q), 2.18 (3H, s), 1.45 (3H, d).

製造例１
　０．１３ｇの中間体１及びクロロホルム３．０ｍＬの混合物に、トリフルオロ酢酸１．０ｍＬを室温下で加え、２時間攪拌した。得られた混合物を濃縮した後、ＴＨＦ３．７ｍＬ、Ｎ，Ｎ－ジイソプロピルエチルアミン０．３３ｍＬ、３，５－ビストリフルオロメチルベンゾイルクロリド０．１０ｇを室温下で順次加え、１時間攪拌した。得られた混合物に水を加え、クロロホルムを用いて抽出した。得られた有機層を水、及び飽和食塩水で洗浄後、硫酸ナトリウムで乾燥し、濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される本発明化合物１を０．０５９ｇ得た。

Figure JPOXMLDOC01-appb-C000145
本発明化合物１：ＬＣＭＳ：４９５［Ｍ＋Ｈ］+、ＲＴ＝１．７４分 Production Example 1
To a mixture of 0.13 g of intermediate 1 and 3.0 mL of chloroform, 1.0 mL of trifluoroacetic acid was added at room temperature and stirred for 2 hours. The resulting mixture was concentrated, and then 3.7 mL of THF, 0.33 mL of N,N-diisopropylethylamine, and 0.10 g of 3,5-bistrifluoromethylbenzoyl chloride were added successively at room temperature and stirred for 1 hour. Water was added to the resulting mixture, and the mixture was extracted with chloroform. The resulting organic layer was washed with water and saturated saline, dried over sodium sulfate, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.059 g of the present invention compound 1 represented by the following formula.
Figure JPOXMLDOC01-appb-C000145
 Compound 1 of the present invention: LCMS: 495 [M+H] + , RT = 1.74 min

製造例２
　０．０５８ｇの中間体６及びＤＭＦ２．４ｍＬの混合物に、Ｎ，Ｎ－ジイソプロピルエチルアミン０．２１ｍＬ及び３，５－ビス（トリフルオロメチル）ベンゾイルクロリド０．０６６ｇを順次加え、室温で１時間攪拌した。得られた混合物に水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、本発明化合物２を０．０６０ｇ得た。

Figure JPOXMLDOC01-appb-C000146
本発明化合物２：1H-NMR (CDCl3) δ: 9.00 (2H, d), 8.61-8.59 (1H, m), 8.50 (1H, d), 8.33 (2H, s), 8.07-8.05 (1H, m), 8.00 (1H, s), 7.32 (1H, t), 7.24-7.22 (1H, m), 6.21-6.19 (1H, m), 1.67 (3H, d). Production Example 2
To a mixture of 0.058 g of intermediate 6 and 2.4 mL of DMF, 0.21 mL of N,N-diisopropylethylamine and 0.066 g of 3,5-bis(trifluoromethyl)benzoyl chloride were added in that order, and the mixture was stirred at room temperature for 1 hour. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated saline in that order. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.060 g of the present compound 2.
Figure JPOXMLDOC01-appb-C000146
 Compound 2 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.00 (2H, d), 8.61-8.59 (1H, m), 8.50 (1H, d), 8.33 (2H, s), 8.07-8.05 (1H, m), 8.00 (1H, s), 7.32 (1H, t), 7.24-7.22 (1H, m), 6.21-6.19 (1H, m), 1.67 (3H, d).

製造例３
　中間体６に代えて中間体７を使用し、製造例２に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000147
本発明化合物３：ＬＣＭＳ：４９５［Ｍ＋Ｈ］+、ＲＴ＝１．７３分 Production Example 3
The compound produced in accordance with Production Example 2 using Intermediate 7 instead of Intermediate 6 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000147
 Compound 3 of the present invention: LCMS: 495 [M+H] + , RT = 1.73 minutes

製造例４
　０．１１ｇの中間体７及びＴＨＦ２．０ｍＬの混合物に、３，５－ビス（ジフルオロメトキシ）安息香酸０．１００ｇ、１－(３－ジメチルアミノプロピル) －３－エチルカルボジイミド塩酸塩０．１３６ｇ及び４－ジメチルアミノピリジン０．１３０ｇを順次加え、室温で６時間攪拌した。得られた混合物に水を加えて酢酸エチルを用いて抽出した。得られた有機層を飽和食塩水で洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される本発明化合物４を０．０４１ｇ得た。

Figure JPOXMLDOC01-appb-C000148
本発明化合物４：ＬＣＭＳ：４９１［Ｍ＋Ｈ］+、ＲＴ＝１．５８分 Production Example 4
To a mixture of 0.11 g of intermediate 7 and 2.0 mL of THF, 0.100 g of 3,5-bis(difluoromethoxy)benzoic acid, 0.136 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, and 0.130 g of 4-dimethylaminopyridine were added in that order, and the mixture was stirred at room temperature for 6 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.041 g of the present invention compound 4 represented by the following formula.
Figure JPOXMLDOC01-appb-C000148
 Compound 4 of the present invention: LCMS: 491 [M+H] + , RT = 1.58 min

製造例５
　中間体３に代えて中間体１２を使用し、参考製造例４に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000149
本発明化合物５：1H-NMR (CDCl3) δ: 10.05 (1H, d), 8.95 (2H, d), 8.82 (1H, dd), 8.74 (1H, dd), 8.37 (2H, s), 8.00 (1H, s), 7.27 (1H, t), 7.02 (1H, dd), 6.14-6.10 (1H, m), 1.61 (3H, d). Production Example 5
The compound prepared according to Reference Production Example 4 using Intermediate 12 instead of Intermediate 3 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000149
 Compound 5 of the present invention: 1 H-NMR (CDCl 3 ) δ: 10.05 (1H, d), 8.95 (2H, d), 8.82 (1H, dd), 8.74 (1H, dd), 8.37 (2H, s), 8.00 (1H, s), 7.27 (1H, t), 7.02 (1H, dd), 6.14-6.10 (1H, m), 1.61 (3H, d).

製造例６
　０．１６５ｇの３，５－ビス（ジフルオロメトキシ）安息香酸に、２．９ｍＬのＴＨＦ、２．３μＬのＤＭＦ及び０．０６１ｍＬの塩化オキサリルを順次加え、室温で１時間撹拌した。得られた混合物を濃縮し、残渣に０．５ｍＬのＴＨＦを加えて混合物Ｃとした。０．１５ｇの中間体１７、０．１６４ｍＬのトリエチルアミン及び１．２ｍＬのＴＨＦの混合物に混合物Ｃを加え、室温で１時間撹拌した。得られた混合物に水を加えてクロロホルムを用いて抽出した。得られた有機層を飽和食塩水で洗浄し、硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される本発明化合物６を０．２０６ｇ得た。

Figure JPOXMLDOC01-appb-C000150
本発明化合物６：ＬＣＭＳ：４９１［Ｍ＋Ｈ］+、ＲＴ＝１．５７分 Production Example 6
2.9 mL of THF, 2.3 μL of DMF, and 0.061 mL of oxalyl chloride were added to 0.165 g of 3,5-bis(difluoromethoxy)benzoic acid in this order, and the mixture was stirred at room temperature for 1 hour. The resulting mixture was concentrated, and 0.5 mL of THF was added to the residue to obtain mixture C. Mixture C was added to a mixture of 0.15 g of intermediate 17, 0.164 mL of triethylamine, and 1.2 mL of THF, and the mixture was stirred at room temperature for 1 hour. Water was added to the resulting mixture, and the mixture was extracted with chloroform. The resulting organic layer was washed with saturated saline, dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.206 g of the present invention compound 6 represented by the following formula.
Figure JPOXMLDOC01-appb-C000150
 Compound 6 of the present invention: LCMS: 491 [M+H] + , RT = 1.57 min

製造例７
　製造例６に準じて製造した化合物及びその物性値を以下に示す。
　式（Ｂ－４）

Figure JPOXMLDOC01-appb-C000151
で示される化合物において、Ａ１、Ａ２、Ａ３及びＡ４の組合せが［表Ｂ－４］に記載のいずれかの組合せである化合物。 Production Example 7
The compounds prepared according to Preparation Example 6 and their physical properties are shown below.
Formula (B-4)
Figure JPOXMLDOC01-appb-C000151
 In the compound represented by the formula (I), a combination of A 1 , A 2 , A 3 and A 4 is any of the combinations described in [Table B-4].

Figure JPOXMLDOC01-appb-T000152
本発明化合物７：ＬＣＭＳ：５１５/５１７/５１９［Ｍ＋Ｈ］+、ＲＴ＝１．６４分
本発明化合物８：ＬＣＭＳ：４６２/４６４［Ｍ＋Ｈ］+、ＲＴ＝１．４４分
本発明化合物９：ＬＣＭＳ：５４７［Ｍ＋Ｈ］+、ＲＴ＝１．３３分
本発明化合物１０：ＬＣＭＳ：５３１/５３３［Ｍ＋Ｈ］+、ＲＴ＝１．４５分
本発明化合物１１：ＬＣＭＳ：５１６/５１８/５２０［Ｍ＋Ｈ］+、ＲＴ＝１．５０分
本発明化合物１２：ＬＣＭＳ：５１５/５１７［Ｍ＋Ｈ］+、ＲＴ＝１．３３分
本発明化合物１３：ＬＣＭＳ：４３８/４４０［Ｍ＋Ｈ］+、ＲＴ＝１．２５分
本発明化合物１４：ＬＣＭＳ：４９５［Ｍ＋Ｈ］+、ＲＴ＝１．７２分
本発明化合物１５：ＬＣＭＳ：５０２/５０４［Ｍ＋Ｈ］+、ＲＴ＝１．５２分
本発明化合物１６：ＬＣＭＳ：５０４/５０６［Ｍ＋Ｈ］+、ＲＴ＝１．５６分
本発明化合物１７：ＬＣＭＳ：５４１/５４３［Ｍ＋Ｈ］+、ＲＴ＝１．４５分
Figure JPOXMLDOC01-appb-T000152
 Inventive compound 7: LCMS: 515/517/519 [M+H] + , RT = 1.64 min Inventive compound 8: LCMS: 462/464 [M+H] + , RT = 1.44 min Inventive compound 9: LCMS: 547 [M+H] + , RT=1.33 min Inventive compound 10: LCMS: 531/533 [M+H] + , RT=1.45 min Inventive compound 11: LCMS: 516/518/520 [M+H] + , RT=1.50 min Inventive compound 12: LCMS: 515/517 [M+H] + , RT=1.33 min Inventive compound 13: LCMS: 438/440 [M+H] + , RT=1.25 min Inventive compound 14: LCMS: 495 [M+H] + , RT = 1.72 min Compound 15: LCMS: 502/504 [M+H] + , RT = 1.52 min Compound 16: LCMS: 504/506 [M+H] + , RT = 1.56 min Compound 17: LCMS: 541/543 [M+H] + , RT = 1.45 min

製造例８
　製造例２に準じて製造した化合物及びその物性値を以下に示す。
式（Ｂ－５）

Figure JPOXMLDOC01-appb-C000153
で示される化合物において、Ｒ3q1、Ｒ3q2及びＲ3q3の組合せが［表Ｂ－５］に記載のいずれかの組合せである化合物。 Production Example 8
The compounds prepared according to Preparation Example 2 and their physical properties are shown below.
Formula (B-5)
Figure JPOXMLDOC01-appb-C000153
 In the compound represented by the following formula (1), the combination of R 3q1 , R 3q2 and R 3q3 is any of the combinations described in [Table B-5].

Figure JPOXMLDOC01-appb-T000154
本発明化合物１８：ＬＣＭＳ：５２３［Ｍ＋Ｈ］+、ＲＴ＝１．９２分
本発明化合物１９：ＬＣＭＳ：５２９/５３１［Ｍ＋Ｈ］+、ＲＴ＝１．９４分
本発明化合物２０：ＬＣＭＳ：５０９［Ｍ＋Ｈ］+、ＲＴ＝１．８３分
本発明化合物２１：ＬＣＭＳ：５０９［Ｍ＋Ｈ］+、ＲＴ＝１．８７分
Figure JPOXMLDOC01-appb-T000154
 Inventive compound 18: LCMS: 523 [M+H] + , RT = 1.92 min Inventive compound 19: LCMS: 529/531 [M+H] + , RT = 1.94 min Inventive compound 20: LCMS: 509 [M+H] + , RT = 1.83 min Inventive compound 21: LCMS: 509 [M+H] + , RT=1.87 minutes

製造例９
　中間体６に代えて中間体３６を使用し、製造例２に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000155
本発明化合物２２：ＬＣＭＳ：４７４［Ｍ＋Ｈ］+、ＲＴ＝１．７８分 Production Example 9
A compound produced according to Production Example 2 using Intermediate 36 instead of Intermediate 6 and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000155
 Compound 22 of the present invention: LCMS: 474 [M+H] + , RT = 1.78 min

製造例１０
　製造例２に準じて製造した化合物及びその物性値を以下に示す。
　式（Ｃ－１）

Figure JPOXMLDOC01-appb-C000156
で示される化合物において、Ｒ10、Ｒ4及びＲ3q4の組合せが［表Ｃ－１］に記載のいずれかの組合せである化合物。 Production Example 10
The compounds prepared according to Preparation Example 2 and their physical properties are shown below.
Formula (C-1)
Figure JPOXMLDOC01-appb-C000156
 In the compound represented by the following formula (1), the combination of R 10 , R 4 and R 3q4 is any of the combinations described in [Table C-1].

Figure JPOXMLDOC01-appb-T000157
本発明化合物２３：1H-NMR (CDCl3) δ: 9.04 (2H, d), 8.46 (1H, s), 8.22 (2H, s), 8.01 (1H, s), 7.55 (1H, d), 7.45 (1H, t), 5.85-5.83 (1H, m), 3.12 (3H, s), 1.66 (3H, d).
本発明化合物２４：1H-NMR (CDCl3) δ: 9.54 (1H, s), 9.06 (2H, d), 8.50 (1H, s), 8.21 (2H, s), 8.01 (1H, s), 7.48 (1H, t), 7.42 (1H, d), 5.86-5.84 (1H, m), 1.69 (3H, d).
本発明化合物２６：1H-NMR (DMSO-D6) δ: 9.82 (1H, s), 9.35 (1H, d), 9.00 (2H, d), 8.40 (2H, s), 8.29 (1H, s), 7.60 (1H, t), 5.36-5.31 (1H, m), 2.48 (3H, s), 1.64 (3H, d).
本発明化合物４９：1H-NMR (CDCl3) δ: 9.51 (1H, s), 8.97 (2H, d), 8.49 (1H, s), 7.87 (1H, s), 7.70 (2H, s), 7.40-7.38 (1H, m), 6.31-6.30 (1H, m), 2.87 (3H, s), 1.75 (3H, d).
Figure JPOXMLDOC01-appb-T000157
 Compound 23 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.04 (2H, d), 8.46 (1H, s), 8.22 (2H, s), 8.01 (1H, s), 7.55 (1H, d), 7.45 (1H, t), 5.85-5.83 (1H, m), 3.12 (3H, s), 1.66 (3H, d).
Compound 24 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.54 (1H, s), 9.06 (2H, d), 8.50 (1H, s), 8.21 (2H, s), 8.01 (1H, s), 7.48 (1H, t), 7.42 (1H, d), 5.86-5.84 (1H, m), 1.69 (3H, d).
Compound 26 of the present invention: 1 H-NMR (DMSO-D 6 ) δ: 9.82 (1H, s), 9.35 (1H, d), 9.00 (2H, d), 8.40 (2H, s), 8.29 (1H, s), 7.60 (1H, t), 5.36-5.31 (1H, m), 2.48 (3H, s), 1.64 (3H, d).
Compound 49 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.51 (1H, s), 8.97 (2H, d), 8.49 (1H, s), 7.87 (1H, s), 7.70 (2H, s), 7.40-7.38 (1H, m), 6.31-6.30 (1H, m), 2.87 (3H, s), 1.75 (3H, d).

製造例１１
　製造例４に準じて製造した化合物及びその物性値を以下に示す。
　式（Ｃ－２）

Figure JPOXMLDOC01-appb-C000158
で示される化合物において、Ａ5、Ａ6、Ｒ10、Ｒ4及びＲ3q4の組合せが［表Ｃ－２］に記載のいずれかの組合せである化合物。 Production Example 11
The compounds prepared according to Preparation Example 4 and their physical properties are shown below.
Formula (C-2)
Figure JPOXMLDOC01-appb-C000158
 In the compound represented by the following formula (1), a combination of A 5 , A 6 , R 10 , R 4 and R 3q4 is any one of the combinations described in [Table C-2].

Figure JPOXMLDOC01-appb-I000159
本発明化合物２７：1H-NMR (DMSO-D6) δ: 9.00-8.97 (3H, m), 8.61 (1H, d), 8.00-7.99 (1H, m), 7.92-7.91 (2H, m), 7.61-7.58 (1H, m), 5.33-5.27 (1H, m), 2.99 (3H, s), 1.60 (3H, d). 
本発明化合物２８：1H-NMR (CDCl3) δ:: 9.03 (2H, d), 8.45 (1H, s), 7.63 (2H, d), 7.48 (1H, t), 7.43 (1H, t), 7.36 (1H, d), 5.79-5.76 (1H, m), 3.13 (3H, s), 1.62 (3H, d).
本発明化合物２９：1H-NMR (CDCl3) δ: 9.41 (1H, s), 9.03 (2H, d), 7.82 (2H, d), 7.78 (1H, t), 7.46-7.43 (1H, m), 7.30 (1H, d), 5.71-5.68 (1H, m), 2.65 (3H, s), 1.60 (3H, d).
本発明化合物５０：1H-NMR (DMSO-D6) δ: 9.95 (1H, s), 9.03 (1H, d), 9.01 (2H, d), 8.64 (1H, s), 7.99 (1H, t), 7.93 (2H, d), 7.62 (1H, t), 5.32-5.27 (1H, m), 1.61 (3H, d).
本発明化合物５１：1H-NMR (DMSO-D6) δ: 9.95 (1H, s), 9.03 (1H, d), 9.02 (2H, d), 8.65 (1H, s), 7.78-7.76 (3H, m), 7.63 (1H, t), 5.32-5.28 (1H, m), 1.61 (3H, d).
本発明化合物５２：1H-NMR (CDCl3) δ: 9.50 (1H, s), 8.98 (2H, d), 8.48 (1H, s), 7.65 (1H, s), 7.41-7.39 (1H, m), 7.30 (2H, s), 6.30-6.27 (1H, m), 2.83 (3H, s), 1.71 (3H, d).
本発明化合物５３：1H-NMR (CDCl3) δ: 9.50 (1H, s), 8.98 (2H, d), 8.48 (1H, s), 7.40-7.39 (1H, m), 7.34 (1H, s), 7.11 (2H, s), 6.29-6.28 (1H, m), 2.84 (3H, s), 1.71 (3H, d).
本発明化合物５４：1H-NMR (CDCl3) δ: 9.50 (1H, s), 8.98 (2H, d), 8.48 (1H, s), 8.03 (1H, s), 7.49 (2H, s), 7.40-7.39 (1H, m), 6.30-6.27 (1H, m), 2.81 (3H, s), 1.70 (3H, d).
本発明化合物５５：ＬＣＭＳ：４９２［Ｍ＋Ｈ］+、ＲＴ＝１．５７分
本発明化合物５６：ＬＣＭＳ：５１６/５１８［Ｍ＋Ｈ］+、ＲＴ＝１．３１分
本発明化合物５７：ＬＣＭＳ：５０３/５０５［Ｍ＋Ｈ］+、ＲＴ＝１．５０分
本発明化合物５８：1H-NMR (CDCl3) δ: 9.50 (1H, s), 8.99 (2H, d), 8.48 (1H, s), 7.58 (1H, s), 7.41-7.40 (1H, m), 7.29 (2H, s), 6.29-6.28 (1H, m), 2.85 (3H, s), 1.73 (3H, d), 1.68 (6H, d).
Figure JPOXMLDOC01-appb-I000159
Compound 27 of the present invention: 1 H-NMR (DMSO-D 6 ) δ: 9.00-8.97 (3H, m), 8.61 (1H, d), 8.00-7.99 (1H, m), 7.92-7.91 (2H, m), 7.61-7.58 (1H, m), 5.33-5.27 (1H, m), 2.99 (3H, s), 1.60 (3H, d).
Compound 28 of the present invention: 1 H-NMR (CDCl 3 ) δ:: 9.03 (2H, d), 8.45 (1H, s), 7.63 (2H, d), 7.48 (1H, t), 7.43 (1H, t), 7.36 (1H, d), 5.79-5.76 (1H, m), 3.13 (3H, s), 1.62 (3H, d).
Compound 29 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.41 (1H, s), 9.03 (2H, d), 7.82 (2H, d), 7.78 (1H, t), 7.46-7.43 (1H, m), 7.30 (1H, d), 5.71-5.68 (1H, m), 2.65 (3H, s), 1.60 (3H, d).
Compound 50 of the present invention: 1 H-NMR (DMSO-D 6 ) δ: 9.95 (1H, s), 9.03 (1H, d), 9.01 (2H, d), 8.64 (1H, s), 7.99 (1H, t), 7.93 (2H, d), 7.62 (1H, t), 5.32-5.27 (1H, m), 1.61 (3H, d).
Compound 51 of the present invention: 1 H-NMR (DMSO-D 6 ) δ: 9.95 (1H, s), 9.03 (1H, d), 9.02 (2H, d), 8.65 (1H, s), 7.78-7.76 (3H, m), 7.63 (1H, t), 5.32-5.28 (1H, m), 1.61 (3H, d).
Compound 52 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.50 (1H, s), 8.98 (2H, d), 8.48 (1H, s), 7.65 (1H, s), 7.41-7.39 (1H, m), 7.30 (2H, s), 6.30-6.27 (1H, m), 2.83 (3H, s), 1.71 (3H, d).
Compound 53 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.50 (1H, s), 8.98 (2H, d), 8.48 (1H, s), 7.40-7.39 (1H, m), 7.34 (1H, s), 7.11 (2H, s), 6.29-6.28 (1H, m), 2.84 (3H, s), 1.71 (3H, d).
Compound 54 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.50 (1H, s), 8.98 (2H, d), 8.48 (1H, s), 8.03 (1H, s), 7.49 (2H, s), 7.40-7.39 (1H, m), 6.30-6.27 (1H, m), 2.81 (3H, s), 1.70 (3H, d).
Compound of the present invention 55: LCMS: 492 [M+H] + , RT = 1.57 min Compound of the present invention 56: LCMS: 516/518 [M+H] + , RT = 1.31 min Compound of the present invention 57: LCMS: 503/505 [M+H] + , RT = 1.50 min Compound of the present invention 58: 1 H-NMR (CDCl 3 ) δ: 9.50 (1H, s), 8.99 (2H, d), 8.48 (1H, s), 7.58 (1H, s), 7.41-7.40 (1H, m), 7.29 (2H, s), 6.29-6.28 (1H, m), 2.85 (3H, s), 1.73 (3H, d), 1.68 (6H, d).

製造例２１
　０．１６ｇの中間体５１及びＤＭＦ６．３ｍＬの混合物に、３－ジフルオロメチル－１－メチル－１Ｈ－ピラゾール－５－カルボン酸０．１７ｇ、１－(３－ジメチルアミノプロピル) －３－エチルカルボジイミド塩酸塩０．２４ｇ、Ｎ，Ｎ－ジイソプロピルエチルアミン０．３２ｍＬ及び１－ヒドロキシベンゾトリアゾール０．１３ｇを順次加え、室温で２２時間攪拌した。得られた混合物に水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される本発明化合物４７を０．１０ｇ得た。

Figure JPOXMLDOC01-appb-C000160
本発明化合物４７：1H-NMR (CDCl3) δ: 9.03 (2H, d), 8.46 (1H, s), 7.43 (1H, t), 7.34 (1H, d), 6.77-6.58 (2H, m), 5.77-5.75 (1H, m), 4.13 (3H, s), 3.13 (3H, s), 1.61 (3H, d). Production Example 21
To a mixture of 0.16 g of intermediate 51 and 6.3 mL of DMF, 0.17 g of 3-difluoromethyl-1-methyl-1H-pyrazole-5-carboxylic acid, 0.24 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 0.32 mL of N,N-diisopropylethylamine, and 0.13 g of 1-hydroxybenzotriazole were added in order, and the mixture was stirred at room temperature for 22 hours. Water was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.10 g of the present invention compound 47 represented by the following formula.
Figure JPOXMLDOC01-appb-C000160
 Compound 47 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.03 (2H, d), 8.46 (1H, s), 7.43 (1H, t), 7.34 (1H, d), 6.77-6.58 (2H, m), 5.77-5.75 (1H, m), 4.13 (3H, s), 3.13 (3H, s), 1.61 (3H, d).

製造例２２
　０．０５２ｇの中間体６１及びトリフルオロ酢酸２．８ｍＬの混合液を、７０℃で４時間攪拌した。得られた混合物を室温まで放冷した後に濃縮し、メチルｔｅｒｔ－ブチルエーテル及び水を加えて抽出した。得られた水層に飽和炭酸水素ナトリウムを加えてｐＨ１０とした後、クロロホルム（２０容量％イソプロパノール含有）で抽出した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。
　得られた残渣にＤＭＦ２．８ｍＬ、Ｎ，Ｎ－ジイソプロピルエチルアミン０．０７１ｍＬ及び３，５－ビストリフルオロメチルベンゾイルクロリド０．８２ｇを室温下で順次加え、３時間攪拌した。得られた混合物に水を加え、クロロホルムを用いて抽出した。得られた有機層を水、及び飽和食塩水で洗浄後、硫酸ナトリウムで乾燥し、濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、次式で示される本発明化合物２５を０．０４６ｇ得た。

Figure JPOXMLDOC01-appb-C000161
本発明化合物２５：1H-NMR (CDCl3) δ: 9.02 (2H, d), 8.23 (2H, s), 8.00 (1H, s), 7.76 (1H, d), 7.67 (1H, d), 7.59 (1H, d), 7.42 (1H, t), 5.61-5.59 (1H, m), 2.94 (3H, s), 1.58 (3H, d). Production Example 22
A mixture of 0.052 g of Intermediate 61 and 2.8 mL of trifluoroacetic acid was stirred at 70° C. for 4 hours. The resulting mixture was allowed to cool to room temperature, concentrated, and extracted with methyl tert-butyl ether and water. Saturated sodium bicarbonate was added to the resulting aqueous layer to adjust the pH to 10, and then extracted with chloroform (containing 20% by volume of isopropanol). The resulting organic layer was dried over sodium sulfate, filtered, and concentrated.
To the resulting residue, 2.8 mL of DMF, 0.071 mL of N,N-diisopropylethylamine, and 0.82 g of 3,5-bistrifluoromethylbenzoyl chloride were added in that order at room temperature, and the mixture was stirred for 3 hours. Water was added to the resulting mixture, and the mixture was extracted with chloroform. The resulting organic layer was washed with water and saturated saline, dried over sodium sulfate, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.046 g of the present compound 25 represented by the following formula.
Figure JPOXMLDOC01-appb-C000161
 Compound 25 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.02 (2H, d), 8.23 (2H, s), 8.00 (1H, s), 7.76 (1H, d), 7.67 (1H, d), 7.59 (1H, d), 7.42 (1H, t), 5.61-5.59 (1H, m), 2.94 (3H, s), 1.58 (3H, d).

製造例１２
　０．５０ｇの中間体６３、トルエン１０ｍＬ及び水１．０ｍＬの混合物に、窒素雰囲気下、１－メチル－３－（４，４，５，５－テトラメチル－１，３，２－ジオキサボロラン－２－イル）－１－Ｈ－ピラゾール０．２４ｇ、［１，１´－ビス（ジフェニルホスフィノ）フェロセン］ジクロロパラジウム（ＩＩ）０．０７３ｇ及びリン酸カリウム０．６５ｇを順次加え、加熱還流下で３時間攪拌した。得られた混合物を室温まで放冷して、水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、本発明化合物３０を０．０６０ｇ得た。

Figure JPOXMLDOC01-appb-C000162
本発明化合物３０：1H-NMR (CDCl3) δ: 9.40 (1H, s), 8.45 (1H, s), 8.25 (2H, s), 8.01 (1H, s), 7.74 (1H, d), 7.58 (1H, d), 7.19 (1H, d), 6.28-6.26 (1H, m), 4.07 (3H, s), 1.67 (3H, d). Production Example 12
To a mixture of 0.50 g of intermediate 63, 10 mL of toluene and 1.0 mL of water, 0.24 g of 1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-H-pyrazole, 0.073 g of [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II) and 0.65 g of potassium phosphate were added in this order under a nitrogen atmosphere, and the mixture was stirred under heating and reflux for 3 hours. The mixture was allowed to cool to room temperature, water was added, and the mixture was extracted with ethyl acetate. The organic layer obtained was washed with water and saturated saline in this order. The organic layer obtained was dried over sodium sulfate, filtered and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.060 g of the present invention compound 30.
Figure JPOXMLDOC01-appb-C000162
 Compound 30 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.40 (1H, s), 8.45 (1H, s), 8.25 (2H, s), 8.01 (1H, s), 7.74 (1H, d), 7.58 (1H, d), 7.19 (1H, d), 6.28-6.26 (1H, m), 4.07 (3H, s), 1.67 (3H, d).

製造例１２－１
　製造例１２に準じて製造した化合物及びその物性値を以下に示す。
　式（Ｃ－３）

Figure JPOXMLDOC01-appb-C000163
で示される化合物において、Ｒ２ａ、Ｒ２ｂ、Ｒ２ｃ及びＲ２ｄの組合せが［表Ｃ－３］に記載のいずれかの組合せである化合物。 Production Example 12-1
The compounds prepared according to Preparation Example 12 and their physical properties are shown below.
Formula (C-3)
Figure JPOXMLDOC01-appb-C000163
 In the compound represented by the following formula (I), the combination of R 2a , R 2b , R 2c and R 2d is any of the combinations described in [Table C-3].

Figure JPOXMLDOC01-appb-T000164
本発明化合物３１：1H-NMR (CDCl3) δ: 9.47 (1H, s), 8.43 (1H, s), 8.23 (2H, s), 8.03 (1H, s), 7.97-7.95 (2H, m), 7.87-7.85 (1H, m), 7.77-7.75 (1H, m), 7.12 (1H, d), 5.47-5.43 (1H, m), 1.57 (3H, d).
本発明化合物３２：1H-NMR (CDCl3) δ: 9.46 (1H, s), 8.42 (1H, s), 8.23 (2H, s), 8.03 (1H, s), 7.92 (2H, d), 7.82 (2H, d), 7.09 (1H, d), 5.50-5.48 (1H, m), 1.55 (3H, d).
本発明化合物３３：1H-NMR (CDCl3) δ: 9.44 (1H, s), 8.42 (1H, s), 8.23 (2H, s), 8.03 (1H, s), 7.38-7.36 (2H, m), 7.05 (1H, d), 5.53-5.50 (1H, m), 1.57 (3H, d).
本発明化合物３４：1H-NMR (CDCl3) δ: 9.45 (1H, s), 8.42 (1H, s), 8.23 (2H, s), 8.02 (1H, s), 7.67-7.65 (1H, m), 7.60 (1H, d), 7.51 (1H, d), 7.42 (1H, d), 7.12 (1H, d), 5.56-5.49 (1H, m), 1.55 (3H, d).
本発明化合物３５：ＬＣＭＳ：４９８［Ｍ＋Ｈ］+、ＲＴ＝２．０１分
本発明化合物３６：1H-NMR (CDCl3) δ: 9.42 (1H, s), 8.40 (1H, s), 8.24 (2H, s), 8.02 (1H, s), 7.56-7.54 (2H, m), 7.21 (1H, d), 7.14-7.12 (2H, m), 5.68-5.66 (1H, m), 3.90 (3H, s), 1.54 (3H, d).
Figure JPOXMLDOC01-appb-T000164
 Compound 31 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.47 (1H, s), 8.43 (1H, s), 8.23 (2H, s), 8.03 (1H, s), 7.97-7.95 (2H, m), 7.87-7.85 (1H, m), 7.77-7.75 (1H, m), 7.12 (1H, d), 5.47-5.43 (1H, m), 1.57 (3H, d).
Compound 32 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.46 (1H, s), 8.42 (1H, s), 8.23 (2H, s), 8.03 (1H, s), 7.92 (2H, d), 7.82 (2H, d), 7.09 (1H, d), 5.50-5.48 (1H, m), 1.55 (3H, d).
Compound 33 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.44 (1H, s), 8.42 (1H, s), 8.23 (2H, s), 8.03 (1H, s), 7.38-7.36 (2H, m), 7.05 (1H, d), 5.53-5.50 (1H, m), 1.57 (3H, d).
Compound 34 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.45 (1H, s), 8.42 (1H, s), 8.23 (2H, s), 8.02 (1H, s), 7.67-7.65 (1H, m), 7.60 (1H, d), 7.51 (1H, d), 7.42 (1H, d), 7.12 (1H, d), 5.56-5.49 (1H, m), 1.55 (3H, d).
Compound 35 of the present invention: LCMS: 498 [M+H] + , RT = 2.01 min Compound 36 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.42 (1H, s), 8.40 (1H, s), 8.24 (2H, s), 8.02 (1H, s), 7.56-7.54 (2H, m), 7.21 (1H, d), 7.14-7.12 (2H, m), 5.68-5.66 (1H, m), 3.90 (3H, s), 1.54 (3H, d).

製造例１２－２
　１－メチル－３－（４，４，５，５－テトラメチル－１，３，２－ジオキサボロラン－２－イル）－１－Ｈ－ピラゾールに代えて、４‐ピリジルボロン酸を使用し、製造例１２に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000165
本発明化合物４８：1H-NMR (CDCl3) δ: 9.47 (1H, s), 8.90-8.89 (2H, m), 8.43 (1H, s), 8.24 (2H, s), 8.03 (1H, s), 7.64-7.63 (2H, m), 7.14 (1H, d), 5.54-5.52 (1H, m), 1.55 (3H, d). Production Example 12-2
The compound prepared according to Preparation Example 12 using 4-pyridylboronic acid instead of 1-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-H-pyrazole and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000165
 Compound 48 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.47 (1H, s), 8.90-8.89 (2H, m), 8.43 (1H, s), 8.24 (2H, s), 8.03 (1H, s), 7.64-7.63 (2H, m), 7.14 (1H, d), 5.54-5.52 (1H, m), 1.55 (3H, d).

製造例１３
　０．３０ｇの中間体６３、０．２２ｇの５－（トリフルオロメチル）ピリジン－２－スルフィン酸ナトリウム、０．０２７ｇの酢酸パラジウム（ＩＩ）、０．０３４ｇのトリシクロヘキシルホスフィン、０．１７ｇの炭酸カリウム及び３．１ｍＬの１，４‐ジオキサンの混合物を、マイクロ波反応装置を用いて１５０℃で１．５時間攪拌した。得られた混合物を室温まで放冷して減圧下で濃縮した後に、クロロホルムに溶解した。セライトろ過を行った後に、得られた溶液を減圧下で濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、本発明化合物３７を０．２６ｇ得た。

Figure JPOXMLDOC01-appb-C000166
本発明化合物３７：1H-NMR (CDCl3) δ: 9.50 (1H, s), 9.12 (1H, s), 8.46 (1H, s), 8.25 (1H, d), 8.21-8.20 (3H, m), 8.01 (1H, s), 7.24 (1H, d), 5.77-5.72 (1H, m), 1.75 (3H, d). Production Example 13
A mixture of 0.30 g of intermediate 63, 0.22 g of sodium 5-(trifluoromethyl)pyridine-2-sulfinate, 0.027 g of palladium(II) acetate, 0.034 g of tricyclohexylphosphine, 0.17 g of potassium carbonate and 3.1 mL of 1,4-dioxane was stirred at 150° C. for 1.5 hours using a microwave reaction apparatus. The resulting mixture was allowed to cool to room temperature, concentrated under reduced pressure, and then dissolved in chloroform. After filtration through Celite, the resulting solution was concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 0.26 g of the present compound 37.
Figure JPOXMLDOC01-appb-C000166
 Compound 37 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.50 (1H, s), 9.12 (1H, s), 8.46 (1H, s), 8.25 (1H, d), 8.21-8.20 (3H, m), 8.01 (1H, s), 7.24 (1H, d), 5.77-5.72 (1H, m), 1.75 (3H, d).

製造例１４
　０．５０ｇの中間体６３、０．０７３ｇの［１，１´－ビス（ジフェニルホスフィノ）フェロセン］ジクロロパラジウム（ＩＩ）、０．４３ｇの炭酸カリウム及び１０．４ｍＬの１，４‐ジオキサンの混合物に、窒素雰囲気下、０．４４ｍＬのエタンチオールを加え、８０℃で６時間攪拌した。得られた混合物を室温まで放冷して減圧下で濃縮した後に、水を加えてクロロホルムを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、本発明化合物３８を０．１６ｇ得た。

Figure JPOXMLDOC01-appb-C000167
本発明化合物３８：1H-NMR (CDCl3) δ: 9.34 (1H, s), 8.45 (1H, s), 8.28 (2H, s), 8.03 (1H, s), 7.40 (1H, d), 6.17-6.14 (1H, m), 3.53-3.36 (2H, m), 1.58 (3H, d), 1.32 (3H, t). Production Example 14
To a mixture of 0.50 g of intermediate 63, 0.073 g of [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II), 0.43 g of potassium carbonate, and 10.4 mL of 1,4-dioxane, 0.44 mL of ethanethiol was added under a nitrogen atmosphere, and the mixture was stirred at 80°C for 6 hours. The mixture was allowed to cool to room temperature and concentrated under reduced pressure, after which water was added and extraction was performed using chloroform. The organic layer obtained was washed successively with water and saturated saline. The organic layer obtained was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.16 g of the present invention compound 38.
Figure JPOXMLDOC01-appb-C000167
 Compound 38 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.34 (1H, s), 8.45 (1H, s), 8.28 (2H, s), 8.03 (1H, s), 7.40 (1H, d), 6.17-6.14 (1H, m), 3.53-3.36 (2H, m), 1.58 (3H, d), 1.32 (3H, t).

製造例１５
　０．４５ｇの中間体６３、０．３８ｇの２－トリブチルスタンニルチアゾール、０．１０ｇのテトラキストリフェニルホスフィンパラジウム（０）、０．０３６ｇのヨウ化銅（Ｉ）、０．０３９ｇの塩化リチウム及び９．３ｍＬの１，４‐ジオキサンの混合物を１００℃で１３時間攪拌した。得られた混合物を室温まで放冷して減圧下で濃縮した後に、クロロホルムに溶解した。セライトろ過を行った後に、得られた溶液を減圧下で濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、本発明化合物３９を０．１２ｇ得た。

Figure JPOXMLDOC01-appb-C000168
本発明化合物３９：1H-NMR (CDCl3) δ: 9.44 (1H, s), 8.54 (1H, s), 8.25 (2H, s), 8.19 (1H, d), 8.01 (1H, s), 7.77 (1H, d), 7.74 (1H, d), 6.73-6.70 (1H, m), 1.75 (3H, d). Production Example 15
A mixture of 0.45 g of intermediate 63, 0.38 g of 2-tributylstannylthiazole, 0.10 g of tetrakistriphenylphosphinepalladium(0), 0.036 g of copper(I) iodide, 0.039 g of lithium chloride, and 9.3 mL of 1,4-dioxane was stirred at 100° C. for 13 hours. The resulting mixture was allowed to cool to room temperature, concentrated under reduced pressure, and then dissolved in chloroform. After filtration through Celite, the resulting solution was concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 0.12 g of the present compound 39.
Figure JPOXMLDOC01-appb-C000168
 Compound 39 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.44 (1H, s), 8.54 (1H, s), 8.25 (2H, s), 8.19 (1H, d), 8.01 (1H, s), 7.77 (1H, d), 7.74 (1H, d), 6.73-6.70 (1H, m), 1.75 (3H, d).

製造例１５－１
　２－トリブチルスタンニルチアゾールに代えて、２－トリブチルスタンニルピリジンを使用し、製造例１５に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000169
本発明化合物４０：1H-NMR (CDCl3) δ: 9.47 (1H, s), 8.85-8.84 (1H, m), 8.45 (1H, s), 8.22 (2H, s), 8.01-8.00 (2H, m), 7.97-7.96 (1H, m), 7.51 (1H, d), 7.47-7.46 (1H, m), 5.80-5.77 (1H, m), 1.67 (3H, d). Production Example 15-1
A compound prepared according to Preparation Example 15 using 2-tributylstannylpyridine instead of 2-tributylstannylthiazole and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000169
 Compound 40 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.47 (1H, s), 8.85-8.84 (1H, m), 8.45 (1H, s), 8.22 (2H, s), 8.01-8.00 (2H, m), 7.97-7.96 (1H, m), 7.51 (1H, d), 7.47-7.46 (1H, m), 5.80-5.77 (1H, m), 1.67 (3H, d).

製造例１６
　０．３０ｇの中間体６４、ＴＨＦ１．６ｍＬ及び３ｍｏｌ／Ｌの塩酸１．６ｍＬの混合物を室温で１時間攪拌した。得られた混合物に飽和炭酸ナトリウム水溶液を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、本発明化合物４１を０．１６ｇ得た。

Figure JPOXMLDOC01-appb-C000170
本発明化合物４１：1H-NMR (CDCl3) δ: 9.43 (1H, s), 8.49 (1H, s), 8.21 (2H, s), 8.02 (1H, s), 7.07 (1H, d), 5.71-5.66 (1H, m), 3.03 (3H, s), 1.71 (3H, d). Production Example 16
A mixture of 0.30 g of intermediate 64, 1.6 mL of THF, and 1.6 mL of 3 mol/L hydrochloric acid was stirred at room temperature for 1 hour. A saturated aqueous sodium carbonate solution was added to the resulting mixture, and the mixture was extracted with ethyl acetate. The resulting organic layer was washed with water and saturated saline in that order. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.16 g of the present compound 41.
Figure JPOXMLDOC01-appb-C000170
 Compound 41 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.43 (1H, s), 8.49 (1H, s), 8.21 (2H, s), 8.02 (1H, s), 7.07 (1H, d), 5.71-5.66 (1H, m), 3.03 (3H, s), 1.71 (3H, d).

製造例１７
　０．２０ｇの本発明化合物４１、０．１０ｇのメトキシアミン塩酸塩、０．０７４ｇの酢酸ナトリウム及びエタノール４．５ｍＬの混合物を５０℃で３時間攪拌した。得られた混合物を室温まで放冷し、水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、本発明化合物４２を０．２０ｇ得た。

Figure JPOXMLDOC01-appb-C000171
本発明化合物４２：1H-NMR (CDCl3) δ: 9.39 (1H, s), 8.44 (1H, s), 8.23 (2H, s), 8.02 (1H, s), 7.19 (1H, d), 5.76-5.72 (1H, m), 4.06 (3H, s), 2.48 (3H, s), 1.69 (3H, d). Production Example 17
A mixture of 0.20 g of the present compound 41, 0.10 g of methoxyamine hydrochloride, 0.074 g of sodium acetate, and 4.5 mL of ethanol was stirred at 50° C. for 3 hours. The resulting mixture was allowed to cool to room temperature, water was added, and extraction was performed using ethyl acetate. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.20 g of the present compound 42.
Figure JPOXMLDOC01-appb-C000171
 Compound 42 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.39 (1H, s), 8.44 (1H, s), 8.23 (2H, s), 8.02 (1H, s), 7.19 (1H, d), 5.76-5.72 (1H, m), 4.06 (3H, s), 2.48 (3H, s), 1.69 (3H, d).

製造例１７－１
　メトキシアミン塩酸塩に代えて、ヒドロキシルアミン塩酸塩を使用し、製造例１７に準じて製造した化合物及びその物性値を以下に示す。

Figure JPOXMLDOC01-appb-C000172
本発明化合物４３：1H-NMR (DMSO-D6) δ: 9.30 (1H, d), 9.20 (1H, s), 8.80 (1H, s), 8.45 (2H, s), 8.30 (1H, s), 5.16 (1H, s), 2.29 (3H, s), 1.50 (3H, d). Production Example 17-1
A compound prepared according to Preparation Example 17 using hydroxylamine hydrochloride instead of methoxyamine hydrochloride and its physical properties are shown below.
Figure JPOXMLDOC01-appb-C000172
 Compound 43 of the present invention: 1 H-NMR (DMSO-D 6 ) δ: 9.30 (1H, d), 9.20 (1H, s), 8.80 (1H, s), 8.45 (2H, s), 8.30 (1H, s), 5.16 (1H, s), 2.29 (3H, s), 1.50 (3H, d).

製造例１９
　１．０ｇの中間体７８、０．１９ｇのヒドロキシルアミン塩酸塩、０．２５ｇの酢酸ナトリウム及び１０．０ｍＬのエタノールの混合物を８０℃で６時間攪拌した。得られた混合物を室温まで放冷し、水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、本発明化合物４５を０．４７ｇ得た。

Figure JPOXMLDOC01-appb-C000173
本発明化合物４５：ＬＣＭＳ：４７５［Ｍ＋Ｈ］+、ＲＴ＝１．４３分 Production Example 19
A mixture of 1.0 g of intermediate 78, 0.19 g of hydroxylamine hydrochloride, 0.25 g of sodium acetate and 10.0 mL of ethanol was stirred at 80° C. for 6 hours. The resulting mixture was allowed to cool to room temperature, water was added and extracted with ethyl acetate. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.47 g of the present compound 45.
Figure JPOXMLDOC01-appb-C000173
 Compound 45 of the present invention: LCMS: 475 [M+H] + , RT = 1.43 min

製造例２０
　０．１７ｇの本発明化合物４５及びピリジン３．６ｍＬの混合物に、塩化アセチル０．０４２ｇを加え、室温で２時間攪拌した。さらに、８０℃で１３時間攪拌した。得られた混合物を室温まで放冷し、水を加えて酢酸エチルを用いて抽出した。得られた有機層を水、及び飽和食塩水で順次洗浄した。得られた有機層を硫酸ナトリウムで乾燥し、ろ過して濃縮した。残渣をシリカゲルカラムクロマトグラフィーに付し、本発明化合物４６を０．０７２ｇ得た。

Figure JPOXMLDOC01-appb-C000174
本発明化合物４６：ＬＣＭＳ：４９９［Ｍ＋Ｈ］+、ＲＴ＝１．８６分 Production Example 20
To a mixture of 0.17 g of the present invention compound 45 and 3.6 mL of pyridine, 0.042 g of acetyl chloride was added and stirred at room temperature for 2 hours. The mixture was further stirred at 80° C. for 13 hours. The resulting mixture was allowed to cool to room temperature, water was added, and extraction was performed using ethyl acetate. The resulting organic layer was washed successively with water and saturated saline. The resulting organic layer was dried over sodium sulfate, filtered, and concentrated. The residue was subjected to silica gel column chromatography to obtain 0.072 g of the present invention compound 46.
Figure JPOXMLDOC01-appb-C000174
 Compound 46 of the present invention: LCMS: 499 [M+H] + , RT = 1.86 min

　次に、実施例に記載された製造例及び本明細書に記載された製造法のいずれかに準じて製造される本発明化合物の例を以下に示す。 Next, examples of the compounds of the present invention that are produced in accordance with the production examples described in the Examples and the production methods described in this specification are shown below.

　式（Ｌ－１）

Figure JPOXMLDOC01-appb-C000175
で示される化合物（以下、化合物（Ｌ－１）と記す）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり（＃4はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX1と記す）。 Formula (L-1)
Figure JPOXMLDOC01-appb-C000175
 (hereinafter, referred to as compound (L-1)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Table L1] to [Table L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX1).

Figure JPOXMLDOC01-appb-T000176
Figure JPOXMLDOC01-appb-T000176

Figure JPOXMLDOC01-appb-T000177
Figure JPOXMLDOC01-appb-T000177

Figure JPOXMLDOC01-appb-T000178
Figure JPOXMLDOC01-appb-T000178

Figure JPOXMLDOC01-appb-T000179
Figure JPOXMLDOC01-appb-T000179

Figure JPOXMLDOC01-appb-T000180
Figure JPOXMLDOC01-appb-T000180

　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX2と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX3と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX4と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX5と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX6と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX7と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX8と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX9と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX10と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX11と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX12と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX13と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX14と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX15と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX16と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX17と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX18と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX19と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX20と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX21と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX22と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX23と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX24と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX25と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX26と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX27と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX28と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX29と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX30と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX31と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX32と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX33と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX34と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX35と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX36と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX37と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX38と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX39と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX40と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX41と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX42と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX43と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX44と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX45と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX46と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX47と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX48と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX49と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX50と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX51と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX52と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX53と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX54と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX55と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX56と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX57と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX58と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX59と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX60と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX61と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX62と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX63と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX64と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX65と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX66と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX67と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX68と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX69と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX70と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX71と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX72と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX73と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX74と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX75と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX76と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX77と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX78と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX79と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX80と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX81と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX82と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX83と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX84と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX85と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX86と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX87と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX88と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX89と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX90と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX91と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX92と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX93と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX94と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX95と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX96と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX97と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX98と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX99と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX100と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX101と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX102と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX103と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX104と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX105と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX106と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX107と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX108と記す）。 In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-1, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX2).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX3).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX4).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX5).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX6).
Compounds (L-1) in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX7).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX8).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX9).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX10).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX11).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX12).
Compounds in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] in the compound (L-1) (hereinafter, referred to as compound group SX13).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX14).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX15).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX16).
Compound (L-1), in which R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX17).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX18).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX19).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX20).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX21).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX22).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX23).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX24).
Compound (L-1), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX25).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX26).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX27).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX28).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX29).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX30).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX31).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX32).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX33).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX34).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX35).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX36).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX37).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX38).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX39).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX40).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX41).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX42).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX43).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX44).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX45).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX46).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX47).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX48).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX49).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX50).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX51).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX52).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX53).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX54).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX55).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX56).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX57).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX58).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX59).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX60).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX61).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX62).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX63).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX64).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX65).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX66).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX67).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX68).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX69).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX70).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX71).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX72).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX73).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX74).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX75).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX76).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX77).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX78).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX79).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX80).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX81).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX82).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX83).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX84).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX85).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX86).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX87).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX88).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX89).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX90).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX91).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX92).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX93).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX94).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX95).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX96).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX97).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX98).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX99).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX100).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX101).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX102).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX103).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX104).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX105).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX106).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX107).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX108).

　式（Ｌ－２）

Figure JPOXMLDOC01-appb-C000181
で示される化合物（以下、化合物（Ｌ－２）と記す）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり（＃4はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX109と記す）。 Formula (L-2)
Figure JPOXMLDOC01-appb-C000181
 (hereinafter, referred to as compound (L-2)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents a bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX109).

　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX110と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX111と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX112と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX113と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX114と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX115と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX116と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX117と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX118と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX119と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX120と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX121と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX122と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX123と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX124と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX125と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX126と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX127と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX128と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX129と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX130と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX131と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX132と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX133と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX134と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX135と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX136と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX137と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX138と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX139と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX140と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX141と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX142と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX143と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX144と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX145と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX146と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX147と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX148と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX149と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX150と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX151と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX152と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX153と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX154と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX155と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX156と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX157と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX158と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX159と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX160と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX161と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX162と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX163と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX164と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX165と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX166と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX167と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX168と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX169と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX170と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX171と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX172と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX173と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX174と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX175と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX176と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX177と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX178と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX179と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX180と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX181と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX182と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX183と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX184と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX185と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX186と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX187と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX188と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX189と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX190と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX191と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX192と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX193と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX194と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX195と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX196と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX197と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX198と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX199と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX200と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX201と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX202と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX203と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX204と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX205と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX206と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX207と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX208と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX209と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX210と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX211と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX212と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX213と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX214と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX215と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX216と記す）。 In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX110).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX111).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX112).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX113).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX114).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX115).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX116).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX117).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX118).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX119).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX120).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX121).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX122).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX123).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX124).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX125).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX126).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX127).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX128).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX129).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX130).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX131).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX132).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX133).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX134).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX135).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX136).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX137).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX138).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX139).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX140).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX141).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX142).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX143).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX144).
In the compound (L-2), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX145).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX146).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX147).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX148).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX149).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX150).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX151).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX152).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX153).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX154).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX155).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX156).
In the compound (L-2), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX157).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX158).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX159).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX160).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX161).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX162).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX163).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX164).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX165).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX166).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX167).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX168).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX169).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX170).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX171).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX172).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX173).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX174).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX175).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX176).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX177).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX178).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX179).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX180).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX181).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX182).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX183).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX184).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX185).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX186).
In the compound (L-2), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX187).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX188).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX189).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX190).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX191).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX192).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX193).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX194).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX195).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX196).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX197).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX198).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX199).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX200).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX201).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX202).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX203).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX204).
In the compound (L-2), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX205).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX206).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX207).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX208).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX209).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX210).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX211).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX212).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX213).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX214).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX215).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX216).

　式（Ｌ－３）

Figure JPOXMLDOC01-appb-C000182
で示される化合物（以下、化合物（Ｌ－３）と記す）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり（＃4はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX217と記す）。 Formula (L-3)
Figure JPOXMLDOC01-appb-C000182
 (hereinafter, referred to as compound (L-3)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX217).

　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX218と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX219と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX220と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX221と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX222と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX223と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX224と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX225と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX226と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX227と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX228と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX229と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX230と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX231と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX232と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX233と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX234と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX235と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX236と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX237と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX238と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX239と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX240と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX241と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX242と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX243と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX244と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX245と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX246と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX247と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX248と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX249と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX250と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX251と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX252と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX253と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX254と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX255と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX256と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX257と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX258と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX259と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX260と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX261と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX262と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX263と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX264と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX265と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX266と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX267と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX268と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX269と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX270と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX271と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX272と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX273と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX274と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX275と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX276と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX277と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX278と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX279と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX280と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX281と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX282と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX283と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX284と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX285と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX286と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX287と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX288と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX289と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX290と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX291と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX292と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX293と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX294と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX295と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX296と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX297と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX298と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX299と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX300と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX301と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX302と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX303と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX304と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX305と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX306と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX307と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX308と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX309と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX310と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX311と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX312と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX313と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX314と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX315と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX316と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX317と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX318と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX319と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX320と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX321と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX322と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX323と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX324と記す）。 In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX218).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX219).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX220).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX221).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX222).
In the compound (L-3), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX223).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX224).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX225).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX226).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX227).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX228).
In the compound (L-3), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX229).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX230).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX231).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX232).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX233).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX234).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX235).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX236).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX237).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX238).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX239).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX240).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX241).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX242).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX243).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX244).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX245).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX246).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX247).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX248).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX249).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX250).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX251).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX252).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX253).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX254).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX255).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX256).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX257).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX258).
In the compound (L-3), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX259).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX260).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX261).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX262).
In the compound (L-3), a compound in which R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX263).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX264).
In the compound (L-3), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX265).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX266).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX267).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX268).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX269).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX270).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX271).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX272).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX273).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX274).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX275).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX276).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX277).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX278).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX279).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX280).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX281).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX282).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX283).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX284).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX285).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX286).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX287).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX288).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX289).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX290).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX291).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX292).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX293).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX294).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX295).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX296).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX297).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX298).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX299).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX300).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX301).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX302).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX303).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX304).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX305).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX306).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX307).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX308).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX309).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX310).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX311).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX312).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX313).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX314).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX315).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX316).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX317).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX318).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX319).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX320).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX321).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX322).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX323).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX324).

　式（Ｌ－４）

Figure JPOXMLDOC01-appb-C000183
で示される化合物（以下、化合物（Ｌ－４）と記す）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり（＃4はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX325と記す）。 Formula (L-4)
Figure JPOXMLDOC01-appb-C000183
 (hereinafter, referred to as compound (L-4)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Table L1] to [Table L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX325).

　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX326と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX327と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX328と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX329と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX330と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX331と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX332と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX333と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX334と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX335と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX336と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX337と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX338と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX339と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX340と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX341と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX342と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX343と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX344と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX345と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX346と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX347と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX348と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX349と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX350と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX351と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX352と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX353と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX354と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX355と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX356と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX357と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX358と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX359と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX360と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX361と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX362と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX363と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX364と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX365と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX366と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX367と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX368と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX369と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX370と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX371と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX372と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX373と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX374と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX375と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX376と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX377と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX378と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX379と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX380と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX381と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX382と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX383と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX384と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX385と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX386と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX387と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX388と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX389と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX390と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX391と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX392と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX393と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX394と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX395と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX396と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX397と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX398と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX399と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX400と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX401と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX402と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX403と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX404と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX405と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX406と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX407と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX408と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX409と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX410と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX411と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX412と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX413と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX414と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX415と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX416と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX417と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX418と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX419と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX420と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX421と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX422と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX423と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX424と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX425と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX426と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX427と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX428と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX429と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX430と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX431と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX432と記す）。 In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX326).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX327).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX328).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX329).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX330).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX331).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX332).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX333).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX334).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX335).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX336).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX337).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX338).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX339).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX340).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX341).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX342).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX343).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX344).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX345).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX346).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX347).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX348).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX349).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX350).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX351).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX352).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX353).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX354).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX355).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX356).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX357).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX358).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX359).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX360).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX361).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX362).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX363).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX364).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX365).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX366).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX367).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX368).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX369).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX370).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX371).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX372).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX373).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX374).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX375).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX376).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX377).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX378).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX379).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX380).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX381).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX382).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX383).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX384).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX385).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX386).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX387).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX388).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX389).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX390).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX391).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX392).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX393).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX394).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX395).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX396).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX397).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX398).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX399).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX400).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX401).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX402).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX403).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX404).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX405).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX406).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX407).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX408).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX409).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX410).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX411).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX412).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX413).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX414).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX415).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX416).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX417).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX418).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX419).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX420).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX421).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX422).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX423).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX424).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX425).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX426).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX427).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX428).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX429).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX430).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX431).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX432).

　式（Ｌ－５）

Figure JPOXMLDOC01-appb-C000184
で示される化合物（以下、化合物（Ｌ－５）と記す）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり（＃4はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX433と記す）。 Formula (L-5)
Figure JPOXMLDOC01-appb-C000184
 (hereinafter, referred to as compound (L-5)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents a bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Table L1] to [Table L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX433).

　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX434と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX435と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX436と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX437と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX438と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX439と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX440と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX441と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX442と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX443と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX444と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX445と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX446と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX447と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX448と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX449と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX450と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX451と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX452と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX453と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX454と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX455と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX456と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX457と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX458と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX459と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX460と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX461と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX462と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX463と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX464と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX465と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX466と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX467と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX468と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX469と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX470と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX471と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX472と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX473と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX474と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX475と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX476と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX477と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX478と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX479と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX480と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX481と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX482と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX483と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX484と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX485と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX486と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX487と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX488と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX489と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX490と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX491と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX492と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX493と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX494と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX495と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX496と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX497と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX498と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX499と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX500と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX501と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX502と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX503と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX504と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX505と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX506と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX507と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX508と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX509と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX510と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX511と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX512と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX513と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX514と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX515と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX516と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX517と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX518と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX519と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX520と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX521と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX522と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX523と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX524と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX525と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX526と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX527と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX528と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX529と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX530と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX531と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX532と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX533と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX534と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX535と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX536と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX537と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX538と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX539と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX540と記す）。 In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX434).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX435).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX436).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX437).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX438).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX439).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX440).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX441).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX442).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX443).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX444).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX445).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX446).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX447).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX448).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX449).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX450).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX451).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX452).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX453).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX454).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX455).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX456).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX457).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX458).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX459).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX460).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX461).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX462).
In the compound (L-5), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX463).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX464).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX465).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX466).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX467).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX468).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX469).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX470).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX471).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX472).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX473).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX474).
In the compound (L-5), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX475).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX476).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX477).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX478).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX479).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX480).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX481).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX482).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX483).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX484).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX485).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX486).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX487).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX488).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX489).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX490).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX491).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX492).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX493).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX494).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX495).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX496).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX497).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX498).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX499).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX500).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX501).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX502).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX503).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX504).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX505).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX506).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX507).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX508).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX509).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX510).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX511).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX512).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX513).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX514).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX515).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX516).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX517).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX518).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX519).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX520).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX521).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX522).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX523).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX524).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX525).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX526).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX527).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX528).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX529).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX530).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX531).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX532).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX533).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX534).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX535).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX536).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX537).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX538).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX539).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX540).

　式（Ｌ－６）

Figure JPOXMLDOC01-appb-C000185
で示される化合物（以下、化合物（Ｌ－６）と記す）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり（＃4はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX541と記す）。 Formula (L-6)
Figure JPOXMLDOC01-appb-C000185
 (hereinafter, referred to as compound (L-6)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents a bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Table L1] to [Table L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX541).

　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX542と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX543と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX544と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX545と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX546と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX547と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX548と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX549と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX550と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX551と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX552と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX553と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX554と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX555と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX556と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX557と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX558と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX559と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX560と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX561と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX562と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX563と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX564と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX565と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX566と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX567と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX568と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX569と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX570と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX571と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX572と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX573と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX574と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX575と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX576と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX577と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX578と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX579と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX580と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX581と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX582と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX583と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX584と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX585と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX586と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX587と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX588と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX589と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX590と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX591と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX592と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX593と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX594と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX595と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX596と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX597と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX598と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX599と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX600と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX601と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX602と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX603と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX604と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX605と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX606と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX607と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX608と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX609と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX610と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX611と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX612と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX613と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX614と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX615と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX616と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX617と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX618と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX619と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX620と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX621と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX622と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX623と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX624と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX625と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX626と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX627と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX628と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX629と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX630と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX631と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX632と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX633と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX634と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX635と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX636と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX637と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX638と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX639と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX640と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX641と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX642と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX643と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX644と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX645と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX646と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX647と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX648と記す）。 In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX542).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX543).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX544).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX545).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX546).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX547).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX548).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX549).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX550).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX551).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX552).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX553).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX554).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX555).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX556).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX557).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX558).
In the compound (L-6), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX559).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX560).
In the compound (L-6), a compound in which R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX561).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX562).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX563).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX564).
In the compound (L-6), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX565).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX566).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX567).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX568).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX569).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX570).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX571).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX572).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX573).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX574).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX575).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX576).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX577).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX578).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX579).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX580).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX581).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX582).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX583).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX584).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX585).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX586).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX587).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX588).
In the compound (L-6), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX589).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX590).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX591).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX592).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX593).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX594).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX595).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX596).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX597).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX598).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX599).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX600).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX601).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX602).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX603).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX604).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX605).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX606).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX607).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX608).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX609).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX610).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX611).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX612).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX613).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX614).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX615).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX616).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX617).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX618).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX619).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX620).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX621).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX622).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX623).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX624).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX625).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX626).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX627).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX628).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX629).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX630).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX631).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX632).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX633).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX634).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX635).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX636).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX637).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX638).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX639).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX640).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX641).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX642).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX643).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX644).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX645).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX646).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX647).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX648).

　式（Ｌ－７）

Figure JPOXMLDOC01-appb-C000186
で示される化合物（以下、化合物（Ｌ－７）と記す）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１であり（＃5は窒素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX649と記す）。 Formula (L-7)
Figure JPOXMLDOC01-appb-C000186
 (hereinafter, referred to as compound (L-7)), in which R 1 is a hydrogen atom, R 11 is T2-1 (# 5 represents a bonding site to the nitrogen atom), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX649).

Figure JPOXMLDOC01-appb-T000187
Figure JPOXMLDOC01-appb-T000187

　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX650と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX651と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX652と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX653と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX654と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX655と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX656と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX657と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX658と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX659と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX660と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX661と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX662と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX663と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX664と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX665と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX666と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX667と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX668と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX669と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX670と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX671と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX672と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX673と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX674と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX675と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX676と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX677と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX678と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX679と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX680と記す）。
　化合物（Ｌ－７）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX681と記す）。
　化合物（Ｌ－７）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX682と記す）。 In the compound (L-7), R 1 is a methyl group, R 11 is T2-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX650).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX651).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX652).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-3, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX653).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX654).
In the compound (L-7), a compound in which R 1 is a hydrogen atom, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX655).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX656).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX657).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX658).
In the compound (L-7), a compound in which R 1 is a hydrogen atom, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX659).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX660).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX661).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX662).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX663).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX664).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX665).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX666).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX667).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX668).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX669).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX670).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX671).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX672).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX673).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX674).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX675).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX676).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX677).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX678).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX679).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX680).
In the compound (L-7), R 1 is a hydrogen atom, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX681).
In the compound (L-7), R 1 is a methyl group, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX682).

　式（Ｌ－８）

Figure JPOXMLDOC01-appb-C000188
で示される化合物（以下、化合物（Ｌ－８）と記す）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１であり（＃5は窒素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX683と記す）。 Formula (L-8)
Figure JPOXMLDOC01-appb-C000188
 (hereinafter, referred to as compound (L-8)), in which R 1 is a hydrogen atom, R 11 is T2-1 (# 5 represents a bonding site to the nitrogen atom), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX683).

　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX684と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX685と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX686と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX687と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX688と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX689と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX690と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX691と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX692と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX693と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX694と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX695と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX696と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX697と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX698と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX699と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX700と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX701と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX702と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX703と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX704と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX705と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX706と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX707と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX708と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX709と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX710と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX711と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX712と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX713と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX714と記す）。
　化合物（Ｌ－８）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX715と記す）。
　化合物（Ｌ－８）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX716と記す）。 In the compound (L-8), R 1 is a methyl group, R 11 is T2-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX684).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX685).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX686).
In the compound (L-8), a compound in which R 1 is a hydrogen atom, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX687).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX688).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX689).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX690).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-5, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX691).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX692).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX693).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX694).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX695).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX696).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX697).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX698).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX699).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX700).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX701).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX702).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX703).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX704).
In the compound (L-8), a compound in which R 1 is a hydrogen atom, R 11 is T2-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX705).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX706).
In the compound (L-8), a compound in which R 1 is a hydrogen atom, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX707).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX708).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX709).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX710).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX711).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX712).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX713).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX714).
In the compound (L-8), R 1 is a hydrogen atom, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX715).
In the compound (L-8), R 1 is a methyl group, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX716).

　式（Ｌ－９）

Figure JPOXMLDOC01-appb-C000189
で示される化合物（以下、化合物（Ｌ－９）と記す）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１であり（＃5は窒素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX717と記す）。 Formula (L-9)
Figure JPOXMLDOC01-appb-C000189
 (hereinafter, referred to as compound (L-9)), in which R 1 is a hydrogen atom, R 11 is T2-1 (# 5 represents a bonding site to the nitrogen atom), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX717).

　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX718と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX719と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX720と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX721と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX722と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX723と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX724と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX725と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX726と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX727と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX728と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX729と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX730と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX731と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX732と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX733と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX734と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX735と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX736と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX737と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX738と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX739と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX740と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX741と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX742と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX743と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX744と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX745と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX746と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX747と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX748と記す）。
　化合物（Ｌ－９）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX749と記す）。
　化合物（Ｌ－９）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX750と記す）。 In the compound (L-9), R 1 is a methyl group, R 11 is T2-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX718).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX719).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX720).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX721).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX722).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX723).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX724).
In the compound (L-9), a compound in which R 1 is a hydrogen atom, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX725).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX726).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX727).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX728).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX729).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX730).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX731).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX732).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX733).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX734).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX735).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX736).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX737).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX738).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX739).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX740).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX741).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX742).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX743).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX744).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX745).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX746).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX747).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX748).
In the compound (L-9), R 1 is a hydrogen atom, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX749).
In the compound (L-9), R 1 is a methyl group, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX750).

　式（Ｌ－１０）

Figure JPOXMLDOC01-appb-C000190
で示される化合物（以下、化合物（Ｌ－１０）と記す）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１であり（＃5は窒素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX751と記す）。 Formula (L-10)
Figure JPOXMLDOC01-appb-C000190
 (hereinafter, referred to as compound (L-10)), in which R 1 is a hydrogen atom, R 11 is T2-1 (# 5 represents a bonding site to the nitrogen atom), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX751).

　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX752と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX753と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX754と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX755と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX756と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX757と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX758と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX759と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX760と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX761と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX762と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX763と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX764と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX765と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX766と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX767と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX768と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX769と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX770と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX771と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX772と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX773と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX774と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX775と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX776と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX777と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX778と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX779と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX780と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX781と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX782と記す）。
　化合物（Ｌ－１０）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX783と記す）。
　化合物（Ｌ－１０）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX784と記す）。 In the compound (L-10), R 1 is a methyl group, R 11 is T2-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX752).
In compound (L-10), R 1 is a hydrogen atom, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX753).
In the compound (L-10), R 1 is a methyl group, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX754).
In the compound (L-10), a compound in which R 1 is a hydrogen atom, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX755).
In the compound (L-10), R 1 is a methyl group, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX756).
In the compound (L-10), a compound in which R 1 is a hydrogen atom, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX757).
In compound (L-10), R 1 is a methyl group, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX758).
In the compound (L-10), a compound in which R 1 is a hydrogen atom, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX759).
In compound (L-10), R 1 is a methyl group, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX760).
In compound (L-10), R 1 is a hydrogen atom, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX761).
In compound (L-10), R 1 is a methyl group, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX762).
In compound (L-10), R 1 is a hydrogen atom, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX763).
In compound (L-10), R 1 is a methyl group, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX764).
In the compound (L-10), a compound in which R 1 is a hydrogen atom, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX765).
In the compound (L-10), R 1 is a methyl group, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX766).
In the compound (L-10), R 1 is a hydrogen atom, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX767).
In the compound (L-10), R 1 is a methyl group, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX768).
In the compound (L-10), R 1 is a hydrogen atom, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX769).
In compound (L-10), R 1 is a methyl group, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX770).
In the compound (L-10), R 1 is a hydrogen atom, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX771).
In the compound (L-10), R 1 is a methyl group, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX772).
In compound (L-10), R 1 is a hydrogen atom, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX773).
In the compound (L-10), R 1 is a methyl group, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX774).
In the compound (L-10), R 1 is a hydrogen atom, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX775).
In compound (L-10), R 1 is a methyl group, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX776).
In compound (L-10), R 1 is a hydrogen atom, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX777).
In the compound (L-10), R 1 is a methyl group, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX778).
In the compound (L-10), a compound in which R 1 is a hydrogen atom, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX779).
In compound (L-10), R 1 is a methyl group, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX780).
In compound (L-10), R 1 is a hydrogen atom, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX781).
In compound (L-10), R 1 is a methyl group, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX782).
In compound (L-10), R 1 is a hydrogen atom, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX783).
In the compound (L-10), R 1 is a methyl group, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX784).

　式（Ｌ－１１）

Figure JPOXMLDOC01-appb-C000191
で示される化合物（以下、化合物（Ｌ－１１）と記す）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１であり（＃5は窒素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX785と記す）。 Formula (L-11)
Figure JPOXMLDOC01-appb-C000191
 (hereinafter, referred to as compound (L-11)), in which R 1 is a hydrogen atom, R 11 is T2-1 (# 5 represents a bonding site to the nitrogen atom), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX785).

　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX786と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX787と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX788と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX789と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX790と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX791と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX792と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX793と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX794と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX795と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX796と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX797と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX798と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX799と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX800と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX801と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX802と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX803と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX804と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX805と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX806と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX807と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX808と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX809と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX810と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX811と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX812と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX813と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX814と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX815と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX816と記す）。
　化合物（Ｌ－１１）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX817と記す）。
　化合物（Ｌ－１１）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX818と記す）。 In the compound (L-11), R 1 is a methyl group, R 11 is T2-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX786).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX787).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX788).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX789).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX790).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX791).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX792).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX793).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX794).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX795).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX796).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX797).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX798).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX799).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX800).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX801).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX802).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX803).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX804).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX805).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX806).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX807).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX808).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX809).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX810).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX811).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX812).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX813).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX814).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX815).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX816).
In the compound (L-11), R 1 is a hydrogen atom, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX817).
In the compound (L-11), R 1 is a methyl group, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX818).

　式（Ｌ－１２）

Figure JPOXMLDOC01-appb-C000192
で示される化合物（以下、化合物（Ｌ－１２）と記す）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１であり（＃5は窒素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX819と記す）。 Formula (L-12)
Figure JPOXMLDOC01-appb-C000192
 (hereinafter, referred to as compound (L-12)), in which R 1 is a hydrogen atom, R 11 is T2-1 (# 5 represents a bonding site to the nitrogen atom), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents a bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX819).

　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX820と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX821と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX822と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX823と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX824と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX825と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX826と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX827と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX828と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX829と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX830と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX831と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX832と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX833と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX834と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX835と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX836と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX837と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX838と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX839と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX840と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX841と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX842と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX843と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX844と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX845と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX846と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX847と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX848と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX849と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX850と記す）。
　化合物（Ｌ－１２）において、Ｒ1が水素原子であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX851と記す）。
　化合物（Ｌ－１２）において、Ｒ1がメチル基であり、Ｒ11がＴ２－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX852と記す）。 In the compound (L-12), R 1 is a methyl group, R 11 is T2-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX820).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX821).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX822).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX823).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX824).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX825).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX826).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX827).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX828).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX829).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX830).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX831).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX832).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX833).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX834).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX835).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX836).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX837).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX838).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX839).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX840).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX841).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX842).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX843).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX844).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX845).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX846).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX847).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX848).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX849).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX850).
In the compound (L-12), R 1 is a hydrogen atom, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX851).
In the compound (L-12), R 1 is a methyl group, R 11 is T2-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX852).

　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり（＃6はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX853と記す）。 In compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-1 (# 6 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Table L1] to [Table L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX853).

Figure JPOXMLDOC01-appb-T000193
Figure JPOXMLDOC01-appb-T000193

　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX854と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX855と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX856と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX857と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX858と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX859と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX860と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX861と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX862と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX863と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX864と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX865と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX866と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX867と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX868と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX869と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX870と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX871と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX872と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX873と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX874と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX875と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX876と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX877と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX878と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX879と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX880と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX881と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX882と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX883と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX884と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX885と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX886と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX887と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX888と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX889と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX890と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX891と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX892と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX893と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX894と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX895と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX896と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX897と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX898と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX899と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX900と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX901と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX902と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX903と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX904と記す）。
　化合物（Ｌ－１）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX905と記す）。
　化合物（Ｌ－１）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX906と記す）。 In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX854).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX855).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX856).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX857).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX858).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX859).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX860).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX861).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX862).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX863).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX864).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX865).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX866).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX867).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX868).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX869).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX870).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX871).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX872).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX873).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX874).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX875).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX876).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX877).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX878).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX879).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX880).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX881).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX882).
In compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX883).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX884).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX885).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX886).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX887).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX888).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX889).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX890).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX891).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX892).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX893).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX894).
In the compound (L-1), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX895).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX896).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX897).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX898).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX899).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX900).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX901).
In the compound (L-1), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX902).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX903).
In the compound (L-1), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX904).
In the compound (L-1), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX905).
In the compound (L-1), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX906).

　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり（＃6はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX907と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX908と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX909と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX910と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX911と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX912と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX913と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX914と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX915と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX916と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX917と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX918と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX919と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX920と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX921と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX922と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX923と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX924と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX925と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX926と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX927と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX928と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX929と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX930と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX931と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX932と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX933と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX934と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX935と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX936と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX937と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX938と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX939と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX940と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX941と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX942と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX943と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX944と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX945と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX946と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX947と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX948と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX949と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX950と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX951と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX952と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX953と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX954と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX955と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX956と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX957と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX958と記す）。
　化合物（Ｌ－２）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX959と記す）。
　化合物（Ｌ－２）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX960と記す）。 In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-1 (# 6 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Table L1] to [Table L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX907).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX908).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX909).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX910).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX911).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX912).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX913).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX914).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX915).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX916).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX917).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX918).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX919).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX920).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX921).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX922).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX923).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX924).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX925).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX926).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX927).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX928).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX929).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX930).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX931).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX932).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX933).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX934).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX935).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX936).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX937).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX938).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX939).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX940).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX941).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX942).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX943).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX944).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX945).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX946).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX947).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX948).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX949).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX950).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX951).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX952).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX953).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX954).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX955).
In the compound (L-2), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX956).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX957).
In the compound (L-2), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX958).
In the compound (L-2), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX959).
In the compound (L-2), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX960).

　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり（＃6はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX961と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX962と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX963と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX964と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX965と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX966と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX967と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX968と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX969と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX970と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX971と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX972と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX973と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX974と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX975と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX976と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX977と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX978と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX979と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX980と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX981と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX982と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX983と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX984と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX985と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX986と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX987と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX988と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX989と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX990と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX991と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX992と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX993と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX994と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX995と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX996と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX997と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX998と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX999と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1000と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1001と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1002と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1003と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1004と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1005と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1006と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1007と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1008と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1009と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1010と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1011と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1012と記す）。
　化合物（Ｌ－３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1013と記す）。
　化合物（Ｌ－３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1014と記す）。 In compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-1 (# 6 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX961).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX962).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX963).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX964).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX965).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX966).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX967).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX968).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX969).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX970).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX971).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX972).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX973).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX974).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX975).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX976).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX977).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX978).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX979).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX980).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX981).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX982).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX983).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX984).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX985).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX986).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX987).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX988).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX989).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX990).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX991).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX992).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX993).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX994).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX995).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX996).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX997).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX998).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX999).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1000).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1001).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1002).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1003).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1004).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1005).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1006).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1007).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1008).
In the compound (L-3), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1009).
In the compound (L-3), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1010).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1011).
In the compound (L-3), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1012).
In the compound (L-3), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1013).
In the compound (L-3), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1014).

　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり（＃6はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX1015と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1016と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1017と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1018と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1019と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1020と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1021と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1022と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1023と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1024と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1025と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1026と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1027と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1028と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1029と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1030と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1031と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1032と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1033と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1034と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1035と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1036と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1037と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1038と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1039と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1040と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1041と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1042と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1043と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1044と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1045と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1046と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1047と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1048と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1049と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1050と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1051と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1052と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1053と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1054と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1055と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1056と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1057と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1058と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1059と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1060と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1061と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1062と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1063と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1064と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1065と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1066と記す）。
　化合物（Ｌ－４）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1067と記す）。
　化合物（Ｌ－４）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1068と記す）。 In compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-1 (# 6 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX1015).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1016).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1017).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1018).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1019).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1020).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1021).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1022).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1023).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1024).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1025).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1026).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1027).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1028).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1029).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1030).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1031).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1032).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1033).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1034).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1035).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1036).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1037).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1038).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1039).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1040).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1041).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1042).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1043).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1044).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1045).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1046).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1047).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1048).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1049).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1050).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1051).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1052).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1053).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1054).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1055).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1056).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1057).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1058).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1059).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1060).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1061).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1062).
In the compound (L-4), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1063).
In the compound (L-4), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1064).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1065).
In the compound (L-4), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1066).
In the compound (L-4), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1067).
In the compound (L-4), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1068).

　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり（＃6はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX1069と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1070と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1071と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1072と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1073と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1074と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1075と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1076と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1077と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1078と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1079と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1080と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1081と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1082と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1083と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1084と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1085と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1086と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1087と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1088と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1089と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1090と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1091と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1092と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1093と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1094と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1095と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1096と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1097と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1098と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1099と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1100と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1101と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1102と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1103と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1104と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1105と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1106と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1107と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1108と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1109と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1110と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1111と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1112と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1113と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1114と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1115と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1116と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1117と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1118と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1119と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1120と記す）。
　化合物（Ｌ－５）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1121と記す）。
　化合物（Ｌ－５）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1122と記す）。 In compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-1 (# 6 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX1069).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1070).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1071).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1072).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1073).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1074).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1075).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1076).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1077).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1078).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1079).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1080).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1081).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1082).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1083).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1084).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1085).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1086).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1087).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1088).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1089).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1090).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1091).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1092).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1093).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1094).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1095).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1096).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1097).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1098).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1099).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1100).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1101).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1102).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1103).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1104).
In the compound (L-5), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1105).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1106).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1107).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1108).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1109).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1110).
In the compound (L-5), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1111).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1112).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1113).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1114).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1115).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1116).
In compound (L-5), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1117).
In the compound (L-5), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1118).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1119).
In the compound (L-5), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1120).
In the compound (L-5), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1121).
In the compound (L-5), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1122).

　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり（＃6はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX1123と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1124と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1125と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1126と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1127と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1128と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1129と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1130と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1131と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1132と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1133と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1134と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1135と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1136と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1137と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1138と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1139と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1140と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1141と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1142と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1143と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1144と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1145と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1146と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1147と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1148と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1149と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1150と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1151と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1152と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1153と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1154と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1155と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1156と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1157と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1158と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1159と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1160と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1161と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1162と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1163と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1164と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1165と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1166と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1167と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1168と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1169と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1170と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1171と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1172と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1173と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1174と記す）。
　化合物（Ｌ－６）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1175と記す）。
　化合物（Ｌ－６）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1176と記す）。 In compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-1 (# 6 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX1123).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1124).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1125).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1126).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1127).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1128).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1129).
In compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1130).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1131).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1132).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1133).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1134).
In the compound (L-6), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1135).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1136).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1137).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1138).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1139).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1140).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1141).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1142).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1143).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1144).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1145).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1146).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1147).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1148).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1149).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1150).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1151).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1152).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1153).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1154).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1155).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1156).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1157).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1158).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1159).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1160).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1161).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1162).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1163).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1164).
In the compound (L-6), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1165).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1166).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1167).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1168).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1169).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1170).
In compound (L-6), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1171).
In the compound (L-6), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1172).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1173).
In the compound (L-6), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1174).
In the compound (L-6), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1175).
In the compound (L-6), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1176).

　式（Ｌ－１３）

Figure JPOXMLDOC01-appb-C000194
で示される化合物（以下、化合物（Ｌ－１３）と記す）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり（＃4はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX1177と記す）。 Formula (L-13)
Figure JPOXMLDOC01-appb-C000194
 (hereinafter, referred to as compound (L-13)), in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-1 (# 4 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the condensed ring) (hereinafter, referred to as compound group SX1177).

　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1178と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1179と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1180と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1181と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1182と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1183と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1184と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1185と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1186と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1187と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1188と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1189と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1190と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1191と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1192と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1193と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1194と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1195と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1196と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1197と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1198と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1199と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1200と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1201と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1202と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1203と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1204と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1205と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1206と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1207と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1208と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1209と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1210と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1211と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1212と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1213と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1214と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1215と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1216と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1217と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1218と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1219と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1220と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1221と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1222と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1223と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1224と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1225と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1226と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1227と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1228と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1229と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1230と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1231と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1232と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1233と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1234と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1235と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１０であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1236と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1237と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1238と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1239と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1240と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1241と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1242と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1243と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1244と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1245と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1246と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1247と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1248と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1249と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1250と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1251と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1252と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1253と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1254と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1255と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1256と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1257と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1258と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1259と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1260と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1261と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1262と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1263と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1264と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1265と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1266と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1267と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1268と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1269と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1270と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1271と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1272と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1273と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1274と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1275と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1276と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1277と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1278と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1279と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1280と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1281と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1282と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1283と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ１－１８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1284と記す）。 In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1178).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1179).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1180).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1181).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1182).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1183).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1184).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1185).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1186).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1187).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1188).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1189).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1190).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1191).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1192).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1193).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1194).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1195).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1196).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1197).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1198).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1199).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1200).
In compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1201).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1202).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1203).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1204).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1205).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1206).
In compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1207).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1208).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1209).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1210).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1211).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1212).
In compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1213).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1214).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1215).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1216).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1217).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1218).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1219).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1220).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1221).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1222).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1223).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1224).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1225).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1226).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1227).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1228).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1229).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1230).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX1231).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1232).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1233).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1234).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX1235).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-10, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1236).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX1237).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX1238).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1239).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1240).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX1241).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-11, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1242).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Table L1] to [Table L20] (hereinafter, referred to as compound group SX1243).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1244).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1245).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1246).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1247).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-12, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1248).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1249).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1250).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1251).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1252).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1253).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-13, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1254).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1255).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1256).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1257).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1258).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1259).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-14, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1260).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1261).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1262).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1263).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1264).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1265).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-15, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1266).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1267).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1268).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1269).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1270).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1271).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-16, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1272).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1273).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1274).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1275).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1276).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1277).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-17, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1278).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1279).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1280).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1281).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1282).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1283).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T1-18, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1284).

　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり（＃6はカルボニル基の炭素原子との結合部位を表す）、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載（＃3は縮合環の炭素原子との結合部位を表す）のいずれかの置換基である化合物（以下、化合物群SX1285と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1286と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1287と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1288と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1289と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－１であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1290と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1291と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1292と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1293と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1294と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1295と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－２であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1296と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1297と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1298と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1299と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1300と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1301と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－３であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1302と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1303と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1304と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1305と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1306と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1307と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－４であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1308と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1309と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1310と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1311と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1312と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1313と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－５であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1314と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1315と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1316と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1317と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1318と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1319と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－６であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1320と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1321と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1322と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1323と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1324と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1325と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－７であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1326と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1327と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1328と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1329と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1330と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1331と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－８であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1332と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1333と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10が水素原子であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1334と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1335と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がメチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1336と記す）。
　化合物（Ｌ－１３）において、Ｒ1が水素原子であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1337と記す）。
　化合物（Ｌ－１３）において、Ｒ1がメチル基であり、Ｒ10がエチル基であり、Ｒ11がＴ３－９であり、Ｒ2が、［表Ｌ１］～［表Ｌ２０］に記載のいずれかの置換基である化合物（以下、化合物群SX1338と記す）。 In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-1 (# 6 represents the bonding site to the carbon atom of the carbonyl group), and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (# 3 represents the bonding site to the carbon atom of the fused ring) (hereinafter, referred to as compound group SX1285).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1286).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1287).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1288).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1289).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-1, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1290).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1291).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1292).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1293).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1294).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1295).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-2, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1296).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1297).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1298).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1299).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1300).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1301).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-3, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1302).
In compound (L-13), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1303).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1304).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1305).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1306).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1307).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-4, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1308).
In compound (L-13), a compound in which R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1309).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1310).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1311).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1312).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1313).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-5, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1314).
In compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1315).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1316).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1317).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1318).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1319).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-6, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1320).
In compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1321).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1322).
In compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1323).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1324).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1325).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-7, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1326).
In compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1327).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1328).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1329).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1330).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1331).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-8, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1332).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1333).
In the compound (L-13), R 1 is a methyl group, R 10 is a hydrogen atom, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1334).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1335).
In the compound (L-13), R 1 is a methyl group, R 10 is a methyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1336).
In the compound (L-13), R 1 is a hydrogen atom, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1337).
In the compound (L-13), R 1 is a methyl group, R 10 is an ethyl group, R 11 is T3-9, and R 2 is any of the substituents described in [Tables L1] to [Tables L20] (hereinafter, referred to as compound group SX1338).

　次に本発明化合物の製剤例を示す。なお、部は重量部を表す。また、本発明化合物Ｓは、化合物群SX1～SX1338に記載の化合物又は本発明化合物１～５８のいずれかの化合物を表す。 The following are examples of formulations of the compounds of the present invention. Note that "parts" refers to parts by weight. Compound S of the present invention refers to any of the compounds in compound groups SX1 to SX1338 or compounds 1 to 58 of the present invention.

製剤例１
　ポリオキシエチレンアルキルエーテルサルフェートアンモニウム塩及びシリカの混合物（重量比１：１）３５部と、本発明化合物Ｓのいずれか１種１０部と、水５５部とを混合し、湿式粉砕法で微粉砕することにより、製剤を得る。 Formulation Example 1
A mixture of 35 parts of polyoxyethylene alkyl ether sulfate ammonium salt and silica (weight ratio 1:1), 10 parts of any one of the present compound S, and 55 parts of water are mixed and finely pulverized by a wet pulverization method to obtain a preparation.

製剤例２
　本発明化合物Ｓのいずれか１種５０部、リグニンスルホン酸カルシウム３部、ラウリル硫酸ナトリウム２部、及びシリカ４５部を粉砕混合することにより、製剤を得る。 Formulation Example 2
A preparation is obtained by grinding and mixing any one of the present compound S (50 parts), calcium lignosulfonate (3 parts), sodium lauryl sulfate (2 parts), and silica (45 parts).

製剤例３
　本発明化合物Ｓのいずれか１種５部、ポリオキシエチレンスチリルフェニルエーテル９部、ポリオキシエチレンデシルエーテル（エチレンオキシド付加数：５）５部、ドデシルベンゼンスルホン酸カルシウム６部、及びキシレン７５部を混合することにより、製剤を得る。 Formulation Example 3
A preparation is obtained by mixing 5 parts of any one of the present compound S, 9 parts of polyoxyethylene styrylphenyl ether, 5 parts of polyoxyethylene decyl ether (number of ethylene oxide added: 5), 6 parts of calcium dodecylbenzenesulfonate, and 75 parts of xylene.

製剤例４
　本発明化合物Ｓのいずれか１種２部、シリカ１部、リグニンスルホン酸カルシウム２部、ベントナイト３０部、及びカオリンクレー６５部を粉砕混合し、適当量の水を加えて混練し、造粒機で造粒した後、乾燥することにより、製剤を得る。 Formulation Example 4
2 parts of any one of the present compound S, 1 part of silica, 2 parts of calcium lignosulfonate, 30 parts of bentonite, and 65 parts of kaolin clay are pulverized and mixed, an appropriate amount of water is added, the mixture is kneaded, granulated in a granulator, and then dried to obtain a preparation.

製剤例５
　本発明化合物Ｓのいずれか１種１０部を、ベンジルアルコール１８部とジメチルスルホキシド９部との混合物に混合し、そこに６．３部のGERONOL（登録商標） TE250、Ethylan（登録商標） NS-500LQ ２．７部、及びソルベントナフサ５４部を加え、混合して製剤を得る。 Formulation Example 5
10 parts of any one of the present invention compounds S is mixed with a mixture of 18 parts of benzyl alcohol and 9 parts of dimethyl sulfoxide, and 6.3 parts of GERONOL (registered trademark) TE250, 2.7 parts of Ethylan (registered trademark) NS-500LQ, and 54 parts of solvent naphtha are added thereto and mixed to obtain a preparation.

製剤例６
　本発明化合物Ｓのいずれか１種０．１部及びケロシン３９．９部を混合溶解し、エアゾール容器に入れ、液化石油ガス（プロパン、ブタン及びイソブタンの混合物；飽和蒸気圧：０．４７ＭＰａ（２５℃））６０部を充填することにより製剤を得る。 Formulation Example 6
0.1 parts of any one of the present compound S and 39.9 parts of kerosene are mixed and dissolved, placed in an aerosol container, and filled with 60 parts of liquefied petroleum gas (a mixture of propane, butane and isobutane; saturated vapor pressure: 0.47 MPa (25° C.)) to obtain a formulation.

製剤例７
　本発明化合物Ｓのいずれか１種０．２部、除虫菊抽出粕粉５０部、タブ粉３０部及び木粉１９．８部を混合し、適量の水を加えて混練後、押出機にかけて板状シートとし、打抜機で渦巻状とすることにより製剤を得る。 Formulation Example 7
0.2 parts of any one of the present compound S, 50 parts of pyrethrum extract residue powder, 30 parts of Tabu powder, and 19.8 parts of wood flour are mixed, an appropriate amount of water is added, and the mixture is kneaded. The mixture is then extruded into a plate-shaped sheet, and then wound into a spiral shape using a punching machine to obtain a preparation.

　次に、本発明化合物の有害節足動物に対する効力を試験例により示す。下記試験例において、試験は２５℃で行った。 Next, the efficacy of the compound of the present invention against harmful arthropods is shown by test examples. In the following test examples, the tests were carried out at 25°C.

試験法１
　供試化合物を製剤例１に記載の方法に準じて製剤とし、これにシンダイン（登録商標）０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたキャベツ（Brassicae oleracea）苗（第２～３本葉展開期）に該希釈液を２０ｍＬ／苗の割合で散布する。その後、この苗の茎葉部を切り取り、ろ紙を敷いた容器内に入れる。これにコナガ２齢幼虫５頭を放す。５日後、生存虫数を数え、次式より死虫率を求める。
　　　死虫率（％）＝（１－生存虫数／５）×１００ Test method 1
A test compound is formulated according to the method described in Formulation Example 1, and water containing 0.03% by volume of Syndyne (registered trademark) is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
The diluted solution is sprayed at a rate of 20 mL per seedling on cabbage (Brassicae oleracea) seedlings (at the second to third leaf stage) planted in a container. The stems and leaves of the seedlings are then cut off and placed in a container lined with filter paper. Five second-instar diamondback moth larvae are released into the seedlings. After five days, the number of surviving insects is counted and the mortality rate is calculated using the following formula.
Mortality rate (%) = (1-number of living insects/5) x 100

試験例１－１
　所定濃度を５００ｐｐｍとし、下記の本発明化合物を供試化合物として用いて試験法１に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
本発明化合物：１、２、３、４、５、６、７、８、９、１０、１２、１４、１５、１６、１７、１８、１９、２１、２２、２３、２４、２５、２６、２７、２８、２９、３０、３１、３２、３５、３７、３８、３９、４０、４１、４２、４５、４６、４７、４８、４９ Test Example 1-1
The test was carried out according to Test Method 1 using the following compounds of the present invention as test compounds at a predetermined concentration of 500 ppm. As a result, all of the following compounds of the present invention showed a mortality rate of 80% or more.
Compounds of the present invention: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 15, 16, 17, 18, 19, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 35, 37, 38, 39, 40, 41, 42, 45, 46, 47, 48, 49

試験法２
　供試化合物を製剤例１に記載の方法に準じて製剤とし、これにシンダイン（登録商標）０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたキャベツ（Brassicae oleracea）苗（第２～３本葉展開期）に該希釈液を２０ｍＬ／苗の割合で散布する。その後、この苗の茎葉部を切り取り、ろ紙を敷いた容器内に入れる。これにハスモンヨトウ２齢幼虫５頭を放す。５日後、生存虫数を数え、次式より死虫率を求める。
　　　死虫率（％）＝（１－生存虫数／５）×１００ Test method 2
A test compound is formulated according to the method described in Formulation Example 1, and water containing 0.03% by volume of Syndyne (registered trademark) is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
The diluted solution is sprayed at a rate of 20 mL per seedling on cabbage (Brassicae oleracea) seedlings (at the second to third leaf stage) planted in a container. The stems and leaves of the seedlings are then cut off and placed in a container lined with filter paper. Five second-instar larvae of the common cutworm are released into the seedlings. After five days, the number of surviving insects is counted and the mortality rate is calculated using the following formula.
Mortality rate (%) = (1-number of living insects/5) x 100

試験例２－１
　所定濃度を５００ｐｐｍとし、下記の本発明化合物を供試化合物として用いて試験法２に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
本発明化合物：１、２、３、５、２１、２３、２４、２５、２６、２７、２８、３０、３１、３２、３９、４０、４１、４２、４８、４９ Test Example 2-1
The test was carried out according to Test Method 2 using the following compounds of the present invention as test compounds at a predetermined concentration of 500 ppm. As a result, all of the following compounds of the present invention showed a mortality rate of 80% or more.
Compounds of the present invention: 1, 2, 3, 5, 21, 23, 24, 25, 26, 27, 28, 30, 31, 32, 39, 40, 41, 42, 48, 49

試験法３
　供試化合物を製剤例１に記載の方法に準じて製剤とし、これにシンダイン（登録商標）０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたキュウリ（Cucumis sativus）苗（第２本葉展開期）にワタアブラムシ（全ステージ）約３０頭を接種する。１日後、この苗に、該希釈液を１０ｍＬ／苗の割合で散布する。更に５日後、生存虫数を調査し、以下の式により防除価を求める。
　　　防除価（％）＝｛１－（Ｃｂ×Ｔａｉ）／（Ｃａｉ×Ｔｂ）｝×１００
なお、式中の文字は以下の意味を表す。
　　　Ｃｂ：無処理区の供試虫数
　　　Ｃａｉ：無処理区の調査時の生存虫数
　　　Ｔｂ：処理区の供試虫数
　　　Ｔａｉ：処理区の調査時の生存虫数
　ここで無処理区とは、供試化合物を使用しないこと以外は処理区と同じ操作をする区を意味する。 Test method 3
A test compound is formulated according to the method described in Formulation Example 1, and water containing 0.03% by volume of Syndyne (registered trademark) is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
Approximately 30 cotton aphids (all stages) are inoculated onto cucumber (Cucumis sativus) seedlings (at the second leaf stage) planted in a container. After one day, the diluted solution is sprayed onto the seedlings at a rate of 10 mL/seedling. After another five days, the number of surviving insects is counted, and the control value is calculated according to the following formula.
Control value (%) = {1 - (Cb x Tai) / (Cai x Tb)} x 100
The letters in the formula have the following meanings.
Cb: Number of test insects in untreated area Cai: Number of surviving insects at the time of investigation in untreated area Tb: Number of test insects in treated area Tai: Number of surviving insects at the time of investigation in treated area Here, the untreated area means an area in which the same operation as the treated area is performed except that the test compound is not used.

試験例３－１
　所定濃度を５００ｐｐｍとし、下記の本発明化合物を供試化合物として用いて試験法３に従って試験を行った結果、下記の本発明化合物はいずれも防除価９０％以上を示した。
本発明化合物：１、２、３、４、５、６、７、８、１０、１２、１３、１５、１６、１７、１８、１９、２０、２１、２３、２４、２５、２６、２７、２８、２９、３０、４０、４１、４２、４７、４８、４９ Test Example 3-1
Tests were carried out according to Test Method 3 using the following compounds of the present invention as test compounds at a prescribed concentration of 500 ppm. As a result, all of the following compounds of the present invention showed a control value of 90% or more.
Compounds of the present invention: 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 13, 15, 16, 17, 18, 19, 20, 21, 23, 24, 25, 26, 27, 28, 29, 30, 40, 41, 42, 47, 48, 49

試験法４
　供試化合物が２００ｐｐｍとなるように調製したアセトン溶液を内容量２０ｍＬの容器に注ぎ、供試化合物が１０ｍｇ／ｍ2となるように容器の内面に均一にコーティングし、その後乾燥させる。
　該容器にアカイエカ雌成虫５頭を入れ、蓋を閉める。所定時間経過後にアカイエカの状態を調査し死虫率を求める。死虫率は下式により計算する。
　　　死虫率（％）＝（死虫数／供試虫数）×１００ Test method 4
An acetone solution prepared so that the test compound is 200 ppm is poured into a 20 mL container, and the test compound is uniformly coated on the inner surface of the container so that the test compound is 10 mg/m 2 , and then dried.
Five adult female Culex pipiens mosquitoes are placed in the container and the lid is closed. After a predetermined time has passed, the condition of the Culex pipiens mosquitoes is examined and the mortality rate is calculated using the following formula.
Mortality rate (%) = (number of dead insects / number of test insects) x 100

試験例４－１
　所定時間を１時間とし、下記の本発明化合物を供試化合物として用いて試験法４に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
本発明化合物：１、５、２３、２６、２７、２９、４１、４７、５０、５１、５３、５５、５７ Test Example 4-1
The test was carried out according to Test Method 4, using the following compounds of the present invention as test compounds, with the given time being set at 1 hour. As a result, all of the following compounds of the present invention showed a mortality rate of 80% or more.
Compounds of the present invention: 1, 5, 23, 26, 27, 29, 41, 47, 50, 51, 53, 55, 57

試験例４－２
　所定時間を１日とし、下記の本発明化合物を供試化合物として用いて試験法４に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
本発明化合物：１、２、３、４、５、６、７、８、１０、１１、１２、１８、２１、２３、２４、２５、２６、２７、２８、２９、３０、４０、４１、４２、４７、４８、４９、５０、５１、５２、５３、５４、５５、５６、５７、５８ Test Example 4-2
The test was carried out according to Test Method 4 using the following compounds of the present invention as test compounds for a given period of 1 day. As a result, all of the following compounds of the present invention showed a mortality rate of 80% or more.
Compounds of the present invention: 1, 2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 18, 21, 23, 24, 25, 26, 27, 28, 29, 30, 40, 41, 42, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58

試験法５
　供試化合物が８００ｐｐｍとなるように調製したアセトン溶液を内容量２０ｍＬの容器に注ぎ、供試化合物が４０ｍｇ／ｍ2となるように容器の内面に均一にコーティングし、その後乾燥させる。
　該容器にイエバエ雌成虫５頭を入れ、蓋を閉める。所定時間経過後にイエバエの状態を調査し死虫率を求める。死虫率は下式により計算する。
　　　死虫率（％）＝（死虫数／供試虫数）×１００ Test method 5
An acetone solution prepared so that the test compound is 800 ppm is poured into a 20 mL container, and the test compound is uniformly coated on the inner surface of the container so that the test compound is 40 mg/m 2 , and then dried.
Five adult female houseflies are placed in the container and the lid is closed. After a predetermined time has passed, the condition of the houseflies is examined and the mortality rate is calculated using the following formula.
Mortality rate (%) = (Number of dead insects/Number of tested insects) x 100

試験例５－１
　所定時間を１時間とし、下記の本発明化合物を供試化合物として用いて試験法５に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
本発明化合物：１、３、４、５、２３ Test Example 5-1
The test was carried out according to Test Method 5 using the following compounds of the present invention as test compounds for a predetermined time of 1 hour. As a result, all of the following compounds of the present invention showed a mortality rate of 80% or more.
Compounds of the present invention: 1, 3, 4, 5, 23

試験例５－２
　所定時間を１日とし、下記の本発明化合物を供試化合物として用いて試験法５に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
本発明化合物：１、２、３、４、５、７、２１、２３、２４、２６、２８、２９、３０、４０、４１、４２、４７、４９、５０、５２、５３、５４、５５、５７、５８ Test Example 5-2
The test was carried out according to Test Method 5 using the following compounds of the present invention as test compounds for a period of 1 day. All of the following compounds of the present invention showed a mortality rate of 80% or more.
Compounds of the present invention: 1, 2, 3, 4, 5, 7, 21, 23, 24, 26, 28, 29, 30, 40, 41, 42, 47, 49, 50, 52, 53, 54, 55, 57, 58

試験法６
　供試化合物が５０ｐｐｍとなるように調製したアセトン溶液を内容量２０ｍＬの容器に注ぎ、供試化合物が２．５ｍｇ／ｍ2となるように容器の内面に均一にコーティングし、その後乾燥させる。
　該容器にイエヒメアリのワーカー雌成虫１０頭を入れ、蓋を閉める。所定時間経過後にイエヒメアリの状態を調査し死虫率を求める。死虫率は下式により計算する。
　　　死虫率（％）＝（死虫数／供試虫数）×１００ Test Method 6
An acetone solution prepared so that the test compound is 50 ppm is poured into a 20 mL container, and the test compound is uniformly coated on the inner surface of the container so that the test compound is 2.5 mg/m 2 , and then dried.
Ten adult female workers of the house ant are placed in the container and the lid is closed. After a predetermined time has passed, the condition of the house ant is examined and the mortality rate is calculated using the following formula.
Mortality rate (%) = (Number of dead insects/Number of tested insects) x 100

試験例６－１
　所定時間を１時間とし、下記の本発明化合物を供試化合物として用いて試験法６に従って試験を行った結果、下記の本発明化合物はいずれも死虫率７０％以上を示した。
本発明化合物：１、２、３、４、２３、２６、４２、４９ Test Example 6-1
The test was carried out according to Test Method 6 using the following compounds of the present invention as test compounds for a predetermined time of 1 hour. As a result, all of the following compounds of the present invention showed a mortality rate of 70% or more.
Compounds of the present invention: 1, 2, 3, 4, 23, 26, 42, 49

試験例６－２
　所定時間を１日とし、下記の本発明化合物を供試化合物として用いて試験法６に従って試験を行った結果、下記の本発明化合物はいずれも死虫率７０％以上を示した。
本発明化合物：１、２、３、４、５、６、７、１０、１２、１３、１４、１５、１８、１９、２０、２１、２３、２４、２６、２７、２８、２９、３０、３１、３２、３３、３４、３５、３７、３８、３９、４０、４１、４２、４７、４８、４９、５０、５１、５２、５３、５４、５５、５６、５７、５８ Test Example 6-2
The test was carried out according to Test Method 6 using the following compounds of the present invention as test compounds for a given period of 1 day. As a result, all of the following compounds of the present invention showed a mortality rate of 70% or more.
Compound of the present invention: 1, 2, 3, 4, 5, 6, 7, 10, 12, 13, 14, 15, 18, 19, 20, 21, 23, 24, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 37, 38, 39, 40, 41, 42, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58

試験法７
　供試化合物が８００ｐｐｍとなるように調製したアセトン溶液を内容量５０ｍＬの容器に注ぎ、供試化合物が４０ｍｇ／ｍ2となるように容器の内面に均一にコーティングし、その後乾燥させる。
　該容器にチャバネゴキブリ雄成虫５頭を入れ、蓋を閉める。所定時間経過後にチャバネゴキブリの状態を調査し死虫率を求める。死虫率は下式により計算する。
　　　死虫率（％）＝（死虫数／供試虫数）×１００ Test Method 7
An acetone solution prepared so that the test compound is 800 ppm is poured into a 50 mL container, and the test compound is uniformly coated on the inner surface of the container so that the test compound is 40 mg/m 2 , and then dried.
Five adult male German cockroaches are placed in the container and the lid is closed. After a predetermined time has elapsed, the condition of the German cockroaches is examined and the mortality rate is calculated using the following formula.
Mortality rate (%) = (Number of dead insects/Number of tested insects) x 100

試験例７－１
　所定時間を１時間とし、本発明化合物を供試化合物として用いて試験法７に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
本発明化合物： ２３、２６ Test Example 7-1
The test was carried out according to Test Method 7, with the given time being set at 1 hour, and the compounds of the present invention were used as test compounds. As a result, all of the compounds of the present invention shown below showed a mortality rate of 80% or more.
Compounds of the present invention: 23, 26

試験例７－２
　所定時間を１日とし、下記の本発明化合物を供試化合物として用いて試験法７に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
本発明化合物：１、２、３、４、６、７、８、１０、１２、１５、２１、２３、２４、２６、４０、４９、５２、５３、５４、５５ Test Example 7-2
The test was carried out for one day according to Test Method 7 using the following compounds of the present invention as test compounds. All of the following compounds of the present invention showed a mortality rate of 80% or more.
Compounds of the present invention: 1, 2, 3, 4, 6, 7, 8, 10, 12, 15, 21, 23, 24, 26, 40, 49, 52, 53, 54, 55

試験例７－３
　所定時間を３日とし、下記の本発明化合物を供試化合物として用いて試験法７に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
本発明化合物：１、２、３、４、６、７、８、１０、１２、１５、２１、２３、２４、２６、４０、４９、５２、５３、５４、５５、５８ Test Example 7-3
The test was carried out for a period of 3 days according to Test Method 7 using the following compounds of the present invention as test compounds. All of the following compounds of the present invention showed a mortality rate of 80% or more.
Compounds of the present invention: 1, 2, 3, 4, 6, 7, 8, 10, 12, 15, 21, 23, 24, 26, 40, 49, 52, 53, 54, 55, 58

試験法８
　供試化合物を製剤例５に記載の方法に準じて製剤とし、これに水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたキュウリ（Cucumis sativus）苗（第２本葉展開期）に該希釈液を５ｍＬ／苗の割合で株元灌注する。７日後、この苗の葉面にワタアブラムシ（全ステージ）約３０頭を接種する。更に６日後、生存虫数を調査し、以下の式により防除価を求める。
　　　　防除価（％）＝｛１－（Ｃｂ×Ｔａｉ）／（Ｃａｉ×Ｔｂ）｝×１００
なお、式中の文字は以下の意味を表す。
　　　Ｃｂ：無処理区の供試虫数
　　　Ｃａｉ：無処理区の調査時の生存虫数
　　　Ｔｂ：処理区の供試虫数
　　　Ｔａｉ：処理区の調査時の生存虫数
　ここで無処理区とは、供試化合物を使用しないこと以外は処理区と同じ操作をする区を意味する。 Test Method 8
The test compound is formulated according to the method described in Formulation Example 5, and water is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
The diluted solution is irrigated at the base of a cucumber (Cucumis sativus) seedling (at the second true leaf stage) planted in a container at a rate of 5 mL per seedling. After 7 days, about 30 cotton aphids (all stages) are inoculated onto the leaf surface of the seedling. After another 6 days, the number of surviving insects is counted, and the control value is calculated according to the following formula.
Control value (%) = {1 - (Cb x Tai) / (Cai x Tb)} x 100
The letters in the formula have the following meanings.
Cb: Number of test insects in untreated area Cai: Number of surviving insects at the time of investigation in untreated area Tb: Number of test insects in treated area Tai: Number of surviving insects at the time of investigation in treated area Here, the untreated area means an area in which the same operation as the treated area is performed except that the test compound is not used.

試験例８－１
　所定濃度を２００ｐｐｍとし、本発明化合物を供試化合物として用いて試験法８に従って試験を行うと、効果が確認できる。 Test Example 8-1
The effect can be confirmed by carrying out a test according to Test Method 8 using the compound of the present invention as a test compound at a predetermined concentration of 200 ppm.

試験法９
　供試化合物を製剤例１に記載の方法に準じて製剤とし、これにシンダイン（登録商標）０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたイネ（Oryza sativa）苗（第２葉展開期）に該希釈液を１０ｍＬ／苗の割合で散布する。その後、トビイロウンカ３齢幼虫を２０頭放す。６日後、生存虫数を調査し、以下の式により死虫率を求める。
　　　死虫率（％）＝｛１－生存虫数／２０｝×１００ Test Method 9
A test compound is formulated according to the method described in Formulation Example 1, and water containing 0.03% by volume of Syndyne (registered trademark) is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
The diluted solution is sprayed at a rate of 10 mL per seedling on rice (Oryza sativa) seedlings (at the second leaf stage) planted in a container. Then, 20 third-instar larvae of the brown planthopper are released. After 6 days, the number of surviving insects is counted, and the mortality rate is calculated by the following formula.
Mortality rate (%) = {1-number of living insects/20} x 100

試験例９－１
　所定濃度を５００ｐｐｍとし、本発明化合物を供試化合物として用いて試験法９に従って試験を行った結果、下記の本発明化合物はいずれも死虫率９０％以上を示した。
本発明化合物：２４、４９ Test Example 9-1
Tests were carried out according to Test Method 9 using the compounds of the present invention as test compounds at a prescribed concentration of 500 ppm. As a result, all of the compounds of the present invention shown below showed a mortality rate of 90% or more.
Compounds of the present invention: 24, 49

試験法１０
　供試化合物を製剤例５に記載の方法に準じて製剤とし、これにシンダイン（登録商標）０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたトマト（Lycopersicon esculentum）苗に、タバココナジラミ成虫を放して約２４時間産卵させる。この苗を８日間保管し、産下された卵から幼虫を孵化させる。この苗に、該希釈液を１０ｍＬ／苗の割合で散布する。７日後、生存虫数を調査し、次の式により防除価を求める。
　　　防除価（％）＝｛１－（Ｃｂ×Ｔａｉ）／（Ｃａｉ×Ｔｂ）｝×１００
なお、式中の文字は以下の意味を表す。
　　　Ｃｂ：無処理区の処理直前の虫数
　　　Ｃａｉ：無処理区の調査時の生存虫数
　　　Ｔｂ：処理区の処理直前の虫数
　　　Ｔａｉ：処理区の調査時の生存虫数
　ここで無処理区とは、供試化合物を使用しないこと以外は処理区と同じ操作をする区を意味する。 Test Method 10
The test compound is formulated according to the method described in Formulation Example 5, and water containing 0.03% by volume of Syndyne (registered trademark) is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
Tomato (Lycopersicon esculentum) seedlings planted in a container are released with adult Bemisia tabaci and allowed to lay eggs for about 24 hours. The seedlings are stored for 8 days, and larvae are allowed to hatch from the eggs laid. The diluted solution is sprayed on the seedlings at a rate of 10 mL/seedling. After 7 days, the number of surviving insects is counted, and the control value is calculated according to the following formula.
Control value (%) = {1 - (Cb x Tai) / (Cai x Tb)} x 100
The letters in the formula have the following meanings.
Cb: number of insects in untreated area just before treatment Cai: number of surviving insects at the time of investigation in untreated area Tb: number of insects in treated area just before treatment Tai: number of surviving insects at the time of investigation in treated area Here, untreated area means an area which is operated in the same manner as the treated area except that the test compound is not used.

　試験例１０－１
所定濃度を２００ｐｐｍとし、本発明化合物を供試化合物として用いて試験法１０に従って試験を行うと、効果が確認できる。 Test Example 10-1
The effect can be confirmed by setting the predetermined concentration at 200 ppm and carrying out a test according to Test Method 10 using the compound of the present invention as a test compound.

試験法１１
　供試化合物を製剤例１に記載の方法に準じて製剤とし、これにシンダイン（登録商標）０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたインゲンマメ（Phaseolus vulgaris）苗（第１本葉展開期）に約４０頭のナミハダニ雌成虫を放つ。１日後、この苗に該希釈液を１０ｍＬ／苗の割合で散布する。更に７日後、生存虫数を調査し、次式により防除価を算出する。
　　　防除価（％）＝｛１－（Ｃｂ×Ｔａｉ）／（Ｃａｉ×Ｔｂ）｝×１００
なお、式中の文字は以下の意味を表す。
　　　Ｃｂ：無処理区の供試虫数
　　　Ｃａｉ：無処理区の調査時の生存虫数
　　　Ｔｂ：処理区の供試虫数
　　　Ｔａｉ：処理区の調査時の生存虫数
　ここで無処理区とは、供試化合物を使用しないこと以外は処理区と同じ操作をする区を意味する。 Test Method 11
A test compound is formulated according to the method described in Formulation Example 1, and water containing 0.03% by volume of Syndyne (registered trademark) is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
About 40 adult female two-spotted spider mites are released onto a container of kidney bean (Phaseolus vulgaris) seedlings (at the first true leaf stage). After one day, the diluted solution is sprayed onto the seedlings at a rate of 10 mL per seedling. After another seven days, the number of surviving insects is counted, and the control value is calculated according to the following formula.
Control value (%) = {1 - (Cb x Tai) / (Cai x Tb)} x 100
The letters in the formula have the following meanings.
Cb: Number of test insects in untreated area Cai: Number of surviving insects at the time of investigation in untreated area Tb: Number of test insects in treated area Tai: Number of surviving insects at the time of investigation in treated area Here, the untreated area means an area in which the same operation as the treated area is performed except that the test compound is not used.

試験例１１－１
　所定濃度を５００ｐｐｍとし、本発明化合物を供試化合物として用いて試験法１１に従って試験を行うと、効果が確認できる。 Test Example 11-1
The effect can be confirmed by carrying out a test according to Test Method 11 using the compound of the present invention as a test compound at a predetermined concentration of 500 ppm.

試験法１２
　供試化合物を製剤例５に記載の方法に準じて製剤とし、これにシンダイン（登録商標）展着剤０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたキャベツ（Brassicae oleracea）苗（第２葉展開期）に該希釈液を１０ｍＬ／苗の割合で散布する。その後、第２本葉を切り取り容器内に収容し、これにミカンキイロアザミウマの幼虫を約２０頭放す。６日後、生存虫数を調査し、次の式により死虫率を求める。
　　　死虫率（％）＝｛１－生存虫数／２０｝×１００ Test Method 12
The test compound is formulated according to the method described in Formulation Example 5, and water containing 0.03% by volume of Syndyne (registered trademark) spreading agent is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
The diluted solution is sprayed at a rate of 10 mL per seedling on cabbage (Brassicae oleracea) seedlings (at the second leaf stage) planted in a container. The second true leaves are then cut off and placed in a container, into which about 20 larvae of western flower thrips are released. After 6 days, the number of surviving insects is counted, and the mortality rate is calculated using the following formula.
Mortality rate (%) = {1-number of living insects/20}×100

試験例１２－１
　所定濃度を２００ｐｐｍとし、本発明化合物を供試化合物として用いて試験法１２に従って試験を行うと、効果が確認できる。 Test Example 12-1
The effect can be confirmed by setting the predetermined concentration at 200 ppm and carrying out a test according to Test Method 12 using the compound of the present invention as a test compound.

試験法１３
　供試化合物１ｍｇあたり、ポリオキシエチレンソルビタンモノココエート：アセトン＝５：９５（容量比）の混合溶液５０μＬに溶解させる。これにシンダイン（登録商標）０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　トウモロコシ（Zea mays）の若い実生を該希釈液に３０秒間浸漬する。その後、該実生２つをシャーレ（９０ｍｍ径）に入れ、これにウエスタンコーンルートワーム２齢幼虫１０頭を放す。５日後、死亡虫数を数え、次式より死虫率を求める。
　　　死虫率（％）＝（死亡虫数／１０）×１００ Test Method 13
Dissolve 1 mg of a test compound in 50 μL of a mixed solution of polyoxyethylene sorbitan monococoate:acetone = 5:95 (volume ratio) and add water containing 0.03 volume % of Syndyne (registered trademark) to prepare a dilution containing the test compound at a predetermined concentration.
Young seedlings of corn (Zea mays) are immersed in the diluted solution for 30 seconds. Two seedlings are then placed in a petri dish (90 mm diameter) into which 10 second-instar larvae of Western corn rootworm are released. After 5 days, the number of dead insects is counted and the mortality rate is calculated by the following formula.
Mortality rate (%) = (number of dead insects/10) x 100

試験例１３－１
　所定濃度を２００ｐｐｍとし、本発明化合物を供試化合物として用いて試験法１３に従って試験を行うと、効果が確認できる。 Test Example 13-1
The effect can be confirmed by setting the predetermined concentration at 200 ppm and carrying out a test according to Test Method 13 using the compound of the present invention as a test compound.

試験法１４
　供試化合物を製剤例１に記載の方法に準じて製剤とし、これに水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたイネ（Oryza sativa）苗（第２葉展開期）に該希釈液を５ｍＬ／苗の割合で株元灌注する。７日後、トビイロウンカ３齢幼虫を２０頭放す。更に６日後、生存虫数を調査し、以下の式により死虫率を求める。
　　　死虫率（％）＝｛１－生存虫数／２０｝×１００ Test Method 14
The test compound is formulated according to the method described in Formulation Example 1, and water is added to the formulation to prepare a diluent containing the test compound at a predetermined concentration.
The diluted solution is irrigated at the base of rice (Oryza sativa) seedlings (at the second leaf stage) planted in a container at a rate of 5 mL per seedling. After 7 days, 20 third-instar larvae of the brown planthopper are released. After another 6 days, the number of surviving insects is counted and the mortality rate is calculated using the following formula.
Mortality rate (%) = {1-number of living insects/20} x 100

試験例１４－１
　所定濃度を５００ｐｐｍとし、本発明化合物を供試化合物として用いて試験法１４に従って試験を行うと、効果が確認できる。 Test Example 14-1
The effect can be confirmed by carrying out a test according to Test Method 14 using the compound of the present invention as a test compound at a predetermined concentration of 500 ppm.

試験法１５
　供試化合物を製剤例５に記載の方法に準じて製剤とし、これにシンダイン（登録商標）０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　ろ紙を敷いた容器に、２．６ｇの人工飼料（シルクメイト２Ｓ、日本農産工業）を置く。モモシンクイガの卵１００個を接種したネットを該人工飼料の上に置く。これに該希釈液０．５ｍＬを卵の上から灌注する。１０日後、生存虫数を数え、次式より死虫率を求める。
　　　生存虫率（％）＝生存虫数／接種した卵の数×１００
　　　死虫率（％）＝｛無処理区の生存虫率（％）－処理区の生存虫率（％）｝／無処理区の生存虫率（％）×１００
　ここで無処理区とは、供試化合物を使用しないこと以外は処理区と同じ操作をする区を意味する。 Test Method 15
The test compound is formulated according to the method described in Formulation Example 5, and water containing 0.03% by volume of Syndyne (registered trademark) is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
2.6 g of artificial feed (Silkmate 2S, Nippon Nosan Kogyo) is placed in a container lined with filter paper. A net inoculated with 100 eggs of the peach fruit moth is placed on the artificial feed. 0.5 mL of the diluted solution is poured onto the eggs. After 10 days, the number of surviving insects is counted and the mortality rate is calculated using the following formula.
Survival rate (%) = number of surviving insects / number of inoculated eggs x 100
Mortality rate (%) = {survival rate (%) in untreated area - survival rate (%) in treated area} / survival rate (%) in untreated area x 100
The term "untreated group" used herein means a group in which the same procedures as those for the treated group are carried out except that the test compound is not used.

試験例１５－１
　所定濃度を２００ｐｐｍとし、本発明化合物を供試化合物として用いて試験法１５に従って試験を行うと、効果が確認できる。 Test Example 15-1
The effect can be confirmed by setting the predetermined concentration at 200 ppm and carrying out a test according to Test Method 15 using the compound of the present invention as a test compound.

試験法１６
　供試化合物を製剤例１に記載の方法に準じて製剤とし、これに水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　該希釈液中にアカイエカ終齢幼虫３０頭を放ち、１日後にアカイエカ幼虫の状態を調査し死虫率を求める。死虫率は下式により計算する。
　死虫率（％）＝（死虫数／供試虫数）×１００ Test Method 16
A test compound is formulated according to the method described in Formulation Example 1, and water is added to the formulation to prepare a diluent containing the test compound at a predetermined concentration.
Thirty final stage larvae of Culex pipiens mosquito are released into the diluted solution, and the condition of the larvae is examined one day later to determine the mortality rate. The mortality rate is calculated by the following formula:
Mortality rate (%) = (number of dead insects / number of test insects) x 100

試験例１６－１
　所定濃度を３．５ｐｐｍとし、本発明化合物を供試化合物として用いて試験法１６に従って試験を行うと、効果が確認できる。 Test Example 16-1
The effect can be confirmed by setting the predetermined concentration at 3.5 ppm and carrying out a test according to Test Method 16 using the compound of the present invention as a test compound.

試験法１７
　供試化合物が２０００ｐｐｍとなるように調整したアセトン溶液を内容量２０ｍＬの容器に注ぎ、供試化合物が１００ｍｇ／ｍ2となるように容器の内面に均一にコーティングし、その後乾燥させる。
　該容器にフタトゲチマダニ若虫５頭を入れ、蓋を閉める。所定時間経過後にフタトゲチマダニの状態を調査し死虫率を求める。死虫率は下式により計算する。
　　　死虫率（％）＝（死虫数／供試虫数）×１００ Test Method 17
An acetone solution adjusted to have a test compound of 2000 ppm is poured into a 20 mL container, and the test compound is uniformly coated on the inner surface of the container to have a coverage of 100 mg/m 2 , and then dried.
Five nymphal Haemaphysalis longicornis mites are placed in the container and the lid is closed. After a predetermined time has elapsed, the condition of the Haemaphysalis longicornis mites is examined and the mortality rate is calculated using the following formula.
Mortality rate (%) = (number of dead insects / number of test insects) x 100

試験例１７－１
　所定時間を２日とし、本発明化合物を供試化合物として用いて試験法１７に従って試験を行うと、効果が確認できる。 Test Example 17-1
The effect can be confirmed by carrying out the test according to Test Method 17 using the compound of the present invention as the test compound for a predetermined period of time of 2 days.

試験法１８
　供試化合物が８８５ｐｐｍとなるように調整したアセトン溶液（０．０８％のＴｗｅｅｎ２０を含有）を内容量２０ｍＬの容器に注ぎ、供試化合物が４０ｍｇ／ｍ2となるように容器の内面に均一にコーティングし、その後乾燥させる。
　該容器にＡｍｂｌｙｏｍｍａ　ａｍｅｒｉｃａｎｕｍ若虫１０頭を入れ、蓋を閉める。所定時間経過後にＡｍｂｌｙｏｍｍａ　ａｍｅｒｉｃａｎｕｍの状態を調査し死虫率を求める。死虫率は下式により計算する。
　　　死虫率（％）＝（死虫数／供試虫数）×１００ Test Method 18
An acetone solution (containing 0.08% Tween 20) adjusted to have a test compound at 885 ppm is poured into a 20 mL container, and the test compound is uniformly coated on the inner surface of the container to have a coverage of 40 mg/ m2 , and then dried.
Ten Amblyomma americanum nymphs are placed in the container and the lid is closed. After a predetermined time has passed, the condition of Amblyomma americanum is examined and the mortality rate is calculated using the following formula.
Mortality rate (%) = (number of dead insects / number of test insects) x 100

試験例１８－１
　所定時間を２日とし、本発明化合物を供試化合物として用いて試験法１８に従って試験を行った結果、下記の本発明化合物はいずれも死虫率８０％以上を示した。
　本発明化合物： ３、７、８、１０、１１、１２、１７、１８、２０、２３、４０、４２、４７ Test Example 18-1
The test was carried out for a period of 2 days according to Test Method 18 using the compounds of the present invention as test compounds. As a result, all of the compounds of the present invention shown below showed a mortality rate of 80% or more.
Compounds of the present invention: 3, 7, 8, 10, 11, 12, 17, 18, 20, 23, 40, 42, 47

試験法１９
　本発明化合物１ｍｇを、キシレン：ＤＭＦ：界面活性剤＝４：４：１（容量比）の混合溶液１０μＬに溶解し、展着剤を０．０２容量％含有する水で希釈して、本発明化合物を所定濃度含有する希釈液Ａを調製する。
　本成分１ｍｇを、キシレン：ＤＭＦ：界面活性剤＝４：４：１（容量比）の混合溶液１０μＬに溶解し、展着剤を０．０２容量％含有する水で希釈して、本成分を所定濃度含有する希釈液Ｂを調製する。
　希釈液Ａと希釈液Ｂとを混合し、希釈液Ｃを得る。
　キュウリ子葉の葉片（長さ１．５ｃｍ）を２４穴マイクロプレートの各ウェルに収容し、１ウェルあたりワタアブラムシ無翅成虫２匹及び幼虫８匹を放し、１ウェルあたり２０μＬの希釈液Ｃを散布する。これを処理区とする。
　なお、希釈液Ｃの代わりに展着剤０．０２容量％を含有する水を２０μＬ散布するウェルを無処理区とする。
　希釈液Ｃが乾燥した後、マイクロプレート上部をフィルムシートで覆う。５日後に、各ウェルの生存虫数を調査する。
　防除価を次式より算出する。
　　　防除価（％）＝｛１－（Ｔａｉ）／（Ｃａｉ）｝×１００
なお、式中の記号は以下の意味を表す。
　　　Ｃａｉ：無処理区の調査時の生存虫数
　　　Ｔａｉ：処理区の調査時の生存虫数 Test Method 19
1 mg of the compound of the present invention is dissolved in 10 μL of a mixed solution of xylene:DMF:surfactant=4:4:1 (volume ratio), and diluted with water containing 0.02 vol% of a spreading agent to prepare dilution solution A containing the compound of the present invention at a predetermined concentration.
1 mg of this component is dissolved in 10 μL of a mixed solution of xylene:DMF:surfactant = 4:4:1 (volume ratio), and diluted with water containing 0.02 vol.% of a spreading agent to prepare dilution solution B containing the specified concentration of this component.
Diluent A and diluent B are mixed to obtain diluent C.
Cucumber cotyledonary leaf pieces (1.5 cm long) are placed in each well of a 24-well microplate, 2 wingless adults and 8 larvae of cotton aphids are released per well, and 20 μL of diluent C is sprayed per well. This is used as a treatment group.
In addition, 20 μL of water containing 0.02% by volume of a spreading agent was sprayed onto wells instead of diluent C to serve as an untreated group.
After the diluent C has dried, the top of the microplate is covered with a film sheet. After 5 days, the number of surviving insects in each well is counted.
The control value is calculated according to the following formula.
Control value (%) = {1 - (Tai) / (Cai)} x 100
The symbols in the formula have the following meanings.
Cai: Number of surviving insects at the time of investigation in the untreated area Tai: Number of surviving insects at the time of investigation in the treated area

　試験法１９にて、効果を確認することができる具体的な希釈液Ｃについて、下記１）～５）に示す。 Specific dilution solutions C whose effectiveness can be confirmed using Test Method 19 are shown below in 1) to 5).

１）リストＡに記載の組合せにおいて、本発明化合物の濃度が２００ｐｐｍであり、本成分の濃度が２０００ｐｐｍである希釈液Ｃ。なお、リストＡにおいて、Comp Xは、化合物群SX1～SX1338及び本発明化合物１～５８から選ばれるいずれか１つの化合物を意味する。
リストＡ：
Comp X + クロチアニジン；Comp X + チアメトキサム；Comp X + イミダクロプリド；Comp X + チアクロプリド；Comp X + フルピラジフロン；Comp X + スルホキサフロル；Comp X + トリフルメゾピリム；Comp X + ジクロロメゾチアズ；Comp X + ベータシフルトリン；Comp X + テフルトリン；Comp X + フィプロニル；Comp X + クロラントラニリプロール；Comp X + シアントラニリプロール；Comp X + テトラニリプロール；Comp X + チオジカルブ；Comp X + カルボフラン；Comp X + フルキサメタミド；Comp X + アフォキソラネル；Comp X + フルララネル；Comp X + ブロフラニリド；Comp X + アバメクチン；Comp X + フルオピラム；Comp X + フルエンスルホン；Comp X + フルアザインドリジン；Comp X + チオキサザフェン；Comp X + フルピリミン；Comp X + 菌根菌；Comp X + ブラディリゾビウム・ジャポニカムＴＡ－１１株；Comp X + バチルス・フィルムス；Comp X + バチルス・フィルムスＩ－１５８２株；Comp X + バチルス・アミロリケファシエンス；Comp X + バチルス・アミロリケファシエンスＦＺＢ４２株；Comp X + パスツーリア・ニシザワエ；Comp X + パスツーリア・ニシザワエＰｎ１株；Comp X + パスツーリア・ペネトランス；Comp X + テブコナゾール；Comp X + プロチオコナゾール；Comp X + メトコナゾール；Comp X + イプコナゾール；Comp X + トリチコナゾール；Comp X + ジフェノコナゾール；Comp X + イマザリル；Comp X + トリアジメノール；Comp X + テトラコナゾール；Comp X + フルトリアホール；Comp X + マンデストロビン；Comp X + アゾキシストロビン；Comp X + ピラクロストロビン；Comp X + トリフロキシストロビン；Comp X + フルオキサストロビン；Comp X + ピコキシストロビン；Comp X + フェナミドン；Comp X + メタラキシル；Comp X + メタラキシルＭ；Comp X + フルジオキソニル；Comp X + セダキサン；Comp X + ペンフルフェン；Comp X + フルキサピロキサド；Comp X + ベンゾビンジフルピル；Comp X + ボスカリド；Comp X + カルボキシン；Comp X + ペンチオピラド；Comp X + フルトラニル；Comp X + キャプタン；Comp X + チウラム；Comp X + トルクロホスメチル；Comp X + チアベンダゾール；Comp X + エタボキサム；Comp X + マンコゼブ；Comp X + ピカルブトラゾクス；Comp X + オキサチアピプロリン；Comp X + シルチオファム； Comp X + インピルフルキサム。 1) Dilution solution C in which the concentration of the compound of the present invention is 200 ppm and the concentration of this component is 2000 ppm in the combination described in List A. In List A, Comp X means any one compound selected from the compound group SX1 to SX1338 and the present compounds 1 to 58.
List A:
Comp X + Clothianidin;Comp X + Thiamethoxam;Comp X + Imidacloprid;Comp X + Thiacloprid;Comp X + Flupyradifurone;Comp X + Sulfoxaflor;Comp X + Triflumezopyrim;Comp X + Dichloromezothiaz;Comp X + Beta-cyfluthrin;Comp X + Tefluthrin;Comp X + Fipronil;Comp X + Chlorantraniliprole;Comp X + Cyantraniliprole;Comp X + Tetraniliprole;Comp X + Thiodicarb;Comp X + Carbofuran;Comp X + Fluxamethamide;Comp X + Afoxolaner;Comp X + Fluralaner;Comp X + Brofuranilide;Comp X + Abamectin;Comp X + Fluopyram;Comp X + Fluensulfone;Comp X + Fluazaindolizine;Comp X + Thioxazafen;Comp X + Flupirimine; Comp X + mycorrhizal fungi; Comp X + Bradyrhizobium japonicum strain TA-11; Comp X + Bacillus firmus; Comp X + Bacillus firmus strain I-1582; Comp X + Bacillus amyloliquefaciens; Comp X + Bacillus amyloliquefaciens strain FZB42; Comp X + Pasteuria nishizawae; Comp X + Pasteuria nishizawae strain Pn1; Comp X + Pasteuria penetrans; Comp X + tebuconazole; Comp X + prothioconazole; Comp X + metconazole; Comp X + ipconazole; Comp X + triticonazole; Comp X + difenoconazole; Comp X + imazalil; Comp X + triadimenol; Comp X + tetraconazole; Comp X + flutriafol; Comp X + Mandestrobin;Comp X + azoxystrobin;Comp X + pyraclostrobin;Comp X + trifloxystrobin;Comp X + fluoxastrobin;Comp X + picoxystrobin;Comp X + fenamidone;Comp X + metalaxyl;Comp X + metalaxyl M;Comp X + fludioxonil;Comp X + sedaxane;Comp X + penflufen;Comp X + fluxapyroxad;Comp X + benzobindiflupyr;Comp X + boscalid;Comp X + carboxin;Comp X + penthiopyrad;Comp X + flutolanil;Comp X + captan;Comp X + thiuram;Comp X + tolclofos methyl;Comp X + thiabendazole;Comp X + ethaboxam;Comp X + mancozeb;Comp X + picarbutrazox;Comp X + oxathiapiproline;Comp X + silthiofam;Comp X + Impirfluxam.

２）リストＡに記載の組合せにおいて、本発明化合物の濃度が２００ｐｐｍであり、本成分の濃度が２００ｐｐｍである希釈液Ｃ。 2) Dilution solution C, in which the concentration of the compound of the present invention is 200 ppm and the concentration of this component is 200 ppm in the combination described in List A.

３）リストＡに記載の組合せにおいて、本発明化合物の濃度が５００ｐｐｍであり、本成分の濃度が５０ｐｐｍである希釈液Ｃ。 3) Dilution solution C, in which the concentration of the compound of the present invention is 500 ppm and the concentration of this component is 50 ppm in the combination described in List A.

４）リストＡに記載の組合せにおいて、本発明化合物の濃度が５００ｐｐｍであり、本成分の濃度が５ｐｐｍである希釈液Ｃ。 4) Dilution solution C, in which the concentration of the compound of the present invention is 500 ppm and the concentration of this component is 5 ppm in the combination described in List A.

５）リストＡに記載の組合せにおいて、本発明化合物の濃度が５００ｐｐｍであり、本成分の濃度が０．５ｐｐｍである希釈液Ｃ。 5) Dilution solution C, in which the concentration of the compound of the present invention is 500 ppm and the concentration of this component is 0.5 ppm in the combination described in List A.

　次に、比較試験例を示す。国際公開第２０２２／２３３７７７号に記載の下記化合物Ｃｆ－Ｉ－１５（以下、比較試験化合物Ｃｆ－Ｉ－１５と記す）を用いて、比較試験を行った。

Figure JPOXMLDOC01-appb-C000195
Next, a comparative test example will be shown. A comparative test was carried out using the following compound Cf-I-15 (hereinafter referred to as comparative test compound Cf-I-15) described in WO 2022/233777.
Figure JPOXMLDOC01-appb-C000195

比較試験法１
　供試化合物を製剤例５に記載の方法に準じて製剤とし、これにシンダイン（登録商標）０．０３容量％含有する水を加え、供試化合物を所定濃度含有する希釈液を調製する。
　容器に植えたキュウリ（Cucumis sativus）苗（第２本葉展開期）にワタアブラムシ（全ステージ）約３０頭を接種する。１日後、この苗に、該希釈液を１０ｍＬ／苗の割合で散布する。更に６日後、生存虫数を調査し、以下の式により防除価を求める。
　　　防除価（％）＝｛１－（Ｃｂ×Ｔａｉ）／（Ｃａｉ×Ｔｂ）｝×１００
なお、式中の文字は以下の意味を表す。
　　　Ｃｂ：無処理区の供試虫数
　　　Ｃａｉ：無処理区の調査時の生存虫数
　　　Ｔｂ：処理区の供試虫数
　　　Ｔａｉ：処理区の調査時の生存虫数
　ここで無処理区とは、供試化合物を使用しないこと以外は処理区と同じ操作をする区を意味する。 Comparative Test Method 1
The test compound is formulated according to the method described in Formulation Example 5, and water containing 0.03% by volume of Syndyne (registered trademark) is added to the formulation to prepare a dilution containing the test compound at a predetermined concentration.
Approximately 30 cotton aphids (all stages) are inoculated onto cucumber (Cucumis sativus) seedlings (at the second leaf stage) planted in a container. After one day, the diluted solution is sprayed onto the seedlings at a rate of 10 mL/seedling. After another six days, the number of surviving insects is counted, and the control value is calculated according to the following formula.
Control value (%) = {1 - (Cb x Tai) / (Cai x Tb)} x 100
The letters in the formula have the following meanings.
Cb: Number of test insects in untreated area Cai: Number of surviving insects at the time of investigation in untreated area Tb: Number of test insects in treated area Tai: Number of surviving insects at the time of investigation in treated area Here, the untreated area means an area in which the same operation as the treated area is performed except that the test compound is not used.

比較試験例１－１
　所定濃度を５０ｐｐｍとし、本発明化合物１、２、２４、２６及び比較試験化合物Ｃｆ－Ｉ－１５を供試化合物として用いて比較試験法１に従って試験を行った結果、本発明化合物１、２、２４及び２６はいずれも防除価９０％以上を示した。一方で、比較試験化合物Ｃｆ－Ｉ－１５は防除価３０％以下であった。 Comparative Test Example 1-1
The test was carried out according to Comparative Test Method 1 using the compounds 1, 2, 24, and 26 of the present invention and the comparative test compound Cf-I-15 as test compounds at a predetermined concentration of 50 ppm. As a result, the compounds 1, 2, 24, and 26 of the present invention all showed a control value of 90% or more. On the other hand, the comparative test compound Cf-I-15 showed a control value of 30% or less.

　本発明化合物は、有害節足動物に対して優れた防除効果を示す。 The compound of the present invention exhibits excellent control effects against harmful arthropods.

Claims (8)

　式（Ｉ）
Figure JPOXMLDOC01-appb-C000001
 〔式中、
　Ｌは、単結合、又は－（ＣＲ4aＲ4b）n－を表し、
　Ｒ4a及びＲ4bは、同一又は相異なり、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、シアノ基、ヒドロキシ基、ハロゲン原子、又は水素原子を表し、
　ｎは、１、２、３、４、５、又は６を表し、
　Ｒ1は、シクロプロピル基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、シアノ基、ハロゲン原子、ヒドロキシ基、又は水素原子を表し、
　Ｑは、式Ａ１で示される基、式Ａ２で示される基、式Ａ３で示される基、式Ａ４で示される基、式Ａ５で示される基、又は式Ａ６で示される基（＃はＲ2との結合部位を表し、●は炭素原子との結合部位を表す）を表し、
Figure JPOXMLDOC01-appb-C000002
 　Ｑ1、Ｑ2、及びＱ3の組合せは、
　　Ｑ1がＣＲ3q1であり、Ｑ2がＣＲ3q2であり、Ｑ3がＣＲ3q3である組合せ；
　　Ｑ1が窒素原子であり、Ｑ2がＣＲ3q2であり、Ｑ3がＣＲ3q3である組合せ；
　　Ｑ1がＣＲ3q1であり、Ｑ2が窒素原子であり、Ｑ3がＣＲ3q3である組合せ；又は
　　Ｑ1がＣＲ3q1であり、Ｑ2がＣＲ3q2であり、Ｑ3が窒素原子である組合せを表し、
　Ｑ1a及びＱ2aの組合せは、
　　Ｑ1aがＣＲ3q4であり、Ｑ2aがＣＲ3q5である組合せ；
　　Ｑ1aが窒素原子であり、Ｑ2aがＣＲ3q5である組合せ；又は
　　Ｑ1aがＣＲ3q4であり、Ｑ2aが窒素原子である組合せを表し、
　Ｒ3q1、Ｒ3q2、Ｒ3q3、Ｒ3q4、Ｒ3q5及びＲ4は、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、ＮＲ6Ｃ（Ｏ）Ｒ5、ＮＲ6Ｃ（Ｏ）ＯＲ5、ＮＲ6Ｃ（Ｏ）ＮＲ5Ｒ12、Ｃ（Ｏ）ＮＲ6Ｒ7、Ｃ（＝ＮＯＲ9）Ｒ5、Ｃ（＝ＮＯＲ9）（ＮＲ6Ｒ7）、Ｎ＝Ｓ（Ｏ）pＲ28Ｒ15、シアノ基、ハロゲン原子、又は水素原子を表し、
　Ｚ1は、酸素原子、又は硫黄原子を表し、
　ｐは、０又は１を表し、
　Ｒ5は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ6は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ7は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ9は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ12は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ15は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基を表し、
　Ｒ2は、群Ａより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ａより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、Ｃ（Ｏ）ＮＲ6Ｒ7、Ｃ（＝ＮＯＲ9）Ｒ5、Ｃ（＝ＮＯＲ9）（ＮＲ6Ｒ7）、Ｃ（Ｏ）Ｒ5、ＮＲ16Ｃ（Ｏ）Ｒ17、ＮＲ16Ｃ（Ｏ）ＯＲ17、ＮＲ16Ｃ（Ｏ）ＮＲ17Ｒ18、Ｓ（Ｏ）2ＮＲ16Ｒ17、ＯＲ18、Ｓ（Ｏ）mＲ15、メルカプト基、式Ｅ１で示される基、式Ｅ２で示される基、又は式Ｅ３で示される基（＃2は式Ａ１で示される基、式Ａ２で示される基、式Ａ３で示される基、式Ａ４で示される基、式Ａ５で示される基、又は式Ａ６で示される基との結合部位を表す）を表し、
Figure JPOXMLDOC01-appb-C000003
 　ｍは、０、１、又は２を表し、
　Ｒ16、Ｒ17、及びＲ18は、同一又は相異なり、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員複素環基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ2がＮＲ16Ｃ（Ｏ）Ｒ17である場合、Ｒ16及びＲ17は、Ｒ16が結合する窒素原子、及びＲ17が結合する炭素原子と一緒になって、Ｃ１－Ｃ３鎖式炭化水素基｛該Ｃ１－Ｃ３鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよい｝で置換されていてもよい５若しくは６員非芳香族複素環を形成していてもよく、
　Ｒ2がＮＲ16Ｃ（Ｏ）ＯＲ17である場合、Ｒ16及びＲ17は、Ｒ16が結合する窒素原子、窒素原子が結合する炭素原子、及びＲ17が結合する酸素原子と一緒になって、Ｃ１－Ｃ３鎖式炭化水素基｛該Ｃ１－Ｃ３鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよい｝で置換されていてもよい５若しくは６員非芳香族複素環を形成していてもよく、
　Ｒ2がＮＲ16Ｃ（Ｏ）ＮＲ17Ｒ18である場合、Ｒ16及びＲ17は、Ｒ16が結合する窒素原子、窒素原子が結合する炭素原子、及びＲ17が結合する窒素原子と一緒になって、Ｃ１－Ｃ３鎖式炭化水素基｛該Ｃ１－Ｃ３鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよい｝で置換されていてもよい５若しくは６員非芳香族複素環を形成していてもよく、
　Ｑ5は、ＣＲE11Ｒ27、ＮＲE12、酸素原子、又は硫黄原子を表し、
　Ｑ4は、ＣＲE13又は窒素原子を表し、
　Ｑ6は、ＣＲE14又は窒素原子を表し、
　Ｑ7は、ＣＲE15又は窒素原子を表し、
　Ｑ8は、ＣＲE16又は窒素原子を表し、
　Ｑ9は、ＣＲE17又は窒素原子を表し（但し、式Ｅ２で示される基において、Ｑ6及びＱ7が同時に窒素原子である場合、Ｑ6、Ｑ8、及びＱ9が同時に窒素原子である場合、並びにＱ7、Ｑ8、及びＱ9が同時に窒素原子である場合を除く）、
　Ｑ10は、ＣＲE18又は窒素原子を表し、
　ＲE11及びＲE31は、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、Ｃ（Ｏ）ＮＲ7Ｒ8、ＮＲ9Ｃ（Ｏ）Ｒ5、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、シアノ基、ハロゲン原子、又は水素原子を表し、
　Ｒ8は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　ＲE12及びＲE32は、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ27は、ハロゲン原子及びシアノ基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は水素原子を表し、
　ＲE13、ＲE14、ＲE15、ＲE16、ＲE17、及びＲE18は、同一又は相異なり、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、Ｃ（Ｏ）ＮＲ7Ｒ8、ＮＲ9Ｃ（Ｏ）Ｒ5、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、シアノ基、ハロゲン原子、又は水素原子を表し、
　Ｘは、ＮＲ10Ｃ（Ｚ）Ｒ11、ＮＲ10Ｃ（Ｏ）ＯＲ11、ＮＲ10Ｃ（Ｚ）ＮＲ11Ｒ12、ＮＲ10Ｃ（＝ＮＯＲ9）Ｒ11、ＮＲ10Ｃ（＝ＮＯＲ9）（ＮＲ11Ｒ12）、Ｎ＝Ｃ（ＯＲ9）Ｒ11、Ｎ＝Ｃ（ＳＲ15）Ｒ11、Ｎ＝Ｃ（ＮＲ6Ｒ7）Ｒ11、ＮＲ10Ｘ1、又はＮ＝Ｓ（Ｏ）pＲ11Ｒ28を表し、
　Ｚは、酸素原子、又は硫黄原子を表し、
　Ｘ1は、群Ａより選ばれる１以上の置換基で置換されていてもよい９若しくは１０員芳香族複素環基を表し、
　Ｒ10は、群Ｆより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキルスルホニル基、ＯＲ14、Ｃ（Ｏ）Ｒ13、Ｃ（Ｏ）ＯＲ13、Ｃ（＝ＮＲ7）Ｒ13、Ｃ（Ｏ）ＮＲ6Ｒ7 、又は水素原子を表し、
　Ｒ11は、群Ａより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は群Ａより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基を表し、
　Ｒ13は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、フェニル基｛該フェニル基は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、１以上のハロゲン原子で置換されていてもよい５若しくは６員芳香族複素環基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ14は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいフェニルメチル基、１以上のハロゲン原子で置換されていてもよいフェニル基、又は水素原子を表し、
　Ｒ28は、群Ｃより選ばれる１以上の置換基で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基を表す。
　群Ａ：Ｃ１－Ｃ６鎖式炭化水素基｛該Ｃ１－Ｃ６鎖式炭化水素基は、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、Ｃ３－Ｃ６シクロアルキル基｛該Ｃ３－Ｃ６シクロアルキル基は、Ｃ１－Ｃ６アルコキシ基、シアノ基及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ＯＲ3a、ＳＦ5、ＮＲ3dＯＲ3b、ＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3dＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3bＣ（Ｏ）ＯＲ3e、ＮＲ3dＮＲ3bＣ（Ｏ）ＯＲ3e、ＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、ＮＲ3dＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、Ｎ＝Ｓ（Ｏ）pＲ3hＲ3i、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）2ＮＲ3fＲ3g、ＮＲ3bＣ（＝ＮＯＲ3j）Ｒ3d、ＮＲ3bＳ（Ｏ）2Ｒ3k、Ｓ（Ｏ）mＲ3k、シアノ基、ニトロ基、及びハロゲン原子からなる群。
　Ｒ3aは、ハロゲン原子及びシアノ基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）2Ｒ3k、又は水素原子を表し、
　Ｒ3bは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子を表し、
　Ｒ3cは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、又は水素原子を表し、
　Ｒ3dは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子を表し、
　Ｒ3eは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよい（Ｃ３－Ｃ６シクロアルキル）Ｃ１－Ｃ３アルキル基、又は（Ｃ１－Ｃ３アルキル）フェニル基｛該（Ｃ１－Ｃ３アルキル）フェニル基におけるフェニル部分は、群Ｂより選ばれる１以上の置換基で置換されていてもよい｝を表し、
　Ｒ3fは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、又は水素原子を表し、
　Ｒ3gは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、又は水素原子を表し、
　Ｒ3hは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、又は１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基を表し、
　Ｒ3iは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルキル基、又は１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基を表し、
　Ｒ3jは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は水素原子を表し、
　Ｒ3kは、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、又は１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基を表す。
　群Ｂ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、１以上のハロゲン原子で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６アルコキシ基、シアノ基、ヒドロキシ基、及びハロゲン原子からなる群。
　群Ｃ：群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ＯＲ3a、ＮＲ3dＯＲ3b、ＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3dＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3bＣ（Ｏ）ＯＲ3e、ＮＲ3dＮＲ3bＣ（Ｏ）ＯＲ3e、ＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、ＮＲ3dＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、Ｎ＝Ｓ（Ｏ）pＲ3hＲ3i、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、Ｓ（Ｏ）mＲ3k、シアノ基、ニトロ基、及びハロゲン原子からなる群。
　群Ｅ：１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、ＯＲ3a、Ｓ（Ｏ）mＲ3k、オキソ基、シアノ基、及びハロゲン原子からなる群。
　群Ｆ：群Ｅより選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、ＯＲ3a、Ｓ（Ｏ）mＲ3k、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、ＮＲ3bＲ3c、ＮＲ3bＣ（Ｏ）Ｒ3c、ＮＲ3bＣ（Ｏ）ＮＲ3fＲ3g、Ｎ＝Ｓ（Ｏ）pＲ3hＲ3i、３－６員非芳香族複素環基、シアノ基、及びハロゲン原子からなる群。〕
で示される化合物又はそのＮオキシド。 Formula (I)
Figure JPOXMLDOC01-appb-C000001
 [Wherein,
L represents a single bond or --(CR 4a R 4b ) n --;
R 4a and R 4b are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a cyano group, a hydroxyl group, a halogen atom, or a hydrogen atom;
n represents 1, 2, 3, 4, 5, or 6;
R 1 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of a cyclopropyl group and a halogen atom, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a cyano group, a halogen atom, a hydroxyl group, or a hydrogen atom;
Q represents a group represented by formula A1, a group represented by formula A2, a group represented by formula A3, a group represented by formula A4, a group represented by formula A5, or a group represented by formula A6 (# represents a bonding site to R2 , and ● represents a bonding site to a carbon atom);
Figure JPOXMLDOC01-appb-C000002
 The combination of Q 1 , Q 2 , and Q 3 is
A combination in which Q1 is CR3q1 , Q2 is CR3q2 , and Q3 is CR3q3 ;
A combination in which Q 1 is a nitrogen atom, Q 2 is CR 3q2 , and Q 3 is CR 3q3 ;
a combination in which Q 1 is CR 3q1 , Q 2 is a nitrogen atom, and Q 3 is CR 3q3 ; or a combination in which Q 1 is CR 3q1 , Q 2 is CR 3q2 , and Q 3 is a nitrogen atom;
The combination of Q 1a and Q 2a is
A combination in which Q 1a is CR 3q4 and Q 2a is CR 3q5 ;
a combination in which Q 1a is a nitrogen atom and Q 2a is CR 3q5 ; or a combination in which Q 1a is CR 3q4 and Q 2a is a nitrogen atom;
R 3q1 , R 3q2 , R 3q3 , R 3q4 , R 3q5 and R 4 are the same or different and are a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, NR 6 C(O)R 5 , NR 6 C(O)OR 5 , NR 6 C(O)NR 5 R 12 , C(O)NR 6 R 7 , C(═NOR 9 )R 5 , C(═NOR 9 )( NR 6 R 7 ), N═S(O) p R 28 R 15 , a cyano group, a halogen atom, or a hydrogen atom;
Z represents an oxygen atom or a sulfur atom;
p represents 0 or 1;
R5 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom;
R 6 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
R 7 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a phenyl group which may be substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group which may be substituted with one or more substituents selected from group B, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
R 9 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom;
R 12 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
R 15 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a phenyl group which may be substituted with one or more substituents selected from group B, or a 5- or 6-membered aromatic heterocyclic group which may be substituted with one or more substituents selected from group B;
R2 is a phenyl group which may be substituted by one or more substituents selected from group A, a 5- or 6-membered aromatic heterocyclic group which may be substituted by one or more substituents selected from group A, C(O) NR6R7 , C(= NOR9 ) R5 , C(= NOR9 )( NR6R7 ), C(O) R5 , NR16C (O) R17 , NR16C (O) OR17 , NR16C (O) NR17R18 , S(O ) 2NR16R17 , OR18 , S( O ) mR15 , a mercapto group, a group represented by formula E1 , a group represented by formula E2, or a group represented by formula E3 (# 2 represents a bonding site to a group represented by formula A1, a group represented by formula A2, a group represented by formula A3, a group represented by formula A4, a group represented by formula A5, or a group represented by formula A6),
Figure JPOXMLDOC01-appb-C000003
 m represents 0, 1, or 2;
R 16 , R 17 , and R 18 are the same or different and represent a phenyl group which may be substituted with one or more substituents selected from group B, a 5- or 6-membered heterocyclic group which may be substituted with one or more substituents selected from group B, a C1-C6 alkyl group which may be substituted with one or more halogen atoms, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
When R 2 is NR 16 C(O)R 17 , R 16 and R 17 may together with the nitrogen atom to which R 16 is bonded and the carbon atom to which R 17 is bonded form a 5- or 6-membered non-aromatic heterocycle which may be substituted with a C1-C3 chain hydrocarbon group (the C1-C3 chain hydrocarbon group may be substituted with one or more halogen atoms);
When R 2 is NR 16 C(O)OR 17 , R 16 and R 17 may together with the nitrogen atom to which R 16 is bonded, the carbon atom to which the nitrogen atom is bonded, and the oxygen atom to which R 17 is bonded form a 5- or 6-membered non-aromatic heterocycle which may be substituted with a C1-C3 chain hydrocarbon group (the C1-C3 chain hydrocarbon group may be substituted with one or more halogen atoms);
When R 2 is NR 16 C(O)NR 17 R 18 , R 16 and R 17 may together with the nitrogen atom to which R 16 is bonded, the carbon atom to which the nitrogen atom is bonded, and the nitrogen atom to which R 17 is bonded form a 5- or 6-membered non-aromatic heterocycle which may be substituted with a C1-C3 chain hydrocarbon group (the C1-C3 chain hydrocarbon group may be substituted with one or more halogen atoms);
Q5 represents CR E11 R 27 , NR E12 , an oxygen atom or a sulfur atom;
Q4 represents CR E13 or a nitrogen atom;
Q6 represents CR E14 or a nitrogen atom;
Q7 represents CR E15 or a nitrogen atom;
Q8 represents CR E16 or a nitrogen atom;
Q9 represents CR E17 or a nitrogen atom (excluding the cases where, in the group represented by formula E2, Q6 and Q7 are simultaneously nitrogen atoms, Q6 , Q8 and Q9 are simultaneously nitrogen atoms, and Q7 , Q8 and Q9 are simultaneously nitrogen atoms);
Q represents CR or a nitrogen atom;
R E11 and R E31 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, C(O)NR 7 R 8 , NR 9 C(O)R 5 , a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, a cyano group, a halogen atom, or a hydrogen atom;
R 8 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E, or a hydrogen atom;
R E12 and R E32 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, or a hydrogen atom;
R 27 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from the group consisting of halogen atoms and cyano groups, a phenyl group optionally substituted with one or more substituents selected from group B, or a hydrogen atom;
R E13 , R E14 , R E15 , R E16 , R E17 , and R E18 are the same or different and represent a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group C, a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, C(O)NR 7 R 8 , NR 9 C(O)R 5 , a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, a cyano group, a halogen atom, or a hydrogen atom;
X represents NR10C (Z) R11 , NR10C (O)OR11, NR10C(Z) NR11R12 , NR10C (= NOR9 ) R11 , NR10C (= NOR9 ) ( NR11R12 ), N = C( OR9 ) R11 , N = C( SR15 ) R11 , N=C ( NR6R7 ) R11 , NR10X1 , or N = S(O) pR11R28 ;
Z represents an oxygen atom or a sulfur atom;
X 1 represents a 9- or 10-membered aromatic heterocyclic group optionally substituted by one or more substituents selected from group A;
R 10 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more substituents selected from group F, a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from group E, a C1-C6 alkylsulfonyl group optionally substituted with one or more halogen atoms, OR 14 , C(O)R 13 , C(O)OR 13 , C(═NR 7 )R 13 , C(O)NR 6 R 7 , or a hydrogen atom;
R 11 represents a phenyl group which may be substituted with one or more substituents selected from group A, or a 5- or 6-membered aromatic heterocyclic group which may be substituted with one or more substituents selected from group A,
R 13 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group {the phenyl group may be substituted with one or more substituents selected from the group consisting of a C1-C6 alkoxy group optionally substituted with one or more halogen atoms, a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom}, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 14 represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a phenylmethyl group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 28 represents a C1-C6 chain hydrocarbon group which may be substituted with one or more substituents selected from group C, or a C3-C6 cycloalkyl group which may be substituted with one or more substituents selected from group E.
Group A: C1-C6 chain hydrocarbon group {the C1-C6 chain hydrocarbon group may be substituted with one or more substituents selected from the group consisting of a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom}, a C3-C6 cycloalkyl group {the C3-C6 cycloalkyl group may be substituted with one or more substituents selected from the group consisting of a C1-C6 alkoxy group, a cyano group, and a halogen atom}, a phenyl group optionally substituted with one or more substituents selected from Group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from Group B, OR 3a , SF 5 , NR 3d OR 3b , NR 3b C(O)R 3c , NR 3d NR 3b C(O)R 3c , NR 3b C (O)OR 3e , NR 3d NR 3b C (O)OR 3e , NR 3b C(O)NR 3f R 3g , NR 3d NR 3b C(O)NR 3f R 3g , N=S(O) p R 3h R 3i , C(O)R 3c , C(O)OR 3j , C(O)NR 3f R 3g , S(O) 2 A group consisting of NR 3f R 3g , NR 3b C(=NOR 3j )R 3d , NR 3b S(O) 2 R 3k , S(O) m R 3k , a cyano group, a nitro group, and a halogen atom.
R 3a represents a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of a halogen atom and a cyano group, a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, C(O)R 3c , C(O)OR 3j , C(O)NR 3f R 3g , S(O) 2 R 3k , or a hydrogen atom;
R 3b represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 3c represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, or a hydrogen atom;
R 3d represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 3e represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, a (C3-C6 cycloalkyl)C1-C3 alkyl group optionally substituted with one or more halogen atoms, or a (C1-C3 alkyl)phenyl group {the phenyl moiety in the (C1-C3 alkyl)phenyl group may be substituted with one or more substituents selected from group B},
R 3f represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 3g represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms, or a hydrogen atom;
R 3h represents a C1-C6 alkyl group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms;
R 3i represents a C1-C6 alkyl group optionally substituted with one or more halogen atoms, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms;
R 3j represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, or a hydrogen atom;
R 3k represents a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, or a C3-C6 cycloalkyl group optionally substituted with one or more halogen atoms.
Group B: a group consisting of C1-C6 chain hydrocarbon groups optionally substituted with one or more halogen atoms, C3-C6 cycloalkyl groups optionally substituted with one or more halogen atoms, C1-C6 alkoxy groups optionally substituted with one or more halogen atoms, cyano groups, hydroxy groups, and halogen atoms.
Group C: a C3-C6 cycloalkyl group optionally substituted by one or more substituents selected from group E, a phenyl group optionally substituted by one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted by one or more substituents selected from group B, OR 3a , NR 3d OR 3b , NR 3b C(O)R 3c , NR 3d NR 3b C(O)R 3c , NR 3b C(O)OR 3e , NR 3d NR 3b C(O)OR 3e , NR 3b C(O ) NR 3f R 3g , NR 3d NR 3b C(O)NR 3f R 3g , N═S(O) p R 3h R 3i , C(O)R 3c , C(O) OR the group consisting of C(O)NR 3f R 3g , S(O) m R 3k , a cyano group, a nitro group, and a halogen atom ;
Group E: a group consisting of a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, OR 3a , S(O) m R 3k , an oxo group, a cyano group, and a halogen atom.
Group F: a group consisting of a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from Group E, a phenyl group optionally substituted with one or more substituents selected from Group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from Group B, OR 3a , S(O) mR 3k , C(O)R 3c , C(O)OR 3j , C(O)NR 3fR 3g , NR 3bR 3c , NR 3bC (O)R 3c , NR 3bC (O)NR 3fR 3g , N═S(O) pR 3hR 3i , a 3- to 6-membered non-aromatic heterocyclic group, a cyano group, and a halogen atom.
or an N-oxide thereof. 　Ｒ3aが、ハロゲン原子及びシアノ基からなる群より選ばれる１以上の置換基で置換されていてもよいＣ３－Ｃ６シクロアルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ６鎖式炭化水素基、群Ｂより選ばれる１以上の置換基で置換されていてもよいフェニル基、群Ｂより選ばれる１以上の置換基で置換されていてもよい５若しくは６員芳香族複素環基、Ｃ（Ｏ）Ｒ3c、Ｃ（Ｏ）ＯＲ3j、Ｃ（Ｏ）ＮＲ3fＲ3g、又は水素原子である、請求項１に記載の化合物又はそのＮオキシド。 The compound or N-oxide thereof according to claim 1, wherein R 3a is a C3-C6 cycloalkyl group optionally substituted with one or more substituents selected from the group consisting of halogen atoms and cyano groups, a C1-C6 chain hydrocarbon group optionally substituted with one or more halogen atoms, a phenyl group optionally substituted with one or more substituents selected from group B, a 5- or 6-membered aromatic heterocyclic group optionally substituted with one or more substituents selected from group B, C(O)R 3c , C(O)OR 3j , C(O)NR 3f R 3g , or a hydrogen atom. 　式（Ｉ）中、
　Ｌが、単結合であり、
　Ｒ1が、メチル基であり、
　Ｑが、式Ａ１で示される基、式Ａ２で示される基、又は式Ａ３で示される基であり、
　Ｑ1がＣＲ3q1であり、Ｑ2がＣＲ3q2であり、Ｑ3がＣＲ3q3であり、
　Ｒ3q1、Ｒ3q2、及びＲ3q3が、同一又は相異なり、メチル基、ハロゲン原子、又は水素原子であり、
　Ｑ1a及びＱ2aの組合せが、
　　Ｑ1aがＣＲ3q4であり、Ｑ2aがＣＲ3q5である組合せ；
　　Ｑ1aが窒素原子であり、Ｑ2aがＣＲ3q5である組合せ；又は
　　Ｑ1aがＣＲ3q4であり、Ｑ2aが窒素原子である組合せであり、
　Ｒ3q4、Ｒ3q5及びＲ4が、同一又は相異なり、メチル基、ハロゲン原子、又は水素原子であり、
　Ｒ2が、フェニル基、ピラゾリル基、チアゾリル基、オキサジアゾリル基、ピリジル基、ピリミジニル基｛該フェニル基、該ピラゾリル基、該チアゾリル基、該オキサジアゾリル基、該ピリジル基、及び該ピリミジニル基は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルコキシ基、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝、Ｃ（Ｏ）ＮＲ6Ｒ7、Ｃ（＝ＮＯＲ9）Ｒ5、Ｃ（＝ＮＯＲ9）（ＮＲ6Ｒ7）、Ｃ（Ｏ）Ｒ5、又はＳ（Ｏ）mＲ15であり、
　Ｒ5が、Ｃ１－Ｃ３アルキル基であり、
　Ｒ6が、メチル基、又は水素原子であり、
　Ｒ7が、Ｃ１－Ｃ３アルキル基、又は水素原子であり、
　Ｒ9が、Ｃ１－Ｃ３アルキル基、又は水素原子であり、
　Ｒ15が、Ｃ１－Ｃ３アルキル基であり、
　ｍが、０、１、又は２であり、
　Ｘが、ＮＲ10Ｃ（Ｚ）Ｒ11、又はＮＲ10Ｃ（Ｚ）ＮＲ11Ｒ12であり、
　Ｚが、酸素原子であり、
　Ｒ10が、メチル基、又は水素原子であり、
　Ｒ11が、フェニル基、ピラゾリル基、ピリジル基{該フェニル基、該ピラゾリル基、及び該ピリジル基は、トリフルオロメチル基、ジフルオロメチル基、トリフルオロメトキシ基、ジフルオロメトキシ基、メタンスルホニル基、トリフルオロメタンスルホニル基、シアノ基、シアノ基に置換されていてもよいシクロプロピル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、
　Ｒ12が、水素原子である、請求項１若しくは請求項２に記載の化合物又はそのＮオキシド。 In formula (I),
L is a single bond,
R 1 is a methyl group;
Q is a group represented by formula A1, a group represented by formula A2, or a group represented by formula A3;
Q1 is CR3q1 , Q2 is CR3q2 , and Q3 is CR3q3 ;
R 3q1 , R 3q2 , and R 3q3 are the same or different and each is a methyl group, a halogen atom, or a hydrogen atom;
The combination of Q 1a and Q 2a is
A combination in which Q 1a is CR 3q4 and Q 2a is CR 3q5 ;
a combination in which Q 1a is a nitrogen atom and Q 2a is CR 3q5 ; or a combination in which Q 1a is CR 3q4 and Q 2a is a nitrogen atom,
R 3q4 , R 3q5 and R 4 are the same or different and each is a methyl group, a halogen atom, or a hydrogen atom;
R 2 is a phenyl group, a pyrazolyl group, a thiazolyl group, an oxadiazolyl group, a pyridyl group, a pyrimidinyl group {the phenyl group, the pyrazolyl group, the thiazolyl group, the oxadiazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a C1-C3 alkoxy group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom}, C(O)NR 6 R 7 , C(═NOR 9 )R 5 , C(═NOR 9 )(NR 6 R 7 ), C(O)R 5 , or S(O) m R 15 ;
R5 is a C1-C3 alkyl group;
R6 is a methyl group or a hydrogen atom;
R 7 is a C1-C3 alkyl group or a hydrogen atom;
R 9 is a C1-C3 alkyl group or a hydrogen atom;
R 15 is a C1-C3 alkyl group;
m is 0, 1, or 2;
X is NR10C (Z) R11 or NR10C (Z) NR11R12 ;
Z is an oxygen atom;
R 10 is a methyl group or a hydrogen atom;
R 11 is a phenyl group, a pyrazolyl group, or a pyridyl group {the phenyl group, the pyrazolyl group, and the pyridyl group may be substituted with one or more substituents selected from the group consisting of a trifluoromethyl group, a difluoromethyl group, a trifluoromethoxy group, a difluoromethoxy group, a methanesulfonyl group, a trifluoromethanesulfonyl group, a cyano group, a cyclopropyl group which may be substituted with a cyano group, and a halogen atom},
3. The compound according to claim 1 or 2, wherein R 12 is a hydrogen atom, or an N-oxide thereof. 　式（Ｉ）中、
　Ｌが、単結合であり、
　Ｒ1が、メチル基であり、
　Ｑが、式Ａ１で示される基、又は式Ａ２で示される基であり、
　Ｑ1がＣＲ3q1であり、Ｑ2がＣＲ3q2であり、Ｑ3がＣＲ3q3であり、
　Ｒ3q1、Ｒ3q2、及びＲ3q3が、水素原子であり、
　Ｒ2が、フェニル基、ピラゾリル基、ピリジル基、又はピリミジニル基｛該フェニル基、該ピラゾリル基、該ピリジル基、及び該ピリミジニル基は、１以上のハロゲン原子で置換されていてもよいＣ１－Ｃ３アルキル基、シアノ基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、
　Ｘが、ＮＲ10Ｃ（Ｚ）Ｒ11、又はＮＲ10Ｃ（Ｚ）ＮＲ11Ｒ12であり、
　Ｚが、酸素原子であり、
　Ｒ10が、メチル基、又は水素原子であり、
　Ｒ11が、フェニル基、ピラゾリル基、ピリジル基{該フェニル基、該ピラゾリル基、及び該ピリジル基は、トリフルオロメチル基、ジフルオロメチル基、トリフルオロメトキシ基、ジフルオロメトキシ基、メタンスルホニル基、トリフルオロメタンスルホニル基、シアノ基、シアノ基に置換されていてもよいシクロプロピル基、及びハロゲン原子からなる群より選ばれる１以上の置換基で置換されていてもよい｝であり、
　Ｒ12が、水素原子である、請求項１～請求項３のいずれかに記載の化合物又はそのＮオキシド。 In formula (I),
L is a single bond;
R 1 is a methyl group;
Q is a group represented by formula A1 or a group represented by formula A2,
Q1 is CR3q1 , Q2 is CR3q2 , and Q3 is CR3q3 ;
R 3q1 , R 3q2 , and R 3q3 are a hydrogen atom;
R 2 is a phenyl group, a pyrazolyl group, a pyridyl group, or a pyrimidinyl group {the phenyl group, the pyrazolyl group, the pyridyl group, and the pyrimidinyl group may be substituted with one or more substituents selected from the group consisting of a C1-C3 alkyl group optionally substituted with one or more halogen atoms, a cyano group, and a halogen atom},
X is NR10C (Z) R11 or NR10C (Z) NR11R12 ;
Z is an oxygen atom;
R 10 is a methyl group or a hydrogen atom;
R 11 is a phenyl group, a pyrazolyl group, or a pyridyl group {the phenyl group, the pyrazolyl group, and the pyridyl group may be substituted with one or more substituents selected from the group consisting of a trifluoromethyl group, a difluoromethyl group, a trifluoromethoxy group, a difluoromethoxy group, a methanesulfonyl group, a trifluoromethanesulfonyl group, a cyano group, a cyclopropyl group which may be substituted with a cyano group, and a halogen atom},
The compound or N-oxide thereof according to any one of claims 1 to 3, wherein R 12 is a hydrogen atom. 　請求項１～請求項４のいずれかに記載の化合物又はそのＮオキシドと、不活性担体とを含有する有害節足動物防除組成物。 A composition for controlling harmful arthropods, comprising a compound according to any one of claims 1 to 4 or an N-oxide thereof, and an inert carrier. 　群（ａ）、群（ｂ）、群（ｃ）及び群（ｄ）からなる群より選ばれる１以上の成分、並びに、請求項１～請求項４のいずれかに記載の化合物又はそのＮオキシドを含有する組成物：
　群（ａ）：殺虫活性成分、殺ダニ活性成分及び殺線虫活性成分からなる群；
　群（ｂ）：殺菌活性成分；
　群（ｃ）：植物成長調整成分；
　群（ｄ）：忌避成分。 A composition comprising one or more components selected from the group consisting of group (a), group (b), group (c) and group (d), and a compound or an N-oxide thereof according to any one of claims 1 to 4:
Group (a): A group consisting of insecticidal active ingredients, acaricidal active ingredients and nematicidal active ingredients;
Group (b): bactericidal active ingredient;
Group (c): plant growth regulating ingredients;
Group (d): repellent components. 　請求項１～請求項４のいずれかに記載の化合物若しくはそのＮオキシドの有効量又は請求項６に記載の組成物の有効量を有害節足動物又は有害節足動物の生息場所に施用する有害節足動物の防除方法。 A method for controlling harmful arthropods, comprising applying an effective amount of a compound or N-oxide thereof according to any one of claims 1 to 4, or an effective amount of a composition according to claim 6 to harmful arthropods or to a habitat of harmful arthropods. 　請求項１～請求項４のいずれかに記載の化合物若しくはそのＮオキシドの有効量又は請求項６に記載の組成物の有効量を保持している種子又は栄養生殖器官。 A seed or vegetative reproductive organ carrying an effective amount of a compound or N-oxide thereof according to any one of claims 1 to 4, or an effective amount of the composition according to claim 6.
PCT/JP2024/036248 2023-10-12 2024-10-10 Condensed ring compound, and harmful arthropod-controlling composition containing same Pending WO2025079634A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023176517 2023-10-12
JP2023-176517 2023-10-12

Publications (1)

Publication Number Publication Date
WO2025079634A1 true WO2025079634A1 (en) 2025-04-17

Family

ID=95395760

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2024/036248 Pending WO2025079634A1 (en) 2023-10-12 2024-10-10 Condensed ring compound, and harmful arthropod-controlling composition containing same

Country Status (1)

Country Link
WO (1) WO2025079634A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014200882A1 (en) * 2013-06-11 2014-12-18 Janssen Pharmaceutica Nv PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES
WO2016148145A1 (en) * 2015-03-16 2016-09-22 大正製薬株式会社 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUND
WO2022233777A1 (en) * 2021-05-06 2022-11-10 Bayer Aktiengesellschaft Alkylamide substituted, annulated imidazoles and use thereof as insecticides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014200882A1 (en) * 2013-06-11 2014-12-18 Janssen Pharmaceutica Nv PDE10a INHIBITORS FOR THE TREATMENT OF TYPE II DIABETES
WO2016148145A1 (en) * 2015-03-16 2016-09-22 大正製薬株式会社 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUND
WO2022233777A1 (en) * 2021-05-06 2022-11-10 Bayer Aktiengesellschaft Alkylamide substituted, annulated imidazoles and use thereof as insecticides

Similar Documents

Publication Publication Date Title
JP7442463B2 (en) Heterocyclic compound and harmful arthropod control composition containing the same
JP7667745B2 (en) Heterocyclic compound and pest control composition containing the same
WO2019131575A1 (en) Heterocyclic compounds and noxious arthropod control agent containing same
JP7492946B2 (en) Heterocyclic compound and pest control composition containing the same
JP7253498B2 (en) Heterocyclic compound and harmful arthropod control agent containing the same
JP7675087B2 (en) Heterocyclic compound and pest control composition containing the same
JP7301042B2 (en) Heterocyclic compound and harmful arthropod control composition containing the same
US20240228472A1 (en) Heterocyclic compound and harmful-arthropod-controlling composition containing same
JP7704770B2 (en) Heterocyclic compound and harmful arthropod control composition containing the same
JP7428693B2 (en) Ether compound and harmful arthropod control composition containing the same
JP7489564B1 (en) Crystal of 2-(5-cyclopropyl-3-(ethylsulfonyl)pyridin-2-yl)-5-((trifluoromethyl)sulfinyl)benzo[d]oxazole
JP7489565B1 (en) Crystal of 2-(5-cyclopropyl-3-(ethylsulfonyl)pyridin-2-yl)-5-((trifluoromethyl)sulfonyl)benzo[d]oxazole
WO2024096093A1 (en) Heterocyclic compound and harmful arthropod control composition containing same
WO2025079634A1 (en) Condensed ring compound, and harmful arthropod-controlling composition containing same
WO2025089403A1 (en) Heterocyclic compound and harmful arthropod-controlling composition containing same
WO2024080330A1 (en) Sulfonamide compound and harmful-arthropod controlling composition containing same
WO2025079605A1 (en) Heterocyclic compound and harmful arthropod-controlling composition containing same
WO2024080354A1 (en) Sulfonamide compound and harmful-arthropod-controlling composition containing same
WO2024071393A1 (en) Heterocyclic compound and harmful arthropod-controlling composition containing same
WO2024122450A1 (en) Amide compound and harmful arthropod control composition containing same
WO2024248015A1 (en) Heterocyclic compound and noxious arthropod-controlling composition containing same
WO2024080355A1 (en) Sulfonamide composition and harmful-arthropod control composition containing same
WO2024147306A1 (en) Amide compound and harmful arthropod control composition containing same
WO2024071219A1 (en) Sulfonamide compound, and harmful-arthropod extermination composition containing same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24877228

Country of ref document: EP

Kind code of ref document: A1